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Structure of the thesis 
The thesis is divided into two different parts. The first part contains two chapters on 
perfluoroalkylation of aromatic compounds. This part of the thesis have been done in 
the Institut Català d'Investigació Química (ICIQ, Tarragona) in the group of Prof. V.V. 
Grushin. The second part contains four chapters on catalysts design for C-X forming 
and water oxidation reactions. This part has been done in the Department of Química 
Física i Inorgànica under the supervision of Prof. M. Diéguez and Dr. O. Pàmies. 
-Chapter 1.  Objectives. This chapters contains de objectives of the thesis.  
-Chapter 2. General introduction I: progress in perfluoroalkylation of aromatic 
compounds contains a general introduction about the progress made in 
perfluoroalkylation of aromatic compounds with the discussion of antecedents, 
performance and main achievements.  
-Chapter 3. Perfluoroalkylation of aromatic compounds. This chapter contains two 
section. The first section Continuous process for production of CuCF3 via direct 
cupration of fluoroform, includes the first continuous flow process for the synthesis of a 
superior trifluoromethylating reagent, "ligandless" CuCF3, from fluoroform, by far the 
best CF3 source in terms of availability, cost and atom economy. The second section 
Trifluoromethylation and pentafluoroethylation of vinylic halides with low-cost RfH-
derived CuRf (Rf = CF3, C2F5), presents the trifluoromethylation and 
pentafluoroethylation of a variety of vinylic bromides and iodides with RfH-derived 
CuRf (Rf = CF3, C2F5) to give the corresponding fluroalkylated olefins. These reactions 
proceed with high yields and excellent chemo- and stereoselectivity under mild reaction 
conditions. 
-Chapter 4. General introduction II: Catalyst design for C-X forming and water 
oxidation reactions. This chapter first presents the importance of metal catalysis in the 
synthesis of compounds. An important step in this synthesis is the design and 
preparation of ligands. Among them, new oxygen/oxazole/thiazole-mesoionic carbene 
ligands and phosphite-oxazoline ligands are presented. These ligands are applied to four 
catalytic reactions, which are reviewed in detail in this chapter. For each reaction, the 
antecedents, performance and main achievements are discussed. The state-of-the-art and 
current needs in this field justify the objectives of this part of the thesis. 
-Chapter 5. Ru and Ir-transfer hydrogenation and dehydrogenation reactions. This 
chapter contains two sections on the development of new Ru and Ir complexes with 





mesionic carbene-based ligands. The first section, synthesis, hemilability, and catalytic 
transfer hydrogenation activity of iridium(III) and ruthenium(II) complexes containing 
oxygen-functionalised triazolylidene ligands, includes the synthesis and characterisation 
of iridium(III) and ruthenium(II) complexes bearing pendant hydroxy- and ester-
wingtip substituents. Both monodentate and C,O-bidentate binding modes were 
observed for these O-functionalised triazolylidene complexes. The two bonding modes 
are interconvertible, which demonstrates the hemilability of this coordinating group. 
The catalytic activity of the complexes was compared in transfer hydrogenation, 
revealing that pendant hydroxyfunctionalities are beneficial for enhancing the 
performance of triazolylidene iridium(III) catalysts, while they have no effect in 
ruthenium-catalyzed transfer hydrogenation. The second section, Ir-complexes 
containing mesoionic carbenes for the highly efficient and versatile transfer 
hydrogenation of C=O, C=N and C=C functionalities and for dehydrogenation of 
alcohols, reports the first examples of mixed benzoxazole/thiazole-MIC ligands. We 
used these ligands to generate the corresponding Ir(I) and Ir(III) 
benzoxazole/thiazole/ether-appended MIC complexes.  The coordination was achieved 





C spectroscopies, high resolution mass spectrometry, 
elementary analysis and X-ray diffraction. Apart from synthetic and structural aspects, 
we also present the successful application of these complexes in transfer hydrogenation 
of a broad range of substrates (ketones, aldehydes, imines, etc.) and also the more 
challenging mono-, di- and trisubstituted olefins and in the base-free dehydrogenation 
reactions of alcohols. We also discuss some mechanistic insights for both 
transformations.  
-Chapter 6. Iridium molecular catalysts for catalytic water oxidation. This chapter 
contains one section, benzoxazole/thiazole-triazolidene iridium complexes as new 
efficient molecular catalysts for water oxidation, that includes the application of the 
new iridium complexes previously synthesized in chapter 4 in the water oxidation 
reactions using CAN and NaIO4 as oxidants. Using CAN as oxidant at low pH, the 
catalyst precursors provided similar activities (TOF’s ca 0.06s
-1
) and lower than those 
achieved using parent pyridine complex. However, excellent activities (much better 
than related pyridine analogues; TOF’s up to 0.58 s
-1
) were achieved when using more 
appealing almost neutral conditions (pH = 5.6) and NaIO4 as oxidant. In this chapter we 
have also disclosed the electrochemical properties of the complexes in a non-protic 




solvent as well as in aqueous solution at different pHs. We have also studied the Cl
-
/H2O ligand exchange propensity of the complexes in water solution.  
-Chapter 7. Pd-catalyzed asymmetric intermolecular Heck reaction. This chapter 
contains one section, air stable and simple phosphite-oxazoline ligands for Pd-
intermolecular asymmetric Heck reaction. Mechanistic insights that includes the 
synthesis of a reduced but structurally valuable library of phosphite-oxazoline ligands 
for the enantioselective Pd-catalyzed Heck reaction of several cyclic substrates and 
triflates. These ligands, which are prepared in a few steps from commercially available 
materials include the benefits of the high robustness of the phosphite moiety and the 
additional control provided by the flexibility of the chiral pocket through a modular 
ligand scaffold. Other advantages of these ligands are that they are solid, stable to air 
and other oxidizing agents and are, therefore, easy to handle and can be manipulated 
and stored in air. In a simple two or four step-procedure, several ligand parameters have 
been easily tuned to maximize the catalyst performance. In this paper we have also 
carried out mechanistic investigations by combining in situ NMR studies of key 
intermediates and kinetics studies. 
-Chapter 8. Conclusions. This chapter presents the conclusions of the work 
presented in this thesis. 
-Chapter 9. Summary. This chapter contains a summary of the thesis. 
-Chapter 10. The Appendix contains the list of papers, including the papers from the 
master period, meeting presentations (also those during the master period) given by the 






















































This thesis focusses on the development of new protocols for the perfluoroalkylation 
of aromatic compounds and the development of new robust and highly efficient 
catalytic systems for relevant C-X forming and water oxidation reactions. 
 
The more specific aims are: 
 
1. The development of a reliable continuous process for the production of CuCF3 
from CHF3 as well as their use as an efficient trifluoromethylating agent of aromatic 
compounds. 
 
2. The development of new protocols for the highly chemo- and steroselective 
perfluoroalkylation of of vinylic halides using cheap and environmentally friendly CuRf 
(Rf = CF3, C2F5) reagents. 
 
3. The synthesis and application of heterodonor oxygen/benzoxazole/thiazole-
triazolylidene ligands (Figure 1.1) in the following metal-catalyzed reactions: a) Ru- 
and Ir-catalyzed transfer-hydrogenation of ketones, aldehydes, imines and olefins; b) Ir-
catalyzed base-free dehydrogenation of alcohols; and c) Ir-catalyzed water oxidation. In 
all the catalytic reactions mechanistic and kinetic studies have been carried out to better 
understand their catalytic behavior. 
 
 
Figure 1.1. Heterodonor oxygen/benzoxazole/thiazole-triazolylidene salts. 
 
4. The synthesis and application of novel robust phosphite-oxazoline ligands (Figure 
1.2) for the asymmetric Pd-catalyzed Heck reaction using aryl- and vinyl triflates and 
halides. Valuable catalytic intermediates have been synthesized and kinetic studies have 



















General introduction: progress in perfluoroalkylation 























Organic compounds bearing fluoroalkyl groups play a dominant role in the 
development of pharmaceuticals, agrochemicals, polymers and specialty materials. 
Incorporation of fluorinated fragments into organic compounds might affect their 
physical, chemical and biological properties.
1,2
 For instance from a biologically point of 
view, by introducing the perfluoroalkyl moiety into the molecule the lipophilicity 
increased which make a better in-vivo absorption and transport rate and even this group 
makes the molecules metabolically more resistance. In addition these fluoroalkyl groups 
are chemically more stable rather than their hydrocarbon counterparts while they are 
sterically similar to them.
3 
 
The first report of the pharmacological evaluation of compounds containing the 




Up to 20% of all modern drugs and more than 30% of agrochemicals commercially 
used are based on fluorine-containing active ingredients.
5 
Although trifluorometylated 
molecules have an important place in chemistry, pentafluoroethylated compounds also 
have special place as they are more lipophilic and often have better activity than their 
CF3 analogs. Therefore some biologically active compounds are including C2F5 group. 
Some examples of active ingredients of agrochemicals and pharmaceuticals containing 
CF3 and C2F5 groups are shown in Figure 2.1. 
 
 
Figure 2.1. Selected commercially available pharmaceuticals and agrochemicals 
containing CF3 and C2F5 groups. 
 
In this chapter the progress in trifluoromethylation and pentafluoroethylation of 
aromatic substrates will be mentioned separately. 
  




2.1. Aromatic trifluoromethylation with metal complexes 
Nowadays trifluoromethylated aromatic compounds are manufactured by a Swarts-
type process which is neither atom-economical nor environmentally benign as it 
involves hazardous chemicals and generate big amount of chlorine waste in order to 
convert CH3 group on the ring to CCl3 (that produce 3 equiv of HCl as a byproduct) and 




Scheme 2.1. Trifluoromethylated aromatic compounds manufactured in industry. 
 
In general 3 equiv of Cl2 are consumed and 6 equiv of HCl are produced to generate 




this transformation is 
sorely limited to the number of functional groups and even harsh reaction conditions is 
another obstacle.  
Despite all these drawbacks the Swarts reaction still remains the method used for the 
large scale manufacturing of trifluoromethylated aromatic compounds as there is no 
industrially possible alternative. A possible desired alternative to the Swarts reaction is 
shown in Scheme 2.2.
9 
It consists in a selective trifluoromethylation of 
prefunctionalized aromatic substrates. 
 
 
Scheme 2.2. Selective trifluoromethylation of aromatic compounds. 
 
Since the first discovery of metal-mediated perfluoroalkylation of iodoarenes by 
McLoughlin and Thrower in the late 1960s
7 
and further advancement by Kumadaki et 
al,
8
 enormous progress has been done by different groups in this area. The most metals 
that particularly capable of activating Ar-X bonds (X = I, Br, Cl, OTf, etc.) are 
palladium, copper and nickel and among them copper used mostly as a catalyst with 
various CF3 sources such as polyfluorinated methanes (CF3I, CF3Br, CF3H), 







(CF3SiMe3, CF3SiEt3), trifluoroacetic acid salts and derivatives (CF3CO2X, where X = 
Na, K, Me, etc.) and preisolated well-defined or generated in situ CuCF3 compounds.
9 
The aromatic trifluoromethylation methods can be classified into four different types 
depending on the source of aromatic substrates (Scheme 2.3).
9,10
 They are: (i) 
nucleophilic trifluoromethylation of haloarenes, (ii) oxidative trifluoromethylation of 
aryl boronic acids or borates, (iii) trifluoromethylation of arenediazonium salts based on 
Sandmeyer reactions of these substrates and (iv) direct C−H aryl trifluoromethylation 
with or without directing group assistance.  
 
 
Scheme 2.3. General protocols for trifluoromethylation of aromatic compounds with 
copper. 
 
2.1.1. Trifluoromethylation of aryl halides 
As mentioned before, McLoughlin and Trower reported the first perfluoroalkylation 
of aromatic halides using stoichiometric or super-stoichiometric amounts of Cu metal 
powder in 1969 (Scheme 2.4).
7b 
This reaction can be successfully applied in many 
examples. In addition, different functional groups can be presented like OAC, OH, 
CO2H, NH2 and NO2 and the order of ease of replacement of aryl halides is I > Br >> Cl 
that is supported by reaction mechanism. 
  





Scheme 2.4. The McLoughlin and Trower protocol. 
  
In the same year, further work was done by Kobayashi and Kumadaki
 
on 
optimization of the reaction of Rf = CF3 with a series of haloarenes and heteroarenes.
8 
In 
both cases the cross-coupling of aromatic halides with stoichiometric amount of CuCF3 
that generated in situ controled the trifluoromethylation process. Kondratenko, 
Vechirko, and Yagupolskii reported the formation of CuCF3 from (CF3)2Hg or CF3HgI 
and copper powder in NMP (N-methylpyrrolidone) or DMAC (dimethylacetamide) in 
1980.
11 
In 1985 Wiemers and Burton
12
 reported the transformation of CF3 from Zn or 
Cd to Cu for trifluoromethylation of iodobenzene. Even later trifluoromethyl copper 






The methodologies between 1970-1980 were based on pre-formed or generated in 
situ CuCF3
11,12,15
 and the first spectroscopic study of this species was performed by 
Wiemers and Burton in 1986.
12, 16 
By treatment of CuBr with CF3CdX (X = Br or Cl) in 
DMF at -50°C a CuCF3 spiecies was observed at -28.8 ppm in the 
19
F NMR.  
By using silylated reagent and CuX under mild conditions, CuCF3 was  generated in 
order to trifluoromethylate the aryl iodides (Scheme 2.5).
17
 Copper was used in 
stoichiometric amount because the copper-mediated trifluoromethylation on the 
iodoarenes proceeded more slowly than the generation of CuCF3 species.  
       
 
Scheme 2.5. Trifluoromethylation with trifluoroethylsilyl reagent. 
 
For these trifluoromethylation reactions until 2008 that Vivic and co-workers 
reported the first structurally characterized CF3Cu(I) complexes,
18
 there was no 





more CF3Cu(I) compounds have been synthesized and characterized by X-ray analysis 
specially by Grushin et al.
19
 Some of these structures are represented in Figure 2.2. 
 
 
Figure 2.2. X-ray structures of some CF3Cu(I) complexes as examples. 
 
Ancillary ligands on Cu(I) species can affect the trifluoromethylation of haloarenes 
by increasing or decreasing the rate of the reaction. One of the examples is 1,10-
phenanthroline.
20
 It seem available vacant coordination site on Cu has a dominant effect 
in the formation of final trifluoromethyl aromatic compound.  
The first Cu-catalyzed trifluoromethylation of aryl iodides was originally developed 
by Amii et al in 2009.
21 
In this case they added chelating ligands like (Phen) in order to 
improve the trifluoromethylation reactions. It was suggested that the reaction went 
through a phenanthroline-ligated Cu(I) complex (Scheme 2.6). 
 
 
Scheme 2.6. Cu-catalyzed trifluoromethylation of haloarenes. 
 




In general considerable progress has been done in the area of trifluoromethylation of 
aryl halides with copper complexes containing different ligands.
9,10a,19b,22,23,24,25
  
One of the best and efficient methods for trifluoromethilation of aryl halides with 
fluoroform-derived CuCF3 has been recently developed by Grushin et al (Scheme 
2.7).
19a
 It is the first direct cupration of fluoroform that is low-cost and highly 
chemoselective as there is no observation of side products. Moreover, addition of  an 
auxilarly ligand to this CuCF3 reagent is not beneficial.  
 
 
Scheme 2.7. Direct cupration of fluoroform. 
 
Due to the importance of the fluoroform-drived CuCF3 reagent in the first part of 
this thesis, it will be disscuced in details in chapter 2.1. 
 
2.1.2. Trifluoromethylation of arylboronic acids and borates 
The first example of oxidative trifluoromethylation of aryl boranic acids was 
reported by Chu and Qing in 2010.
26
 The reaction was applied in a range of substrates 
by in situ formation of CuCF3 in smoothly high yield with different additives and 
Ag2CO3 as an oxidant.  The reaction is presented in Scheme 2.8. 
 
 
Scheme 2.8. Trifluoromethylation of arylbronic acids by Chu and Qing reaction. 
 
Senecal, Parsons, and Buchwald developed a more economical methodology using 
dry O2 as an oxidant and twofold excess of CF3SiMe3 (2 equiv).
27
 Morover, a similar 






The best method for selective trifluoromethylation of arylboronic acid in nondried 







 As both Cu(I)CF3 and ArB(OH)2 are nucleophiles they do not 
react toghether, then the O2 [air] oxidizes the Cu(I)CF3 to Cu(II)CF3 which is 
electrophile and then it can smoothly react with aryl bronic acids. The mechanism is 
proposed in Scheme 2.9. 
 
 
Scheme 2.9. Suggested simple mechanism for trifluoromethylation of aryl boronic 
acids. 
 
Later on, a similar methodology for trifluoromethylation of arylbronic acid was 
published under air atmosphier at room temperature. The source of trifluoromethyl 
group was phenyltrifluoromethyl sulfoxide instead of fluoromorm.
24
 The general 




Scheme 2.10. Trifluoromethylation of arylboronic acids with “CuCF3” generated from 
PhSOCF3. 
  
2.1.3. Trifluoromethylation of arenediazonium salts 
The amino group of the aromatic amines can be transformed into the trifluoromethyl 
group by converting to the diazonium salt like Sandmeyer reaction.
31
 Very recently, Fue 
et al. mentioned the first report on this transformation with copper mediated Sandmeyer 
protocol.
32 
The simplified mechanism is shown in Scheme 2.11 and it is a radical type 
reaction. 





Scheme 2.11. Copper mediated Sandmeyer protocol for trifluoromethylation of 
aromatic amines in Fue reaction. 
 
Gooßen and coworkers developed one pot procedure for the trifluoromethylation of 
a variety of aromatic amines.
33
 Afterward, Wang et al. reported trifluoromethylation of 
aromatic diazonium salts by using AgCF3 instead of CuCF3.
34
 Later the group of 
Grushin used fluoroform derived CuCF3 to do this transformation in aques conditions 
with several arylamines and with a variety of electron-donating and electron-
withdrawing functional groups via a radical mechanism.
35
 It was found that acetonitrile 
as a solvent or co-solvent was critical to improve the reaction yield and selectivity.
 
 
2.1.4. Direct C-H aromatic trifluoromethylation 
The most effective way to prepare CF3-substituted arenes would be direct 
trifluoromethylation of C-H bonds in aromatic substrates. In general transition metal-
free C-H aromatic trifluoromethylation  reagents has been used since 1960s
36,37 







 However, the use of this reagents in the direct 
radical trifluoromethylation of aromatic C-H moieties in substituted arenes provides low 




A new protocol, EDA (electron-donor-acceptor) complex-mediated process can also 
be successfully used to render trifluoromethylation of arenes without a directing 
group.
42
 An example is shown in Scheme 2.12 where Umemoto
,
s reagent is envisaged 







Scheme 2.12. C-H trifluoromethylation of arenes via an EDA complex. 
 
In the literature there are few examples about Cu-mediated trifluoromethylation of 
aromatic C-H bonds. The first transformation of this type was reported by Chu and 
Qing in 2012.
43 
The oxidative trifluoromethylation of electron deficient arenes such as 
pentafluorobenzene were performed in the precence of Cu(I) complex, base or cobases 
(cobases 
t
BuONa/NaOAc) and oxidant. The reaction is shown in Scheme 1.13. 
 
 
Scheme 2.13. Cu-mediated oxidative trifluoromethylation of an electron-deficient 
arene. 
 
As mentioned above, lack of regioselectivity in the products is the main difficulty in 
the trifluoromethylation of aromatic C-H bonds without a directing group. To avoid the 
mixture of regioisomers, arenes bearing different directing groups like amide (they have 
a good ortho-selectivity) has been used.
10a 
For instance, Cu-catalyzed radical 
trifluoromethylation of pivalamido arenes with high selectivity at the ortho-position. 
This transformation is presented in Scheme 2.14.
44
 The proposed mechanism is the 
oxidative addition between CuCl and Togni
ʼ
s reagent to generate the CF3 radical. 
 





Scheme 2.14. Radical trifluoromethylation of pivalamido arenes. 
 
2.2. Aromatic pentafluoroethylation with metal complexes 
Pentafluoroethylation reactions are less developed than trifluoromethylation
9,45
 
although in certain cases compounds with C2F5 group exhibit premier properties in 
comparison with their CF3 conterparts. There are several reported examples about 
biologically active pentafluoroethylated compounds that are superior than 
trifluoromethylated congeners.
46
 For example, some valylprolylvalylpentafluoroethyl 
ketones act as active inhibitors of human neutrophil elastase while the 
valylprolylvalyltrifluoromethyl ketones present no activity.
46a
 
C2F5Li has been successfully applied for pentafluoroethylation of carbonyl 
compounds and other electrophiles since 1985 that Gassman and O
’
Reilly reported the 
original work in this area.
3,47 
They found that pentafluoroethyllithium could be easily 
generated in situ by the exchange reaction between C2F5I and MeLi at -78°C (Scheme 
2.15). This reaction was selective in many reported cases.  
 
 




Then more developments have been done by other research groups.
48 
For instance, 
  sche th  er   d c w r ers performed C2F5Li by using the easily available and 
inexpensive pentafluoroethane (C2F5H). 
Several efficient methods for the production of C2F5
-
 carbanion have been 
reported
49-52 
but neither they are nor the previous ones
47,48 
are not applicable to 
pentafluoroethylation of some organic halides like haloarenes. In addition by the Swarts 
reaction
6 
which industrially prepares trifluoromethylated aromatic compounds it is not 





The available synthetic methods for aromatic pentafluoroethylation found in the 
literature are two dozen or so. Moreover, the majority of them are limited in substrate 
scope and the number of functional groups. For instance, decarboxylative 
pentafluoroethylation of iodoarenes with CuI/C2F5CO2M (M = Na, K, Me) required 
high reaction temperature (150-180 °C)
53 
which assists the decarboxylation but it causes 
functional group incompatibility. Another source for pentafluoroethylation of aromatic 
iodides is C2F5 silane source (CuI/C2F5SiMe3/KF system)
54 
that is costly for large scale 
operation, moreover low availability and limited functional group tolerance are other 
drawbacks.  
The mentioned protocols are all copper-mediated pentafluoroethylation of aromatic 
iodines. Although there are some reports of C2F5Cu(I) complexes as fluoroalkylating 
agents and in this case the number of these complexes are less than in the case of 
CF3Cu(I) complexes but like in the case of CF3Cu(I) complexes ancillary ligands might 
affect the perfluoroalkylation. 




that was extremely unstable and formed by thermal decomposition of a CuCF3 
derivative in just 14% yield (Scheme 2.16 (a)).
55,13
 Another X-ray structure reported in 
the same article was [(C2F5)2Zn(DMPU)2] in 59% yield as a first zincation of 





Scheme 2.16. (a) Anionic copper complex characterized by X-ray crystallography. (b) 
Activation of pentafluoroethane by zinc characterized by X-ray crystallography. 
 
Hartwig group reported stable (Phen)CuC2F5 prepared from [CuOBu
t
]4 and 
C2F5SiMe3 (Scheme 2.17) to be successfully used in the pentafluoroethylation of 









Scheme 2.17. Synthesis of phenanthroline-ligated (pentafluoroethyl) copper (I) 
complex. 
 
Grushin et al reported several [LnCuC2F5] complexes with X-ray structures (L = 
PPh3, bpy, Phen and IPr*) that they were applied in pentafluoroethylation of acid 
chlorides.
57 
Some of their crystal structures  are shown in Figure 2.4. 
 
 
Figure 2.4. X-ray structures of C2F5Cu(I) complexes. 
 
Recently, Amii and coworkers reported Cu-catalyzed aromatic pentafluoroethylation 
of haloarenes using potassium (pentafluoroethyl)trimethoxyborate.
58 
The general 
process is exhibited in Scheme 2.18. 
 
 
Scheme 2.18. Catalytic perfluoroalkylation of aryl halides. 
 
As mentioned above the first cupration reaction of fluoroform was discovered by 
Grushin and coworkers.
19a 
 For more developments they also examined this method for 
higher H-perfluoroalkanes. They found that C2F5H underwent direct cupration process 
to give C2F5Cu in almost quantitative yield (Scheme 2.19).
59 
This reagent was 
successfully applied in the pentafluoroethylation of a number of substrates in high 
yields.
59








Scheme 2.19. Direct cupration of pentafluoroethane. 
 
In the next two chapters the results of the research works using trifluoromethylated 
and pentafluoromethylated reagents will be fully discussed. 
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3.1 Continuous process for production of CuCF3 via direct 
cupration of fluoroform 
Mazloomi, Z.; Bansode, A.; Benavente, P.; Lishchynskyi, A.; Urakawa, A.; Grushin, V. 
V. Org. Process Res. Dev. 2014, 18, 1020. 
 
3.1.1. Introduction 
Trifluoromethylated organic compounds play an important role in the synthesis of 
modern pharmaceuticals, agrochemicals, and specialty materials.
1,2
 Over the last 25 
years, considerable progress has been made toward the development of efficient and 
selective methods for the introduction of the CF3 group into a variety of organic 
substrates.
2
 The vast majority of these methods, however, employ cost-prohibitive 
trifluoromethylating reagents and therefore cannot be used on an industrial scale.
3
 
Fluoroform (CHF3, trifluoromethane, HFC-23, R-23) is a colorless gas (bp = -82.1 
°C and mp = −155.2 °C) that is soluble in organic solvents and it is weakly acicid (pKa 
= 27 in H2O).
4
 It is by far the best source of CF3 group for the synthesis of 
trifluoromethylated building blocks
2a-h,2r 
by the following reasons:
5
 
(1) Fluoroform is readily available and cheap. The fluorochemical and 
fluoropolymer industries sidegenerate large quantities of HFC-23 in 
chlorodifluoromethane (HCFC-22, R-22) manufacture. Approximately 20,000 t of 
HFC-23 that are produced annually
7
 lack applications on a commensurate scale.  
(2) Fluoroform is nontoxic and ozone-friendly. Unlike many polyfluorinated small 
molecules, CHF3 is not on the Montreal Protocol list of substances that deplete the 
ozone layer. 
(3) As a CF3 source for trifluoromethylation reactions, fluoroform is second to none 
in terms of atom economy. 
(4) The extremely high warming potential of HFC-23 (11,700 times that of CO2) 
and its long atmospheric lifetime (>250 years) have raised serious environmental 
concerns.
6−8
 To eliminate the risk of the so-called “climate bomb”,
8
 HFC-23 waste 
streams cannot be released into the atmosphere and therefore should be treated. The 
obviously preferred alternative to the costly destruction of HFC-23 is its use as a 
chemical feedstock for valuable fluorinated compounds. 
Fluoroform is highly thermodynamically stable, the reported C-F and C-H bond 
activation energies are 106 and 127 kcal/mol respectively
9 
thus it is inert enough in a 




chemoselective reactions and activation of CHF3 with low-cost materials for industrial 
applications is a significant challenge.
5a
  
The usual methodology for synthetic application of fluoroform was deprotonation of 
the weakly acicid CHF3 (Scheme 3.1.1).
10
 This protocol is limited in large scale 
reactions for several reasons such as need of low temperatures to avoid the formation of 
difluorocarbene CF2 by decomposition of the CF3
-
 carbanion.  
 
Scheme 3.1.1. Deprotonation of CHF3 and its application in trifluoromethylation of 
carbonyl and sulfur electrophiles. 




Another different approach to activate CHF3 is metal-mediated C-H bond activation 
of fluoroform to form a stable M-CF3. Daugulis et al. communicated the first direct 





Scheme 3.1.2. Fluoroform activation by zinc. 
 






Scheme 3.1.3. C-H activation of CHF3 by copper. 
 
Goldman and co-workers in 2011 showed oxidative addition of CHF3 on an Ir-
pincer complex
13
 and Takemoto and Grushin in 2013 reported the highly selective 
activation of CHF3 by a palladium diphosphine complex.
14
 These complexes are 
represented in Figure 3.1.1.  
 
 
Figure 3.1.1. C-H bond activation of CHF3 by Ir and Pd complexes. 
 
Among the mentioned methods for utilization of fluoroform direct cupration 
reaction is more beneficial as it employs the best conditions such as room temperature, 
atmospheric pressure and low-cost substrates (the most expensive chemical used being 
potassium tert-butoxide) whithout using any ligand. In addition the group of Grushin 
has demonstrated the efficiency of “ligandless CuCF3” for trifluoromethylation of 
different substrates in high yield with excellent selectivity (Scheme 3.1.4).
12,15 
Apart 
from CuCF3 reagent there are several different methods for trifluoromethylation of 




various organic substrates catalyzed by copper.
16
 There are some mechanism studies 








Based on the evidences that mentioned above about the high efficiency of 
fluoroform-drived CuCF3 reagent in a variety of high-yielding trifluoromethylation 
reactions,
12,15 
there is a demand for scale up the production of CuCF3 reagent.
 
In a 
nonindustrial batch setting, it was possible to perform the synthesis of CuCF3 via direct 
cupration of fluoroform up to a 0.1 mol scale.
15c 
 
Continous flow systems have numerous advantages rather than batches operations
18
 
for instance they serve as a safe and effective method for precise control of chemical 




reactions and accurate temperature, pressure and residence time control can be 
acheiwed by applying continuous flow methodology.
19
 
Considering the potential of fluoroform-drived CuCF3, we explored the possibility 
of making the direct cupration of fluoroform in a continuous flow manner to be able to 
handle it easily and scale up the production industrially. 
The objective of the work describe in this chapter was to investigate the reliable 
continuous process for the production of CuCF3 from CHF3 and also demonstrate the 
efficiency of the CuCF3 prepared in our flow setup which was as efficient a 
trifluoromethylating agent as the one performed in the batch system. 
 
3.1.3. Results and discusion 
3.1.3.1. Background and general considerations 
The preparation of CuCF3 from fluoroform consists of three steps that are shown in 
Scheme 3.1.5. In Step 1, a solution of the cuprating reagent is prepared by agitating 
CuCl and 
t
BuOK in a 1:2 molar ratio in DMF. The reaction is usually complete within 
20-30 min in a batch reactor to give quantitatively the dialkoxycuprate 
[K(DMF)][Cu(OBu
t
)2] (1), whose solid state structure has been previously established 
by single-crystal diffraction.
12
 As 1 goes into the DMF solution during the reaction, the 
KCl byproduct precipitates out. Although we conventionally separate the KCl 
precipitate by filtration, this is not critical for the next step and the overall CuCF3 
synthesis. What is critical, however, is to maintain rigorously anhydrous, air-free 




Scheme 3.1.5. Reaction sequence for the cupration of fluoroform. 
 
A DMF solution of 1 prepared in Step 1 is then used to cuprate fluoroform in Step 2.  
The reaction of CHF3 with 1 occurs smoothly and quickly at room temperature and 
atmospheric pressure to give the CuCF3 product within minutes.  If carried out properly, 
the yield of the cupration reaction is reproducibly close to quantitative. Although the 




product of Step 2 is too unstable for isolation and structural characterization, sufficient 
evidence has been obtained
20,21 
for this compound being a mixed cuprate bearing one 
CF3 and one 
t
BuO ligand on the Cu(I) center, [K(DMF)n][(CF3)Cu(OBu
t
)]. In particular, 
the treatment of the reaction solution obtained in Step 2 with 18-crown-6 has been 
shown
20
 to give [K(18-crown-6)][(CF3)Cu(OBu
t
)] (X-ray structure). 
Once formed in Step 2, begins to decay
12
 in some hours and it is not stable in order 
to be isolated and should be promptly stabilized with Et3N∙3HF (TREAT HF) or another 
HF source (for example Py(HF)n) in Step 3. This stabilization serves the dual purpose of 
(i) sequestering, in the form of KF, the potassium ions that decompose the CF3 group on 
Cu via to give Cu(I) carbine (Scheme 3.1.6)
2r,12
 and (ii) acidolyzing the 
t
BuO-Cu bond 
to suppress the unwanted competition of t-butoxylation with the desired 
trifluoromethylation, as previously observed for some substrates.
12,15c
  The “ligandless” 
CuCF3 reagent thus prepared can be stored in an inert atmosphere at room temperature 
for a few days without signs of significant decomposition.
12 
 




3.1.3.2. Flow process design and optimization 
The above analysis provided guidelines for the development of a continuous process 
to produce CuCF3 from fluoroform. In the current work, the cupration and stabilization 
steps (Steps 2 and 3 in Scheme 3.1.5) were selected for continuous process 
development.
23
 The cuprating reagent 1 was prepared separately and fed into the flow 
reactor using a syringe pump, as shown in Figure 3.1.2.  Fluoroform gas was fed into 
the reactor through a separate line (Figure 3.1.2) by means of a mass flow controller 
(MFC). All experiments were carried out at room temperature (ca. 23 °C) and 
atmospheric pressure under argon. The results of a series of runs toward optimization of 
process efficiency and the yield of CuCF3 are compiled in Table 2.1.1. In all 
experiments, the concentration of 1 in DMF was close to the solubility limit (0.48 M). 
The yield of the CuCF3 was monitored by 
19
F NMR analysis with an internal standard 
every 5-10 min during each run. In the first 2-3 min, the yield of CuCF3 was lower 
because of the presence of residual traces of air in the system and the time required for 




the addition and efficient mixing of the reagents in the reactor to synchronize and level 
off. During this short initial period prior to system stabilization, the yield invariably 
increased to plateau for the rest of the run. It is these yields of fluoroform-derived 
CuCF3 that are presented in Table 3.1.1 and discussed throughout this report. 
 
Figure 3.1.2.  Flow process setup for the production of CuCF3 from fluoroform. 












1 0.61 2 6 1.25 85 
2 1.04 2 6 2.00 87 
3 1.40 2 6 2.50 94 
4 1.52 2 6 2.75 94 
5 1.53 1.5 4.5 6.00 90 
6 1.95 1.5 4.5 8.83 92 
7 2.32 1.5 4.5 9.33 94 
8 2.73 1.5 4.5 11.33 88 
9 1.10 1.2 3.6 5.58 75 
10 1.32 1.2 3.6 8.83 86 
11 1.53 1.2 3.6 11.83 79 
(a) In all experiments, the rates of addition of 1 in DMF (0.48 M) and TREAT HF in DMF (2.00 M) 
were 18 mL h-1 and 1.5 mL h-1, respectively.  (b) 19F NMR yield determined with an internal standard. 
 
Initially, the flow rates of 1 in DMF and fluoroform were set to 18 mL h
-1
 and 6 mL 
min
-1
, respectively, in order to maintain the CHF3 to Cu ratio at 2:1 (Table 3.1.1, entries 
1-4). The residence time (RT), i.e. the reaction time before the addition of TREAT HF, 
was controlled by the length of the reaction zone, a 1.55 mm inner diameter PTFE 
(polytetrafluoroethylene; Teflon) tube. As pictorially shown in Figure 3.1.2, the volume 
of the fluoroform gas decreased as it moved inside the cupration reaction zone due to 




dissolution and reaction with 1. Changing RT from 1.25 to 2.00 and then to 2.50 min 
led to an increase in the yield of CuCF3 from 85% to 87%, and to 94%, respectively 
(entries 1-3); a further increase in RT to 2.75 min, however, did not affect the yield 
(entry 4). Although the best yield of 94% obtained in this series of experiments (entries 
3 and 4) was as high as that from the batch process,
11
 further optimization was 
performed in order to minimize the amount of CHF3 used. Toward this goal, the 
fluoroform feed rate was lowered to 4.5 mL min
-1
 to change the CHF3 to Cu ratio to 1.5.  
By subsequently varying RT in a 6.00-11.33 min range (entries 5-8) we found the 
optimal value of 9.33 min for the formation of CuCF3 in the highest possible yield of 
94% (entry 7). Still high yet slightly lower yields (88-92%) resulted from both shorter 
(entries 5 and 6) and longer (entry 8) reaction times. Finally, a series of runs were 
performed with a CHF3 to Cu ratio of 1.2 that was achieved by slowing the fluoroform 
feed rate to 3.6 mL min
-1
. In these experiments, the yield of CuCF3 passed through a 
maximum (86%; entry 10) at RT = 8.83 min, an intermediate value between the other 
two points (entries 9 and 11). The lower CHF3 concentration in these three runs resulted 
in slower cupration rates and hence the CuCF3 product began to decompose (see 
above)
11
 to a noticeable extent even before full conversion could be reached. While at 
the shorter RT of 5.58 min (entry 9) the yield of CuCF3 was only 75% because of 
incomplete conversion, the longer RT of 11.83 min (entry 11) resulted in partial 
decomposition of the product, resulting in 79% yield. It is believed, however, that an 
engineering solution could be found for the cupration of CHF3 in a continuous manner 
in over 90% yield while using CHF3 in only 20% excess and even less. One option is to 
run the process at an increased pressure in the reaction zone. Another possibility is to 
recycle and reuse the easily separable fluoroform gas from the head space of the 
receiver during the process employing CHF3 in the 1.5-fold excess that is sufficient to 
obtain CuCF3 in 94% yield under normal pressure (entry 7). Performing such 
experiments, however, was beyond the scope of our work. 
In all of the experiments described above, the stabilization of CuCF3 was performed 
by adding TREAT HF to the receiving vessel, as shown in Figure 2.1.2. An alternative 
setup with a T-connector at the end of the cupration reaction zone for TREAT HF 
addition was also tested but found less efficient (∼70% yield). The inferior results were 
caused by the KF precipitate produced in the stabilization step, thereby preventing the 
free passage of the reaction mixture through the small diameter tube and eventually 




clogging the system. Although increasing the reactor tube diameter could eliminate this 
problem, such further developments are the subject of a separate project. 
 
3.1.3.3. Trifluoromethylation reactions with CuCF3 produced in the flow 
process 
Having developed and optimized the continuous flow synthesis of CuCF3 from 
fluoroform, we examined the usefulness of the thus prepared reagent for a series of 
known trifluoromethylation reactions. In these studies we used the temperature and 
reactant ratios previously found and optimized for the analogous transformations
15a-c 
performed with the CuCF3 reagent from the batch process.
12
 The different setups used 
in the current studies are shown in Figure 3.1.3 and a summary of the results is 
presented in Table 3.1.2. All yields were determined by 
19
F NMR because isolation 






Figure 3.1.3. Four different configurations for the trifluoromethylation reactions with 
the CuCF3 reagent from the continuous flow process. 
 
First, the trifluoromethylation reaction of 2-bromoacetophenone (2a)
15a
 was 
examined using configuration (i). In that experiment (Table 2.1.2, entry 1), TREAT HF 
was employed in superstoichiometric quantities (0.63 mol per mol Cu; see the 
Experimental Section for specifics). Of the total of 0.63 mol of TREAT HF used, 0.33 
mol (1 equiv) was required for the conventional stabilization of the copper reagent 
(Scheme 3.1.5), whereas the extra 0.30 mol was needed to avoid the HF elimination 
from the desired trifluoromethylated product.
15b
 As the CuCF3 was produced and 




stabilized with TREAT HF in excess, a solution of 2a was fed simultaneously to the 
glass receiver/reactor at such a rate so as to maintain the CuCF3 to substrate ratio at 1.2. 
Under such conditions, 2a was trifluoromethylated in 72−73% yield (Table 3.1.2, entry 
1). This yield was noticeably lower than that (93−96%) previously reported
15b
 for the 
same reaction with the CuCF3 reagent from the batch process. In the latter, however, the 
CuCF3 was first prepared and stabilized with only 1 equiv of HF from TREAT HF and 
then used for the reaction in the presence of an additional amount of TREAT HF.
15b
 The 
lower yields obtained under the current flow conditions were caused by the enhanced 
side formation of the hydrodebromination product, acetophenone (∼12% by GC−MS). 
This undesired hydrodebromination was likely prompted by the reasonably DMF-
soluble KHF2, generated from extra HF and KF formed upon addition of 
superstoichiometric amounts of TREAT HF to the just produced unstabilized CuCF3 
solution. In contrast, the estabilization with stoichiometric quantities of TREAT HF 
produces only KF that is poorly soluble in DMF and efficiently precipitates out on 
standing. In this way, virtually potassium-free CuCF3 solutions are produced,
12
 to which 
extra TREAT HF can be added
15b
 without the risk of KHF2 formation. The 
trifluoromethylation of α-haloketones with such fluoroformderived CuCF3 solutions 
containing extra TREAT HF, but not KHF2, is significantly higher yielding and 
chemoselective, producing only very small quantities, if any, of the 
hydrodehalogenation side-products.
15b
 However, a substantially more complex flow 
setup would be required to perform the trifluoromethylation of α-haloketones with such 
KHF2-free, TREAT HF-enriched CuCF3 reagent in a fully continuous manner. 
Considering the above, we tested the three other configurations (ii), (iii), and (iv) 
shown in Figure 3.1.3 for the trifluoromethylation of 2a. In all these experiments, the 
CuCF3 stabilized with 0.33 mol of TREAT HF per 1 mol of Cu was prepared using the 
flow reactor (Figure 3.1.2), as described above. The resultant reagent solution was then 
transferred with a peristaltic pump to a glass reactor for the trifluoromethylation to be 
performed. Using configuration (ii), the required extra amount of TREAT HF, 2a, and 
the already stabilized CuCF3 were fed into the reactor simultaneously. In this way, 3a 
was produced in 85−87% yield (Table 3.1.2, entry 2), nearly as high as the best yields 
reported previously for the batch method.
15b
 With configuration (iii), extra TREAT HF 
(0.2 equiv) was first added to the already stabilized CuCF3, which was then used for the 
reaction with 2a. This technique afforded 3a in a yield (81−83%) that was 
indistinguishable, within the determination error, from the one achieved in the setup (ii) 




experiment (entries 2 and 3). It is worth noting that the error of yield determination by 
19
F NMR is at least ±5%. Performing the trifluoromethylation of 2a in a continuous 
manner with setup (iv) using a T-connection (Figure 3.1.3) resulted in a lower yield of 
3a (75%, entry 4) because of precipitation of inorganic copper byproducts and eventual 
clogging of the tube. As expected, the side formation of acetophenone in the 
trifluoromethylationsof 2a performed with the two-step addition of TREAT HF in 
configurations (ii)−(iv) did not exceed 4−6%, whereas the all at-once TREAT HF 
addition method gave ∼12% of the hydrodebrominated side-product. 
 
Table 3.1.2. Trifluoromethylation of different substrates with fluoroform-derived 




















2 1.3 0.2 0.25 85-87 (ii) 
3 1.3 0.2 0.25 80-83 (iii) 





























(a) All reactions were performed at 23 ºC, using CuCF3 prepared in the optimized flow process (Table 2.1.1, 
entry 7). (b) Reaction time after mixing the substrate with CuCF3. 
(c) Yields determined by 19F NMR. (d) See 
Figure 2.1.2 for setup configurations. (e) No extra TREAT HF used. (f) Reactions performed in air. 
 
The results described above indicated that configurations (ii) and/or (iii) should be 
used for further runs, in which we intended to trifluoromethylate aromatic substrates. 
Thus, 2-iodobenzamide (2b) and 2-bromobenzoic acid (2c) were trifluoromethylated 




using configuration (ii) to give 3b and 3c in 79−85% and 80−89% yield, respectively 
(Table 3.1.2, entries 5 and 6). These yields are nearly identical with those (82−87%) 
previously reported for the same transformations employing the CuCF3 reagent from the 
batch preparation.
15c
 It is noteworthy that no extra TREAT HF was needed for the 
reaction of 2c that bears an acidic functionality (COOH). Finally, we performed 
oxidative trifluoromethylation of 2-naphthylboronic acid (2d) and 4-biphenylylboronic 
acid (2e) with CuCF3 produced in the continuous process. As in the reported
15a
 batch 
method, both reactions were performed in open air, without extra TREAT HF to give 3d 
and 3e quantitatively (entries 7 and 8). 
 
3.1.4. Conclusions 
We have successfully demonstrated the first continuous flow process for the 
synthesis of the valuable trifluoromethylating reagent CuCF3 via the direct cupration of 
fluoroform. The reaction smoothly occurs at room temperature and atmospheric 
pressure. Under optimized conditions, the yield of CuCF3 in the flow reactor (up to 
94%) is as high as in the previously developed batch process. The continuously 
produced CuCF3 has been found to trifluoromethylate a number of organic substrates 
with excellent efficiencies and yields comparable to those previously observed for the 
same reagent prepared by the batch methodology. It is hoped that the demonstrated 
feasibility of the flow synthesis of the low-cost fluoroformderived CuCF3 adds to its 
attractiveness as a trifluoromethylating reagent for larger-scale operations. 
 
3.1.5. Experimental section 
3.1.5.1. General information 
Fluoroform (98%) in a cylinder was purchased from Apollo Scientific. All other 
chemicals and solvents were purchased from Aldrich, Alfa Aesar, TCI, and Acros 
chemical companies. Anhydrous DMF (Alfa Aesar or from an MBraun SPS) was stored 
over freshly calcined 4 Å molecular sieves in a glovebox. All manipulations were 
performed under argon, unless noted otherwise. NMR spectra were obtained with a 
Bruker Avance 400 Ultrashield NMR spectrometer. Quantitative 
19
F NMR analyses 
were carried out with D1 = 5 s. An Agilent Technologies 7890A chromatograph 
equipped with a 5975C MSD unit was used for GC−MS analysis. 
 




3.1.5.2. Continuous reaction system 
Gaseous fluoroform was fed into the system (Figure 3.1.2) by a thermal mass flow 
controller (MFC, Alicat Scientific) calibrated for CHF3. A PTFE tube of 3.25 mm outer 
diameter and 1.55 mm inner diameter was used as both the reactor and connector 
between the syringes and valves with standard SS-316 compression fittings (Hy-Lok). 
The MFC outlet was connected to an SS-316 T-piece where the solution of 1 and 
gaseous CHF3 met and were mixed together. An in-house fabricated PTFE adapter 
facilitated the coupling of the syringe to the reaction system. To keep solutions of 1 and 
TREAT HF in syringes isolated from oxygen and moisture during the transfer from the 
glovebox to the reaction system, a standard 1/8 in. ball valve was fitted on the PTFE 
adapter. The liquid reagents were transferred to a syringe of appropriate volume and fed 
to the reaction system using high-accuracy syringe pumps (Fisher Scientific). The outlet 
streams were connected via PTFE-to-glass fittings (Bola, Germany) to a glass 
receiver/reactor for the stabilization with TREAT HF (Step 3). The receiver/reactor was 
equipped with a stopcock for evacuation/backfilling with argon, an airlock to maintain a 
slow argon flow throughout the experiment, and a PTFE-coated magnetic stir bar for 
continuous agitation. A TREAT HF solution was added to the receiver/reactor using a 
separate syringe pump. In the trifluoromethylation experiments, the CuCF3 solution 
product was pumped out continuously from the glass receiver/reactor using a peristaltic 
pump and fed to the second glass reactor or premixed with the substrate, depending on 
the configuration employed (see above, Figure 3.1.3 and Table 3.1.2). Vigorous 
agitation of the trifluoromethylation reaction mixtures was used in all experiments. 
 
3.1.5.3. Preparation of [K(DMF)][Cu(OBu-t)2] (1)
12
 and the continuous 
cupration of fluoroform 
In a glovebox, a mixture of CuCl (purity 99%; 1.50 g; 15.1 mmol), KO
t
Bu (purity 
97%; 3.54 g; 30.6 mmol), and DMF (25 mL) was vigorously stirred for 30 min at room 
temperature. The precipitated KCl was filtered off and washed on the filter with DMF 
(5 mL). To the combined filtrate and the washing, was added PhF (purity 99%; 0.42 
mL; 4.5 mmol) as an internal standard for CuCF3 yield determination. The thus 
prepared solution was placed in a 20 mL syringe. A 2 M solution of TREAT HF in 
DMF prepared inside the glovebox from 3.3 mL (20 mmol) of TREAT HF in a 10 mL 
graduated flask was placed in a 10 mL syringe. Both syringes equipped with PTFE 




adapters fitted with 1/8 in. ball valves were brought out and connected to the continuous 
flow reactor. After the system was evacuated to ∼1−2 mbar and backfilled with argon 
three times, the flow synthesis was commenced. As described above, the yield of CuCF3 
in the first 2−3 min of the run was always lower, and the product solution was dark 
because of partial decomposition with trace residual air in the system. After this initial 
period, the solution produced was pale yellow, and the CuCF3 yield was consistently 
high (see Table 3.1.1 for specifics), as established by frequent 
19
F NMR monitoring 
(every 5−10 min). 
 
3.1.5.4. Preparation of trifluoromethylated compounds under flow 
conditions 
3,3,3-Trifluoro-1-phenylpropan-1-one (3a; Table 3.1.2, entries 1−4). 
Procedure A (entry 1). Configuration (i) shown in Figure 2.1.3 was used. All reaction 
solutions for the synthesis were prepared inside a glovebox and placed in syringes 
equipped with PTFE adapters fitted with 1/8 in. ball valves. A 5 mL syringe was 
charged with 2.9 mL of a DMF solution of 2-bromoacetophenone (2a; 995 mg; 5.00 
mmol; [2a] = 1.72 M) and 1,3-bis(trifluoromethyl)benzene (194 μL; 1.25 mmol; 
internal standard). A 20 mL syringe was filled up with a 0.48 M solution of 1 in DMF 
prepared as described above. A 10 mL syringe was charged with 5 mL of a 2 M TREAT 
HF solution prepared as described above. The three syringes were brought out and 
connected to the reaction system of configuration (i) shown in Figure 3.1.3, and the 
continuous cupration process was commenced using the parameters specified in entry 7 
of Table 1, except that the rate of addition of the TREAT HF solution was 2.9 mL h
−1
. 
The first ∼2 mL portion of the dark, partially oxidized CuCF3 solution product was 
completely removed from the receiver/ reactor and discarded. 
19
F NMR analysis of the 
fully withdrawn next, light-yellow 1 mL fraction of the product indicated 90% yield of 
CuCF3. At that point, the addition of the solution of 2a was started at a rate of 3.87 mL 
h
−1
 as the CuCF3 was continuously produced. After ∼3 mL of the reaction mixture 
accumulated in the reactor, the entire amount was withdrawn via syringe, kept under 
argon for an additional 15 min, and treated with ∼10 mL of water and ∼4 mL of ether 
in air. After agitation, the organic layer was separated and filtered through a short silica 
gel plug. Quantitative 
19
F NMR analysis of the filtrate indicated that 3a was produced in 
73% yield. 
19
F NMR, δ: = −61.2 (t, J = 10.3 Hz).
13b
 Acetophenone (∼11%) was detected 




in the filtrate by GC−MS. The continuously produced reaction mixture was withdrawn 
from the reactor two more times. Analysis of these two fractions as described above 
indicated 73% and 72% yield of 3a (
19
F NMR) and ∼12% and ∼12% of acetophenone 
(GC−MS). 
Procedure B (entry 2). Configuration (ii) shown in Figure 3.1.3 was used. CuCF3 in 
DMF was prepared as described in Table 3.1.1 (entry 7) in 92% yield. After the KF 
byproduct had settled at the bottom of the receiver, the solid-free supernatant was 
pumped into the glass reactor with the peristaltic pump through a PTFE tube equipped 
with a microfiber filter at the inlet. Simultaneously, solutions of 2a and TREAT HF in 
DMF were fed to the same reactor via two independently operating syringe pumps. A 5 
mL syringe was used for the addition of the substrate solution (2.8 mL) in DMF 
containing 2a (995 mg; 5.00 mmol; [2a] = 1.79 M) and 1,3-bis(trifluoromethyl)- 
benzene (194 μL; 1.25 mmol; internal standard). The TREAT HF solution (2 M; 4 mL) 
was added via a 10 mL syringe. The rates of addition of the CuCF3, 2a, and TREAT HF 
solutions were 19 mL h
−1
, 3.34 mL h
−1
, and 0.9 mL h
−1
, respectively. After the first ∼3 
mL portion was discarded, three sequential fractions of ∼3 mL each were withdrawn 
and analyzed by 
19
F NMR and GC−MS as described above. The yields of 3a 
(acetophenone) were 85 (5)%, 87 (5)%, and 85 (4)%. 
Procedure C (entry 3). CuCF3 in DMF was prepared as described in Table 3.1.1 (entry 
7) in 91% yield. After the KF byproduct had settled at the bottom of the receiver, the 
solidfree supernatant was pumped into the glass reactor with the peristaltic pump 
through a PTFE tube equipped with a microfiber filter at the inlet. Simultaneously, 
solutions of 2a and TREAT HF in DMF were fed to the system via two independently 
operating syringe pumps, as shown in Figure 3, setup (iii). A 5 mL syringe was used for 
the addition to the reactor of the substrate solution (2.8 mL) in DMF containing 2a (995 
mg; 5.00 mmol; [2a] = 1.79 M) and 1,3-bis(trifluoromethyl)benzene (194 μL; 1.25 
mmol; internal standard). The TREAT HF solution (2 M; 4 mL) was added via a 10 mL 
syringe into the CuCF3 solution flow. The rates of addition of the CuCF3, 2a, and 
TREAT HF solutions were 19 mL h
−1
, 3.30 mL h
−1
, and 0.9 mL h
−1
, respectively. After 
the first ∼3 mL portion was discarded, three sequential fractions of ∼3 mL each were 
withdrawn and analyzed by 
19
F NMR and GC−MS as described above. The yields of 3a 
(acetophenone) were 81 (4)%, 80 (5)%, and 83 (5)%. 
Procedure D (entry 4). CuCF3 in DMF was prepared as described in Table 3.1.1 (entry 
7) in 94% yield. After the KF byproduct had settled at the bottom of the receiver, the 




solidfree supernatant was pumped into the glass reactor with the peristaltic pump 
through a PTFE tube equipped with a microfiber filter at the inlet. Simultaneously, 
solutions of 2a and TREAT HF in DMF were fed to the flow of the CuCF3 reagent 
solution via two independently operating syringe pumps, as shown in Figure 3.1.3, 
setup (iv). A 5 mL syringe was used for the addition of the substrate solution (2.8 mL) 
in DMF containing 2a (995 mg; 5.00 mmol; [2a] = 1.79 M) and 1,3-
bis(trifluoromethyl)benzene (194 μL; 1.25 mmol; internal standard). The TREAT HF 
solution (2 M; 4 mL) was added via a 10 mL syringe into the CuCF3 solution flow. The 
rates of addition of the CuCF3, 2a, and TREAT HF solutions were 19 mL h
−1
, 3.49 mL 
h
−1
, and 0.9 mL h
−1
, respectively. As the reaction occurred in the tube, a solid was 
produced. Three sequential fractions of ∼3 mL each were withdrawn from the reactor 
and analyzed by 
19
F NMR and GC−MS as described above. The yields of 3a 
(acetophenone) were 71 (6)%, 75 (5)%, and 74 (4)%. Also, unreacted 2a (∼5%) was 
detected in the first fraction by GC−MS. A few min after the third fraction was 
withdrawn, signs of clogging of the system with the solid byproduct were observed and 
the experiment was stopped. 
2-(Trifluoromethyl)benzamide (3b; Table 3.1.2, entry 5). Configuration (ii) 
shown in Figure 3.1.3 was used. CuCF3 in DMF was prepared as described in Table 
3.1.1 (entry 7) in 88% yield. After the KF byproduct had settled at the bottom of the 
receiver, the solid-free supernatant was pumped into the glass reactor with the 
peristaltic pump through a PTFE tube equipped with a microfiber filter at the inlet. 
Simultaneously, solutions of 2b and TREAT HF in DMF were fed to the same reactor 
via two independently operating syringe pumps. A 5 mL syringe was used for the 
addition of the substrate solution (2.8 mL) in DMF containing 2b (617 mg; 2.50 mmol; 
[2b] = 0.89 M) and 1,3-bis(trifluoromethyl)benzene (194 μL; 1.25 mmol; internal 
standard). The TREAT HF solution (2 M; 4 mL) was added via a 10 mL syringe. The 
rates of addition of the CuCF3, 2b, and TREAT HF solutions were 19 mL h
−1
, 7.77 mL 
h
−1
, and 0.9 mL h
−1
, respectively. Three sequential fractions of ∼3 mL each were 
withdrawn and analyzed by 
19
F NMR “as is”. The yields of 3b were 85%, 83%, and 
79%. 
19
F NMR, δ: −58.3 (s).
13c
 After treatment of the samples with H2O/ether, the 
organic layers were analyzed by GC−MS. No side products were detected. A small 
quantity of the starting material (2b) was detected in the third fraction but not in the first 
two. 




2-(Trifluoromethyl)benzoic acid (3c; Table 2.1.2, entry 6). Configuration (ii) or 
(iii) shown in Figure 3.1.3 was used (no extra TREAT HF). CuCF3 in DMF was 
prepared as described in Table 2.1.1 (entry 7) in 88% yield. After the KF byproduct had 
settled at the bottom of the receiver, the solid-free supernatant was pumped into the 
glass reactor with the peristaltic pump through a PTFE tube equipped with a microfiber 
filter at the inlet. Simultaneously, a solution of 2c was fed to the same reactor via a 
syringe pump. A 5 mL syringe was used for the addition of the substrate solution (2.4 
mL) in DMF containing 2c (503 mg; 2.50 mmol; [2c] = 1.04 M) and 1,3-
bis(trifluoromethyl)benzene (194 μL; 1.25 mmol; internal standard). The rates of 
addition of the CuCF3 and 2c solutions were 19 mL h
−1
, and 6.49 mL h
−1
, respectively. 
Four sequential fractions of ∼3 mL each were withdrawn and analyzed by 19F NMR “as 
is”. The yields of 3c were 80%, 88%, 88%, and 89%. 
19
F NMR, δ: −58.4 (s).
13c 
2-(Trifluoromethyl)naphthalene (3d; Table 3.1.2, entry 7). Configuration (ii) or 
(iii) shown in Figure 3.1.3 was used (no extra TREAT HF). CuCF3 in DMF was 
prepared as described in Table 3.1.1 (entry 7) in 89% yield. After the KF byproduct had 
settled at the bottom of the receiver, the solid-free supernatant was pumped into the 
glass reactor with the peristaltic pump through a PTFE tube equipped with a microfiber 
filter at the inlet. Simultaneously, a solution of 2d (430 mg; 2.50 mmol) and 4,4′-
difluorobiphenyl (178 mg; 0.94 mmol; internal standard) in a mixture of DMF (1.2 mL) 
and toluene (2.0 mL) of 3.8 mL total volume ([2d] = 0.66 M) was fed to the reactor in 
air via a syringe pump. The rates of addition of the CuCF3 and 2d solutions were 19 mL 
h
−1
 and 5.68 mL h
−1
, respectively. Three sequential fractions of ∼3 mL each were 
withdrawn. Each fraction was vigorously agitated in air for 1 h and then treated with 
H2O/ether, and the organic layers were analyzed by 
19
F NMR. The yields of 3d were 
92%, 99%, and 99%. 
19
F NMR, δ: −62.7 (s).
13a
 The yield of naphthalene in these 
fractions was 4%, 2%, and 1%, respectively (GC−MS). 
4-(Trifluoromethyl)biphenyl (3e; Table 2.1.2, entry 8). Configuration (ii) or (iii) 
shown in Figure 3.1.3 was used (no extra TREAT HF). CuCF3 in DMF was prepared as 
described in Table 3.1.1 (entry 7) in 91% yield. After the KF byproduct had settled at 
the bottom of the receiver, the solid-free supernatant was pumped into the glass reactor 
with the peristaltic pump through a PTFE tube equipped with a microfiber filter at the 
inlet. Simultaneously, a solution of 2e (495 mg; 2.50 mmol) and 4,4′-difluorobiphenyl 
(178 mg; 0.94 mmol; internal standard) in a mixture of DMF (1.0 mL) and toluene 
(3.4mL) of 4.9 mL total volume ([2e] = 0.51 M) was fed to the reactor in air via a 









, respectively. Four sequential fractions of ∼3 mL each were withdrawn. 
Each fraction was vigorously agitated in air for 0.5 h and then treated with H2O/ether, 
and the organic layers were analyzed by 
19
F NMR. The yields of 3e were 99%, 98%, 
99%, and 98%. 
19
F NMR, δ: −62.8 (s).
13a
 The yield of biphenyl could not be estimated 
in this experiment because of the close retention times of Ph2 and 4,4′-difluorobiphenyl 
(internal standard) under the GC−MS conditions used. Therefore, the 
trifluoromethylation was repeated in the absence of 4,4′-difluorobiphenyl. The yield of 
biphenyl was estimated at ≤1%. 
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3.2. Trifluoromethylation and pentafluoroethylation of 
vinylic halides with low-cost RfH-derived CuRf (Rf = CF3, 
C2F5) 
Lishchynskyi, A.; Mazloomi, Z.; Grushin, V. V. Synlett 2015, 26, 45. 
  
3.2.1. Introduction 
Perfluoroalkylation of aromatic compounds have been the subject of interesting 
research topics recently as it plays the important role for the synthesis of biologically 
active ingredients and specialty materials.
1,2 
Different methodologies for trifluoromethylation and pentafluoeoethylation of 
aromatic compounds were discussed in chapter 2 and 3.1 in details. Cupration of 
fluoroform and pentafluoroethane were among the best known processes for 
perfluoroalkylation. Direct cupration of trifluoromethane was mentioned in chapter 3.1 
and cupration of pentafluoroethane as a higher H-perfluoroalkane will be considered in 
this chapter. 
Pentafluoroethane (C2F5H, HFC-125, R-125) is a colorless gas (bp = -48.5 °C and 
mp = -103 °C) that is soluble in organic solvents.It is nontoxic and ozon-friendly. It has 
high warming potential (3450 times that of CO2) therefore cannot be released into the 
atmosphere. It can be applied as a chemical feedstock for fluorinated compounds 
instead of releasing in air. 




 which is generated in situ from CuCl and 
t
BuOK (1:2) in DMF at room temperature resulted CuC2F5 solution in ca. 95% yield 
(Scheme 3.2.1). This product is more robust than the CuCF3 conterpart prepared from 
fluoroform in the very similar way and the reason is the less favored α-F-elimination of 
CuC2F5 than of CuCF3 analog. Due to the higher stability of pentafluoroethane 
cupration product, it was possible to isolate the compound and make a crystal. The 
structure of the [K(DMF)2][(
t




The “ligandless CuC2F5” has been efficiently applied for pentafluoroethylation of 
different substrates (Scheme 3.2.1).
3,4
 Perfluoroalkylation of vinylic halides have 
methodologically less developed. There are some primary reports about copper-
mediated coupling of perfluoroalkyl iodides (RfI) with haloalkenes
5 
which has been 





























 being the only vinylic halides investigated. Some examples 
of trifluoromethylation of RCH=CHX (R = H, X = Br
10
















X = Br, I)
15
 have been noted briefly. 
One paper
7b
 mentiones the trifluoromethylation of structurally alike 4-bromo-3-oxo-Δ
4
-





 substrates. There are two reports that perform this type of 
transformations for several vinylic halides other than bromo- and iodostyrene. Nowak 
and Robins
9
 have shown trifluoromethylation of 18 vinylic bromides and iodides in 75–
95% yield. Unfortunately, they applied toxic Hg(CF3)2 as a CF3 source in their method. 
Hafner and Bräse
11b
 have improved the Urata–Fuchikami protocol.
11a
 They applied 
CF3TMS to make the trifluoromethylation reaction on five vinylic bromides and six 
iodides in 23–99% yield. The reaction was performed in costly DMPU
11b
 to avoide the 
formation of C2F5-substituted side products due to α-F elimination.
11
 Contamination of 
a desired triluoromethylated product with its C2F5 counterpart is a serious problem 
because separation of the two is difficult, if not impossible. 
 
 
Scheme 3.2.1. Direct cupration of pentafluoroethane and various pentafluoroethylation 
reactions with CuC2F5.  










have been applied for fluoroalkylation of a broad variety of 
substrates in high yield and excellent selectivities.
15-19 
These RfCu reagents are not 
neither toxic nor expensive. Even there is no formation of side products whenever they 
are handled for perfluoroalkylation reactions. Considering the great potential of RfCu 
reagents we explored the possibility of fluoroalkylation of vinylic halides with the RfH-
drived CuCF3 and CuC2F5 reagents as it was the objective of the work which describe in 
this chapter. 
 
3.2.3. Results and discusion 
We initially found that fluoroform-derived CuCF3 readily trifluoromethylates β-
bromostyrene (4a, E/Z = 8:1), the substrate of choice for our initial studies, with full 
retention of stereochemistry. A summary of the optimization work is presented in Table 
3.2.1 showing that the trifluoromethylation of 4a occurs at as low as ambient 
temperature. Our goal was to drive the reaction to nearly full conversion in order to 
eliminate the need to separate the product PhCH=CHCF3 from the unreacted starting 
material. To achieve >90% yield at ≥99% conversion, the reaction was performed at 
40–50 °C with 2.5 equivalents of CuCF3 in the presence of Et3N·3HF as a promoter.
19c 
After the optimization work, we proceeded to explore the substrate scope, using 
various vinylic bromides. The trifluoromethylation and pentafluoroethylation were 
performed in parallel (Table 3.2.2). The enhanced thermal stability of the CuC2F5 
reagent
17
 allowed us to use it in only 10% excess to achieve full conversion for most of 
the substrates, while running the reactions at 70–80 °C. The data collected in Table 
2.2.2 show that styryl bromides bearing such substituents as Me (4b–d), MeO (4e), F 
(4f), Cl (4g,h), and Br (4i,j) in various positions of the aromatic ring undergo clean 
perfluoroalkylation to give the desired products in ≥90% yield (Table 3.2.2, entries 1–
20). The stereochemistry of the starting material is retained in the product. While F and 
Cl on the ring remain intact during the reaction, the aromatic C–Br bond in 4i and 4j 
(Table 3.2.2, entries 17–20) undergoes fluoroalkylation, albeit only to a minor extent 
(5–8%). Therefore, unactivated bromoarenes are estimated to be approximately an order 
of magnitude less reactive toward CuRf than β-bromostyrene. This difference in 
reactivity provides an opportunity for further functionalization of the Rf-substituted 








Table 3.2.1. Optimization of the reaction conditions for trifluoromethylation of -














1 1.5 0.33 50 23 84 76 
2 2 0.33 23 120 95 86 
3 2 0.33 50 25 97 84 
4 2 0.43 50 24 96 92 
5 2 0.53 50 20 94 87 
6 2 0.63 50 20 92 85 
7 2.5 0.43 50 24 99 93 
8 2.5 0.53 50 26 98 91 
9 2.5 0.63 50 26 96 90 
10 2.5 0.43 40 62 99 90 
11 2.5 0.53 40 62 98 90 
12 2 0.53 80 4+1e 89 86 
(a) Reaction conditions: 1a (0.125–0.25 mmol), CuCF3 in DMF (0.35–0.38 M) in the presence of 1,3-
bis(trifluoromethyl)benzene or 4,4′-difluoro-1,1′-biphenyl as internal standards (see experimental section for 
details). (b) Equiv per 1 equiv of CuCF3. 
(c) Determined by GC–MS. (d) Determined by 19F NMR spectroscopy 
(accuracy ±5%). (e) CuCF3 in DMF was added during 4 h via a syringe pump, followed by heating for one 
additional hour. 
 
The fluoroalkylation of β-bromostyrenes with geminal CHO (4k) or CO2Me (4l) 
also proceeded smoothly to furnish the corresponding products in 68–80% yield (Table 
3.2.2, entries 21–24). Although the stereochemistry is not fully preserved in the 
reactions of these substrates, the E/Z ratio ranges from good  (85:15, Table 3.2.2, entries 
21 and 23) to excellent (99:1, Table 3.2.2, entry 24). In accord with the literature 
data,
11b
 α-bromostyrene  (4n) was less reactive, likely for steric reasons, furnishing the 
desired product in only 26% and 64% yield at 50% and 100% conversion in the 
reactions with CuCF3 and CuC2F5, respectively (Table 3.2.2, entries 27 and 28). In 
contrast, α-methyl-β-bromostyrene (4m) underwent perfluoroalkylation in >90% yield 
with full retention of stereochemistry (Table 2.2.2, entries 25 and 26). Bromoethylene 




(4o), isopropenyl bromide (4p), and 2-bromo-2-butene (4q) were perfluoroalkylated in 
35–78% yield (Table 3.2.2, entries 29–33). 
 
Table 3.2.2. Trifluoromethylation and pentafluoroethylation of bromoalkenes with 



























1 5a 50 24 99 93 89:11 89:11 
2 6a 70 14 100 97   
3 5b 50 23 100 93 99:1 99:1 
4 6b 70 20 100 92   
5 5c 50 23 100 92 99:1 99:1 
6 6c 70 20 100 99   
7 5d 50 23 99 96 100:0 100:0 
8 6d 70 14 100 99   
9 5e 50 24 100 90 99:1 99:1 
10 6e 70 18 100 91   
11 5f 50 23 100 97 98:2 98:2 
12 6f 70 20 100 98   
13 5g 50 23 100 94 100:0 100:0 
14 6g 70 14 100 97   
15 5h 50 24 100 90 99:1 99:1 
16 6h 70 18 100 94   
17e 5i 50 21 99 87+5
f 100:0 100:0 
18e 6i 70 16 100 89+5
f   




19e 5j 50 21 100 89+7
f 99:1 99:1 
20e 6j 70 16 100 89+8
f   
21 5k 50 24 100 71 0:100 15:85 
22 6k 50 16 100 80  6:94 
23 5l 50 25 86 74 28:72 16:84 
24 6l 70 16 98 68  1:99 
25 5m 50 25 96 94 97:3 97:3 
26 6m 80 14 100 92   
27 5n 50 28 50 26 -  - 
28 6n 70 30 100 64   
29 5o 50 30 60 35 -  - 
30 6o 50 28 55 58 -  - 
31 5p 80 21 92 70   
32 6p 50 28 65 60 50:50 63:37 
33 5q 80 21 91 78  56:44 
(a)Reaction conditions: bromoalkene 1 (0.125–0.25 mmol), CuCF3 in DMF (0.35–0.38 M, 2.5 equiv) or 
CuC2F5 in DMF (0.67–0.70 M, 1.1 equiv), 1,3-bis(trifluoromethyl)benzene or 4,4′-difluoro-1,1′-biphenyl 
(internal standards). See experimental section for details. (b) Determined by GC–MS. c Determined by 19F 
NMR spectroscopy (accuracy ±5%). (d) Determined by 1H NMR spectroscopy. (e) 2.2 equiv of CuCF3 or 1 
equiv of CuC2F5.
(f) Bis-perfluoroalkylated side product was also formed.  
 
Although more costly and often less accessible than their bromo counterparts, 
vinylic iodides are considerably more reactive coupling partners. We therefore explored 
fluoroalkylation of a series of iodoalkenes with CuCF3 and CuC2F5 (Table 3.2.3).  
The mono β-substituted iodoethylenes appeared reactive enough to undergo the 
fluoroalkylation at room temperature (Table 3.2.3, entries 1–8). Importantly, full 
conversion of these substrates was reached with only 1.1 equivalents of the CuRf 
reagent not only for Rf = C2F5, but also for Rf = CF3. The fluoroalkylations of more 
sterically hindered and therefore less reactive iodoalkenes were performed at 50–70 °C 
(Table 3.2.3, entries 9–12). The formation of the desired products in excellent yields of 
up to 97% was observed in all cases. 
  




Table 3.2.3. Trifluoromethylation and pentafluoroethylation of iodoalkenes.  
 






1 H 2-ClC6H4 H 5h 23 1.5 92 
2    6h 23 10 90 
3 H 4-NCC6H4 H 5r 23 1.5 92 
4    6r 23 10 92 
5 H 2-naphthyl H 5s 23 2 91 
6    6s 23 10 90 
7 1-naphthyl H H 5t 23 6 89 
8    6t 23 16 87 
9 Ph H Me 5u 50 8 97 
10    6u 50 24 95 
11 H (CH2)4 - 5v 50 13 93 
12    6v 70 7 91 
(a) Reaction conditions: iodoalkene 4 (0.125-0.25 mmol), CuCF3 in DMF (0.36-0.38 M; 1.1 equiv) or CuC2F5 in 
DMF (0.68-0.7 M; 1.1 equiv), 1,3-bis(trifluoromethyl)benzene or 4,4'-difluoro-1,1'-biphenyl (internal 
standards).  See experimental section for details. (b) Determined by 19F NMR. 
 
 
After the substrate scope studies (Tables 3.2.2 and 3.2.3), a number of vinylic 
halides were selected for the synthesis and isolation of the corresponding CF3 and C2F5 
derivatives on a 1–10 mmol scale (Scheme 3.2.2). As can be seen from Scheme 3.2.2, 
the new protocol is suitable for the preparation and isolation in pure form of 
trifluoromethylated and pentafluoroethylated olefins in up to 93% yield. Note that the 
diminished yields of 74–86% are mainly due to losses during the isolation of these 
rather volatile compounds and hence likely can be improved in the synthesis on a larger 
scale.  
 





Scheme 3.2.2. Isolated trifluoromethylated and pentafluoroethylated products (1-10 
mmol). 
 
Single-crystal X-ray diffraction studies of two of the isolated products, (E)-1-
(trifluoromethyl)-2-(4-methoxyphenyl) ethylene (5e, Figure 3.2.1) and (E)-1-
(pentafluoroethyl)- 2-(2-naphthyl)ethylene (6s, Figure 3.2.2) confirmed the structures 
and stereochemistry in the solid state.
20 
 








The high chemo- and stereoselectivity of the fluoroalkylation reactions described 
above suggests that radical processes are unlikely involved in the olefinic C–Rf bond 




formation. The fluoroalkylation reactions of vinylic halides are in many respects similar 
to those of aryl halides.
3,16,17,19c
 As has been recently established,
21
 the 
trifluoromethylation of haloarenes with fluoroform-derived CuCF3 is a nonradical 
process that involves ArX oxidative addition (OA) to Cu(I), followed by ArRf reductive 
elimination (RE) from the copper(III) intermediate. The fluoroalkylation reactions 
developed in the current work are likely governed by a similar OA–RE mechanism. The 
new method compares favorably with the previously reported ones
6–14 
for 
perfluoroalkylation of haloalkenes. Apart from the vastly lower cost of the Rf sources 
used, our procedures obviate the need for toxic mercury compounds
9
 or expensive 
DMPU
11b
 employed in the only two reported methods with a defined substrate scope. 
 
3.2.4. Conclusions 
In summary, a general new protocol has been developed for the trifluoromethylation 
and pentafluoroethylation of vinylic bromides and iodides with RfH-derived CuCF3 and 
CuC2F5. The reactions occur at 23–80 °C with high chemo and stereoselectivity to 
furnish the desired fluoroalkylated olefin products in high, often >90% yield. Various 
functional groups are well tolerated. The method employs the most economical CuRf 
reagents known to date and neither costly nor toxic materials. Scalability and isolation 
of pure products have been demonstrated on selected examples. The new protocol may 
find use in both academic and industrial research. 
 
3.2.5. Experimental section 
3.2.5.1. General information 
All chemicals, solvents, and deuterated solvents were purchased from Aldrich, Alfa 
Aesar, Apollo Scientific, TCI, Acros, and Deutero companies. Anhydrous DMF (Alfa 
Aesar or from an MBraun SPS) was used without additional purification. Ether and 
THF were distilled from Na/benzophenone. All anhydrous solvents were stored over 
freshly calcined 4 Å molecular sieves in a glove-box. Glass pressure reaction vessels 
(Fischer-Porter tubes) were purchased from Andrews Glass Co., Inc. Fluoroform-
derived CuCF3 was prepared on a 15-120 mmol scale, stabilized with Et3N∙3HF (0.33 
equiv per equiv of CuCF3), and extra amount of Et3N∙3HF (0.1-0.3 equiv per equiv of 
CuCF3) was added to the reagent after stabilization, as previously reported.
3,19c
 The 
CuC2F5 reagent was prepared from C2F5H on a 20-50 mmol scale, neutralized with 




Et3N∙3HF (0.33 equiv per equiv of CuC2F5) and extra amount of Et3N∙3HF (0.2 equiv 
per equiv of CuC2F5) was added, as previously reported.
17
 Literature procedures were 





 and ethyltriphenylphosphonium iodide.
24
 NMR spectra 
were recorded on Bruker Avance 400 Ultrashield and Bruker Avance 500 Ultrashield 
NMR spectrometers. Quantitative 
19
F NMR analyses were carried out with D1 = 5 s. An 
Agilent Technologies 7890A chromatograph equipped with a 5975C MSD unit was 
used for GC-MS analysis. Single-crystal X-ray diffraction studies were performed using 
a Bruker-Nonius diffractometer equipped with an APEX II 4K CCD area detector. 
 
3.2.5.2. Preparation of vinyl halides 
All vinyl halides, except for commercial β-bromostyrene 4a, α-bromostyrene 4n, 
vinyl bromide 4o (1M solution in THF), 2-bromopropene 4p, and 2-bromobutene 4q, 
were synthesized following the literature procedures (Table 3.2.4). 
 
Table 3.2.4. Vinyl halides prepared following literature procedures. 





































 (a)Purified by recrystallization from hexanes rather than by flash chromatography, as reported in ref. 7. 
 




3.2.5.3. Trifluoromethylation of β-bromostyrene. Optimization experiments 
Procedure A. In a glovebox, to 4,4'-difluoro-1,1'-biphenyl (18 mg; internal 
standard) in an NMR tube was added CuCF3 in DMF (0.35 M; 1.5-2 equiv), the tube 
was sealed with a rubber septum and brought out. β-Bromostyrene (4a; 16 μL; 0.125 
mmol) was added at room temperature via a microsyringe, and the NMR tube was kept 
at 50 ºC (oil bath) for 23-25 h (entries 1 and 3, Table 3.2.5). Ether (0.5 mL) and water 
(1 mL) were added in air. After agitation, the organic layer was filtered through a short 
silica gel plug and analyzed by GC-MS to determine the conversion of 4a. The yield of 
5a was determined by quantitative 
19
F NMR analysis of the filtrate. 
Procedure B. In a glovebox, an NMR tube was charged with CuCF3 in DMF (0.37-
0.38 M; 2-2.5 equiv), sealed with a rubber septum, and brought out. β-Bromostyrene 
(4a; 16 μL; 0.125 mmol) and 1,3-bis(trifluoromethyl)benzene (10 μL; internal standard) 
were added at room temperature via microsyringe, and the NMR tube was kept at 23-50 
ºC for an indicated period of time (entries 2 and 4-11, Table 3.2.5). Ether (0.5 mL) and 
water (1 mL) were added in air. After agitation, the organic layer was filtered through a 
short silica gel plug and analyzed by GC-MS to determine the conversion of 4a. The 
yield of 5a was determined by quantitative 
19
F NMR analysis of the filtrate. 
Procedure C. To a solution of β-bromostyrene (4a; 32 μL; 0.25 mmol) in DMF 
(0.25 mL) placed in an oil bath at 80 °C under argon, was added, via a syringe pump 
over a period of 4 h, a solution of CuCF3 in DMF (0.38 M; 1.3 mL; 2 equiv) containing 
0.2 extra equiv of Et3N∙3HF. The mixture was then stirred for an additional 1 h at the 
same temperature (entry 12, Table 3.2.5). After the reaction mixture was allowed to 
cool to room temperature, ether (5 mL), 1,3-bis(trifluoromethyl)benzene (internal 
standard; 19 μL), and water (8 mL) were added in air. After agitation, the organic layer 
was filtered through a short silica gel plug and analyzed by GC-MS to determine the 
conversion of 4a (89%). Quantitative 
19
F NMR analysis of the filtrate indicated that 5a 
was produced in 86% yield. 




Table 3.2.5.  Trifluoromethylation of β-bromostyrene with fluoroform-derived CuCF3. 


















1 1.5 0.33 50 23 0.35 A 84 76 
2 2 0.33 23 120 0.38 B 95 86 
3 2 0.33 50 25 0.35 A 97 84 
4 2 0.43 50 24 0.37 B 96 92 
5 2 0.53 50 20 0.37 B 94 87 
6 2 0.63 50 20 0.37 B 92 85 
7 2.5 0.43 50 24 0.37 B 99 93 
8 2.5 0.53 50 26 0.37 B 98 91 
9 2.5 0.63 50 26 0.37 B 96 90 
10 2.5 0.43 40 62 0.38 B 99 90 
11 2.5 0.53 40 62 0.38 B 98 90 
12 2 0.53 80 4+1d 0.38 C 89 86 
(a) Equiv per 1 equiv of CuCF3. 
(b) The reaction scale is 0.125 mmol except entry 12 that is 0.250 mmol. (c) 
Determined by GC-MS. (d) Determined by 19F NMR. (e) CuCF3 in DMF was added during 4 h via a syringe 
pump, followed by heating for one additional h. 
 
3.2.5.4. Trifluoromethylation of bromoalkenes 
Procedure A. In a glovebox, to bromoalkene 4 (0.125 mmol) and 4,4'-difluoro-1,1'-
biphenyl (18 mg; internal standard) in an NMR tube was added, at room temperature, 
CuCF3 in DMF (0.36-0.38 M; 2.5 equiv) containing 0.1 extra equiv of Et3N∙3HF. The 
tube was sealed with a rubber septum, brought out, and kept at 50 ºC (oil bath) for 21-
28 h (entries 1-12 and 16, Table 3.2.6). Ether (0.5 mL) and water (1 mL) were added in 
air. After agitation, the organic layer was filtered through a short silica gel plug and 
analyzed by GC-MS to determine the conversion of 4. The yield of 5 was determined by 
quantitative 
19
F NMR analysis of the filtrate. 
Procedure B. In a glove-box, to CuCF3 in DMF (0.35-0.38 M; 2.5 equiv) 
containing 0.1 extra equiv of Et3N∙3HF (0.2 equiv in the case of 5o; entry 14) in an 
NMR tube was added, at room temperature, bromoalkene 4 (0.125 mmol) and 1,3-
bis(trifluoromethyl)benzene (10 μL; internal standard) via microsyringe. The tube was 




sealed with a rubber septum, brought out, and kept at 50 ºC (oil bath) for 28-30 h  
(entries 13-15, Table 3.2.6). Ether (0.5 mL) and water (1 mL) were added in air. After 
agitation, the organic layer was filtered through a short silica gel plug and analyzed by 
GC-MS to determine the conversion of 4. The yield of 5 was determined by quantitative 
19
F NMR analysis of the filtrate (for 5p, the yield was determined before workup; entry 
15). 
 
3.2.5.5. Pentafluoroethylation of bromoalkenes 
Procedure A. In a glovebox, to 4,4'-difluoro-1,1'-biphenyl (18 mg; internal 
standard) in an NMR tube was added CuC2F5 reagent (0.69 M; 0.2 mL; 1.1 equiv) 
containing extra 0.2 equiv of Et3N·3HF, the tube was sealed with a rubber septum and 
brought out. β-Bromostyrene (4a; 16 μL; 0.125 mmol) was added, at room temperature, 
via microsyringe and the NMR tube was kept at 70 ºC (oil bath) for 14 h (entry 1, Table 
3.2.7). Ether (1 mL) and water (2 mL) were added in air. After agitation, the organic 
layer was filtered through a short silica gel plug and analyzed by GC-MS to determine 
the full conversion of 4a. Quantitative 
19
F NMR analysis of the filtrate indicated that 6a 
was produced in 97% yield. 
Procedure B. In a glovebox, to bromoalkene 4 (0.125 or 0.25 mmol) in an NMR 
tube was added, at room temperature, CuC2F5 in DMF (0.67-0.7 M; 1.1 equiv) 
containing 0.2 extra equiv of Et3N∙3HF. The tube was sealed with a rubber septum, 
brought out, and 1,3-bis(trifluoromethyl)benzene (10 or 19 μL; internal standard) was 
added via microsyringe. The NMR tube was kept at 50-80 ºC (oil bath) for an indicated 
period of time (entries 2, 3, 5, 6 and 8-14, Table 3.2.7). Ether (1 mL) and water (2 mL)  
were added in air. After agitation, the organic layer was filtered through a short silica 
gel plug and analyzed by GC-MS to determine the conversion of 4. The yield of 3 was 
determined by quantitative 
19
F NMR analysis of the filtrate. 
Procedure C. In a glove-box, to bromoalkene 4 (0.125 mmol) and 4,4'-difluoro-
1,1'-biphenyl (18 mg; internal standard) in an NMR tube was added, at room 
temperature, CuC2F5 in DMF (0.67 M; 0.21 mL; 1.1 equiv) containing 0.2 extra equiv 
of Et3N∙3HF. The tube was sealed with a rubber septum, brought out, and kept at 70 ºC 
(oil bath) for 14 h (entries 4 and 7, Table 3.2.7). Ether (1 mL) and water (2 mL) were 
added in air. After agitation, the organic layer was filtered through a short silica gel 
plug and analyzed by GC-MS to determine the full conversion of 4. The yield of 6 was 
determined by quantitative 
19
F NMR analysis of the filtrate. 




Procedure D. In a glovebox, to CuC2F5 in DMF (0.7 M; 0.39 mL; 1.1 equiv) 
containing 0.2 extra equiv of Et3N∙3HF in an NMR tube equipped with a J. Young valve 
was added, at room temperature, bromoalkene 4 (0.25 mmol) and 1,3-
bis(trifluoromethyl)benzene (19 μL; internal standard) via microsyringe. The NMR tube 
was sealed, brought out, and kept at 80 ºC (oil bath) for 21 h (entries 15 and 16, Table 
3.2.7). The NMR tube was brought back to the glovebox, the reaction mixture was 
diluted with ether (1 mL), and filtered through a Teflon syringe filter. The filtrate was 
placed in a clean NMR tube, which was then sealed with a rubber septum and brought 
out. The yield of 3 was determined by quantitative 
19
F NMR analysis. Then the tube 
was unsealed in air, the solution was washed with water (3 mL), filtered through a short 
silica gel plug, and analyzed by GC-MS to determine the conversion of 4. 
 











































24 0.38 A 100 90 99:1 99:1 



























28 0.38 B 50 26 - - 
14  
5o 
30 0.35h B 60 35 - - 
15  
5p 
28 0.38 B 55 58i - - 
16  
5q 
28 0.38 A 75 73i 50:50 63:37 
(a) Reactions were performed on 0.125 mmol scale, at 50 °C. (b) CuCF3 reagent (2.5 equiv) containing 0.1 equiv 
of extra Et3N·3HF (0.43 equiv overall) was used. 
(c) Determined by GC-MS. (d) Determined by 19F NMR. (e) 
Determined by 1H NMR. (f) 2.2 equiv of CuCF3 was used. 
(g) Bis-trifluoromethylated side-product was also 
formed. (h) CuCF3 reagent containing 0.2 equivof extra Et3N·3HF was used. 
(i) The yield of the reaction was 
determined before workup. 
 

























70 20 0.67 B 100 92 99:1 99:1 



















































70 30 0.7 B 100 64 - - 
15  
6p 
80 21 0.7 D 92 70g - - 
16  
6q 
80 21 0.7 D 91 78g 50:50 56:44 
(a) CuC2F5 reagent (1.1 equiv) containing 0.2 equiv of extra Et3N.3HF (0.53 equiv overall) was used. 
(b) The reaction 
scale is 0.125 mmol for entry 1-8 except entry 5 and for enrty 5 and 9-18 it is 0.250 mmol. (c) Determined by GC-MS. (d) 
Determined by 19F NMR. (e) Determined by 1H NMR. (f) 1 equiv of CuC2F5 was used. 
(g) Bis-pentafluoroethylated side-
product was also formed. (h) The yield was determined before workup.  




3.2.5.6. Trifluoromethylation of iodoalkenes 
In a glovebox, to iodoalkene 7 (0.125 mmol) and 4,4'-difluoro-1,1'-biphenyl (18 mg; 
internal standard) in an NMR tube was added, at room temperature, CuCF3 in DMF 
(0.36-0.38 M; 1.1 equiv) containing 0.1 extra equiv of Et3N∙3HF. The tube was sealed 
with a rubber septum, brought out, and kept at 23-50 ºC for an indicated 
period of time (Table 3.2.8). Ether (0.5 mL) and water (1 mL) were added in air. After 
agitation, the organic layer was filtered through a short silica gel plug and analyzed by 
GC-MS to determine the conversion of 7. The yield of 5 was determined by quantitative 
19
F NMR analysis of the filtrate. 
 
3.2.5.7. Pentafluoroethylation of iodoalkenes 
In a glovebox, to iodoalkene 7 (0.125 or 0.25 mmol) in an NMR tube was added, at 
room temperature, CuC2F5 in DMF (0.68-0.7 M; 1.1 equiv) containing 0.2 extra equiv 
of Et3N∙3HF. The tube was sealed with a rubber septum, brought out, and 1,3-
bis(trifluoromethyl)benzene (10 or 19 μL; internal standard) was added via 
microsyringe. The NMR tube was kept at 23-70 ºC for an indicated period of time 
(Table 3.2.9). Ether (1 mL) and water (2 mL) were added in air. After agitation, the 
organic layer was filtered through a short silica gel plug and analyzed by GC-MS to 
determine the conversion of 7. The yield of 6 was determined by quantitative 
19
F NMR 
analysis of the filtrate. 
 




















23 1.5 0.36 100 92 95:5 95:5 
2 
5r 
23 1.5 0.38 100 92 98:2 98:2 
3 
5s 
23 2 0.38 100 91 99:1 99:1 















50 13 0.38 100 93 100:0 100:0 
(a) Reactions were performed on 0.125 mmol scale using 4,4'-difluoro-1,1'-biphenyl (18 mg) as internal standard. 
(b) CuCF3 reagent (1.1 equiv) containing 0.1 equiv of extra Et3N.3HF (0.43 equiv overall) was used. 
(c) Determined 
by GC-MS. (d) Determined by 19F NMR. (e) Determined by 1H NMR. (f) Substrate also contained 6 mol % of 1-(2,2-
diiodovinyl)naphthalene  (1H NMR, GC-MS). 
 























23 10 0.7 100 92 98:2 98:2 
3 
6s 




23 16 0.7 100 87 99:1f 99:1 
5  
6u 




70 7 0.7 100 91 100:0 100:0 
(a) Reactions were performed in the presence of 1,3-bis(trifluoromethyl)benzene (10 µl per 0.125 mmol of 
iodoalkene) as internal standard.  (b) The reaction scale is 0.250 mmol except for entry 2,5 and 6 it is 0.125 
mmol. (c) CuC2F5 reagent (1.1 equiv) containing 0.2 equiv of extra Et3N.3HF (0.53 equiv overall) was used. 
(d) 
Determined by GC-MS. (e) Determined by 19F NMR. (f) Determined by 1H NMR. (g) Substrate also contained 6 
mol% of 1-(2,2-diiodovinyl)naphthalene (1H NMR, GC-MS).  






F NMR data 
Tables 3.2.10 and 3.2.11 list 
19
F NMR chemical shifts of the trifluoromethylated and 
pentafluoroethylated products as measured directly for the organic solvent extracts used 
for the quantitative 
19
F NMR yield determination with 1,3-bis(trifluoromethyl)benzene 




F NMR shifts of trifluoromethylated products (unlocked). 
Product 19F NMR, ppm Ref. 
 
5a 
E: -62.5 (dd, 3JF-H = 6.5 Hz; 
4JF-H = 2.1 Hz); 




E: -63.5 (dd, 3JF-H = 6.2 Hz, 
4JF-H = 1.9 Hz); 




E: -63.4 (dd, 3JF-H = 6.6 Hz, 
4JF-H = 2.0 Hz); 




-63.5 (dd, 3JF-H = 6.3 Hz, 
4JF-H = 1.7 Hz) 30 
 
5e 
E: -63.3 (dd, 3JF-H = 6.5 Hz, 
4JF-H = 1.5 Hz); 




E: -63.6 (dd, 3JF-H = 6.5 Hz, 
4JF-H = 1.9 Hz, 3F), -111.0 (m, 
1F); 




-63.9 (dd, 3JF-H = 6.5 Hz, 
4JF-H = 2.0 Hz) 30 
 
5h 
E: -64.2 (dd, 3JF-H = 6.4, 
4JF-H = 2.0 Hz); 




mono: -63.8 (d, 3JF-H = 6.5 Hz, 
4JF-H = 1.6 Hz); 
bis: -63.2 (s), -64.1 (dd, 3JF-H = 6.4 Hz, 
4JF-H = 1.4 Hz) 
30 






mono, E: -64.1 (dd, 3JF-H = 6.4 Hz, 
4JF-H = 2.0 Hz); 
bis, E: -59.3 (s), -64.5 (dd, 3JF-H = 6.3 Hz, 
4JF-H = 2.0 Hz); 




Z: -64.2 (dd; 4JF-H = 2.3, 1.4 Hz); 




Z: -64.2 (s); 




E: -57.3 (m); 




-63.9 (s) 11b 
 
5o 
-65.6 (d, 3JF-H = 5.8 Hz) 33 
 
5p 
-69.7 (s) 34 
 
5q 
E: -68.8 (m); 




E: -64.2 (dd, 3JF-H = 6.3, 
4JF-H = 2.0 Hz); 




E: -62.4 (dd, 3JF-H = 6.5, 
4JF-H = 2.0 Hz) 





Z: -58.1 (d, 3JF-H = 8.3 Hz); 
E: -63.8 (dd, 3JF-H = 6.5 Hz, 




-61.2 (s) - 
 
5v 
-70.2 (s) 38 
  






F NMR shifts of pentafluoroethylated products (unlocked). 
Product 19F NMR, ppm Ref. 
 
6a 
E: -85.5 (t, 3JF-F = 2.2 Hz, 3F), -115.0 (ddq, 
3JF-H = 12.0 Hz, 
4JF-H = 
3JF-F = 2.2 Hz, 2F); 
Z: -86.0 (t, 3JF-F = 2.6 Hz, 3F), -109.1 (ddq, 
3JF-H = 15.6 Hz, 
4JF-H = 




E: -84.3 (m, 3F), -113.7 (ddq, 3JF-H = 11.8 Hz, 
4JF-H = 
3JF-F = 
2.1 Hz, 2F); 




E: -84.3 (m, 3F), -113.7 (ddq, 3JF-H = 12.0 Hz, 
4JF-H = 
3JF-F = 
2.0 Hz, 2F); 




-85.6 (s, 3F), -114.8 (d, 3JF-H = 12.7 Hz, 2F) - 
 
6e 
E: -84.4 (t, 3JF-F = 2.4 Hz, 3F), -113.6 (ddq, 
3JF-H = 12.1 Hz, 
4JF-H = 
3JF-F = 2.4 Hz, 2F); 




E: -84.3 (s, 3F), -109.4 (m, 1F), -113.7 (d, 3JF-H =11.5 Hz, 
2F); 





85.5 (t, 3JF-F = 2.4 Hz, 3F), -115.1 (ddq, 
3JF-H = 11.6 Hz, 
4JF-H 




E: -84.2 (s, 3F), -114.0 (d, 3JF-H = 11.9 Hz, 2F); 




mono: -84.3 (m, 3F), -113.9 (d, 3JF-H = 12.1 Hz, 2F); 
bis: -83.9 (s, 3F), -84.2 (s, 3F), -114.0 (s, 2F), -114.2 (d, 3JF-H 




mono, E: -84.2 (m, 3F), -114.1 (ddq, 3JF-H = 11.7 Hz, 
4JF-H = 
3JF-F = 2.0 Hz, 2F); 
bis, E: -83.2 (s, 3F), -84.2 (s, 3F), -108.1 (s, 2F), -114.5 (d, 
3JF-H = 12.1 Hz, 2F); 
mono, Z: -84.5 (s, 3F), -109.2 (d, 3JF-H = 15.0 Hz, 2F) 
- 






Z: -82.7 (s, 3F), -113.2 (s, 2F); 




Z: -82.8 (s, 3F), -111.8 (s, 2F); 




E: -84.6 (s, 3F), -108.0 (m, 2F); 




-81.9 (m, 3F), -112.1 (m, 2F) 39 
 
6p 
-82.9 (s, 3F), -116.3 (s, 2F) - 
 
6q 
E: -83.0 (s, 3F), -115.7 (s, 2F); 




E: -84.1 (t, 3JF-F = 2.3 Hz, 3F), -114.7 (ddq, 
3JF-H = 11.5 Hz, 
4JF-H = 
3JF-F = 2.3 Hz, 2F); 
Z: -84.6 (t, 3JF-F = 2.3 Hz, 3F), -108.9 (ddq, 
3JF-H = 15.3 Hz, 
4JF-H = 




E: -84.2 (t, 3JF-F = 2.3 Hz, 3F), -113.6 (ddq, 
3JF-H = 12.1 Hz, 
4JF-H = 
3JF-F = 2.3 Hz, 2F); 




Z: -84.5 (s, 3F), -108.7 (d, 3JF-H = 14.8 Hz, 2F); 




E: -82.0 (s, 3F), -108.9 (s, 2F) - 
 
6v 
-83.0 (s, 3F), -116.4 (s, 2F) - 
  




3.2.5.9. Products isolation 
(3,3,3-Trifluoroprop-1-enyl)benzene (5a). To β-bromostyrene (4a; trans/cis = 8:1; 
purity 96%, 1.91 g, 10 mmol) was added under argon at room 
temperature CuCF3 in DMF (0.36 M; 69.0 mL; 2.5 equiv) containing 
an extra 0.1 equiv of TREAT HF, and the mixture was stirred for 24 h at 50 °C.  
Pentane (50 mL), water (500 mL), and aqueous NH3 (33%; 5 mL) were added.  The 
organic layer was separated and the aqueous layer was washed with pentane (2 × 25 
mL).  The combined pentane solutions were washed with brine (2 × 100 mL), dried 
over MgSO4, and filtered through a short silica gel plug.  Evaporation (23 °C, 10 mbar) 
of the filtrate gave 5a as a slightly yellowish oil (1.27 g; 74%; E/Z = 8:1).  E isomer: 
1
H 
NMR (CDCl3, 400 MHz): δ = 7.50 – 7.43 (m, 2H), 7.43 – 7.34 (m, 3H), 7.16 (dq, 
3
JH-H 
= 16.1 Hz, 
4
JF-H = 2.2 Hz, 1H), 6.21 (dq, 
3
JH-H = 16.1 Hz, 
3
JF-H = 6.5 Hz, 1H). 
13
C NMR 
(CDCl3, 101 MHz): δ = 137.8 (q, 
3
JC-F = 6.8 Hz), 133.6, 130.2, 129.1, 127.7, 123.8 (q, 
1
JC-F = 268.8 Hz), 116.0 (q, 
2
JC-F = 33.8 Hz).
 19
F NMR (376 MHz, CDCl3): δ = -63.4 
(dd, 
3
JH-F = 6.5 Hz, 
4




(E)-1-Methyl-3-(3,3,3-trifluoroprop-1-enyl)benzene (5c). To (E)-1-(2-bromovinyl)-
3-methylbenzene (4c; 1.38 g, 7 mmol) was added under argon at 
room temperature CuCF3 in DMF (0.38 M; 46.1 mL; 2.5 equiv) 
containing an extra 0.1 equiv of TREAT HF, and the mixture was stirred for 23 h at 50 
°C. Pentane (100 mL), water (200 mL), and aqueous NH3 (33%; 5 mL) were added. 
The organic layer was separated and the aqueous layer was washed with pentane (2 × 
50 mL).  The combined pentane solutions were washed with brine (2 × 50 mL), dried 
over MgSO4, filtered, and evaporated (23 °C, <100 mbar). Column chromatography of 
the residue in pentane produced 5c as a colorless oil (1.125 g; 86%). The product 




H NMR (CDCl3, 500 
MHz): δ = 7.31 – 7.24 (m, 3H), 7.22 – 7.18 (m, 1H), 7.12 (dq, 
2
JH-H = 16.1 Hz, 
4
JF-H= 
2.1 Hz, 1H), 6.19 (dq, 
3
JH-H = 16.1 Hz, 
3
JF-H = 6.6 Hz, 1H), 2.38 (s, 3H).  
13
C NMR 
(CDCl3, 101 MHz): δ = 138.8, 138.0 (q, 
3
JC-F = 6.8 Hz), 133.5, 131.0, 128.9, 128.3, 
124.9, 123.9 (q, 
1
JC-F = 268.7 Hz), 115.7 (q, 
2
JC-F = 33.7 Hz), 21.4. 
19
F NMR (376 MHz, 
CDCl3): δ = -63.4 (dd, 
3
JH-F = 6.6 Hz, 
4








(E)-1-Methoxy-4-(3,3,3-trifluoroprop-1-enyl)benzene (5e). To (E)-1-(2-
bromovinyl)-4-methoxybenzene (4e; 213 mg, 1mmol) was 
added under argon at room temperature CuCF3 in DMF (0.38 
M; 6.6 mL; 2.5 equiv) containing an extra 0.1 equiv of TREAT HF, and the mixture 
was stirred for 24 h at 50 °C. Pentane (50 mL), water (50 mL), and aqueous NH3 (33%; 
1 mL) were added. The organic layer was separated and the aqueous layer was washed 
with pentane (2 × 20 mL). The combined pentane solutions were washed with brine (2 
× 25 mL), dried over MgSO4, filtered, and evaporated (23 °C, 10 mbar). Column 
chromatography of the residue in pentane produced 5e as a white solid (178 mg; 88%). 







H NMR (CDCl3, 400 MHz): δ = 7.43 – 
7.37 (m, 2H), 7.09 (dq, 
3
JH-H =16.1 Hz, 
4
JF-H = 2.1 Hz, 1H), 6.94 – 6.88 (m, 2H), 6.06 
(dq, 
3
JH-H = 16.1 Hz, 
3
JF-H = 6.6 Hz, 1H), 3.84 (s, 3H). 
13
C NMR (CDCl3, 101 MHz): δ 
= 161.2, 137.3 (q, 
3
JC-F = 6.8 Hz), 129.2, 126.2, 124.1 (q, 
1
JC-F = 268.5 Hz), 114.4, 
113.5 (q, 
2
JC-F = 33.6 Hz), 55.4. 
19
F NMR (376 MHz, CDCl3): δ = -62.9 (dd, 
3
JH-F = 6.6 
Hz, 
4




(E)-1-Chloro-2-(3,3,3-trifluoroprop-1-enyl)benzene (5h). To 1-chloro-2-(2-
bromovinyl)benzene (4h; 218 mg, 1mmol) was added under 
argon at room temperature CuCF3 in DMF (0.38 M; 6.6 mL; 2.5 
equiv) containing an extra 0.1 equiv of TREAT HF, and the 
mixture was stirred for 24 h at 50 °C. Pentane (50 mL), water 
(50 mL), and aqueous NH3 (33%; 1 mL) were added. The organic layer was separated 
and the aqueous layer was washed with pentane (2 × 20 mL). The combined pentane 
solutions were washed with brine (2 × 25 mL), dried over MgSO4, filtered, and 
evaporated (23 °C, 10 mbar). After column chromatography of the residue in pentane 
and subsequent trap-to-trap distillation 5h was obtained as a colorless oil (192 mg; 
92%). The product contained 1% of the corresponding Z-isomer (GC-MS; 
19
F NMR).  
1
H NMR (CDCl3, 400 MHz): δ = 7.60 (dq, 
3
JH-H = 16.2 Hz, 
4
JF-H = 2.1 Hz, 1H), 7.56 – 
7.51 (m, 1H), 7.45 – 7.40 (m, 1H), 7.36 – 7.27 (m, 2H), 6.22 (dq, 
3
JH-H = 16.1 Hz, 
3
JF-H 
= 6.4 Hz, 1H). 
13
C NMR (CDCl3, 101 MHz): δ = 134.6, 134.2 (q, 
3
JC-F = 6.9 Hz), 
131.9, 131.1, 130.3, 127.5, 127.3, 123.4 (q, 
1
JC-F = 269.2 Hz), 118.5 (q, 
2
JC-F = 34.1 
Hz). 
19
F NMR (376 MHz, CDCl3): δ = -63.7 (dd, 
3
JH-F = 6.4 Hz, 
4








3-Phenyl-2-(trifluoromethyl)acrylaldehyde (5k). To (Z)-2-bromo-3-
phenylacrylaldehyde (4k; 215 mg, 1mmol) was added under 
argon at room temperature CuCF3 in DMF (0.38 M; 6.6 mL; 
2.5 equiv) containing an extra 0.2 equiv of TREAT HF, and 
the mixture was stirred for 24 h at 50 °C. Ether (40 mL), water (80 mL), and aqueous 
NH3 (33%; 1 mL) were added. The organic layer was separated and the aqueous layer 
was washed with ether (2 × 20 mL). The combined ether solutions were washed with 
brine (2 × 40 mL), dried over MgSO4, filtered, and evaporated. Purification of the 
residue on a short silica gel plug with pentane gave 5k as a yellow oil (155 mg; 78%). 





F NMR). Z-isomer: 
1
H NMR (CDCl3, 400 MHz): δ = 9.86 (q, 
4
JF-H 
= 2.8 Hz, 1H), 8.17 (s, 1H), 7.59-7.41 (m, 5H).  
13
C NMR (CDCl3, 101 MHz): δ = 
186.7, 149.7 (q, 
3
JC-F = 5.5 Hz), 131.6, 130.8 (q, 
4
JC-F = 2.6 Hz), 130.7, 129.9 (q, 
2
JC-F = 
28.1 Hz), 129.1, 122.2 (q, 
1
JC-F = 274.8 Hz). 
19
F NMR (376 MHz, CDCl3): δ = -64.9 (q, 
4




(E)-4-(3,3,3-Trifluoroprop-1-enyl)benzonitrile (5r). To (E)-4-(2-
iodovinyl)benzonitrile (4r; 255 mg, 1mmol) was added under 
argon at room temperature CuCF3 in DMF (0.38 M; 2.9 mL; 
1.1equiv) containing an extra 0.1 equiv of TREAT HF, and 
the mixture was stirred for 1.5 h at 23 °C. Ether (30 mL), water (60 mL), and aqueous 
NH3 (33%; 5 mL) were added. The organic layer was separated and the aqueous layer 
was washed with ether (2 × 20 mL). The combined ether solutions were washed with 
brine (2 × 15 mL), dried over MgSO4, filtered, and evaporated (23 °C, 5 mbar). 
Column chromatography of the residue in pentane produced 5r as a yellow solid (160 





H NMR (CDCl3, 500 MHz): δ = 7.72 – 7.67 (m, 2H), 7.58 – 7.53 (m, 2H), 
7.17 (dq, 
3
JH-H = 16.1 Hz, 
4
JF-H = 2.0 Hz, 1H), 6.31 (dq, 
3
JH-H = 16.2 Hz, 
3
JF-H = 6.3 Hz, 
1H). 
13
C NMR (CDCl3, 100 MHz): δ = 137.8, 136.0 (q, 
3
JC-F = 6.8 Hz), 132.8, 128.2, 
123.1 (q, 
1
JC-F = 269.4 Hz), 119.5 (q, 
2
J C-F = 34.3 Hz), 118.3, 113.6. 
19
F NMR (376 
MHz, CDCl3): δ = -64.0 (dd, 
3
JH-F = 6.3 Hz, 
4








(E)-2-(3,3,3-Trifluoroprop-1-enyl)naphthalene (5s). To (E)-2-(2-
iodovinyl)naphthalene (4s; 560 mg, 2mmol) was added 
under argon at room temperature CuCF3 in DMF (0.38 M; 
5.8 mL; 1.1 equiv) containing an extra 0.1 equiv of TREAT 
HF, and the mixture was stirred for 2 h at 23 °C. Ether (50 mL), water (80 mL), and 
aqueous NH3 (33%; 5 mL) were added. The organic layer was separated and the 
aqueous layer was washed with ether (2 × 20 mL). The combined ether solutions were 
washed with brine (2 × 25 mL), dried over MgSO4, filtered, and evaporated (23 °C, 5 
mbar). Column chromatography of the residue in pentane produced 5s as a white solid 





H NMR (CDCl3, 400 MHz): δ = 7.89 – 7.82 (m, 4H), 7.60 (dd, 
3
JH-H = 8.6 Hz, 
4
JH-H = 1.7 Hz, 1H), 7.55 – 7.49 (m, 2H), 7.32 (dq, 
3
JH-H = 16.2 Hz, 
4
JF-H = 2.0 Hz, 1H), 
6.32 (dq, 
3
JH-H = 16.1 Hz, 
3
JF-H = 6.5 Hz, 1H).  
13
C NMR (CDCl3, 101 MHz): δ = 137.9 
(q, 
3
JC-F = 6.8 Hz), 134.2, 133.4, 131.0, 129.2 (q, 
4
JC-F = 0.7 Hz), 128.9, 128.6, 127.9, 
127.3, 126.9, 123.9 (q, 
1
JC-F = 268.8 Hz), 123.3, 116.1 (q, 
2
JC-F = 33.8 Hz). 
19
F NMR 
(376 MHz, CDCl3): δ = -63.2 (dd, 
2
JH-F = 6.5 Hz, 
4




(3,3,4,4,4-Pentafluorobut-1-enyl)benzene (6a). To β-bromostyrene (4a; trans/cis = 
8:1; purity 96%, 953 mg, 5 mmol) was added under argon at 
room temperature CuC2F5 in DMF (0.7 M; 7.9 mL; 1.1 equiv) 
containing an extra 0.2 equiv of TREAT HF, and the mixture 
was stirred for 14 h at 70 °C. Pentane (50 mL), water (80 mL), and aqueous NH3 (33%; 
3 mL) were added. The organic layer was separated and the aqueous layer was washed 
with pentane (2 × 20 mL). The combined pentane solutions were washed with brine (2 
× 40 mL), dried over MgSO4, filtered, and evaporated (23 °C, 10 mbar). Column 
chromatography of the residue in pentane produced 6a as a colorless oil (990 mg; 89%; 
E/Z = 8:1). E isomer: 
1
H NMR (CDCl3, 400 MHz): δ = 7.52 – 7.45 (m, 2H), 7.44 – 
7.34 (m, 3H), 7.19 (dt, 
3
JH-H = 16.2 Hz, 
4
JF-H = 2.3 Hz, 1H), 6.18 (dtq, 
3
JH-H = 16.2 Hz, 
3
JF-H = 11.9 Hz, 
4
JF-H = 0.8 Hz, 1H).  
13
C NMR (CDCl3, 101 MHz): δ = 139.9 (t, 
3
JC-F = 
9.2 Hz), 133.7, 130.3, 129.1, 127.8 (t, 
4
JC-F = 1.0 Hz), 119.3 (qt, 
1
JC-F = 285.5, 
2
JC-F = 
38.5 Hz), 114.2 (t, 
2
JC-F = 23.1 Hz), 113.0 (tq, 
1
JC-F = 250.4 Hz, 
2
JC-F = 38.6 Hz). 
19
F 
NMR (376 MHz, CDCl3): δ = -85.5 (t, 
3
JF-F = 2.2 Hz, 3F), -115.0 (ddq, 
3




JF-F = 2.2 Hz, 2F).
3,23
  




(E)-1-Methoxy-4-(3,3,4,4,4-pentafluorobut-1-enyl)benzene (6e). To (E)-1-(2-
bromovinyl)-4-methoxybenzene (213 mg, 1mmol) was 
added under argon at room temperature CuC2F5 in DMF 
(0.68 M; 1.6 mL; 1.1 equiv) containing an extra 0.2 equiv 
of TREAT HF, and the mixture was stirred for 18 h at 70 °C. Ether (30 mL), water (30 
mL), and aqueous NH3 (33%; 1 mL) were added. The organic layer was separated and 
the aqueous layer was washed with ether (2 × 15 mL). The combined ether solutions 
were washed with brine (2 × 25 mL), dried over MgSO4, filtered, and evaporated (23 
°C, 10 mbar). Column chromatography of the residue in pentane produced 6e as a 
colorless oil (235 mg; 93%). 
1
H NMR (CDCl3, 500 MHz): δ = 7.44 – 7.40 (m, 2H), 
7.12 (dt, 
3
JH-H = 16.2 Hz, 
4





JF-H = 12.0 Hz, 
4
JF-H = 0.7 Hz, 1H). 
13
C NMR (CDCl3, 101 MHz): δ = 161.4, 
139.2 (t, 
3
JC-F = 9.2 Hz), 129.3, 126.4, 119.3 (qt, 
1
JC-F = 285.4 Hz,  
2
JC-F = 38.9 Hz), 114.5, 113.2 (tq, 
1
JC-F = 250.1 Hz, 
2
JC-F = 38.4 Hz), 111.6 (t, 
2
JC-F = 
23.1 Hz), 55.4. 
19
F NMR (376 MHz, CDCl3): δ = -84.4 (t, 
3
JF-F = 2.4 Hz, 3F), -113.6 
(ddq, 
3




JF-F = 2.4 Hz, 2F).  Anal. Calcd. for C11H9F5O: C, 52.4; 
H, 3.6. Found: C, 53.0; H, 3.8. 
 
(E)-1-Chloro-4-(3,3,4,4,4-pentafluorobut-1-enyl)benzene (6g). To (E)-1-(2-
bromovinyl)-4-chlorobenzene (327 mg, 1.5 mmol) was 
added under argon at room temperature CuC2F5 in DMF 
(0.68 M; 2.4 mL; 1.1 equiv) containing an extra 0.2 equiv 
of TREAT HF, and the mixture was stirred for 14 h at 70 °C.  Ether (50 mL) and water 
(100 mL) were added. The organic layer was separated and the aqueous layer was 
washed with ether (2 × 25 mL). The combined ether solutions were washed with brine 
(2 × 30 mL), dried over MgSO4, filtered, and evaporated (23 °C, 10 mbar).  After 
column chromatography of the residue in pentane and subsequent trap-to-trap 
distillation 6g was obtained as a colorless oil (320 mg; 83%). 
1
H NMR (CDCl3, 400 
MHz): δ = 7.44 – 7.34 (m, 4H), 7.14 (dt, 
3
JH-H = 16.2 Hz, 
4
J F-H = 2.3 Hz, 1H), 6.17 
(dtq, 
3
JH-H = 16.1 Hz, 
3
JF-H = 11.7 Hz, 
4
JF-H = 0.7 Hz, 1H). 
13
C NMR (CDCl3, 126 
MHz): δ = 138.5 (t, 
3
JC-F = 9.2 Hz), 136.2, 132.0, 129.3, 129.0, 119.1 (qt, 
1
JC-F = 285.5 
Hz, 
2
JC-F = 38.4 Hz), 114.7 (t, 
2
JC-F = 23.1 Hz), 112.7 (tq, 
1
JC-F = 251.5 Hz, 
2
JC-F = 38.7 
Hz). 
19
F NMR (376 MHz, CDCl3): δ = 85.5 (t, 
3
JF-F = 2.4 Hz, 3F), -115.1 (ddq, 
3
JF-H = 








JF-F = 2.4 Hz, 2F). Anal. Calcd. for C10H6ClF5: C, 46.8; H, 2.4. Found: 
C, 46.9; H, 2.6. 
 
(E)-2-(3,3,4,4,4-Pentafluorobut-1-enyl)naphthalene (6s). To (E)-2-(2-
iodovinyl)naphthalene (2.52 g, 9 mmol) was added under 
argon at room temperature CuC2F5 in DMF (0.7 M; 14.1 
mL; 1.1 equiv) containing an extra 0.2 equiv of TREAT HF, 
and the mixture was stirred for 10 h at 23 °C. Pentane (50 mL), water (100 mL), and 
aqueous NH3 (33%; 10 mL) were added. The organic layer was separated and the 
aqueous layer was washed with pentane (2 × 25 mL). The combined pentane solutions 
were washed with brine (2 × 25 mL), dried over MgSO4, filtered, and evaporated. 
Column chromatography of the residue in pentane produced 6s as a white solid (2.27 g; 
93%). 
1
H NMR (CDCl3, 400 MHz): δ = 7.91 – 7.82 ( m, 4H), 7.62 (dd, 
3
JH-H = 8.6 Hz, 
4
J H-H = 1.7 Hz, 1H), 7.56 – 7.50 (m, 2H), 7.35 (dq, 
3
JH-H = 16.2 Hz, 
4
JH-F = 2.3 Hz, 1H), 
6.29 (dtq, 
3
JH-H = 16.1 Hz, 
3
JF-H = 11.7 Hz, 
4
JF-H = 0.7 Hz, 1H). 
13
C NMR (CDCl3, 101 
MHz): δ = 139.9 (t, 
3
JC-F = 9.2 Hz), 134.2, 133.4, 131.1 (t, 
4
JC-F = 1.2 Hz), 129.4 (t, 
4
JC-F 
= 1.2 Hz), 128.9, 128.6, 127.9, 127.4, 127.0, 123.2, 119.3 (qt, 
1
JC-F = 285.6 Hz, 
2
JC-F = 
38.6 Hz), 114.3 (t, 
2
JC-F = 23.1 Hz), 113.1 (tq, 
1
JC-F = 250.3 Hz, 
2
JC-F = 38.5 Hz). 
19
F 
NMR (376 MHz, CDCl3): δ = -84.2 (t, 
3
JF-F = 2.3 Hz, 3F), -113.6 (ddq, 
3




JF-F = 2.3 Hz, 2F). Anal. Calcd. for C14H9F5: C, 61.8; H, 3.3. Found: C, 61.7; H, 
3.3. 
 
(Z)-(3,3,4,4,4-Pentafluoro-2-methylbut-1-enyl)benzene (6u). To (Z)-2-
iodopropenylbenzene (1.22 g, 5 mmol) was added under argon at 
room temperature CuC2F5 in DMF (0.7 M; 7.9 mL; 1.1 equiv) 
containing an extra 0.2 equiv of TREAT HF, and the mixture was 
stirred for 24 h at 50 °C. Pentane (50 mL), water (80 mL), and aqueous NH3 (33%; 5 
mL) were added. The organic layer was separated and the aqueous layer was washed 
with pentane (2 × 20 mL). The combined pentane solutions were washed with brine (2 
× 40 mL), dried over MgSO4, filtered, and evaporated (23 °C, 10 mbar). Column 
chromatography of the residue in pentane produced 6u as a colorless oil (0.99 g; 84%). 





(CDCl3, 400 MHz): δ = 7.34 – 7.24 (m, 3H), 7.24 – 7.16 (m, 2H), 7.01 (s, 1H), 2.06 (s, 
3H). 
13
C NMR (CDCl3, 101 MHz): δ = 138.4 (t, 
3
JC-F = 4.3 Hz), 135.7, 128.1 (t, 
4
JC-F = 




2.8 Hz), 127.9, 127.6, 125.3 (t, 
2
JC-F = 20.9 Hz), 119.5 (qt, 
1
JC-F = 287.6 Hz, 
2
JC-F = 38.3 
Hz), 114.0 (tq, 
1
JC-F = 255.4 Hz, 
2
JC-F = 38.5 Hz), 19.7 (tq, 
3
JC-F = 4.3 Hz, 
4
JC-F = 1.9 
Hz). 
19
F NMR (376 MHz, CDCl3): δ = -82.0 (s, 3F), -108.9 (s, 2F). Anal. Calcd. for 
C11H9F5: C, 55.9; H, 3.8. Found: C, 56.6; H, 3.9. 
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General introduction II: Catalyst design for C-X 






















It is widely accepted that sustainable industrial production and the generation of 
clean energy must be two of the pillars of our society. Huge amounts of resources for 
research and technological development in this direction have been dedicated and are 
expected to be dedicated. The European Union's H2020 program, for example, has 
identified one of its seven priority lines as “safe, clean and efficient energy”, which has 
allocated almost 6 billion € for the period 2014-2020. Catalysis is one of the driving 
force of these advances. Catalyzed chemical processes allow increase production, 
reduce the number of reaction steps, work under more favorable energy conditions and 
generate less byproducts than the uncatalyzed processes.
1
 The improvement of the 
catalyst stability and selectivity for existing processes and the development of catalysts 
for processes that are not yet available is a fundamental and strategic research for 
achieving sustainable industrial production and clean energy generation. 
To attain the highest levels of reactivity and selectivity in catalytic reactions, several 
parameters must be optimized. Of these, the selection and design of the ligands, in 
which an electronically and sterically well defined scaffold is the most crucial step.
1
 In 
this context, thousands of homo- and hetero-donor ligands, mainly P- and N-containing 
ligands with either C2- or C1-symmetry, have been developed although only a few of 
them have a general scope and are easy to handle and prepared in few step from cheap 
starting materials.
1
 Among them, heterodonor ligands (P-N, P-S, P-P', etc.) equipped 
with strong and weak donor heteroatom pairs have made some of the most fundamental 
contributions to the development of catalysis.
1
 The most widely used ligands in 
catalysis are phosphines and, to a lesser extent phosphinites. Phosphite-based ligands 
has also emerged as very suitable ligands for catalysis.
1,2
  Phosphite-containing ligands 
are very attractive from a synthetic point of view, since they are easy to prepare from 
readily accessible alcohols. The availability of many alcohols makes simple ligand 
tuning possible, which allows the synthesis of series of chiral ligands than can be 
screeend in the search for high activities and selectivities for each type of substrate. 
Another advantage of phosphite compounds is that they are less sensitive to air than 
phosphines and phosphinites. Although they are prone to decomposition reactions, such 
as alcoholysis, hydrolysis, and the Arbuzov reaction, these side reactions can be 
suppressed when bulky aryl phosphites are used. Our groups have contributed with 
improved generations of modular homodonor and heterodonor biaryl phosphite-
containing ligand libraries, obtained from readily available starting materials and easy 
to handle.
2,3
    




In the last two decades N-heterocyclic carbenes (NHCs) have emerged as powerful 
ligands in catalysis. Owing to their strong σ-donation ability, air stability and low 
toxicity they have become practical alternatives to the most commonly used 
phosphines.
4
 A large number of transformations are known to proceed only with NHC-
based catalysts. For that reason, exploring new classes of NHCs is a very important goal 
in recent organometallic chemistry. 1,2,3-Triazol-5-ylidenes are a relevant subclass of 
NHCs possessing a mesoionic carbene (MIC) structure.
5
 Several reactions have been 
explored where triazolylidene-based metal complexes are equally or more efficient 
compared to their NHC analogues, such as cross-coupling reactions, olefin metathesis, 
oxidative transformations, transfer hydrogenation catalysis, and the click reaction.
6
 The 
triazole framework adds the advantages of increased σ-donation compared to classical 
NHCs and the ability to potentially stabilize different metal oxidation states. In addition, 
they are accessible via synthetically highly efficient and modular nature of "click 
reaction". The click reaction tolerates a wide variety of functional groups in the azide 
and in the alkyne reactant which facilitate preparing series of modular MIC-containing 
ligands, with different steric and electronic properties. Despite this, the development of 
heterodonor 1,2,3-triazol-5-ylidene-containing ligands have been scarcely explored. To 
our knowledge the 1,2,3-triazol-5-ylidene carbene moiety has mianly been combined 
with pyridine/pyrimidine and hydroxyl groups.
6e,i,7
 More research is therefore still 
needed to explore new classes of chelating 1,2,3- triazolylidene based ligands. 
In this context, this second part of the thesis focused on the development of new 
mesoionic carbene-based ligands and phosphite-oxazoline ligands, and their application 
to several catalytic transformations. In this respect, we have designed new mixed 
oxazole/thiazole-MIC ligands and evaluated them in the transfer hydrogenation, 
dehydrogenation and water oxidation reactions. Finally, we also sucessfully developed 
and evaluated new biaryl phosphite-oxazoline ligands in the asymmetric intermolecular 
Heck reaction. In the following sections we describe the background of each catalytic 
reaction studied in this thesis. 
 
4.1. Metal-catalyzed transfer hydrogenation reactions 
Hydrogen transfer (HT) reactions as a reduction of ketones to alcohols have been 
known since 1925.
8
 In the original version, which was discovered by Meerwein, 
Ponndorf and Verlay, aluminium isoproxide was applied to promote transfer of 
hydrogen from isopropanol to a ketone (Eq. (4.1)).  Latter in the middle of 1930s, 











In hydrogen transfer reactions the equilibrium can push the reaction to the desired 
direction by using an excess of either alcohol or ketone in the starting material. 
Therefore, for the Meerwein-Ponndorf-Verlay (MPV) reduction of ketones, i.e. transfer 
hydrogenation, isopropanol is utilized in excess and for the opposite reaction, the 
Oppenauer oxidation, acetone as a ketone is employed in excess. A main drawback with 
classical aluminum oxide promoted hydrogen transfer reactions is that the 
stoichiometric amount of aluminum salts is often needed and this is a big obstacle for 
scaling up in industrial application. Catalytic hydrogen transfer reactions have been 
applied as an alternative with an increased interest for more than a decade (Eq. (4.3)).
10 
In this regard lanthanides and transition metals (i.e. Ru, Rh, Ir, Fe) have been found to 




Various “sacrificial” hydrogen sources were employed for transition-metal catalyst-
promoted TH such as cyclohexene, cyclohexadiene, alcohols (including 
i
PrOH, MeOH, 
EtOH, glycerol), formic acid, Hantzsch esters,
11
 hydrazine, benzothiazoles, 
dimethylamine-borane, ... Isopropanol and formate (HCOOH/NEt3) are the main used 
sources of reducing reagent because of their low price. 
A series of organic and inorganic bases have been used in TH such as Et3N, KOH, 











(potassium hexamethylsilazane), K3PO4, Cs2CO3, CsOH, NaOAc and NaOMe. The pKa 
value and the nature of the cation of the base may have an influence the catalytic 
efficiencies of transition-metal catalysts.
12
  
Several unsaturated compounds including ketones, aldehydes, imines, nitro 
compounds, nitriles, oximes, α,β-unsaturated esters, α,β-unsaturated acids, α,β-




unsaturated carbonyl compounds, heterocycles, alkenes, and alkynes have been reduced 
through TH processes in the presence of  transition-metal catalysts. 
 
4.1.1. Mechanism  
From a mechanistic point of view, two main catalytic pathways have been proposed 
for hydrogen transfer reactions. The first one is the direct hydrogen transfer that is 
involved for main group metals. The second one is the so called hydridic route which is 
suggested for transition metals.  
 
4.1.1.1. Direct hydrogen transfer 
This pathway which has been poposed for the MPV reduction, is a concerted 
process that proceeds through a six-membered transition state without involvement of 
metal hydride intermediates (Scheme 4.1). 
 
 
Scheme 4.1. Direct hydrogen transfer mechanism. 
 
4.1.1.2. The hydridic route 
This pathway, which is claimed to occur for transition metal catalysts proceeds via 
involvement of metal hydride species.
13,14
 In some cases, the hydrides were isolated 
from transition metal-catalyzed hydrogenation reactions and some examples are 




Figure 4.1. Examples of isolated metal hydride intermediates. 
 
For the hydridic route, two general mechanisms have been disclosed depending on 
the origin of the hydride on the metal (Scheme 4.2). In the first one, a metal dihydride is 
formed (called dihydride mechanism), while in the second pathway a metal 
monohydride is formed (called monohydride mechanism). 





Scheme 4.2. General mechanisms for the hydric route.
 
 
4.1.1.2.1. The dihydride mechanism 
A common feature for catalysts function via the dihydride mechanism is that both 
C˗H and O˗H from the alcohol are transferred to metal center. In that way both 
hydrogen atoms lose their identity when transferred to the ketone.
17
 The proposed 
catalytic cycle for the transfer hydrogenation of ketones via dihydride pathway is shown 
in Scheme 4.3. The catalyst presursor 11 reacts with isopropanol in the presence of base 
to produce the dihydride complex 12. Reaction of 12 with the substrate produce metal 
(0) species 14 via complex 13 after reductive elimination. Both the dihydride 12 and 




Scheme 4.3. Proposed catalytic cycle for transfer hydrogenation of ketones using 
isopropanol as hydrogen donor via dihydride mechanism. 
 




In the catalytic cycle, species 14 undergoes oxidative addition of the hydrogen donor 
(isopropanol) followed by β-hydride elimination to produce acetone and the metal 
dihydride species 12. Ketone then adds to species 12 to give the corresponding alkoxide 
complex that after reductive elimination provides the desired alcohol and regenerates 
metal (0) species 14. 
 
4.1.1.2.2. The monohydride mechanism 
A general feature for catalyst function through the monohydride mechanism is that 
both C˗H and O˗H hydrogens keep their identity (i.e. the C˗H from the hydrogen donor 
ends up as a C˗H in the product). This is due to the fact that the hydride on the metal is 
just formed from the C˗H hydrogen of the donor (that transfers to the carbonyl carbon) 
while the OH of the donor remains as a proton during the process (and adds to the 
carbonyl oxygen). The metal monohydride can be, however, form via different 
mechanisms. In one of them the metal monohydride is formed via formation of the 
corresponding alkoxyde followed by β-elimination (Scheme 4.4).  
 
 
Scheme 4.4. Proposed catalytic cycle for the TH of ketones using isopropanol as 
hydrogen donor via monohydride mechanism involving the formation of metal-alkoxide 
intermediates. 





In this pathway, the catalyst precursor MXLn is transformed to the metal-alkoxyde 
species 16 by reaction with the hydrogen donor in the presence of base. The key metal 
monohydride intermediate 17 is formed after β˗hydride elimination of intermediate 16. 
In the catalytic cycle, coordination of the corresponding ketone to 17 followed by 1,2-
insertion of the ketone into the metal hydride bond results in the formation of the 
corresponding alkoxyde 19. Alkoxyde ligand exchange with the hydrogen donor 
provides the desired alcohol. The catalytic cycle is completed by means of the 
β˗elimination of the isopropoxide ligand. 
The second pathway involves the simultaneous transfer of the C˗H to the metal and 
O˗H to one of the ligands. The latter does not therefore involve the formation of any 
metal alkoxyde intermediate. This pathway requires that the presence of metal ligand 
bifunctional catalyst (i.e. Ru-Noyori catalyst, Shvo’s catalyst, …), in which one of the 
sites of the ligand plays the role of base.
18
 The mechanism using Shvo’s system is 




Scheme 4.5. Proposed concerted proton and hydride transfer mechanism using the 
Shvo’s catalyst. Phenyl rings of the cyclopendiene ring are omitted for clarity.  




Coordination of the hydrogen donor to the 16-electron species 20 provides the 
corresponding monohydride intermediate 21. The monohydride catalyst then reacts with 
the ketone and the hydride and proton are simultaneously transferred to form the desired 
alcohol and regenerate species 20. 
 
4.1.2. Transition-metal catalysts 
The utilization of late transition-metal catalysts involving first-, second-, and third-
row transition metals of groups 8, 9, 10, and 11 was the outstanding discovery in 
transfer hydrogenation. The pioneering work reported by Henbest, Mitchell, and co-
workers in the 1960s
19-21
 showed that the iridium hydride complex [IrH(dmso)3] 
catalyzed the hydrogenation of ketones to alcohols with isopropanol. In the 1970s, 
Sasson and Blum
22-
 mentioned the first example of Ru complex applicable in TH. They 
showed that [RuCl2(PPh3)3] was active in the TH of acetophenone with isopropanol at 
high temperature.
24 
Two decades later, Chowdhury and   ckvall
25
 demonstrated that 
adding a catalytic amount of NaOH to the [RuCl2(PPh3)3]-catalyst precursor accelerated 




 times. It was shown that the rate enhancement is because of the 
formation of highly active RuH2(PPh3)3.
16b 
The first report of the Ru catalyzed 
asymmetric transfer hydrogenation (ATH) was appeared in the early 1980s.
26-28 
One of 
the most important breaktroughs in ATH came with the discovery of Noyori  and co-
workers that ruthenium η
6
-arene complexes in combination with vicinal amino alcohol 
or diamine ligands (complexes 22; Figure 4.2) served as efficient catalysts for the 
reduction of ketones and ketimines, respectively, under ATH conditions.
29
 Since then 




To date, great advancement has been done about late transition metal-catalyzed TH 
and ATH. A diversity of transition metals, ligands, hydrogen sources, bases, reaction 
media, and unsaturated compounds have been involved in the transformations that are 
critical subjects of TH. Apart from numerous Ru-complexes
32
 that have been developed 
in this field, Ir- and Rh-complexes
33
 are well-documented for this transformation.  
Recently there has been an increased attention to the earth-abundant metal catalysts 





catalyzed TH has been developed during the last decade.
34
 In 2010 Morris group
35,36 
demonstrated that iron(II) complexes containing PNNP pincer ligands (complexes 23; 
Figure 4.2) are effective catalytic precursors for the transfer hydrogenation of ketones 








Bu under mild conditions. More recently, cobalt catalyst precursors 
have also shown their usefulness in this transformation. Thus for instance, the use of 
Co-PNP catalyst precursors (complex 24, Figure 4.2) showed high activities in the TH 




Figure 4.2. Representative examples of Ru-, Fe- and Co- catalysts precursors for TH. 
 











have also been developed, albeit to a lesser extent. Among them, it should be 
highlighted the Pd-catalysts that have been used for the stereo- and chemoselective 
reduction of alkynes to alkenes under transfer hydrogenation conditions.
45 
In summary, albeit there are many transition metals that are able to efficiently 
catalyze transfer hydrogenation reactions, the vast majority and the most efficient 
catalysts precursors are those based on ruthenium, rhodium and iridium modified with 
several ligand types (i.e. amino-alcohols, diamines, phosphines, …). In recent years, 
research has been focused on the evaluation of carbene-type ligands, due to their highly 
adaptable steric and electronic properties. In the next sections I will discuss in more 
details the results obtained using metal-catalyst precursors containing classical N-
heterocyclic and mesoionic carbene ligands. 
 
4.1.2.1. N-Heterocyclic carbene catalyst 
N-Heterocyclic carbenes (NHCs) are cyclic carbenes having at least one α-amino 
substituent.
46 
The NHC ligand family
 
has shortly triggered a true explosion of interest in 
coordination chemistry and organometallic catalysis.
47-51
 This is due to their strong 
coordination ability as σ-donors and remarkable adjustability of the steric and electronic 
properties on the metal center, and almost infinite possibilities of topological 
modifications. NHC ligands were commonly incorporated into chelating, pincer, and 
chiral structures with mainly Ir, Ru and Rh catalysts and rarely Fe and Pd catalysts for 
transfer hydrogenation reactions.
52 
The first example of Rh-NHC catalyst for transfer 




hydrogenation was [Rh(bis-NHC)I2(OAC)] (25; Figure 4.3) which was prepared by the 
groups of Prof. Crabtree and Prof. Peris in 2002.
53
 These type of complexes showed 
good catalytic performance for TH of both ketones and imines but they were inactive in 
TH of alkenes. Some other rhodium complexes containing NHC ligands were also used 
in the TH of ketones (i.e. complex 26; Figure 4.3).
54,55
  
Ru-NHC complexes have also been explored in TH reactions. A series of ruthenium 
complexes containing different donor substituent-functionalized NHCs were prepared in 
the group of Prof. Albrecht
56,57
 and among them the olefin-tethered NHC ruthenium 
complex 27 (Figure 4.3) was very efficient toward TH of olefins, alkynes, ketones, 
nitrobenzene, benzonitrile, and N-benzylideneaniline under various conditions.
56
 Most 
of the Ru-NHC complexes, however, were applied in TH of ketones amd imines.
58,59
 
Nevertheless, Peris and coworkers
 
reported the use of ruthenium complex containing 
bis-NHC 28 (Figure 4.3) for the transfer hydrogenation of carbone dioxide to formate.
60
   
Iridium/NHC complexes have also been succesfully developed mostly for the 
transfer hydrogenation of carbonyl and imine compounds.
61-66 
As representative 
examples, we can highlight the results achieved using the catalyst precursors 29 and 30 
developed in the groups of Prof. Oro and Prof. Crabtree, respectively (Figure 4.3). 
 
 
Few examples are available in the case of Pd-NHCs as some of them are not stable 
and therefore could not be isolated. As representative example, we should highlight the 
Pd-NHC complexes 31 (Figure 4.3) developed by Elsevier and coworkers in the TH of 
alkynes to alquenes.
67 
Fe-NHC complexes, such as complex 32 (Figure 4.3), have also 





Figure 4.3. Representative TH metal catalyst precursors bearing NHC ligands.  




4.1.2.2. Mesoionic carbene catalyst 
Given the increasing interest in 1,2,3-triazol-5-ylidenes ligands in homogeneous 
metal-transition catalysis, the catalytic application of these ligands were also 
investigates in TH. Comparing the catalytic activity of the MIC
 
containing metal 
catalyst precursors with the NHC analogues, we can see that metal-NHCs are superior 
in terms of activity, which it is not unexpected because the use of MIC ligands in 
catalysis has a shorter story than the NHCs.  
TH with ruthenium complexes featuring a chelating triazolylidene ligand have 
appeared, and selected examples of complexes are gathered in Figure 4.4. The air- and 
moisture ruthenium(II) complex 33 bearing an unsymmetrical benzimidazole-
benzotriazole-pyridine ligand has been shown to be a robust and highly active catalyst 





The authors demonstrated that the excellent catalytic performances resulted from the 
hemilabile unsymmetrical coordinating environment around the central metal and 
“N−H” effect. The two halfsandwich ruthenium complexes 34 and 35 containing a 
chelating 1,2,3-triazolyl or 1,2,4-triazolyl units also exhibited good catalytic behaviors 
in TH of carbonyls.
6j,70 
 
Selected examples of Rh-complexes are collected in Figure 4.4. The bidentate 
monovalent rhodium-cod complex 36 with square-planar geometry that contains tzNHC 
and an Arduengo-type NHC motif was successfully used as catalyst for the TH of 
carbonyls, imine, and diene using 
i
PrOH as the hydrogen source.
71
 More importantly, 
catalyst 36 was much more active than its analogue 37 in which the triazolyl moiety 
coordinates through a nitrogen donor. The complexes 38 having the N(2) atom of 1,2,3-
triazole coordinated to the rhodium center have shown better activity in the TH of 
ketones than 39 in which N(3) is involved in ligation. Moreover, the reactivity with 
respect to the ligands is in the order Se > S.
72
 The mechanistic studies indicated that the 
Rh species that had lost the Cp* ligand was an intermediate in the catalytic cycle. The 
iridium analogues of complexes 36-39 were also synthesized and exhibited even better 
catalytic performances in TH reactions than these rhodium counterparts.
71,72
 Iridium 
complexes functionalized by pyridyltriazole 40, bis-triazole 41, or bis-abnormal carbene 
42 with half-sandwich and piano-stool configuration were assayed in the catalytic TH of 
nitrobenzenes using 
i
PrOH providing aniline, azobenzene, and azoxybenzene 
compounds (Figure 4.4).
73
 Investigations of ligand substitution, metal substitution 
(comparison with ruthenium counterparts containing each of the above-mentioned 




triazolyl ligands), and temperature variation on the catalytic behavior indicated that the 
selectivity was moderately controlled by tuning the metals, ligands, and reaction 
conditions. In addition, the iridium-based catalysts provided higher conversion of 





Figure 4.4. Selected metal-catalst precursors containing triazolylidene ligands for TH. 
 
The same research group reported a series of mono- and dinuclear orthometalated 
iridium complexes with both Cp* and triazolyl fragments either with C−N or with C−C 
donor sets to iridium centers with a central phenyl ring as C−H activation sites 
(compounds 43-47; Figure 4.4).
74
 All of these presynthesized complexes 43-47 were 
employed as catalysts for the TH of benzaldehyde and acetophenone revealing that the 




dinuclear iridium complexes 44 and 47 produced faster reactions than their 
mononuclear counterparts. Moreover, the dinuclear cyclometalated iridium complex 47 




4.2. Ir-catalyzed dehydrogenation of alcohols 
One of the most fundamental technologies for organic synthesis is oxidation of 
organic compounds. Alcohols can be oxidized to their corresponding aldehydes and 
ketones. They are synthetically prevalent functional groups because of their outstanding 
versatility for derivatization.
75
 Traditionally alcohols oxidation has been achieved using 
stoichiometric amounts of high-valent chromium (i.e. Cr2O3, pyridium chlorochromate 
…) or manganese oxides.
76 
Another well-known procedure is the Oppenauer-type 
oxidation via hydrogen transfer reaction using a sacrificial hydrogen acceptor (usually a 
ketone).
77
 Other milder and often more selective methodologies have been more 
recently developed based on the use of hypervalent iodine
78
 and the use of perruthenate 
as catalyst using N-oxides as terminal oxidant.
79
 All these methodologies have as an 
important drawback the use of stoichiometric amounts of sacrificial oxidants, which led 
to low atom economy of the overall reactions due to the formation of high amounts of 
reduced (sometimes toxic) side-products. Due to this fact, it is not estrange that in 
recent years research has been focus on the use of more benign terminal oxidants (such 
as water peroxide and oxygen).
80 
As alternative, the oxidant-free dehydrogenation of 
alcohols has been less studied although it is very attractive in terms of atom economy 
and waste (Eq (4.4)). 
 
 
Another advantage of this process is that it generates molecular hydrogen as a useful 
side product that can be used as an alternative to fossil fuels, which has stimulated 
research in this area.
81







 among others have developed ruthenium-catalyzed protocols for the 
dehydrogenation of primary and secondary alcohols. Other transition metals able to 








 In some cases, 
however, the formed product remains coordinated to the metal therefore it is 
predisposed for further coupling to produce esters and acetals.
89
 Most of the catalysts, 




however, require the addition of an external base to activate the catalysts. More research 





From the mechanistic point of view the dehydrogenation reaction is very similar to 
the transfer hydrogenation. The main difference can be found in the fact that 
acceptorless H2 gas elimination (dehydrogenation) is more difficult than the transfer to 
another molecule (transfer hydrogenation) and therefore hardest reactions conditions 
conditions are required for H2 release. One of the possible simplest mechanism for 
dehydrogenation reaction is shown in Scheme 4.6. The first step of the reaction would 
involve the formation of alkoxo metal intermediate 48 by the reaction of metal complex 
with alcohol and libration of HX (X = labile ligand like Cl on the metal center) which 
would be accelerate by the addition of the base. β-Hydrogen elimination of 48 give 
ketone as a dehydrogenated product and metal hydride species 49. Then protonolysis of 
metal hydride 49 by the alcohol addition, which in most cases is ligand-assited, takes 




Scheme 4.6. One of the possible accepted mechanisms for the oxidant-free 
dehydrogenative oxidation of alcohols.  




4.2.2. Transition-metal catalysts 
As it is mentioned in Section 4.2 several transition metal complexes have been 
applied for the dehydrogenation of alcohol such as Ru, Ir, Pd, Cu, Os, … Among them 
the most used catalyst precursors are based on Ru and Ir catalysts. Pincer ligands have 
played a dominant role in the development of succesfull metal-catalyst precursors for 
the acceptorless alcohol dehydrogenation (AAD). Two of the most typical examples of 
this type of catalytic systems are the Ru-PNN 50
91a
 and Ru-PNP 51
92
 catalyst precursors 
developed by the groups of Milstein and Beller, respectively (Figure 4.5). The former 
have been successfully used in the oxidation of alcohols to the corresponding esters, 
while the later has been used for the dehydrogenation of methanol to provide H2 and 





for the oxidation of alcohols to the corresponding carboxylic acids (Figure 
4.5). A comom feature of most of these catalysts is that the addition of an external base 
is necessary to activate the catalyst. AAD catalysts that do not requires the addition of 
base are rare. Most of the examples make use of metal ligand bifunctional catalyst, such 
as the Shvo’s catalyst (Scheme 4.5), in which one of the sites of the ligand plays the 
role of base. Another selected example of base-free dehydrogenation catalysts is the 






Figure 4.5. Representative examples metal catalysts precursors containing pincer and 
bifunctional ligands for the AAD. 
 
As for the TH reactions, NHC’s has also been successfully applied for the AAD, 
being the most widely used the ones bearing a bifunctional catalysts. In particular they 




 reactions of secondary 




alcohols and amines with primary alcohols, respectively. β-Alkylation and N-alkylation 
reactions are tandem processes in which the first step is the alcohol dehydrogenation. 





developed by the groups of Prof. Peris and Martín-Matute, respectively (Figure 4.6). 
 
 
Figure 4.6. Representative examples of IrCp* catalysts precursors containing NHCs 
ligands for the AAD 
 
More recently, metal complexes containing mesoionic triazolylidene ligands have 
also been successfully used in the AAD. This field of research was initiated by Peris 
and Albrecht et al.
6g
 They demonstrated that Ru-based catalyst precursor 57 (Figure 
4.7), containing a monodentate triazolylidene ligand, was able to promote the oxidation 
not only of alcohols but also of amines. Later, Albrecht and coworkers further studied 
the effect of the nature of the triazolylidene substitutents on AAD, by systematically 
replacing the 
n
Bu substituents in 57 by other aryl and alkyl groups.
6f
 They found an 
important effect of them on catalytic activity. Thus, the presence of alkyl substituents 
has a positive effect on activity, while the presence of aryl groups induces much lower 
activity. The Albrecht group also studied the effect of introducing a second donor 
functionality. For that purpose they developed Ru-complexes containing a variety of 
C,X-bidentate triazolylidene ligands (complexes 34, 58-60; Figure 4.7).
6j
 Again they 
found an important effect of the nature of the second donor functionality on activity. 
The use of catalyst precursor 58, containing the C,C-bidentate phenyl triazolylidiene 
ligand, therefore provided the highest activities, while the use of carboxylate or 
pyridine-complexes 34, 59 and 60 provided very low activities. Interestingly, arene 
dissociation was observed as a potential catalyst deactivation pathway. In order to 
overcome this drawback, the same authotrs prepared Shvo’s type Ru(0) complexes with 
triazolylidene ligands (61, Figure 4.7).
100
 Nevertheless, low activites were achieved, 
though activity can be increased by adding cerium ammonium nitrate. 
Ir-catalyst containing mesoionic ligands have also been applied in this 
transformation. Peris and coworkers demonstrated that IrCp*-complexes containing 




abnormal carbenes can be applied for this transformation (catalyst precursor 62; Figure 
4.7).
101
 However, high ammounts of the etherification products were observed. More 
recently, Albrecht and coworkers demonstrated that IrCp* complexes containing 
bidentate triazolylidene complexes are also effective for the AAD (compounds 63 and 
64; Figure 4.7). Again the presence of considerable amounts of etherification products 
were observed using compound 63. Interstingly, the use of dimeric catalyst precursor 64 
supress completely the etherification products and led to the solely formation of the 
corresponding aldehyde or ketone. The different selectivities of monometallic complex 
63 and the bimetallic one 64 has been rationalized by the significative differences 
observed of the electrochemical and spectroscopic analysis of both complexes. 
 
 
Figure 4.7. Representative metal-triazolylidene catalyst precursor developed for the 
acceptorless alcohol dehydrogenation. 
 
4.3. Ir molecular catalysts for water oxidation 
The sustainable production of clean energy from renewable sources is one of the 
most challenging scientific topics.
102
 Nowadays, the significant part of the global energy 
supply is provided by carbon-based energy sources, which is connected to several 
environmental problems such as air pollution and the greenhouse effect. Therefore, 
there is a strong demand for clean and environmentally friendly carbon-neutral 




alternatives that have the potential to provide the needs of present and future 
generations. 
The splitting of water into oxygen and hydrogen, inspired by nature
’
s use of water 
and sunlight as environmentally abundant feedstocks, makes a particularly attractive 
approach towards addressing this issue. In nature, photosynthetic water fixation and 
splitting is a delicately balanced process, overcoming the energetic barrier of O˗H bond 
cleavage and O˗O bond formation by a stunning reaction cascade.
103
 The complexity of 
the photosynthetic machinery requires alternative approaches for artificial 
photosynthesis.
104  
This process requires the coupling of the two half-reactions: (i) water 
oxidation to produce the reducing equivalents (electrons) and oxygen as the only 
byproduct and (ii) reduction of protons using the electrons of the former reaction to 
generate molecular hydrogen. Albeit, both reaction steps are crucial for the generation 
of hydrogen from water, water oxidation is considered to be the bottleneck in the 
sustainable production of hydrogen from water.
105
 This is because water oxidation is 
both thermodynamically and kinetically unfavorable, resulting in slow kinetics without 
the use of a catalyst.
106
 High redox flexibility of the active center constitutes a key 
element in the design of synthetic complexes for water oxidation, since the formation of 




For decades, scientists have sought to understand and imitate nature, creating not 
only biomimetic water oxidation catalysts (WOCs), but also well-defined homogeneous
 
and heterogeneous catalysts. The field of water oxidation have been dominated by Ru- 
and Mn-catalysts. The first homogeneous catalyst for water oxidation was reported by 
Meyer’s group in 1982.
107 
This was the dinuclear μ-oxo-bridged ruthenium complex 65 
(Figure 4.8), cis,cis-[(bpy)2(H2O)Ru(μ-O)Ru(H2O)(bpy)2]
4+
, known as the “blue dimer” 
because of its characteristic blue color. Albeith both productivity (TON’s up to 13) and 
activity (TOF’s up to 0.004 s
-1
) were moderate using cerium ammonium nitrate (CAN) 
as sacrificial one electron oxidant, this study settle the basis for further research. The 
development of Mn-catalysts was inspired by the presence of the Mn4Ca cluster in the 
natural oxygen evolving system. In this context, Crabtree’s group reported that Mn(II)-
containing terpyridine or dipicolinate ligands (such as complex 66; Figure 4.8) are able 
to promote water oxidation using potassium persulfate as sacrificial two electron 
oxidant.
108
 Over the last decades, rapid improvements in both activity and productivity 




of Ru- and Mn-based catalytic systems have been achieved as has been clearly 





















catalysts have also given promising results. 
 
 
Figure 4.8. Representative examples of Ru- and Mn-based WOCs 
 
4.3.1. Mechanism 
The accepted reaction mechanism for iridium-catalyzed water oxidation is shown in 
Scheme 4.7. With a neutral chloro catalyst, the chloro ligand is replaced by a molecule 
of H2O yielding a cationic Ir(III) aqua complex 68. Complex 68 is then oxidized (i.e. 
using CAN as sacrificial oxidant) to form the Ir(IV)-hydroxo intermediate 69 liberating 
one proton and one electron. Further oxidation of 69 provides Ir(V) oxo complex 70, 
which is a key intermediate species in the formation of the O-O bond by reacting with 
water. Complex 70 reacts with water to afford the Ir(III)-peroxo species 71. The 





Scheme 4.7. Proposed reaction mechanism for iridium-catalyzed water oxidation.  




4.3.2. Ir-catalysts for water oxidation 
Iridium complexes applicable in water oxidation process can be classified in three 
categories based on the type of the coordinated ligand to Ir center.  
 
4.3.2.1.1. Cyclometalated iridium complexes 
A vital finding in the field of water oxidation catalysis was published by Bernhard 
and coworkers in 2008.
117
 This group showed that cyclometalated Ir(III) complexes 
bearing unsubstituted or substituted 2-phenylpyridine (ppy) ligands (compounds 72; 
Figure 4.9) could mediate water oxidation. The cyclometalated phenylpyridine was 
employed as a bidentate ligand and created strong carbon-iridium bond in the desired 
iridium complexes and afforded the robustness that is needed for H2O oxidation. The Ir-
complexes have two open sites in the first coordination sphere for binding water to the 
iridium center. A control experiment with [Ir(ppy)(bpy)]
+
, lacking free coordination 
sites, showed no activity, confirming a key role for these open coordination sites in 
binding and activation of water. Oxygen-evolution experiments confirmed essentially 






Figure 4.9. Cyclometalated iridium-based WOCs 72. 
 
4.3.2.1.2. Iridium complexes based on cyclopentadiene-type ligands 
Inspired by the work of Bernhard, in 2009 Crabtree and Brudvig developed a new 
class of single-site iridium WOCs with a pentamethylcyclopentadiene (Cp*) ligand 
(complexes 73; Figure 4.10).
118
 The Cp* ligand acts as an electron-donating ligand and 
probably this effect would result in more active catalysts. O2 production with these type 
of catalysts was 1 order of magnitude faster than previously cyclometalated iridium 
catalysts 72. Later the same groups studied the replacement of the cyclometalated 




ligand by bipyridine, phenantroline, bipyrimidine, tetramethylenediamine and also 
phosphine and carbon monoxide ligands. Among these, the bipyridine-containing 
complex 73 (Figure 4.10) was the most active (TON’s up to 320 and TOF’s up to 0.24 
s
-1
) using CAN under highly acidic conditions.
116
 
Crabtree and Brudvig also disclosed that these type of catalyst are also able to 
promote water oxidation under almost neutral pH media using sodium metaperiodate 
instead of CAN as sacrificial one electron oxidant. In particular they found that complex 
75 is and efficient catalystis under these conditions (Figure 4.10).
119
 Experimental 
studies have confirmed that the cyclopentadiene ligand is degradated under reaction 
conditions and, therefore, 75 is readily transformed to dimeric species 76, which are 





Figure 4.10. Representative iridium-based WOCs based on cyclopentadiene-type 
ligands. 
 
4.3.2.1.3. Iridium complexes with N-heterocyclic carbene ligands 
Crabtree and Brudvig also introduced NHC ligands into the iridium complexes to 





well known for binding tightly to metal centers and stabilizing them at high-
valent states. As predicted, the use of Ir-NHC complex 77 (Figure 4.11) was able of 
oxidizing H2O using CAN as oxidant uner acidic conditions (TOF up to 0.13 s
-1
) as well 




Several modifications of these catalyst have been developed. Thus, for instance, while 
the replacement of the cyclometalated unit in 77 by another NHC fragment (complexes 
78; Figure 4.11) led to lower acitivites,
123
 higher TOFs has been achieved by removing 









The use of Ir-WOC containing pyridyl-triazolidene ligands has 
proved to be highly advantageous. For instance, compound 80 provided high turnover 




numbers (up to 40000) in the CAN mediated water oxidation. Later, modification of the 
remote position of the carbene ligand (complexes 81 and 82) led to a substantially 
increase in activity. It should be pointed out that the simple and counterintuitive 
introduction of more lipophilic n-octyl chain (complex 82) led to one of the most active 
Ir-catalysts using acidic conditions (TOF’s up to 2 s
-1
). Nevertheless, activity 
substantially decrease when using sodium metaperiodate as sacrificial oxidant under 
nearly neutral media (pH 5.6). Thus, for instance, the activity of complex 82 dropped to 
TOF’s up to 0.1 s
-1
 using NaIO4 at pH = 5.6. 
 
 
Figure 4.11. Representative iridium complexes bearing different type of carbene 
ligands applicable in water oxidation. 
 
4.4. Pd-catalyzed asymmetric Heck reaction 
Catalytic enantioselective carbon-carbon bond formation is one of the most 
appealing goals in modern synthesis organic chemistry as they have a wide range of 
application in the synthesis of pharmaceuticals, natural products and functional 
materials. The Pd-catalyzed asymmetric Heck reaction (also known as Mizoroki-Heck), 
that is the coupling of an aryl or alkenyl halide or triflate to an alkene (Scheme 4.8) is 
one way to achieve this objective, as it was recognized with Nobel Prize in Chemistry in 
2010. This reaction is so versatile for preparation of enantioenriched compounds due to 
its large functional group tolerance.
125
 The extensive research dedicated to this process 
can give the erroneous impression that Heck Chemistry is a mature area. 





Scheme 4.8. Pd-catalyzed Heck reaction. X = Halide or triflate. 
 
Heck reaction was discovered more than 40 years ago
126
 however, reports on the 
asymmetric version was not publised until 1980, with most examples dealing with 
intramolecular reactions because the alkene regiochemistry and geometry in the product 
is easily controlled. They showed application of such an important transformation in the 
synthesis of natural compound.
127
 Chiral bidentate phosphines such as (R)-BINAP are 
highly desired for asymmetric intramolecular reaction.
125
 
The first intermolecular asymmetric variant was reported by Hayashi and co-
workers in 1991.
128
 The number of examples about asymmetric intermolecular Heck 
reaction are less than their intramolecular conterparts due to the fact that regioselectivity 
is mostly a problem apart from enantioselectivity. For example, in the intermolecular 
Heck reaction of 2,3-dihydrofuran with phenyl triflate two products are generated, 2-
phenyl-2,5-dihydro dihydrofuran 83 as an envisaged product and 2-phenyl-2,3-
dihydrofuran 84 which is formed due to an isomerization process (Scheme 4.9). 
 
 
Scheme 4.9. The first intermolecular asymmetric Heck reaction. 
 
      Nowadays various substrates in the intermolecular asymmetric Heck reactions 
which most of them are cyclic olefins and amoung them 2,3-dihydrofuran has been 
selected as benchmark substrate (Figure 4.12). A wide range of aryl or vinyl triflates 
have been used for the Heck coupling and phenyl triflate selected as standard. Zhou and 
Wu have recently solved a long-standing problem in asymmetric intermolecular Heck 
chemistry with the sucesful application of aryl halides in the enantioselective Heck 
arylation of cyclic alkenes.
129
 Finally, the base is another important parameter which 
affects both activity and selectivity. N,N-diisopropylamine and proton sponge are the 
standard bases mostly applied in this type of reactions.
125 
 





Figure 4.12. Most common substrates applied in the asymmetric Pd-Heck reaction. 
 
4.4.1. Mechanism 
Scheme 4.10 illustrates a proposed catalytic cycle for the phenylation of 2,3-
dihydrofuran.
125
 In the first step phenyl triflate oxidatively adds to the Pd(0) complex 85 
to produce Pd(II) complex 86. Since the triflate ligand is a good leaving group, 
coordination of 2,3-dihydrofuran on 86 enforces dissociation of the triflate ligand and 
makes a cationic palladium species 87 as a 16˗electron squar˗planar complex, 
convenient for the subsequent enantioselective insertion of olefin. The alkyl Pd(II) 
complex 88 converts to the hydrido Pd(II) complex 89 by β-hydrogen elimination. 
Dissociation of olefin leads to the product 84 and hydrido Pd(II) complex 90. Reductive 
elimination of HOTf which is happened by suitable base, regenerates Pd(0) complex 85 
to continue the catalytic cycle. Depending on the ligands, catalyst precursor and 
reaction parameters, the Pd-complex 89 can also undergo re-insertion of the hydride to 
convert to the Pd(II) complex 91 and subsequently by β-hydrogen elimination 
constructes hydrido Pd(II) complex 92. Dissociation of olefin leads to the product 83 
and hydrido Pd(II) complex 90. Again reductive elimination of HOTf regenerates active 
species 85. 





Scheme 4.10. Proposed mechanism for the Pd-catalyzed arylation of 2,3-dihydrofuran.  
 
4.4.2. Ligand design 
The first ligands developed for this process were diphosphines.
125,128,130
 Although 
Pd-diphosphine catalyst systems provided high enantioselectivities, there were still 
major problems of regioselectivity and activities.
128,131 
For instance, the diphosphine 
BINAP provided an enantioselectivity of 96% but the major product was the isomerized 
2-phenyl-2,3-dihydrofuran  (71% regioselectivity) and the reaction time was 9 days.  
An important breakthrough in this area came with the report by Pfaltz et al., who 
showed that phosphine-oxazoline PHOX ligands minimize the double bond 
isomerization providing high regio- and enantioselectivity to the desired product.
132
 
These ligands were successfully applied in the intermolecular Heck reaction of several 
substrates and triflate sources (Figure 4.13, ee’s up to 98%). Results also indicate that 
the presence of a tert-butyl group in the oxazoline moiety was crucial for obtaining the 
highest levels of enantioselectivity. The main limitation of these catalytic systems was 
the long reaction times (reactions usually take 3-7 days to complete). In an attempt to 
reduce reaction times, Hallberg and coworkers decided to apply the benefits of 




microwave irradiation in the Pd-catalyzed intermolecular Mizoroki-Heck reaction using 
PHOX ligands. They found that reaction times decreased considerably (from 4 days to 1 
hour) but enantioselectivities were lower than those obtained under thermal conditions 




Figure 4.13. Phosphine-oxazoline PHOX type ligands 93. Yields, enantioselectivities 
and reaction times using these Pd/93 in the intermolecular Heck reaction are also 
shown.  
 
4.4.2.1. Phosphine-oxazoline ligands 
Since the initial report by Pfaltz, several other successful phosphine-oxazoline 
ligand libraries have been developed for this process. Figures 4.14 show the most 
representative phosphine-oxazoline ligands applied to this process. 





Figure 4.14. Selected phosphine-oxazoline ligands applied in the Pd-catalyzed 
intermolecular Heck reaction. 
 
In 2000, Hayashi and coworkers reported a modification in the oxazoline moiety of 
the PHOX ligands with the development of an indano-fused ligand 94.
134
 This ligand 
was successfully investigated in the asymmetric arylation and cyclohexenylation of the 
standard substrate 2,3-dihydrofuran. The best result was obtained in the 
cyclohexenylation of 2,3-dihydrofuran showing conversions of up to 91% and 
enantiomeric excesses of up to 98%. More recently, other modifications in the 
oxazoline moiety of the PHOX ligand have also been performed. In this context, Zhang 
and coworkers developed ligands 95 achieving high yields and enantioselectivities (up 
to 94%) in the arylation of 2,3-dihydrofuran using ligand 95a (that contains tert-butyl 




groups at the oxazoline moiety).
135
 Later in 2009, Paquin and coworkers reported ligand 
5,5-(dimethyl)-
i
Pr-PHOX 96, which behaves similarly in terms of enantioselectivity 
(ee’s up to 92% in the phenylation of 2,3-dihydrofuran) to PHOX.
136
  
Hayashi’s group also reported the synthesis of (S,R)- and (S,S)-2-[4-
(isopropyl)oxazol-2-yl)]-2’-diphenylphosphino-1,1’-binaphthyl ligands 97 and applied 
them in the Pd-catalyzed asymmetric arylation of 2,3-dihydrofuran, with a highest ee of 
88% for product 84.
137
 Ligands 97, with opposite configuration of their axial chirality 
on the binaphthyl backbone, induce opposite configurations in the product 83 
respectively. These studies demonstrate that the axial chirality in ligands 97 regulates 
the chiral environment around the palladium center more strongly and has a greater 
influence on the stereochemical outcome than the central chirality in the corresponding 
oxazoline unit. 
Gilbertson developed proline-derived phosphine-oxazoline 98 and bicyclic phosphine-
oxazoline 99 and 100 ligands (Figure 4.14) that were screened in the Pd-catalyzed 




Figure 4.15. Summary of the best results obtained in the Pd-catalyzed Heck reaction 
using ligands 98-100. 
 
Several planar chiral ferrocene phosphine-oxazoline ligands 101-104 have been 
developed (Figure 4.14).
139
 The results indicate: (a) that the position of the phosphine 
group is crucial for high activities and enantioselectivities, and (b) that the planar 
chirality is decisive in exerting control over both the absolute configuration and the 
enantiomeric excess of the product, which can be controlled by changing the size of the 
planar group and/or the configuration of the planar chirality. Therefore, results were 
best using ligands 103c and 104a in the arylation of 2,3-dihydrofuran (75% yield, 92% 
ee) and N-methoxycarbonyl-2-pyrroline (52% yield, 99% ee), respectively. 




Interestingly, ligand 101a provided excellent enantioselectivity (98% ee) in the 
phenylation of 2,2-dimethyl-2,3-dihydrofuran. 
Guiry, Cozzi and coworkers reported the application of ligands 105 and 106, in 
which the phenyl ring of the PHOX has been replaced by thiophene moieties, in the 
arylation and cyclohexenylation of 2,3-dihydrofuran.
140
 Ligand 105d, containing bulky 
substituents at both oxazoline and phosphine moieties, provided the best results for the 
arylation (ee’s up to 96%) and cyclohexenylation (ee’s up to 95%). 
More recently two new studies on the development of new phosphine-oxazoline 
ligands have appeared. One of them reports the synthesis of a new type of PHOX ligand 
with a rigid chiral cyclopropyl backbone (ligands 107, Figure 4.14).
141
 The introduction 
of this rigid cyclopropyl fragment lowered the degrees of freedom in the catalyst and 
led to an efficient Pd-107b catalyst, which demonstrates excellent enantioselectivities in 
the asymmetric arylation of dihydrofuran with various aryl triflates (yields up to 85 and 
ee’s up to 99%). The second study reports the synthesis of the new phosphine-oxazoline 
ligands 108 and 109 (Figure 4.14) based on the PHOX ligands, in which the flat ortho-
phenylene tether is replaced by benzylic type groups.
142
 The authors found that simply 
by changing the substituent of the benzylic group of the ligand backbone both 
enantiomers of the arylated products can been obtained in high regio- and 
enantioselectivities (ee’s up to 95%). 
 
4.4.2.2. Phosphine-nitrogen and phosphinite-oxazoline ligands 
The effectiveness of phosphine-oxazoline ligands in the reactions discussed above 
suggested that it could be profitable to investigate related P,N-ligands further. In this 
respect, new heterodonor P,N-ligands in which the oxazoline and the phosphine moiety 
have been replaced by other nitrogen groups or a phosphinite group, respectively, have 
been developed (Figure 4.16). 
Phosphine-pyridine ligands 110-112 (Figure 4.16) have been successfully applied to 
the phenylation of 2,3-dihydrofuran (regio’s up to 98% and ee’s up to 99%).
143
 The 
results using ligands 110 and 111 showed that the structure of the remote silyl group has 
a small but significant influence on the enantioselectivity. Enantioselectivitites (ee’s up 
to 99%) were therefore best using ligands 110b and 111b, with a tert-butyldiphenylsilyl 
group. The reaction rates were similar to those observed with the above mentioned Pd-
phosphine-oxazoline catalysts. 




Guiry and coworkers developed new phosphine-amine ligands 113-114 (Figure 
4.16) for the arylation and cycloalkenylation of the standard substrate 2,3-dihydrofuran 
but with little success.
144
 These ligands proved to be considerably less reactive (<25% 
after several days) and enantioselective  (ee’s up to 17%) than analogous phosphine-
oxazoline ligands. 
Phosphine-phenylbenzoxazine 115 (Figure 4.16), in which the oxazoline group of 
the PHOX ligands has been replaced by an oxazine moiety, provided slightly lower 
enantioselectivities than those obtained using PHOX ligands in the phenylation and 
cycloalkenylation of 2,3-dihydrofuran (ee’s up to 94%).
145 
More recently, Andersson and coworkers successfully screened phosphine-thiazole 
116 and phosphine-imidazole 117 (Figure 4.16) in the arylation of 2,3-dihydrofuran 
under microwave conditions (ee’s up to 98%).
146
 Results indicated that the presence of a 
bulky mesityl substituent at the thiazole group (116e) has a positive effect on 
selectivity. They also found that catalysts could be prevented from deteriorating with no 




Figure 4.16. Selected phosphine-nitrogen and phosphinite-oxazoline ligands applied in 
the Pd-catalyzed intermolecular Heck reaction. 
 
In 2000, Uemura and coworkers developed a new type of P,N-ligand for this 
process: the phosphinite-oxazoline 118 (Figure 4.16). These ligands, easily synthesized 
from readily available D-glucosamine, were successfully applied in the arylation of 
substrate 2,3-dihydrofuran (ee’s up to 96%).
147
 Results indicated that the oxazoline 
substituent has an important effect on selectivity. In contrast to the results obtained 




using PHOX-type ligands and the vast majority of the phosphine-oxazoline ligands, 
results were best with a benzyl oxazoline substituent (118f). In addition, ligands 118 
were also tested in the phenylation of cis- and trans-crotyl alcohols.  This represented 
the first asymmetric Heck reaction of an acyclic alkene. Thus, the use of phenyl iodide 
resulted in good conversions (up to 76% after 3 days) albeit with low enantioselectivity 
(ee’s up to 17%). It should be pointed out that the use of phenyl triflate did not give any 
coupling product after 3 days.
 
 
4.4.2.3. Mixed phosphine-phosphine oxide and phosphite-oxazoline ligands 
Despite the important advances in ligand design there was still a problem of low 
reaction rates and substrate versatility. Therefore, it was very important to develop 
ligands that induced higher rates and selectivities (regio- and enantioselectivities) for 
several substrate types. For this purpose two main strategies have been used for ligand 
design. One, developed recently by Zhou's group, illustrates the power of mixed 
phosphine-phosphine oxides (Figure 4.17) which had been discarded in the Heck 
reaction for decades. Pd/phosphine-phosphine oxide
129,148 
systems were successfully 
applied in the intermolecular Heck reaction of several cyclic alkenes substrates with 
various aryl triflates and aryl halides.   
 
 
Figure 4.17. Representative phosphine-phosphine oxide ligands 119-120. 
 
The second strategy developed by our group was based on biaryl phosphite-
oxazoline ligands. Their highly modular construction, facile synthesis from available 
alcohols and greater resistance to oxidation than the phosphines have proved to be 
highly advantageous. The application of two phosphite-oxazoline ligand libraries in the 
Heck reaction (Figure 4.18) led us to identify a Pd/phosphite-oxazoline 131a catalyst 
that provided activities of 100% in only 10 min with excellent regio- (up to >99%) and 










Figure 4.18. Selected phosphite-oxazoline ligands develpod in Di guez’s group for Pd-
catalyzed intermolecular Heck reaction. 
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5.1. Synthesis, hemilability, and catalytic transfer 
hydrogenation activity of iridium(III) and ruthenium(II) 
complexes containing oxygen-functionalised triazolylidene 
ligands 




Pincer complexes have made one of the most fundamental contributions to the 
development of modern organometallic chemistry.
1
 In pioneering work, van Koten and 
coworkers explored the consequences of combining hard amine donor sites with soft 
metals such as iridium(I) and platinum(II) nuclei,
2
 which lead to a plethora of 
fascinating applications. 
Building on this fundamental design concept, we became interested in modifying N-
heterocyclic carbenes (NHCs), a classic ligand scaffold of modern catalyst design as 
NHCs much like pincer ligands typically impart high thermal stability and countless 
options for synthetic modifications.
3
 Introducing functional groups on the ligand 
scaffold allows for imparting stability through chelation, or hemilability for catalyst 
activation, or even bifunctional catalysis in which both the ligand and the metal 
participate in the conversion of substrate.
4





 (de)hydrogenation catalysts, which have excellent 
activity in an extended range of applications.
7
 Several examples of O- and N-
functionalised Arduengo-type carbene complexes have been developed that display 
cooperative behaviour and enhanced catalytic properties.
8
 Such functionalisation is even 
more versatile with 1,2,3-triazolylidene ligands,
9
 as the core heterocycle is generally 




N1,N3-disubstituted triazolylidene ligands are mesoionic
11
 and have shown to 
stabilize high and low metal oxidation states.
12
 They impart excellent catalytic activity 
in numerous transformations including cross-coupling,
13
 and in particular redox 
transformation such as water oxidation,
14
 amine and alcohol oxidation
15









While much recent work has been focusing on C,N-chelating triazolylidene 
complexes with imine donor sites, much less work has been directed towards 
understanding the catalytic implications of oxygen donors as functional groups at the 
triazolylidene ligand scaffold.
17
 Due to the demonstrated benefits of oxygen functional 
groups in close proximity to the metal centre, we have designed triazolylidene metal 
complexes with a potential C,O-bidentate bonding motif.
8e,18
 Herein we describe the 
synthesis of O-functionalised 1,2,3-triazolylidene iridium(III) and ruthenium(II) 
complexes and their catalytic activity in transfer hydrogenation. Specifically, we sought 
to introduce pendant oxygen-wingtip groups adjacent to the carbene, to investigate 





5.1.3. Results and discusion 
5.1.3.1. Synthesis and characterisation of 1,2,3-triazolylidene iridium(III) 
complexes. 
The hydroxyfunctionalised ligand precursor L1H·BF4 was prepared by literature 
procedures (Scheme 5.1.1).
18d
 For the synthesis of the ether-functionalised 
triazolylidene precursor L2H·BF4 a Williamson ether synthesis using NaH and MeI was 
applied at the triazole stage to install the methyl ether, followed by triazole N-alkyation 
with [Me3O]BF4, which afforded the triazolium salt L2H·BF4 in high yields (74%). 
Conveniently, NaH was used as the commercially available oil dispersion without any 
negative impact on yield. The purity of the crude triazole intermediate was not an issue 
as any oil residues were readily washed off from the final triazolium product after 
subsequent N-alkylation. The iridium(III) complexes 132-134 were synthesised by 
transmetallation procedures from the corresponding triazolium salt L1H·BF4 or 
L2H·BF4, using Ag2O (2 equiv) and Me4NCl (1 equiv) to form the Ag-carbene 
intermediates and subsequent in situ transmetallation with [Ir(Cp*)Cl2]2 (0.38 equiv). 
This procedure yielded iridium complexes 132-133 when starting from the hydroxy-
functionalised ligand precursor L1H·BF4, and complexes 134a,b when starting from 
triazolium salt L2H·BF4 with ether wingtip group. All complexes were obtained in 
spectroscopically pure form after separation by column chromatography, except for    





Satisfactory yields of ca. 40% were achieved for the desired O-functionalised iridium 
complexes, 132a and 134a. Complexes 132b and 134b were obtained in variable yields 
and purity from this transmetallation protocol. Oxygen chelation and formation of 
complexes 132b and 134b was more reliably achieved upon reaction of the 
monodentate triazolylidene complexes 132a and 134a, respectively, with AgBF4 as 
chloride scavenger.  
Regioisomers 133 and 133′ were obtained in addition to the O-functionalised 
complexes 132a,b as a consequence of wingtip degradation and formal loss of acetone, 
a reactivity pattern of this triazolium salt that was observed previously in the presence 





Scheme 5.1.1. Synthesis of 1,2,3-triazolylidene iridium(III) complexes 132-134. 
 
These results support the hypothesis that degradation of this wingtip group is Ag-
mediated. The regioisomers were isolated in a 1:1 mixture and were used without 
further separation for subsequent applications. Consequently, two sets of resonances 




C NMR spectra and assignments were made using 2-
dimensional spectroscopy, including nuclear Overhauser effect spectroscopy (NOESY). 
The appearance of two low-field Ctrz–H resonances at δH = 7.49 and 7.51 in the 
1
H 
NMR spectrum is diagnostic for the loss of the C–4 wingtip group and confirmed the 
formation of complexes 133 and 133′. Also the carbenic chemical shifts for complexes 




133 and 133′ (δC = 148.4 and 147.9) are well within the range reported for related 
triazolylidene iridium complexes.
14,15,19    
Triazolylidene bonding in a monodentate or C,O-bidentate mode in complexes 
132a/134a and 132b/134b, respectively, was identified by the distinct 
1
H NMR 
spectroscopic characteristics of these complexes. The NCH2 hydrogens of the 
monodentate coordinated triazolylidene in complexes 132a and 134a are diastereotopic 
and separated by ca. 1 ppm (δH = 4.93 and 4.09 for 132a, and multiplets centred at δH = 
4.95 and 4.09 for 134a). In contrast, this group appears in the chelating triazolylidene 
complex 132b as a broad singlet at δH = 4.45, and in complex 134b as two resonances 
with only 0.2 ppm shift difference (multiplets around δH = 4.5 and 4.3 ppm). In addition 
the 
13
C NMR signals due to the triazolylidene carbons appear at 3–9 ppm higher field in 
the monodentate triazolylidenes (δC = 145.5 and 152.9 in 132a, and 146.7 and 150.2 in 
134a) when compared to the chelating triazolylidene complexes (δC = 154.1 and 157.2 
in 132b, and 151.5 and 153.0 in 134b). This shift correlates with the lower donor 
properties of the O-functionalities in comparison to the chlorido ligand, resulting in a 
deshielding of the triazole carbons. Likewise, the 
13
C resonances corresponding to the 
quaternary carbons of the tert–butyl group undergo a diagnostic shift upon chelation and 
appear at δC = 77.6 and 81.5 ppm, for 132b and 134b, respectively (cf. 69.0 and 76.5 
ppm, for 132a and 134a, respectively), in agreement with a reduced electron density on 
the oxygen atom upon coordination to the metal centre.
20 
Chelation of the triazolylidene ligand in complexes 132b and 134b was further 
supported by chloride abstraction experiments performed with the monodentate 
triazolylidene complexes 132a and 134a. For example, reaction of these complexes 
with AgBF4 (1 equiv) in CH2Cl2 solution yielded complexes 132b and 134b, as 
corroborated by 
1
H NMR spectroscopy. Similarly, when NaBPh4 was used as the 
chloride scavenging agent, highly diastereotopic NCH2 hydrogens were observed that 
are characteristic for complexes 3b and 5b. In addition, a 1:1 ratio between the metal 
complex and the BPh4
–
 counter ion indicates that alternative chlorido scavengers yield 
the same type of cationic chelate complexes. 
Finally, the presence of the acidic OH protons in both 132a and 132b was confirmed 
by D2O exchange experiments, which induced disappearance of the resonances at δH = 
6.21 and 3.39 ppm for 132a and 132b respectively (CD2Cl2 solution). Interestingly, 





related O-functionalised imidazolylidene iridium complexes (though MeCN was used 
as solvent in lieu of CH2Cl2).
8e
 
Unambiguous evidence for the proposed structures was obtained from single crystal 
X-ray analyses of complexes 132a,b and 134a (Figure 5.1.1, Table 5.1.1). The 
molecular structures show the typical piano-stool arrangement around iridium(III), and 
general metrics are unexceptional.
14,15,19
 Analysis of the monodentate triazolylidene 
complexes 132a and 134a reveals only slight deviations of bond lengths and angles 
between these complexes. Complex 132b, in contrast, displays C,O-bidendate 
coordination of the triazolylidene through both an Ir–Ccarbene and an Ir–O bond. The 
bond lengths vary only slightly upon chelation.  
Table 5.1.1. Selected bond distances (Å) and angles (°) for complexes 132a, 132b and 
134a. 
                                       132a (X = Cl2)a                        132b (X = O)            134a (X = Cl2) 
 Ir–C1                                      7.077(3)                            2.032(4)                     2.082(3)       
 Ir–Cl1                                     2.4237(7)                          2.3779(10)                 2.4184(8) 
 Ir–X                                        2.4271(7)                          2.225(3)                     2.4448(9) 
 C1–C2                                    1.403(4)                            1.380(5)                     1.405(5) 
 Ir–Centroid                             1.807                                 1.785                         1.814 
 C1–Ir–X                                  89.43(7)                            73.61(12)                  89.22(10) 
 C1–Ir–Cl1                               92.13(8)                            86.29(10)                  89.67(10) 
 Cl1–Ir–X                                 86.33(3)                            86.46(9)                    84.02(10) 
 Ir–C1–C2                                136.7(2)                            119.1(3)                    136.0(3) 
 Ir–C1–N3                                121.54(19)                        138.1(3)                    121.9(2) 
(a) Data only for one of the two (essentially identical) crystallographically independent molecules in the 
unit cell. 
  
The Ir–C and Ir–Cl bonds are contracted by ca 0.04 Å in 132b when compared to 
132a (e.g. Ir–C1 2.032(4) vs 2.077(3) Å), presumably as a consequence of the formally 
cationic nature of the metal centre in 132b. Also, as a consequence of chelation, the Ir–
C1–C2 angle in 132b is smaller than the corresponding angle in 132a (119.1(3) vs 
136.7(2)°). This distortion is compensated by and inverse trend in the Ir–C1–N1 angle 
(increasing to 138.1(3)° in 3b vs. 121.54(19)° in 132a). Accordingly, the overall yaw 
angle is only marginally affected with 7.6° for 132a and 9.0° for 132b. Intramolecular 
H-bonding is observed in complex 132a between the hydroxy functionality and the 
metal-bound chloride with a O–H…Cl donor-acceptor distance of 3.06 Å and a 166.2° 
hydrogen bond angle, thus forming a 7-membered metallacycle. Complex 132b displays 




H-bonding between the coordinated alcohol and the noncoordinating BF4
–
 anion with a 
O–H…F donor-acceptor distance of 2.63 Å and an angle of 174°. These H…X 
interactions fall within the range expected for moderate-strength H-bonds.
21
 The Ir–O 
bond length in complex 132b is 2.225(3) Å, slightly longer than the analogous bond 
distance in a related [Ir(Cp*)(trz-py)(OH2)]
2+
 complex (cf. 2.166(3) Å),
19a
 and at the 
upper end of related NHC iridium(III) complexes (Ir–O bond in 2.15–2.24 Å range). 
8e,22
 The relatively long Ir–O bond in 3b has been attributed to the high steric bulk of the 
tert-butyl wingtip group. 
 
Figure 5.1.1. ORTEP representations of complex 132a (a; only one of the two 
independent molecules shown), complex 132b (b) and complex 134a (c; all structures at 
50% probability, disorder and hydrogen atoms omitted for clarity). 
 
5.1.3.2. Synthesis and characterisation of O-functionalised 1,2,3-
triazolylidene ruthenium(II) complexes.  
The synthetic methodology developed for O-functionalised triazolylidene 
iridium(III) complexes was successfully extrapolated to prepare analogous 
ruthenium(II) complexes. Thus, ruthenium complexes 135 and 136 were synthesised 
from ligand precursor L1H·BF4 using ([Ru(p-cymene)Cl2] (0.3 equiv) instead of 
[Ir(Cp*)Cl2]2 for transmetallation (Scheme 5.1.2). Purification by column 
chromatography yielded complexes 135a,b and 136. Alternatively, complex 135a was 
isolated selectively in up to 60% yield through an aqueous extraction of the crude 
reaction mixture followed by salting out the complex into CH2Cl2. This method of 
purification was applicable because in contrast to 135a, complexes 136/136′ are 





hydoxy functionality in 135a and is an additional benefit of incorporating the alcohol 
functionality, as a wide solubility range increases the scope for potential catalytic 
applications. The synthesis of etherfunctionalised ruthenium complexes was probed 
using triazolium L2H·BF4 in an analogous procedure. While 
1
H NMR spectroscopy and 
specifically the diagnostic shifts of both the ligand and the p-cymene resonances 
suggest the formation of the product in the crude reaction mixture, the product was 




Scheme 5.1.2. Synthesis of 1,2,3-triazolylidene ruthenium(II) complexes 135 and 136, 
and reference compound 137. 
 
In addition to complexes 135a,b, the transmetallation procedure also yielded minor 
quantities of complexes 136 and 136′ as a result of the Ag-mediated degradation of the 
C4-wingtip group of triazolium salt L1H·BF4, analogously to complexes 133. The 
nature of these complexes was confirmed by NMR spectroscopy and elemental analysis. 




C spectra, confirming the 
presence of both regioisomers in a ca. 1:1 mixture. Purification by column 
chromatography provided pure complex 136 in small quantities, yet sufficient for 
unambiguous NMR characterisation of this complex. Consequently, this data in 




C resonances of 
complex 136′ to be assigned from the mixed sample. The 
1
H NMR spectrum of 
complexes 136 and 136′ features two resonances at δH = 7.63 and 7.59 ppm which are 




diagnostic for the loss of the C4-wingtip group. The triazolylidene 
13
C NMR resonances 
of complex 136 were slightly deshielded when compared to the isomer 136′ (δC = 166.0 
and 133.8 vs. 166.4 and 134.5). These data reflect the closely related structures of 136 
and 136′ and the similar donor properties of the methyl and n-butyl groups. 
The monodentate triazolylidene complex 135a and the C,O-bidentate triazolylidene 
ruthenium complex 135b were readily distinguished by their Ccym.H resonances in the 
5.9–4.5 ppm range, and in particular by the resonance of the NCH2 group, which 
appears as a triplet at δH = 4.56 in 6a, while in 135b this group gives rise to a multiplet 
at δH = 4.68–4.52. We note that the 
1
H NMR spectrum of 135b does not reveal 
diastereotopic resonances for the C(CH3)2 group of the p-cymene, even though the 
ruthenium(II) centre is stereogenic. The 
13
C spectra revealed no distinct differences 
between 135a and 135b, and the carbenic resonances of these complexes are within the 
range reported for similar triazolylidene ruthenium complexes (δC = 164.8 and 163.9 for 
135a and 135b respectively).
14a,15,16,23
 NMR data was not sufficient to distinguish the 
structural motifs of 135a and 135b, and analogously to complexes 132 and 134 chloride 
scavenging reactions were used to identified the denticity of the triazolylidene ligand. 
Thus, addition of AgBF4 (1 equiv, CH2Cl2) or NH4BF4 (1 equiv, acetone) to complex 
135a yielded 135b, as evidenced by the diagnostic shift and splitting of the NCH2 
resonance in the 
1
H NMR spectrum. When NaBPh4 was used to abstract the chloride 
ligand from complex 135a, the observed 1:1 ratio between the BPh4
–
 anion and the 
ligand NMR resonances confirmed the monocationic nature of 135b. Conversely, 
complex 135b was converted to complex 135a by the addition of brine to an aqueous 
solution of 135b followed by extraction with CH2Cl2. This methodology is analogous to 
the aqueous purification of the reaction mixture (see above), which yielded exclusively 
complex 135a. Accordingly, the presence of excess chloride ions induces metallacycle 
ring opening and the transformation of the chelate ligand in 135b to a monodentate 
bonding mode in 135a. The reversible interconversion of 135a and 135b demonstrates 
that the hydroxy group provides a hemilabile ligand site. Finally, D2O exchange 
experiments confirmed the presence of acidic OH groups in both complexes 135a and 
135b by the disappearance of the 
1
H NMR resonances at δH = 9.46 and 9.34, 
respectively (D6-DMSO solutions). These data confirm that the C,O-bidentate ligand in 
complex 135b is formally neutral. 
Transformation of 135b to 135a in aqueous media suggested that the chelating and 





polarity of the solvent. NMR spectroscopic investigations of pure complexes 135a and 
135b revealed no equilibrium in CDCl3 and CD2Cl2 and each complex displayed its 
own characteristic resonance pattern for the cymene and NCH2 group (vida supra). In 
CD3OD, the aromatic cymene resonances of complex 135a are relatively broad, while 
the resolution was unaltered for complex 135b. The broadening observed in complex 
135a may hint towards an exchange in the ruthenium coordination sphere and 
competitive MeOH coordination. In D6–DMSO, 135a and 135b have identical 
1
H NMR 
spectra, indicating the formation of a cationic complex involving either C,O-bidentate 
triazolylidene chelation as in 135b, or a Ru–DMSO bond formation by displacement of 
the chlorido and the chelating-hydroxy ligands of 135a and 135b, respectively. Further 
characterization of this species was prevented by the gradual decomposition of both 
135a and 135b in DMSO solution, evidenced by the appearance of 
1
H resonances 
corresponding to free p-cymene already within the first few min. When dissolved in 
CDCl3, CD2Cl2, or CD3OD, complexes 135a,b exhibited better stability and p-cymene 
loss was only observed after extended time periods (ca. 24 h, i.e. when cymene loss was 
complete in DMSO). For comparative purposes, D6-DMSO solutions of a 1,4-dibutyl-
triazolylidene ruthenium complex
15a
 as analogue of complexes 135a,b displayed only 
ca. 2% free p-cymene even 2 days after sample preparation. Cymene loss is presumably 
promoted by the coordinating nature of the wingtip group, which is also corroborated by 




5.1.3.3. Catalytic transfer hydrogenation 
The pendant O-functionalities in complexes 132, 134 and 135 provide opportunities 
for cooperative metal-ligand interaction and proton-shuttling, which is particularly 
beneficial in hydrogen transfer reactions.
4c,8,24
 The catalytic activity of the novel iridium 
complexes 132-134 was therefore evaluated in transfer hydrogenation using standard 
reaction conditions, i.e. refluxing 
i
PrOH as the sacrificial hydrogen source, KOH (10 
mol% relative to the substrate) and benzophenone as model substrate.
25
 An initial run 
with complex 3a as catalyst precursor at 1 mol% loading produced the product alcohol 
in a moderate 67% yield after 8 h (Table 5.1.2, entry 1). Increasing the catalysts loading 
to 2 mol% enhanced the performance and gave quantitative conversions when using the 
Ofunctionalised iridium complexes 132a and 132b (entries 2,3).  




Table 5.1.2. Catalytic transfer hydrogenation of benzophenone. 
 
Entry Cat. mol% time (h)/Conv. (%)b timr (h)/Conv. (%)b TOF50 (h
-1)c 
1 132a 1 2/33 8/67 12 
2 132a 2 2/46 8/96 12 
3 132b 2 2/48 8/97 12 
4 133/133′ 2 2/13 8/35 2 
5 134a 2 2/26 8/64 4 
6 135a 1 0.5/78 1.5/97 210 
7 135b 1 0.5/76 1.5/98 200 
8 137 1 0.5/95 1.5/98 370 
(a) General reaction conditions: Benzophenone (0.5 mmol or 1.0 mmol), KOH (10 mol%), [Ir] (0.1 mmol), 2-
propanol (5 ml), reflux temperature. (b) Conversions determined by 1H NMR spertroscopy using mesitylene 
as internal standard, averaged 2 runs. (c) TOF50 determined at 50% conversion. 
 
 
A time conversion profile indicated no significant difference in performance of these 
two complexes (Figure 5.1.2), suggesting that the catalytically active species formed 
from 132a and 132b is identical. In comparison, complex 133 containing an 
unfunctionalised triazolylidene ligand only achieved 39% conversion within the same 
reaction time. This substantial reactivity difference emphasizes the beneficial role of the 
hydroxy functionality. Moreover, it indicates that the functional wingtip group is 
resistant to base-mediated degradation as observed in the presence of Ag2O (cf 
formation of 133 during the metalation process). The presence of an ether functionality 
as triazolylidene wingtip group as in complex 134a improves the activity of the iridium 
centre slightly when compared to the unfunctionalised ligand in 133 (65%, entry 4), 
though the performance is still significantly lower than in the presence of a hydroxy 
group. These data suggest that the hydroxyl group plays a distinct role, likely in the 
formation of a metal-bound alkoxide as an anionic C,O-bidentate chelate.
26
 Such 
alkoxide formation increases the electron density at the iridium centre and therefore 
enhance its catalytic activity in transfer hydrogenation. Alternatively, the alkoxy group 
may facilitate formal dihydrogen abstraction from 
i
PrOH via an outer sphere 
mechanism, involving transfer of the hydride to the iridum centre and proton transfer to 
the ligand oxygen.
8d,e
 In stoichiometric experiments, reaction of 132b with Cs2CO3 as a 
base indeed revealed formation of a new species with a 
1





from 132a and 132b (e.g. NCH2 appears as a multiplet at 4.27–4.18 ppm), which has 
been assigned tentatively to the deprotonated alkoxide species.  
 
 
Figure 5.1.2. Time-dependent profile for the catalytic transfer hydrogenation of 
benzophenone with complexes 3-5 (solid lines: S/C/B ratio 50:1:5, 2 mol% complex; 
dashed lines: S/C/B ratio 100:1:10, 1 mol% complex). 
 
The ruthenium complexes 135a,b were considerably more active than their iridium 
analogues in transfer hydrogenation under otherwise identical conditions and reached 
full conversion within 1 h when used at 1 mol% loading (Table 5.1.2, entries 6,7). 
Again, both complexes showed a reactivity profile that is identical within standard 
errors. The analogous ruthenium complex 137 containing a 1,4-dibutyltriazolylidene 
ligand
15a
 was evaluated for comparison and reached 92% conversion within 15 min (cf. 
51% for complexes 135a and 135b) and essentially complete conversion after 30 min 
(entry 8). The higher activity of complex 137 (TOF > 370 h
–1
 vs about 200 h
–1
 for 
complexes 135a,b) indicates no beneficial role of the hydroxy group in the ruthenium 
system. These data are in agreement with an inner sphere monohydride mechanism,
27
 in 
which the critical hydride species is formed via β-hydrogen elimination of metal-
coordinated isopropoxide without any participation of ancillary ligands. Previous 
studies revealed that triazolylidene ruthenium(II) complexes are more active transfer 
hydrogenation catalysts than their iridium(III) analogues.
16b,c
 Likewise, ruthenium 
complex 135a reaches nearly quantitative conversion within 1 h, and is more than an 
order of magnitude more active than its iridium analogue 132a which reaches only 18% 
conversion in the same time (TOF 210 h
–1
 vs 12 h
–1
). The different role of the hydroxy 
wingtip group in the iridium and ruthenium complexes suggests a different pathway for 
dihydrogen transfer from the 
i
PrOH donor to the catalyst, and due to the microscopic 




reversibility, also from the catalyst to the substrate ketone. However, the hydrogen 
substituent of the triazolylidene in complex 133 may be susceptible to deprotonation 
thereby deactivating the catalyst. Therefore, it is clear that the catalytic activity of 
complexes 136/136′ or the iridium analogue of complex 137 is needed to make an 
unambiguous comparison between working modes of the iridium and ruthenium 
complexes with O-functionalised triazolylidene ligands, and will be included in future 
work. Finally, in comparison to other 1,2,3-triazolydene complexes employed in 
transfer hydrogenation, the iridium complexes reported here perform only moderately, 




O-functionalised 1,2,3-triazolyldiene iridium(III) and ruthenium(II) complexes were 
synthesized and applied in transfer hydrogenation. Ether- and hydroxy-substituted 
1,2,3-triazolylidene iridium(III) complexes were isolated with the ligand both in mono- 
and bidentate coordination mode. Also, monodentate and C,O-bendate, hydroxy-
functionalised 1,2,3-triazolylidene ruthenium complexes are described. The 
monodentate complexes were converted to the chelating species by chloride abstraction 
and vice versa, the chelates were transformed into monodentate ligands in the presence 
of excess halide. Transfer hydrogenation studies revealed that pendant hydroxy-donors 
substantially enhance the catalytic activity of the triazolylidene iridium(III) catalyst 
while analogous hydroxy-functionalised triazolylidene ruthenium(II) complexes did not 
outperform analogous unfunctionalised complexes. Generally, activity was much higher 
for the ruthenium(II) complexes than the iridium(III) homologues, which hints towards 
diverging activation mechanisms. Caution is therefore required when generalizing 
beneficial ligand features. Future outlooks include a detailed investigation into the 
activity of the ruthenium complexes in transfer hydrogenation to conclusively determine 
the influence of the hydroxygroup. Also, applications in base free oxidations and N-
alkylation reactions pose exciting avenues of research to determine the influence of O-





5.1.5. Experimental section 
5.1.5.1. General information 









 were prepared 
according to reported procedures. All other reagents were used as received from 
commercial suppliers. NMR spectra were recorded on Bruker and Varian spectrometers 
operating at room temperature. Chemical shifts (δ in ppm, coupling constants J in Hz) 
were referenced to residual solvent resonances and are given downfield from SiMe4. 
Elemental analysis and mass spectrometry were carried out by the microanalytical 
services of University College Dublin and University of Bern.  
 
5.1.5.2. Preparation of triazolium salt L2H·BF4 
Under a N2 atmosphere, 1-butyl-4-(CMe2OH)-triazole (0.914 g, 5.0 mmol) was 
dissolved in dry THF (20 mL) and cooled to 0 °C. To this solution, NaH (60% in 
mineral oil, 0.30 g, 7.5 mmol) was added in 3 portions. The temperature was maintained 
at 0 °C for 15 min, after which the reaction mixture was allowed to stir at room 
temperature for 1 h. Iodomethane (0.50 mL, 8.0 mmol) was added to the reaction 
mixture, which was stirred for a further 1 h. Then H2O (100 mL) was slowly added and 
the mixture was stirred for 30 min. The reaction mixture was extracted with Et2O (3 × 
100 mL). The organic fractions were combined and washed with brine (2 × 100 mL), 
dried with Na2SO4, filtered and all volatiles removed under reduced pressure, yielding 
1-butyl-4-(CMe2OMe)-triazole as a pale yellow oil. This intermediate was purified by 
column chromatography (SiO2; EtOAc/pentane, 2:1), however the crude form was 
suitable to be used for the next step. 
1
H NMR (400 MHz, CDCl3): δ = 7.43 (s, 1H, 
CtrzH), 4.34 (t, 
3
JH-H = 7.3 Hz, 2H, NCH2), 3.14 (s, 3H, OCH3), 1.95–1.83 (m, 2H, 
NCH2CH2), 1.61 (s, 6H, C(CH3)2), 1.43–1.30 (m, 2H, CH2CH3), 0.96 (t, 
3





H} NMR (101 MHz, CDCl3): δ = 152.7 (CtrzC), 120.4 (CtrzH), 73.1 
(C(CH3)2), 50.7 (OCH3), 50.1 (NCH2), 32.4 (NCH2CH2), 26.7 (C(CH3)2), 19.9 
(CH2CH3), 13.6 (CH2CH3). The 1-butyl-4-(CMe2OMe)-triazole was dissolved in dry 
CH2Cl2 (30 mL). Then Me3OBF4 (0.845 g, 5.0 mmol) was added and the suspension 
stirred for 20 h under a N2 atmosphere. MeOH (5 mL) was added and stirring continued 
for 30 min. All volatiles were removed under reduced pressure and the residual brown 
oil was dissolved in a minimal amount of CH2Cl2 and precipitated by addition of 




pentane (200 mL). The residue was collected by decantation and dried under reduced 
pressure. The solid was then dissolved in CH2Cl2 (50 mL) and stirred with activated 
carbon (100–325 mesh, 6 g) for 10 min. The suspension was filtered over Celite, and 
volatiles removed under reduced pressure. The residue was redissolved in a minimum 
amount of CH2Cl2 and added dropwise to cold Et2O with vigorous stirring. The white 
precipitate was collected by decantation and thoroughly dried to yield the title product 
as a white solid (1.11 g, 74%). 
1
H NMR (400 MHz, CDCl3): δ = 8.60 (s, 1H, CtrzH), 
4.60 (t, 
3
JH-H = 7.5 Hz, 2H, NCH2), 4.36 (s, 3H, NCH3), 3.20 (s, 3H, OCH3), 2.07–19.5 
(m, 2H, NCH2CH2), 1.70 (s, 6H, C(CH3)2), 1.48–1.36 (m, 2H, CH2CH3), 0.98 (t, 
3
JH-H = 




H} (101 MHz, CDCl3): δ = 146.9 (CtrzC), 130.0 (CtrzH), 
72.8 (C(CH3)2), 54.2 (NCH2), 51.4 (OCH3), 39.7 (NCH3), 31.1 (NCH2CH2), 25.5 
(C(CH3)2), 19.6 (CH2CH3), 13.4 (CH2CH3) HRMS (ESI +): m/z Found 212.1757 [M–
BF4]
+
 (calcd for C11H22N3O, 212.1763) Anal. Calc. for C11H22BF4N3O: C, 44.17; H, 
7.41; N, 14.05%. Found: C, 43.74, H, 7.27; N, 13.96%. 
 
5.1.5.3. Preparation of complexes 132a, 132b, 133 and 133’ 
A suspension of L1H·BF4 (170 mg, 0.60 mmol), Me4NCl (66 mg, 0.60 mmol), 
Ag2O (280 mg, 1.2 mmol) in CH2Cl2/MeCN (1:1 v/v, 10 mL) was stirred protected 
from light for 16 h. The suspension was filtered through Celite, eluted with CH2Cl2 (100 
mL), and [Ir(Cp*)Cl2]2 (180 mg, 0.23 mmol) added and the reaction mixtures stirred for 
5 h protected from light. The reaction mixture was filtered over Celite, eluting with 
CH2Cl2 and the volatiles were removed under reduced pressure to yield the crude 
reaction mixture. Purification by column chromatography (SiO2; CH2Cl2/MeOH 
gradient, 20:1 to 5:1) yielded complex 132a (yellow solid, 120 mg, 43%), 132b 
(yellow-brown solid, 58 mg, 20%) and complexes 133 and 133
′ 
(1:1 mixture, 
hydroscopic yellow solid, 43 mg, 17%). 
Complex 132a. 
1
H NMR (400 MHz, CD2Cl2): δ = 6.21 (b, 1H, OH), 4.93 (b, 1H, 
NCH2), 4.09 (s, 4H, NCH3 and NCH2), 2.04 (br s, 2H, NCH2CH2), 1.64 (s, 6H, 
C(CH3)2), 1.56 (s, 15H, CCpCH3), 1.50–1.44 (m, 2H, CH2CH3), 1.00 (t, 
3





H} NMR (400 MHz, CD2Cl2): δ = 152.9 (Ctrz), 145.5 (Ctrz), 88.7 
(CCp), 69.0 (C(CH3)2), 55.2 (NCH2), 39.7 (NCH3), 33.4 (NCH2CH2), 30.5 (br, 
C(CH3)2), 20.7 (CH2CH3), 14.2 (CH2CH3), 9.5 (CCpCH3). HRMS (ESI+): m/z Found 
560.2002 [M–Cl]
+
 (cald for C20H34ON3ClIr, 560.2014) Anal. Calcd for C20H34N3Cl2IrO: 







H NMR (400 MHz, CD2Cl2): δ = 4.45 (b, 2H, NCH2), 4.10 (s, 3H, 
NCH3), 3.39 (b, 1H, OH), 2.05–1.93 (m, 2H, NCH2CH2), 1.73 (s, 15H, CCpCH3), 1.65 
(s, 6H, (C(CH3)2), 1.47–1.33 (m, 2H, CH2CH3), 0.98 (t, 
3




H} NMR (101 MHz, CD2Cl2): δ = 157.2 (CtrzC), 154.1 (C–Ir), 89.4 (CCp), 77.6 
(C(CH3)2), 54.1 (NCH2), 37.7 (NCH3), 32.4 (NCH2CH2), 28.7 (C(CH3)2), 20.3 
(CH2CH3), 13.9 (CH2CH3), 10.2 (CCpCH3). HRMS (ESI+): m/z Found 524.2240 [M–
H–Cl–BF4]
+
 (cald for C20H33ON3Ir, 524.2247) 
Complex 133. 
1
H NMR (400 MHz, CD2Cl2): δ = 7.49 (s, 
1
H, CtrzH), 4.50–4.46 (m, 
2H, NCH2), 4.05 (s, 3H, NCH3), 2.09–1.98 (m, 2H, NCH2CH2), 1.59 or 1.58 (s, 15H, 
CpCH3), 1.53–1.42 (m, 2H, CH2CH3), 0.99 (t, 
3





NMR (101 MHz, CD2Cl2): δ = 148.4 (Ctrz–Ir), 134.8 (CtrzC), 88.3 (CCp), 53.7 (NCH2), 




H NMR (400 MHz, CD2Cl2): δ = 7.51 (s, 1H, CtrzH), 4.29 (t, 2H, 
3
JH-H = 7.3 Hz, NCH2), 4.25 (s, 3H, NCH3), 2.09–1.98 (m, 2H, NCH2CH2), 1.59 or 1.58 
(2 × s, 15H, CpCH3), 1.42–1.30 (m, 2H, CH2CH3), 0.97 (t, 
3





H} NMR (101 MHz, CD2Cl2): δ = 147.9 (Ctrz–Ir), 134.1 (CtrzC), 88.3 
(CCp), 52.4 (NCH2), 40.3 (NCH3), 33.2 (NCH2CH2), 20.7 (CH2CH3), 14.2 (CH2CH3), 
9.13 or 9.12 (CCpCH3) HRMS (ESI+): m/z Found 502.1580 [M–Cl]
+
 (cald for 
C17H28N3ClIr, 502.1596). 
 
5.1.5.4. Preparation of complexes 134a and 134b 
A suspension of L2H·BF4 (150 mg, 0.50 mmol), Me4NCl (55 mg, 0.50 mmol), 
Ag2O (233 mg, 1.0 mmol) in MeCN (10 mL) was stirred protected from light for 24 h. 
The suspension was then filtered through Celite, and the volatiles removed under 
reduced pressure. The residue was suspended in CH2Cl2 (20 mL) and [Ir(Cp*)Cl2]2 (150 
mg, 0.19 mmol) was added. The reaction mixture was stirred for 5 h protected from 
light, then filtered over Celite, and all volatiles were removed under reduced pressure to 
yield the crude products. Purification by column chromatography (SiO2; CH2Cl2/MeOH 




H NMR (400 MHz, CD2Cl2): δ = 5.01–4.84 (m, 1H, NCH2), 4.19 
(s, 3H, NCH3), 4.15–4.01 (m, 1H, NCH2), 3.06 (s, 3H, OCH3), 2.13–1.96 (m, 2H, 
NCH2CH2), 2.04 (s, 3H, C(CH3)2), 1.76 (s, 3H, C(CH3)2), 1.66–1.39 (m, 2H, CH2CH3), 








H} NMR (101 MHz, CD2Cl2): δ = 
150.2 (CtrzC), 144.7 (Ctrz–Ir), 88.4 (CCp), 76.5 (C(CH3)2), 56.1 (NCH2), 50.0 (OCH3), 
41.0 (NCH3), 33.6 (NCH2CH2), 28.6, 25.3 (C(CH3)2), 20.8 (CH2CH3), 14.3 (CH2CH3), 
9.70 (CCpCH3) HRMS (ESI+): m/z Found 574.2161 [M–Cl]
+
 (cald for C21H36ON3ClIr, 
574.2171). Anal. Calcd for C21H26N3Cl2IrO: C, 41.37; H, 5.95; N, 6.89%; C, 41.43; H, 
5.95; N, 6.74%. 
Complex 134b. 
1
H NMR (400 MHz, CD2Cl2): δ = 4.57–4.49, 4.37–4.27 (2 ×  m, 
1H, NCH2), 4.13 (s, 3H, NCH3), 3.70 (s, 3H, OCH3), 2.02–1.85 (m, 2H, NCH2CH2), 
1.67 (s, 15H, CCpCH3), 1.61, 1.60 (2 × s, 3H, C(CH3)2), 1.41–1.30 (m, 2H, CH2CH3), 
0.95 (t, 
3




H} NMR (101 MHz, CD2Cl2): δ = 153.0 
(Ctrz–Ir), 151.5 (CtrzC), 89.9 (CCp), 81.5 (C(CH3)2), 54.8 (OCH3), 54.3 (NCH2), 38.3 
(NCH3), 32.3 (NCH2CH2), 25.2, 24.6 (2 × C(CH3)2), 20.2 (CH2CH3), 13.9 (CH2CH3), 
10.2 (CCpCH3) HRMS (ESI+): m/z Found 574.2158 [M–BF4]
+
 (cald for 
C21H36ON3ClIr, 574.2171). 
 
5.1.5.5. Preparation of complexes 135a, 135b, 136 and 136’ 
A suspension of L1H·BF4 (170 mg, 0.60 mmol), Me4NCl (66 mg, 0.60 mmol), 
Ag2O (280 mg, 1.2 mmol) in CH2Cl2/MeCN (1:1 v/v, 10 mL) was stirred protected 
from light for 16 h. The suspension was filtered through Celite, eluted with CH2Cl2 (100 
mL), and [Ru(p-cymene)Cl2]2 (110 mg, 0.18 mmol) added. The reaction mixture was 
stirred for 2 h protected from light, filtered over Celite, evaporated to dryness under 
reduced pressure. The crude reaction mixture was purified by column chromatography 
(SiO2; CH2Cl2/MeOH gradient, 20:1 to 5:1), which yielded complex 135a (50 mg, 28%) 
and complex 135b (57 mg, 28%) both as a red-brown, hygroscopic solids, and 
complexes 136 and 136′ in a 1:1 mixture as a brown, hygroscopic solid (22.5 mg, 14%). 
Alternately complex 135a was isolated selectively by applying an alternative 
purification procedure. The crude reaction mixture was suspended in CH2Cl2 (100 mL) 
and extracted with H2O (100 mL). CH2Cl2 (100 mL) was added to the aqueous phase 
followed by brine (200 mL) and the mixture extracted. The organic phase was dried 
over Na2SO4, filtered and the volatiles were removed under reduced pressure. Residual 
[Ru(p-cymene)Cl2]2 was removed from this residue by washing a CH2Cl2 (100 mL) 
solution of the product with copious amounts of saturated NH4Claq until the aqueous 





(SiO2; CH2Cl2/MeOH, 10:1-5:1 gradient), yielding 135a as a red-brown, hygroscopic 
solid (104 mg, 57%).  
Complex 135a. 
1
H NMR (400 MHz, CD2Cl2): δ = 5.82, 5.73, 5.68, 5.18 (4 × br s, 
1H, Hcym), 4.56 (t,
3
JH-H = 7.4 Hz, NCH2), 3.97 (s, 3H, NCH3), 2.81–2.66 (m, 1H, 
CHMe2), 2.14 (s, 3H, CcymCH3), 2.11–1.99 (m, 2H, NCH2CH2), 1.62, 1.54 (2 × br s, 3H, 
C(CH3)2), 1.52–1.38 (m, 2H, CH2CH3), 1.17 (d, 
3
JH-H = 6.7 Hz, 6H, CH(CH3)2), 1.01 (t, 
3




H} NMR (101 MHz, CD2Cl2): δ = 164.8 (Ctrz–Ru), 
152.3 (CtrzC), 104.5 (CcymCH), 100.7 (CcymCH3), 86.5 , 82.0, 79.0 (4 ×  CcymH), 76.1 
(C(CH3)2), 54.3 (NCH2), 37.1 (NCH3), 32.3 (NCH2CH2), 31.5 (CHMe2), 29.3, 28.9 (2 × 
C(CH3)2), 23.3, 22.3 (2 × CH(CH3)2), 20.5 (CH2CH3), 19.3 (CcymCH3), 13.9 (CH2CH3). 
HRMS(ESI+): m/z Found 468.1342 [M–Cl]
+
 (calcd. for C20H33ON3ClRu, 468.1350) 




H NMR (400 MHz, CD2Cl2): δ = 5.85–5.79 (m, 2H, Hcym), 5.49 (d, 
3
JH-H = 6.0 Hz, 1H, Hcym), 5.18 (d, 
3
JH-H = 5.9 Hz, 1H, Hcym), 4.68–4.52 (m, 2H, NCH2), 
4.01 (s, 3H, NCH3), 2.79–2.64 (m, 1H, CHMe2), 2.16 (s, 3H, CcymCH3), 2.09–1.96 (m, 
2H, NCH2CH2), 1.58 (s, 6H, C(CH3)2), 1.51–1.36 (m, 2H, CH2CH3), 1.21 (d, 
3
JH-H = 6.6 
Hz, 6H, CH(CH3)2), 1.01 (t, 
3




H} NMR (101 MHz, 
CD2Cl2): δ = 163.9 (Ctrz–Ru), 149.0 (CtrzC), 106.4 (CcymCH3), 100.8 (CcymCH), 86.3, 
82.0, 80.5, 79.0 (4 × CcymH), 77.5 (C(CH3)2), 54.6 (NCH2), 37.5 (NCH3), 32.2 
(NCH2CH2), 31.7 (CHMe2), 28.5, 28.3 (2 × C(CH3)2), 23.1, 22.2 (2 × CH(CH3)2), 20.5 
(CH2CH3), 19.3 (CcymCH3), 13.9 (CH2CH3) HRMS (ESI+): m/z Found 468.1342 [M–
BF4]
+ 
(calcd. for C20H33ON3ClRu, 468.1350). 
Complex 136. 
1
H NMR (400 MHz, CD2Cl2): δ = 7.63 (s, 1H, CtrzH), 5.28 (d, 
3
JH-H = 
5.9 Hz, 2H, Hcym), 5.14 (d, 
3
JH-H = 5.8 Hz, 2H, Hcym), 4.32–4.24 (m, 5H, NCH3 and 
NCH2), 2.65 (hept, 
3
JH-H = 6.9 Hz, 1H, CHMe2), 2.09 (s, 3H, CcymCH3), 1.96–1.86 (m, 
2H, NCH2CH2), 1.45–1.31 (m, 2H, CH2CH3), 1.19 (d, 
3
JH-H = 6.9 Hz, 6H, CH(CH3)2), 
0.97 (t, 3H, 
3




H} NMR (101 MHz, CD2Cl2): δ = 166.0 
(Ctrz–Ru), 133.8 (CtrzH), 104.1 (CcymCH), 100.7 (CcymCH3), 84.8, 84.3 (2 ×  CcymH), 
52.3 (NCH2), 41.0 (NCH3), 31.9 (NCH2CH2), 31.3 (CHMe2), 22.6 (CH(CH3)), 20.2 
(CH2CH3), 18.7 (CcymCH3), 13.7 (CH2CH3). 
Complex 136′. 
1
H NMR (400 MHz, CD2Cl2): δ = 7.59 (s, 1H, CtrzH), 5.27 (d, 
3
JH-H 
= 5.9 Hz, 2H, Hcym), 5.12 (d, 
3
JH-H = 6.1 Hz, 2H, Hcym), 4.58–4.49 (m, 2H, NCH2), 4.04 
(s, 3H, NCH3), 2.76–2.66 (m, 1H, CHMe2), 2.08 (s, 3H, CcymCH3), 2.07–1.96 (m, 2H, 




NCH2CH2), 1.55–1.44 (m, 2H, CH2CH3), 1.20 (d, 
3
JH-H = 7.0 Hz, 6H, CH(CH3)2), 1.01 
(t, 
3




H} NMR (101 MHz, CD2Cl2): δ = 166.4 (Ctrz–
Ru), 134.5 (CtrzH), 104.3 (CcymCH), 99.6 (CcymCH3), 84.9, 84.5 (2 ×  CcymH), 52.3 
(NCH2), 38.8 (NCH3), 33.8 (NCH2CH2), 31.2 (CHMe2), 22.6 (CH(CH3)2), 20.7 
(CH2CH3), 18.7 (CcymCH3), 14.2 (CH2CH3) HRMS (ESI+): m/z Found 410.0929 [M–
Cl]
+
 (cald for C17H27N3ClRu, 410.0932) Anal. Calcd for C17H27N3Cl2Ru: C, 45.84; H, 
6.11; N, 9.43%; C, 45.85; H, 6.09; N, 9.03%.  
 
5.1.5.6. Chelation of monodentate ligand 
AgBF4 as Chlorido Scavenging Agent. To a solution of the corresponding metal 
complex (1 equiv) in CH2Cl2 (2 mL) was added AgBF4 (1 equiv) followed by CH2Cl2 (3 
mL). The reaction mixture was stirred for 15 min while protected from light, filtered 
over Celite and the volatiles were removed under reduced pressure. Further purification 
included gradient column chromatography (SiO2; CH2Cl2 to MeOH). Alternatively, a 
solution of the metal complex (1 equiv) in acetone (2 mL) was treated with NaBF4 or 
NaBPh4 (1 equiv) in acetone (3 mL). The reaction mixture was stirred for 18 h, all 
volatiles were removed under reduced pressure, and the residue was suspended in 
CH2Cl2 and filtered over Celite. All volatiles were removed under reduced pressure and 
the residue purified by gradient column chromatography (SiO2; CH2Cl2 to MeOH). 
 
5.1.5.7. General procedure for catalytic transfer hydrogenation  
In a one-necked round bottom flask metal complex (1.0 mmol), 2-propanol (5 mL) 
and mesitylene (0.36 mmol or 0.72 mmol) were mixed and KOH (2.0 M, 0.05 mmol or 
0.1 mmol, 10 mol% relative to substrate) added and the mixture heated to a vigorous 
reflux for 10 minutes. Benzophenone (0.5 mmol or 1.0 mmol) was added, and aliquots 
(0.1 mL) were taken and directly dissolved in CDCl3 (0.7 mL) and analysed by 
1
H 
NMR spectroscopy, using mesitylene as internal standard. 
 
5.1.5.8. Crystal structure determination  
Crystal data of 132a, 132b, and 134a were collected on a Oxford Diffraction 
SuperNova area-detector diffractometer using mirror optics monochromated Mo Kα 
radiation (λ = 0.71073 Å) and Al filtered. Data reduction was performed using the 
CrysAlisPro program.
29





effects, and an absorption correction based on the multi-scan method using SCALE3 
ABSPACK in CrysAlisPro
29
 was applied. The structure was solved by direct methods 
using SHELXT, 
30
 which revealed the positions of all nonhydrogen atoms of the title 
compound. The non-hydrogen atoms were refined anisotropically. All Hatoms were 
placed in geometrically calculated positions and refined using a riding model. 
Refinement of the structure was carried out on F
2
 using full-matrix least-squares 






. The weighting scheme was 
based on counting statistics and included a factor to downweight the intense reflections. 
All calculations were performed using the SHELXL-2014/7 program.
31
 Crystallographic 
data for the structures of all compounds reported in this paper have been deposited with 
the Cambridge Crystallographic Data Centre (CCDC) as supplementary publication 
numbers numbers 1537332 (132a), 1537334 (132b), and 1537333 (134a). 
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C NMR resonances for complex 132a and 132b displayed 
natural peak broadening when compared to complexes 133/133′ and 134a,b. This 
broadening was especially evident for 132a, for which high concentrations (ca. 60 mg 
in 0.7 mL CD2Cl2) were required to identify the chemical shifts the quaternary carbons 
in 
13
C NMR spectroscopy (extended relaxation times (t1 = 10 sec.) and scan numbers 
(5000) did not improve the quality of the spectra, albeit at lower concentrations ca. 15 
mg). 
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5.2. Ir-complexes containing mesoionic carbenes for the 
highly efficient and versatile transfer hydrogenation of 
C=O, C=N and C=C functionalities and for 
dehydrogenation of alcohols 
Mazloomi, Z.; Petrorius, R.; Pàmies, O.; Albrecht, M.; Diéguez, M. Manuscript 
to be submitted. 
 
5.2.1. Introduction 
Sustainable production is one of the important challenges our society is facing and 
catalysis is leading the developments in this process. With small amounts of catalysts, 
large quantities of compounds can be produced with fewer reaction steps and fewer 
byproducts than in non-catalyzed approaches. Undoubtedly, the research for improved 
activity and selectivity of the catalysts is at the core of sustainable processes, reduction 
of costs and continuous growth. The performance of catalytic reactions depends, to a 
large extent, on the adequate selection of the ligands, in which an electronically and 
sterically well defined scaffold is the most important factor. In this context, thousands 
of homo- and hetero-donor ligands, mainly P- and N-containing ligands with either C2- 
or C1-symmetry, have been developed although only a few of them have a general 
scope.
1
 Among them, heterodonor ligands (P-N, P-S, P-P', etc.) equipped with strong 
and weak donor heteroatom pairs have made some of the most fundamental 
contributions to the development of catalysis. Our groups have contributed with 
improved generations of modular heterodonor P-X ligand libraries, obtained from 
readily available starting materials and easy to handle.
2
 Among them, P-N ligand 
libraries containing in total more than 300 systematic structural variations were 
synthesized from unexpensive reagents (e.g., sugars) and containing mainly oxazoline, 
oxazole and thiazole moiety in the nitrogen functionality.
2d-e
 
In the last two decades N-heterocyclic carbenes (NHCs) have emerged as powerful 
ligands in catalysis. Owing to their strong σ-donation ability, air stability and low 
toxicity they have become practical alternatives to the most commonly used 
phosphines.
3
 A large number of transformations are known to proceed only with NHC-
based catalysts. For that reason, exploring new classes of NHCs is a very important goal 
in recent organometallic chemistry. 1,2,3-Triazol-5-ylidenes are a relevant subclass of 




NHCs possessing a mesoionic carbene (MIC) structure.
4
 The pioneering work of 
Albrecht
5a




 with mesoionic carbene ligands recently put 
the focus on these type of ligands and spurred their development. Several reactions have 
therefore been explored where triazolylidene-based metal complexes are equally or 
more efficient compared to their NHC analogues, such as cross-coupling reactions, 
olefin metathesis, oxidative transformations, transfer hydrogenation catalysis, and the 
click reaction.
7
 The triazole framework adds the advantages of increased σ-donation 
compared to classical NHCs and the ability to potentially stabilize different metal 
oxidation states. In addition, they are accessible via synthetically highly efficient and 
modular nature of "click reaction". The click reaction tolerates a wide variety of 
functional groups in the azide and in the alkyne reactant. These features facilitate 
preparing series of modular heterodonor MIC-containing ligands, with different steric 
and electronic properties, in the quest to maximize catalytic performance.
4
 Despite this, 
the development of heterodonor 1,2,3-triazol-5-ylidene-containing ligands have been 
scarcely explored. Most of the reported complexes possessing 1,2,3-triazol-5-ylidene 
ligands have a monodentate coordination mode. Only a few MIC complexes with a 
bidentate coordination mode have been reported in the literature recently. To our 
knowledge the 1,2,3-triazol-5-ylidene carbene moiety has only been combined with 
pyridine/pyrimidine and hydroxyl groups.
7e,i,8
  More research is therefore still needed to 
explore new classes of chelating 1,2,3- triazolylidene based ligands. 
 
5.2.2. Objectives 
Inspired by the pioneering work on catalysis using 1,2,3-triazol-5-ylidenes based-
carbenes and the success of oxazole/thiazole containing ligands in homogeneous 
catalysis a combination of these scaffolds is a logical field for investigation. 
Consequently, we here report the first examples of mixed oxazole/thiazole-MIC ligands 
(L3H·OTf and L4H·OTf, Figure 5.2.1).  For comparison purposes we also synthesized 
the ether-functionalized 1,2,3-triazolylidene ligand L2H·BF4 (Figure 5.2.1).
8d
 We used 
these ligands to generate the corresponding Ir(I) and Ir(III) oxazole/thiazole/ether-
appended MIC complexes 134, 138-142 (Figure 5.2.1). The coordination was achieved 





C spectroscopies, high resolution mass spectrometry, 
elementary analysis and X-ray diffraction. Apart from synthetic and structural aspects, 
we also present the application of these complexes in transfer hydrogenation of a broad 




range of substrates (ketones, aldehydes, imines, …) and also the more challenging 
mono-, di- and trisubstituted olefins and in the base-free dehydrogenation reactions of 
alcohols. We also discuss some mechanistic insights for both transformations. 
 
 
Figure 5.2.1. Heterodonor benzoxazole/thiazole/ether-1,2,3-triazol-5-ylidene L2H·BF4, 
L3-L4H·OTf ligands and their Ir(I)/Ir(III) complexes 134, 138-142 used in this work. 
 
5.2.3. Results and discusion 
5.2.3.1. Synthesis and characterization of ligands and complexes 
The triazolium-benzoxazole/thiazole salts L3H·OTf and L2H·OTf used as ligand 
precursors were prepared via conventional copper-catalyzed [3+2] of the methyl azide 
and the corresponding functionalized trimethylsilyl-protected alkyne, followed by the 
methylation at the triazole N3 position as illustrated in (Scheme 5.2.1). This procedure 
yielded the desired triazolium-benzoxazole salt L3H·OTf as a sole product when 
starting from the benzoxazole protected alkyne but a mixture of triazolium-thiazole salts 
(desired ligand L4H·OTf and compound 145) when starting from the thiazole protected 
alkyne. The unselective methylation that leads to the formation of the mixture of 
triazolium salts is attributed to the similar pKa of the triazole N3 position and of the 
thiazole group. Fortunately, pure triazolium-thiazole salts L4H·OTf and 145 were 




obtained after separation by column chromatography.  The formation of ligand 




C NMR spectroscopy 
and mass spectrometry (see experimental section for characterization details). For 
ligand L3H·OTf single crystals suitable for XR-diffraction analysis were obtained 
which further confirm its formation (Figure 5.2.2). The triazolium-ether salt L2H·BF4 
was prepared as previously reported by Albrecht's group.




Scheme 5.2.1. Synthesis of triazolium-benzoxazole/thiazole salts L3-L4H·OTf. 
 
 
Figure 5.2.2. X-Ray structure of triazolium-benzoxazole salt L3H·OTf. 
 
Iridium complexes 134, 138-142 were obtained by a one-pot reaction from the 
corresponding triazolium salts L2H·BF4 and L3-L4H·OTf using Ag2O and Me4NCl to 
form the desired Ag-carbene intermediates, and subsequent in situ transmetallation with 
either [Ir(μ-Cl)(COD)]2 or [Ir(Cp*)Cl2]2 (Scheme 5.2.2).  Note that under the applied 
reaction conditions the analogue [IrCl(L4)(COD)] complex with the triazolium-thiazole 
salt could not be reached. On the other hand, in the case of the triazolium-benzoxazole 
salt, a mixture of Ir (III) compounds 139 (with bidentated coordination of L3) and 140 
(with monodentated coordination of L3) in a ratio 3:1, was obtained. Both complexes, 




139 and 140, were obtained in pure form after separation by column chromatography. 




Scheme 5.2.2. Synthesis of benzoxazole/thiazole/ether-appended 1,2,3-triazol-5-ylidene 
iridium complexes 134, 138-142. 
 





C NMR spectroscopy, elemental analysis, mass spectroscopy and X-ray 
diffraction. In all complexes, coordination of L2-L4 through the 1,2,3-triazol-5-ylidene 
group was confirmed by the disappearance of the H-5 proton signal in the 
1
H NMR 
spectra and by the strong downfield shift of the C-5 carbon signal in the 
13
C NMR 
spectra (see Table 5.2.1). In the [IrCl(L3)(COD)] 138 and 142 complexes, 
monocoordination of ligands L3 and L2 through the 1,2,3-triazol-5-ylidene group was 
also confirmed by the unfolding of the signals of the methinic hydrogens and carbons of 
the cyclooctadiene group. Therefore, two sets of signals at significantly different 
chemical shifts were observed for methinic protons (around 4.5 ppm and 2.8 ppm in the 
1
H NMR)  and carbons (around 80 ppm and 50 ppm in the 
13
C NMR),  see Table 5.2.1, 
which are characteristic of methinic protons trans to chloro and trans to the carbene 




group, respectively. In the case of Ir(III)-complexes, the ability of ligands L3 and L4 to 
coordinate in a mono- or bidentated fashion was easily confirmed  by 
13
C NMR spectra 
where the signals from the quaternary O-C=N group were downfield shifted when the 
ligands were coordinated in a bidentated fashion (Table 5.2.1). Thus for instance, while 
the signal of O-C=N in L3 appears at 154.5 ppm in complex 139 with a bidentated 
coordination of L3, for complex 140, with a monodentated coordination mode of L3, 
this signal appears at 151.9 ppm,  similar to the chemical shift of the free ligand. 
 








 13C  1H 
Compound C-5 C-4 O-C=N CH= (COD)  CH= (COD) 
138 176.7 133.3 154.4 83.3; 82.9 
52.1; 51.7 
 4.62 (bs); 4.51 (bs) 
2.88 (bs); 2.8b (bs) 
139 161.1 136.4 154.5 -  - 
140 152.0 135.5 151.9 -  - 
141 158.4 145.7 158.4 -  - 
142 169.0 146.7 - 81.3; 79.8 
51.3; 51.1 
 4.55 (m); 4.44 (m) 
2.68-2.82 (m) 
L3H·OTf 132.3 132.6 151.2 -  - 
L4H·OTf 131.0 136.9 150.3 -  - 
L2H·BF4
6d 146.9 130.0 - -  - 
(a) Otherwise noted all signals are singlets. Abbreviations used: bs= broad singlet; m= multiplet. 
 
Suitable crystals for single-crystal X-ray diffraction analysis were obtained for all 
complexes by slow diffusion of pentane into a dichloromethane solution of the 
complexes (Figure 5.2.3). The results provide further evidence for the proposed 
structures of complexes 138-142. The molecular structures show the expected square-
planar and piano-stool arrangements for Ir(I) and Ir(III)-complexes, respectively. By 
comparing the structures of Ir(III) complexes 139 and 140, containing the benzoxazole-
MIC ligand L3, we can observe a small contraction of the Ir-C5 and Ir-Cl bonds upon 




chelatation which can be attributed to the cationic nature of complex 139, with the 
ligand coordinated in a bidentated fashion (Table 5.2.2).  
 
Figure 5.2.3. X-Ray structure of Ir(I) and Ir(III) complexes 138-142. H and anions are 
omitted for clarity. 
 
Coordination of L3 as bidentated is also responsible for the Ir-C5-C4 angle in 
complex 139 that is lower than in 140. This distortion is compensated by the increase of 
the reverse angle Ir-C5-N1 (Table 5.2.2). Comparison between the structures of Ir(III) 
complexes 139 and 141 (containing ligands L3 and L4 coordinated in a bidentated 
mode, respectively), we can observe a small contraction of the Ir-N4 bond in complex 
141 and almost no deviation of the C5-Ir-N4 angle (Table 5.2.2). This distortion is 
compensated by a substantial increase of the Cl-Ir-N4 and C5-Ir-Cl angles. Comparison 
between the structures of Ir(I) complexes 138 and 142, we can detect that the Ir-C5 
bond is longer in complex 142 than in 138, while almost no deviation of Ir-Cl bond is 
observed (Table 5.2.2). On the other hand, the C5-Ir-Cl angle is bigger in complex 138 
than in 142. Finally, if we compare Ir-complexes 139 and 141 with the analogous 
complex containing a pyridine group instead of a benzoxazole or a thiazole moiety 
(named as complex 146
8i
 in Table 5.2.2), we found that the Ir-N4 bond is smaller in 146 
than in 141 and 139. This confirms that the coordination ability of the three groups is 
Py> thiazole> benzoxazole.  




Table 5.2.2. Selected bond distances (Å) and angles (o) for complexes 138-142. 
 138 139 140 141 142 1466i 
Ir-Cl 2.3587(16) 2.3949(11) 2.4150(4) 
2.4205(5) 
2.4260(9) 2.3635(11) 2.4220 
Ir-C5 2.035(5) 2.027(4) 2.046(2) 2.022(4) 2.063(4) 2.017 
Ir-N4 - 2.159(4) - 2.141(3) - 2.129 
C5-C4 1.399(8) 1.380(6) 1.401(3) 1.387(5) 1.396(6) 1.389 
C5-Ir-N4 - 76.07(16) - 75.56(13) - 76.07 
Cl-Ir-N4 - 86.38(11) - 90.35(8) - 87.79 
C5-Ir-Cl 91.8 (2) 84.97(13) 87.87(5) 
88.06(6) 
88.69(10) 91.39(12) 89.56 
Ir-C5-C4 132.9(4) 117.8(3) 131.76(14) 117.2(3) 135.7(3) 116.76 
Ir-C5-N1 126.1(4) 140.9(4) 126.92(14) 140.5(3) 121.3(3) 140.25 
 
5.2.3.2. Ir-catalyzed transfer hydrogenation reactions 
Catalytic transfer hydrogenation (TH) of unsaturated bonds is, nowadays, one of the 
most investigated hydrogenation reactions. It is a sustainable, efficient and mild method 
that is operationally simpler and significantly safer than direct hydrogenation with 
molecular hydrogen. Ru-, Rh- and Ir-catalysts bearing NHC ligands have been widely 
used for TH with results comparable to the Noyori-type catalysts for some substrates. 
For other substrates, such as heteroaromatic ketones, imines and alkenes, selectivity and 
turnover frequencies are not optimal yet for TH to be competitive with conventional 
hydrogenation. For these reasons, efforts are focused to extend the range of applicable 
substrates by improving the ligand design. In contrast to classical NHC containing 
complexes, few successful examples using complexes with MIC ligands of the 
triazolylidene type can be found in the literature and they are limited in substrate 
scope.
7i,8c,11
  In addition, these examples needed high amount of base (up to 20 mol%) 
and of hydrogen donor (usually  0.1 M of substrate in 2-propanol). 
 
5.2.3.2.1. Transfer hydrogenation of benzophenone S1. Catalyst precursors 
screening.  
In a first set of experiments the catalytic properties of our Ir(I) and Ir(III) complexes 
134, 138-142 were evaluated in the transfer hydrogenation of benzophenone S1 as 
model substrate, using 2-propanol as both hydrogen donor and solvent, and NaO
i
Pr as a 
base to activate the hydrogen donor. In all cases no induction period was observed from 
the time-conversion profiles (see supporting information for profiles details). The 




results, which are summarized in Table 5.2.3, indicate that activity is highly dependent 
on the nature of the catalyst precursors. Thus, Ir(I)-catalyst precursors provided much 
higher activity than Ir(III)-counterparts (i.e. entry 1 vs 2-4; and entry 5 vs 6 and 7). A 
plausible explanation is that the higher electron density on the metal center of Ir(I)-
catalyst precursors than of Ir(III)-analogues facilitates the formation of the metal-
hydride species. We also found that 134a,d and 142 catalyst precursors, which contain 
ligand L2, provide higher activity that the analogous 138-141 with heterodonor 
benzoxazole/thiazole-MIC ligands L3-L4. This can be attributed to the higher 
coordination ability of the benzoxazole and thiazole moieties (ligands L3 and L4, 
respectively) compared to the methoxy group in L2. Moreover, the different time 
conversion profiles (see Supporting Information) and TOFs obtained with complexes 
139 and 140, with the benzoxazole-MIC ligand coordinated in a monodentated and 
bidentated mode, suggests that the catalytically active species are different. 
 





Entry Cat (mol %) NaOiPr (mol %) TOFb %Yieldc (min) 
1 138 (1) 5 252 84 (60) 
2 139 (1) 5 12 8 (60) 
3 140 (1) 5 24 29 (60) 
4 141 (1) 5 60 58 (60) 
5 142 (1) 5 780 97 (30) 
6 134a (1) 5 96 62 (60) 
7 134b (1) 5 72 54 (60) 
8 142 (1) 10 840 97 (30) 
9 142 (1) 2.5 48 97 (400) 
10 142 (1) 1 24 96 (720) 
11 142 (1) 5 985 96 (30) 
12 142 (1) 5 816 85 (60) 
13 142 (1) 5 1080 98 (150) 
(a) Reaction conditions: 0.4 M benzophenone S1 in 2-propanol, catalyst precursor 
(0.1-1 mol%), NaOiPr (1-10 mol%). (b) TOF in mol S1 × (mol cat × h)-1 measured 
after 5 min. (c) Yield measured by 1H NMR using mesytilene as internal standard. 




We then performed several experiments with different amounts of base and catalyst 
precursor using 142, which had provided the best result. The amount of base had a 
dramatic impact on activity (Table 5.2.3, entries 5 and 8-10):  decreasing it to 2.5 mol% 
had an extremely negative effect (entry 9 vs 5) while a higher amount did not increase 
activity substantially (entries 5 and 8). The best trade-off between amount of base and 
activity was therefore achieved with 5% mol NaO
i
Pr. On the other hand, the amount of 
the catalyst precursor had little impact on activity (Table 5.2.3, entries 5 and 11-13). In 
summary, high activity with TOF’s up to 1080 mol S1 × (mol 142 × h)
-1
 were achieved 
using 5 mol% of base and only 0.1 mol% of catalyst. This result surpasses the ones 
reported in the literature with Ir-containing MIC catalysts.
11 
 
5.2.3.2.2. Transfer hydrogenation of several substrate types. Scope and limitations 
Encouraged by the previous results, we next studied [IrCl(L2)(COD)] (142), which 
had provided the best results, in the reduction of a broad range of substrates bearing 
other unsaturated groups such as ketones (S1-S17), aldehydes (S18-S23), imines (S24-
S25), olefins (S26-S37), α,β-unsaturates ketones (S38-S40) and allylic alcohols (S41-
S42). In all the cases, the reactions were performed using 0.5 mol% of catalyst 
precursor 5 and only 5 mol% of base. 
We first investigated the reduction of 18 ketones with different steric and electronic 
properties including challenging heteroaromatic ketones (S1-S17). The results, which 
are collected in Table 5.2.4 (entries 1-17), indicate that the catalytic activity depends on 
both the steric and electronic demands of the substrate, being the highest TOF’s of this 
series (up to 2100 mol × (mol × h)
-1
) achieved in the reduction of less sterically 
demanding cyclohexenone S2 and electron-poor 4-(trifluoromethyl)acetophenone S8. In 
the reduction of aryl ketones with increasingly sterically demanding alkyl substituents 
(S1 and S3-S5), activity diminished when the steric demands of the alkyl substituent 
increased (i.e. entry 5 vs 3). However, catalytic activity was hardly affected by the steric 
factors on the aryl moiety of the substrate. Positively, ortho-substituted aryl ketones 
were somewhat more reactive than the non-substituted ones (i.e. entry 3 vs 11). The 
results using several para-substituted aryl ketones (S3, S6-S8) indicated that the 
catalytic activity increases when electronic withdrawing groups are present at the para 
position (i.e. entry 8 vs 7 and 6). Finally, the transfer hydrogenation of meta-substituted 
aryl ketones (S9-S10) provided high activities similar to S3 (Table 5.2.4, entry 3 vs 9 
and 10).  




We next considered the transfer hydrogenation of heteroaromatic ketones. The 
reduction of these substrates is more puzzling because the coordination of the 
heteroaromatic group of the substrate to the metal often reduces the activity of the 
catalyst drastically. There are therefore very few catalytic systems able to reduce this 
substrate class under transfer hydrogenation conditions. To our best knowledge the 
reduction of these substrates has not been reported with NHC and MIC-containing 
complexes. We were pleased to find out that again heteroaromatic ketones (S12-S17, 
Table 5.2.4, entries 12-17) could be reduced in high activities (TOF’s up to 1500 mol × 
(mol × h)
-1
). Activity, however, was dependent on the type of heteroaromatic moiety 
and on its substitution pattern. Regarding the effect of the type of heteroaromatic group, 
we found that furyl-based ketones (S16 and S17) provided somewhat higher activities 
(TOF's up to 1500 mol × (mol × h)
-1
) than the non-heteroaromatic substrates (e.g., 
entries 16 and 17 vs 3). The lowest activity was achieved using thienyl-based ketone 
S15 (TOF’s up to 100 mol × (mol × h)
-1
; entry 15). The reduction of pyridyl-based 
ketones (S12-S14, entries 12-14) was dependent on the heteroaromatic ring substitution 
pattern. While similar high activities (TOF’s up to 510 mol × (mol × h)
-1
) were achieved 
with 3- and 4-acetylpiridines S12 and S13, lower TOF’s (up to 260 mol × (mol × h)
-1
) 
were achieved with 2-acetylpiridine S14, which tends to coordinate more effectively 
than the meta and para counterparts. 
Catalytic system 142 also proved to be highly efficient in the TH of several 
aldehydes (Table 5.2.4, entries 18-23). In general the results follow the trend observed 
in the reduction of ketones, albeit the electronic effect is less pronounced than in the 
reduction of ketones (TOF’s in the range of 1400 for S19 and 2300 for S20; entries 19 
and 20 vs 7 and 8, respectively). Therefore, a broad range of aryl aldehydes with 
electron-withdrawing or electron-donating substituents in the para position as well as 
ortho- and meta-substituted aldehydes were reduced with comparable high activities 
than those achieved with ketones.   
  




Table 5.2.4. Transfer hydrogenation of ketones, aldehydes and imines using Ir-complex 
142.
a 
Entry Substrate TOF %Conv 
(min) 




990 96 (30) 14 
 
260 99 (180) 
2 
 
1800 97 (5) 15 
 
100 84 (240) 
3 
 
1200 98 (30) 16 
 
1500 96 (30) 
4 
 
1300 96 (15) 17 
 
1400 93 (30) 
5 
 
500 89 (60) 18 
 
1900 98 (10) 
6 
 
1300 99 (30) 19 
 
1400 97 (15) 
7 
 
770 88 (30) 20 
 
2300 99 (5) 
8 
 
2100 98 (5) 21 
 
1500 96 (15) 
9 
 
1300 96 (30) 22 
 
1600 94 (15) 
10 
 
1200 95 (30) 23 
 
1200 98 (30) 
11 
 
1400 98 (30) 24  770 99 (30) 
12 
 
510 92 (60) 25 
 
30 100 (24) 
13 
 
480 81 (60)  
 
  
(a) Reaction conditions: 0.4 M substrate in 2-propanol, 142 (0.5 mol%), NaOiPr (5 mol%), reflux. (b) TOF in mol 
substrate × (mol 5 × h)-1 measured after 5 min. (c) Yield measured by 1H NMR using mesytilene as internal standard 
or by GC using dodecane as internal standard. 
 




Furthermore, we investigated the reduction of imines (Table 5.2.4; entries 24 and 25). 
Imines are known to be more difficult to reduce than ketones and aldehydes and they 
usually require higher catalyst loading and much longer reaction times. Notably, the 
transfer hydrogenation of aldimine S24 proceed smoothly, under our mild reaction 
conditions, with TOF up to 770 mol × (mol × h)
-1
). Catalyst precursor 142 could also 
reduce ketimine S25, although with a low TOF (up to 30 mol × (mol × h)
-1
), as expected 
for this more sterically difficult substrate. It should be noted that for both substrates, the 
reduction proceeded cleanly providing the desired amines as the sole products as observed 
in the 
1
H NMR.  
In summary, [IrCl(L2)(COD)] (142) catalyst precursor is able to reduce a wide range 
of ketones, including the most challenging heteroaromatic ones, aldehydes and aldimines 
in high activities (TOF’s up to 2300 mol × (mol × h)
-1
). Although there are some metal-
carbene species, mainly Ru-NHC complexes, able to promote these transformations more 
efficiently, our results compete favorably with known Ir-MIC catalytic systems.
7i,8c,11a,c,d,f 
To further study the substrate scope, we next focused on the transfer hydrogenation of 
olefins. Olefins are challenging substrates because they are reduced at a much lower rate 
than ketones. So far only a few reports using NHC or MIC containing complexes with a 
limited in substrate scope have been published.
8c,10a,d,11d,15
  Two of these cases reported by 




 et al. showed that Ir- and Ru- N-heterocyclic 





 showed that cyclooctene could be reduced using Ir-
NHC and Ru/Ir-MIC complexes. They needed, however, long reaction times (20 hours 
with a 50% of Conv. with Ir-NHC and 24 hours with 80% and >99% of convs. with Ir and 
Ru-MIC, respectively), high catalyst loading (1 mol%) and high amount of base (up to 20 
mol%) and hydrogen donor (0.1 M of substrate in 2-propanol).  
Our results (Table 5.2.5) indicate that a broad range of olefins can be efficiently 
reduced using catalyst precursor 142 in milder reaction conditions. We found that the 
catalytic performance is relatively insensitive to the olefins substitution pattern and to the 
geometry of the double bond. Similar high activities were therefore achieved for a range 
of linear mono-, 1,2-di- and 1,1-disubstituted olefins as well as for cyclic olefins (TOF’s 
up to 260 mol × (mol × h)
-1
). 
We also found that activities are influenced by steric effects (compare entries 9-11). In 
this way, the transfer hydrogenation of 1,1-disubstituted olefins S34-S36 with an 




increasingly sterically demanding alkyl substituents proceeded with lower activities 
(Table 5.2.5, entries 9-11). Similarly, the reduction of sterically more hindered 
trisubstituted olefin S37 proceed with the lowest activity of the series. In summary, 
[IrCl(L2)(COD)] (142) catalyst precursor is one of the rare examples of catalyst able to 
efficiently reduce such a range of olefins 
 
Table 5.2.5. Transfer hydrogenation of olefins using Ir-complex 142.
a
 
Entry Substrate TOF %Conv (h)   Entry Substrate TOF %Conv (h) 
1 
 
170 88 (4)   7 
 
190 91 (4) 
2 
 
130 93 (6)   8 
 
240 94 (41) 
3 
 
170 95 (6)   9 
 
200 97 (4) 
4 
 
160 94 (6)   10 
 
190 90 (4) 
5  260 96 (4)   11 
 
110 87 (6) 
6  260 99 (4)   12 
 
80 89 (12) 
(a) Reaction conditions: 0.4 M substrate in 2-propanol, 142 (0.5 mol%), NaOiPr (5 mol%), reflux. (b) TOF in mol 
substrate x (mol 5 x h)-1 measured after 10 min. (c) Yield measured by 1H-NMR using mesytilene as internal 
standard or by GC using dodecane as internal standard. 
 
Finally, this novel set of catalysts was studied in the reduction of α,β-unsaturated 
ketones and allylic alcohols (Table 5.2.6). Again [IrCl(L2)(COD)] was able to efficiently 
reduce these important substrate classes to the corresponding saturated alcohols (full 
conversions in less than 1 hour). The extremely high activity achieved with substrates 
S38-S42 (similar to the corresponding simple ketones) make us believe that the reaction 
proceeded via a tandem isomerization/transfer hydrogenation reaction rather than via the 
direct reduction of the ketone and the olefin as observed by Elsevier et al. using similar 
Ir(I) complexes containing chelating 1,2.3-triazolylidene-NHC ligands.
11d
 To prove this, 
we performed the transfer deuterogenation of α-vinylbenzyl alcohol S41 using 2-
propanol-d8 as a deuterium source and sodium isopropoxide-d7 as a base (Scheme 5.2.3). 




Table 5.2.6. Reduction of α,β-unsaturated ketones and allylic alcohols using Ir-complex 
142 under transfer hydrogenation conditions.
a 
Entry Substrate Product %Yield (min)b 













(a) Reaction conditions: 0.4 M substrate in 2-propanol, 142 (0.5 mol%), NaOiPr (5 mol%), reflux. (b) Yield 
measured by 1H NMR using mesytilene as internal standard or by GC using dodecane as internal standard. 
 
The formed product contained deuterium not only at the double bond (as expected) but 
also at the allylic position which agrees with a competing isomerization pathway.
16
 This 
was supported by the mass spectra of the corresponding deuterated products showing 
species with more than two deuterium atoms incorporated. To study how fast the alkene 
double bond was isomerized we run similar transfer deuterogenation experiments using 
trans-β-methylstyrene S30 and allylbenzene S31. Again the results show that deuterium is 
added at both the double bond and the allylic position. Furthermore, the GC and 
1
H NMR 
spectra over time indicate that the isomerization is faster than the reduction of olefins 
Thus, after 10 minutes the allylbenzene S31 was fully isomerized to the internal olefin 
S30 under TH conditions. These results confirmed that the reduction of α,β-unsaturated 










Scheme 5.2.3. Deuterium labeling experiments of olefins S30 and S31 and allylic 
alcohol S41 using Ir-catalyst precursor 142. The percentage of incorporation of 
deuterium atoms is shown in brackets. The results of the indirect addition of deuterium 
due to the isomerization process are shown in red. 
 
5.2.3.3 Mechanistic insights 
Initially, the mechanism of the Ir-catalyzed transfer hydrogenation with complex 
[IrCl(L2)(COD)] (142) was studied using the racemization of (S)-1-phenylethan-1-d-1-
ol in the presence of acetophenone S3 (Scheme 5.2.4). This simple experiment has been 
previously used to elucidate the nature of the metal-hydride species responsible of the 
catalytic activity. Thus, while a selective carbon-to-carbon hydrogen transfer is 
indicative of metal-monohydride species responsible for the catalytic activity, a non-
selective hydrogen transfer (involving both oxygen-to-carbon and carbon-to-carbon H-
transfer) reveals the involvement of metal-dihydride species. [IrCl(L2)(COD)] showed 
a high degree of retention of deuterium in the α-position (>95%) after full racemization. 
This clearly indicates that the Ir-H species are responsible for the catalytic activity. 
 
 
Scheme 5.2.4. Deuterium content in 1-phenylethan-1-d-1-ol after racemization of (S)-1-
phenylethan-1-d-1-ol using Ir-catalyst precursor 142. 
 




Further mechanistic insights into the rate determining step of the reaction were 
obtained by studying the kinetic isotope effects (KIE) of the transfer hydrogenation of 
acetophenone S3 and styrene S32 (Scheme 5.2.5). We carried out several experiments 
using isopropanol, isopropanol-d7 and isopropanol-d8. In these experiments we used 
sodium tert-butoxide instead of sodium isopropoxide to avoid potential problems with 
H/D scrambling. The reactions were monitored over time by GC analysis. For both 
substrate types, significant KIE for the hydrogen transfer reaction were obtained 
(kCHOH/kCDOH ≈ kCHOH/kCDOD ≈ 4; kCDOD/kCDOH ≈ 1). These results clearly indicate that of 
the two processes involved in the transfer hydrogenation reactions (the hydride transfer 




Scheme 5.2.5. Kinetic isotope effects of the transfer hydrogenation of ketones 
(acetophenone S3 as example) and olefins (styrene S32 as example) using Ir-catalyst 
precursor 142. 
 
To know which of the two possible hydride transfer steps determined the rate (the 
one from the hydrogen donor to the metal to form the metal-hydride, or the one from 
the metal-hydride to the substrate), we compared the activity of catalytic system 142 for 
different para substituted acetophenones (S3, S7-S8) against the Hammett σ values of 
the substrates (Figure 5.2.4). The positive σ value (σ = 0.52) indicates that the electron 
density increases in the rate determining step. Moreover, the fact htat the Hemmet 
parameter affects the rate indicates that the substrate should also participate in the rate 
determining step. These facts, together with the observed KIE, agree with the 
hypothesis that the rate determining step is the C=O insertion on the M-H bond. 






Figure 5.2.4. Hammett plot showing the effect of substituents on the transfer 
hydrogenation using catalytic system 142. 
 
5.2.3.4 Base-free Ir-catalyzed dehydrogenation reactions 
Available procedures for the oxidation of alcohols range from the use of high-valent 
oxo metal species, the Oppenauer-type oxidation and the use of hypervalent iodine 
among others,
20
 to biomimetic approaches using more benign oxidants such as 
hydrogen peroxide or oxygen .
21
 The alternative oxidant-free dehydrogenation of 
alcohols has been less studied although it is very attractive in terms of atom economy 
and reduced waste. This process generates molecular hydrogen as a side product that 
can be used as an alternative to fossil fuels. Research in this area has rapidly moved 
from phosphine ligands to NHC ligands, including triazolylidene-based ligands for Ru- 
and Ir-catalysts. One of the drawbacks of the oxidant-free dehydrogenation of alcohols 
is that the product can remain in the coordination sphere and be subsequently 
transformed into undesired ethers and acetals. In this respect, the work with iridium 
triazolylidene-based catalysts has shown that monomeric species favor the etherification 
of the carbonyl product while dimeric species suppress this transformation.
22 
 
5.2.3.4.1. Dehydrogenation of benzyl alcohol S43. Catalyst precursors screening 
In a first set of experiments, benzyl alcohol S43 was used as the benchmark 
substrate to study the effectiveness of the Ir(I)- and Ir(III)-complexes 134, 138-142 in 
the oxidant-free dehydrogenation. For comparison, we evaluated them using the optimal 
conditions found in previous studies with Ir-MIC compounds.
22
 Reaction were therefore 
carried out without base, using a catalyst loading of 5 mol% in 1,2-dichlorobenzene. 
log k = 0,52 + 3,05 

















Benzaldehyde formation was monitored over time (see Supporting Information) and 
conversions after 12 and 72 h are compiled in Table 5.2.7. For all complexes, the time-
conversion profiles showed no significant activation time. Interestingly, only the 
formation of the desired benzaldehyde was observed in the 
1
H NMR. This behavior 
contrasts with that above mentioned fact that Ir-monomeric species favored the 
etherification of the carbonyl product, which could be suppressed with dimeric 
species.
22
 As observed in the transfer hydrogenation reaction, we found that activity is 
highly dependent on the catalyst precursor (Table 5.2.7). As expected and in contrast to 
TH, cationic Ir(III) catalyst precursors provided much higher activity than the Ir(I) 
counterparts (Table 5.2.7: i.e. entry 1 vs 2-4; and entry 5 vs 6 and 7). The latter tended 
to readily deactivate under reaction conditions, leading to low conversions (entries 1 
and 5). The results using Ir(III)-complexes also show that deactivation takes place 
except for complexes 139 and 141 (entries 2 and 4 vs 3, 6 and 7). This can be attributed 
to the higher coordination ability of the benzoxazole and thiazole moieties (compounds 
139 and 141) compared to that of the methoxy group in complex 6. In summary, the 
best results were obtained with complexes 139 and 141 with a bidentate coordination 
mode of the benzoxoazole/thiazole-1,2,3-triazol-5-ylidne ligands L3 and L4. 
 




Entry  Cat precursor  % Yield (12 h)  % Yield (72 h) 
1  138  30  33 
2  139  33  99 
3  140  18  34 
4  141  28  94 
5  142  30  38 
6  134a  54  60 
7  134b  36  55 
(a) Reaction conditions: 0.1 M benzyl alcohol S43 in 1,2-dichlorobenzene, catalyst 
precursor (5 mol%). (b) Yield measured by 1H NMR using hexamethylbenzene as 
internal standard.  




5.2.3.4.2. Dehydrogenation of other primary and secondary alcohols. Mechanistic 
insights 
Encouraged by the excellent selectivities provided by Ir(III) complexes 139 and 141, 
we decided to further asses their efficiency with a range of benzylic alcohols S43-S46 
and secondary alcohols S47-S50. The results (Table 5.2.8) indicate that a range of 
alcohols can be dehydrogenated to the corresponding carbonyl compounds with good-
to-excellent selectivities.  
 
Table 5.2.8. Dehydrogenation of alcohols using Ir-complexes 139 and 141.
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(a) Reaction conditions: 0.1 M substrate in 1,2-dichlorobenzene, Ir-cat (5 
mol%). (b) Yield measured by 1H NMR using mesytilene as internal standard or 
by GC using dodecane as internal standard. (c) Selectivity measured by 1H 
NMR.  




While the substituents of the substrate do not significantly affect the selectivity for 
secondary alcohols (entries 9-12), they do for benzylic alcohols (entries 1-8). Thus, 
while the excellent selectivity towards the desired carbonyl compounds is maintained 
when using electron-poor benzylic alcohol S45, methyl groups at meta and para 
positions (substrates S44 and S46) reduce selectivity (entry 5 vs 3 and 7). Fortunately, 
the formation of the undesired corresponding ethers can be minimized by using catalyst 
precursor 141 instead of 139 (entries 4 and 8 vs 3 and 7). Activity, depends on the 
substrate structure and are in general best for secondary alcohols (entries 9-12 vs 1-8) 
and are positively affected by electron-donating groups at the para position (e.g., entry 3 
vs 5 and 10 vs 11). 
In order to get some insight into the reaction mechanism, we firstly determined the 
kinetic isotope effects (KIE) of the dehydrogenation reaction by conducting 
experiments using 1-phenylethanol, 1-phenylethan-1-d-1-ol and 1-phenylethan-1-d-1-
ol-d (Scheme 5.2.6). The reactions were monitored over time by GC analysis. In 
contrast to the transfer hydrogenation reaction, very small KIE were obtained 
(kCHOH/kCDOH ≈ kCHOH/kCDOD ≈ 1.1; kCDOD/kCDOH ≈ 1). These low values indicate that 
neither the C-H nor the O-H cleavages are the rate determining step. To gain further 
insight about the rate determining step, we compared the activity of catalytic system 
139 for different para substituted benzyl alcohols (S43-S45) against the Hammett σ 
values
19
 of the substrates (Figure 5.2.5). The negative ρ value (ρ = -0.61) indicates that 
the electron density decreases in the rate determining step. All these results may 
indicate that substrate coordination to the metal center is the rate determining step. 
 
 
Scheme 5.2.6. Kinetic isotope effects of the dehydrogenation of alcohols using Ir-
catalyst precursor 139. 
 





Figure 5.2.5. Hammett plot showing the effect of substituents on the dehydrogenation 
using catalytic system 139. 
 
5.2.4. Conclusions 
In summary, we prepared new triazolium-benzoxazole/thiazole salts as ligands 
L3H·BF4 and L4H·BF4 and also their corresponding complexes (138-142) which were 
fully characterized. The new Ir-complexes were successfully applied as catalysts in 
transfer hydrogenation of different C=O, C=N and C=C functionalities. Encouraged by 
the results, the Ir-complexes were utilized for oxidation of primery and secondary 
alcohols and in this case pleasant results were achieved as well. Kinetic isotope effect 
was studied in both case to have ideas about the mechanism pathway. 
 
5.2.5. Experimental section 
5.2.5.1. General information 
All reactions were carried out using standard Schlenk techniques under an 
atmosphere of argon. Solvents were purified and dried by standard procedures. 
Compounds 2-((trimethylsilyl)ethynyl)benzo[d]oxazole and 2-
((trimethylsilyl)ethynyl)thiazole;
23
  ligand L2H·BF4;
8d




















 were prepared as previously described. All other commercially 









spectra were recorded using a 400 MHz spectrometer. Chemical shifts are relative to 








C assignments were made on 












C gHMBC experiments. 
 
log k = -0,61 + 0,26 
















5.2.5.2. Preparation of ligands and complexes 
5.2.5.2.1. General procedure for the preparation of triazoles 143 and 144 
A suspension of MeI (0.21 ml, 3.30 mmol) and NaN3 (644 mg, 9.90 mmol) in 
H2O/THF (14 mL; 1:1 v/v) was stirred at room temperature for 48 h. CuSO4.5H2O (49.5 
mg, 0.198 mmol), sodium ascorbate (393 mg, 1.98 mmol) and the corresponding 
functionalized trimethylsilyl-protected alkyne (3.96 mmol) were added subsequently 
and the mixture was stirred in the oil bath at 70 ºC for 36 h. The organic solvent (THF) 
was removed under reduced pressure and the residue was suspended in CH2Cl2 (30 mL) 
and washed with water (2 × 50 mL), and brine (2 × 50 mL). After drying over MgSO4, 
charcoal was added to the solution and stirred for 30 min to further purify the 
compound. The suspension filtered off through celite, washed with CH2Cl2 (20 ml) and 
evaporated to obtain the desired triazol as an off-white powder. 
2-(1-Methyl-1H-1,2,3-triazol-4-yl)benzo[d]oxazole (143). Yield: 383 mg (70%). 
1
H NMR (400 MHz, CD3CN): δ = 8.45 (s, 1H, H-5), 7.81 – 7.72 (m, 1H, CH=), 7.72 – 





(101 MHz, CD3CN): δ = 157.4 (C=N), 151.2 (C), 142.5 (C), 137.6 (C–4), 127.7 (C–5), 
126.4 (CH=), 125.7 (CH=), 120.7 (CH=), 111.7 (CH=), 37.5 (CH3–N). MS HR-ESI 
[found 223.0592 (M-Na)
+
, C10H8N4O requires 223.0590]. 
2-(1-Methyl-1H-1,2,3-triazol-4-yl)thiazole (144). Yield: 394 mg (60%). 
1
H NMR 
(400 MHz, CDCl3): δ = 8.05 (s, 1H, H–5), 7.84 (d, 
3
JH-H = 3.2 Hz, 1H, CH=), 7.36 (d, 
3




H}  NMR (101 MHz, CDCl3): δ = 
159.4 (C=N), 143.8 (C–4), 143.3 (CH=), 121.9 (C–5), 119.1 (CH=), 37.1 (CH3–N). MS 
HR-ESI [found 189.0205 (M-Na)
+






A suspension of 2-(1-methyl-1H-1,2,3-triazol-4-yl)benzo[d]oxazole (400 mg, 2.00 
mmol) and MeOTf (249 μL, 2.20 mmol, 1.1 equiv) in CH2Cl2 (6 mL) was stirred at -12 
ºC for 20 h (the reaction was monitored by TLC). Et2O was added in order to precipitate 
out the product. All volatiles were evaporated under reduced pressure. The precipitate 
was washed with Et2O three times to obtain L3H·BF4 as a white solid (400 mg, 55%). 
1
H NMR (400 MHz, CD3CN): δ = 9.05 (s, 1H, CH=trz), 7.93 (d, 
3
JH-H = 7.9 Hz, 1H, 
CH=), 7.80 (d, 
3
JH-H = 8.2 Hz, 1H, CH=), 7.59 (m, 2H, CH=), 4.66 (s, 3H, CH3–N), 4.38 




H}  NMR (101 MHz, CD3CN): δ = 151.2 (C=N), 150.1 (C), 




141.4 (C), 132.6 (C–4), 132.3 (C–5), 129.0 (CH=), 127.1 (CH=), 122.0 (q, 1JC-F = 
320.8, CF3), 122.0 (CH=), 112.4 (CH=), 41.8 (CH3–N), 41.57 (CH3–N). 
19
F NMR (377 
MHz, CD3CN): δ = -79.39 (s). MS HR-ESI [found 215.0927 (M-OTf)
+
, C11H11N4O 
requires 215.0925]. Suitable crystals for X-ray diffraction were achieved by slow 
diffusion of pentane to acetonitrile solution. 
 
5.2.5.2.3. Preparation of 2-(1,3-dimethyl-1H-1,2,3λ
4
-triazol-4-yl)thiazole 
trifluoromethanesulfonate (L4H·OTf)  
A suspension of 2-(1-methyl-1H-1,2,3-triazol-4-yl)thiazole (597.43 mg, 3.30 mmol) 
and MeOTf (411 μL, 3.63 mmol, 1.1 equiv) in CH2Cl2 (15 mL) was stirred at -12 ºC for 
36 h (the reaction was monitored by TLC). All volatiles were evaporated under reduced 
pressure. The residue was washed with Et2O. Analysis of the crude product by 
1
H NMR 
spectroscopy showed a mixture of the desired L4H·BF4 and 3-methyl-2-(1-methyl-1H-
1,2,3-triazol-4-yl)-3λ
4
-thiazole trifluoromethanesulfonate (145) in approximately a 1:3 
ratio. Purification by column chromatography (SiO2, CH2Cl2/MeOH gradient 20:1 to 
0:1) yielded L4H·BF4 in the first fraction (120 mg, 11%) and 10 in the second fraction 
(240 mg, 33%) as waxy pale yellow solids. 
2-(1,3-Dimethyl-1H-1,2,3λ4-triazol-4-yl)thiazole trifluoromethanesulfonate 
(L4H·OTf). 1H NMR (400 MHz, CD3CN): δ = 8.84 (s, 1H, H–5), 8.14 (d, 
3
JH-H = 3.2 
Hz, 1H, CH=), 7.96 (d, 
3





H} NMR (101 MHz, CD3CN): δ = 150.3 (C=N), 145.9 (CH=), 136.9 (C–
4), 131.0 (C–5), 125.7 (CH=), 121.5 (q, 
1
JC-F = 319.32, CF3), 41.2 (CH3–N), 41.20 
(CH3–N). 
19
F NMR (377 MHz, CD3CN): δ = -79.38 (s). MS HR-ESI [found 181.544 






H NMR (400 MHz, CD3CN): δ = 8.74 (s, 1H, H–5), 8.09 (d, 
3
JH-H = 4.0 Hz, 
1H, CH=), 7.99 (d, 
3





H} NMR (101 MHz, CD3CN): δ = 162.7 (C=N), 140.0 (CH=), 135.2 (C–4), 
128.7 (C–5), 123.4 (CH=), 121.7 (q, 
1
JC-F = 320.33, CF3), 42.1 (CH3–N), 37.9 (CH3–N). 
19
F NMR ( 377 MHz, CD3CN): δ = -79.38 (s). MS HR-ESI [found 181.0545 (M-OTf)
+
, 
C7H9N4S requires 181.0542].  




5.2.5.2.4. Preparation of [IrCl(L3)(COD)] (138) 
A suspension of L3H·OTf (107 mg, 0.30 mmol), Me4NCl (33 mg, 0.30 mmol), 
Ag2O (140 mg, 0.6 mmol) in MeCN (8 mL) was stirred protected from light for 16 h. 
The suspension was then filtered through celite, and the volatiles removed under 
reduced pressure. The residue was suspended in CH2Cl2 (8 mL) and [Ir(μ-Cl)(COD)]2 
(100 mg, 0.15 mmol, 0.5 equiv) was added. The reaction mixture was stirred for 1 h 
protected from light, then filtered over celite, and all volatiles were removed under 
reduced pressure to yield the crude products. The compound triturated with pentane 
yielded product 138 as a light brown solid (90 mg, 55%). 
1
H NMR (400 MHz, CD2Cl2): 
δ = 7.87 – 7.72 (m, 2H, CH=), 7.46 (m, 2H, CH=), 4.62 (bs, 1H, CH=, COD), 4.51 (bs, 
1H, CH=, COD), 4.49 (s, 3H, CH3–N), 4.43 (s, 3H, CH3–N), 2.88 (bs, 1H, CH=, COD), 
2.80 (bs, 1H, CH=, COD), 2.34 (bs, 1H, CH2, COD), 2.19 (bs, 3H, CH2, COD), 1.76 




H} NMR (101 MHz, CD2Cl2): δ = 
176.7 (C–5), 154.4 (C=N), 150.7 (C), 141.7 (C), 133.3 (C–4), 126.6 (CH=), 125.5 
(CH=), 120.6 (CH=), 111.4 (CH=), 83.3 (CH=, COD), 82.9 (CH=, COD), 52.1 (CH=, 
COD), 51.7 (CH=, COD), 42.4 (CH3–N), 40.3 (CH3–N), 34.3 (CH2, COD), 33.7 (CH2, 
COD), 30.2 (CH2, COD). MS HR-ESI [found 515.1417 (M-Cl)
+
, C19H22IrN4O requires 
515.1410]. Anal. Calcd for C19H22ClIrN4O: C, 41.49; H, 4.03; N, 10.19%. Found: C, 
41.13; H, 3.87; N, 9.89%. Suitable crystals for X-ray diffraction were achieved by slow 
diffusion of pentane to dichloromethane solution. 
 
5.2.5.2.5. Preparation of [IrCp*Cl(L3)]OTf (139) and [IrCp*Cl2(L3)] (140) 
A suspension of L3H·OTf (107 mg, 0.30 mmol), Me4NCl (33 mg, 0.30 mmol), 
Ag2O (140 mg, 0.6 mmol) in MeCN (8 mL) was stirred protected from light for 16 h. 
The suspension was then filtered through celite, and the volatiles removed under 
reduced pressure. The residue was suspended in CH2Cl2 (8 mL) and [Ir(Cp*)Cl2]2 (90 
mg, 0.11 mmol, 0.4 equiv) was added. The reaction mixture was stirred for 5 h 
protected from light, then filtered over celite, and all volatiles were removed under 
reduced pressure to yield the crude products. Purification by column chromatography 
(neutral Al2O3; CH2Cl2/MeCN gradient, 3:1 to 0:1) yielded product [IrCp*Cl(L3)]OTf 
(139) in the first fraction (70 mg, 32%) and [IrCp*Cl2(L3)] (140) in the second fraction 
(25 mg, 14%) as yellow and orange solids, respectively. 
[IrCp*Cl(L3)]OTf (139). 
1
H NMR (400 MHz, CD2Cl2): δ = 7.86 – 7.78 (m, 1H, 
CH=), 7.77 – 7.70 (m, 1H, CH=), 7.66 – 7.56 (m, 2H, CH=), 4.58 (s, 3H, CH3–N), 4.37 








H}  NMR (101 MHz, CD2Cl2): δ = 
161.1 (C–5), 160.4 (C=N), 152.0 (C), 137.3 (C), 136.3 (C–4), 128.1 (CH=), 127.4 
(CH=), 121.2 (q, 
1
JC-F = 321.27, CF3), 117.6 (CH=), 113.4 (CH=), 91.5 (C, Cp*), 40.6 
(CH3–N), 39.3 (CH3–N), 10.4 (CH3, Cp*). 
19
F NMR (377 MHz, CD2Cl2): δ = -78.92 
(s). MS HR-ESI [found 577.1338 (M-OTf)
+
, C21H25ClIrN4O requires 577.1340]. Anal. 
Calcd for C22H25ClF3IrN4O4S: C, 36.39; H, 3.47; N, 7.72%. Found: C, 36.43; H, 3.58; 
N, 7.65%. Suitable crystals for X-ray diffraction were achieved by slow diffusion of 
pentane to dichloromethane solution. 
[IrCp*Cl2(L3)] (140). 
1
H NMR (400 MHz, CDCl3): δ = 7.80 – 7.74 (m, 1H, CH=), 
7.57 – 7.51 (m, 1H, CH=), 7.42 – 7.34 (m, 2H, CH=), 4.46 (s, 3H, CH3–N), 4.26 (s, 3H, 




H}  NMR (101 MHz, CDCl3): δ = 152.0 (C–5), 
151.9 (C=N), 149.7 (C), 140.4 (C), 135.5 (C–4), 125.1 (CH=), 123.9 (CH=), 119.8 
(CH=), 110.0 (CH=), 87.6 (C, Cp*), 40.5 (CH3–N), 37.6 (CH3–N), 8.4 (CH3, Cp*). MS 
HR-ESI [found 577.1341 (M-Cl)
+
, C21H25ClIrN4O requires 577.1341]. Anal. Calcd for 
C21H25Cl2IrN4O with one molecule of H2O: C, 40.00; H, 4.32; N, 8.89%. Found: C, 
39.51; H, 3.72; N, 8.47%. Suitable crystals for X-ray diffraction were achieved by slow 
diffusion of pentane to dichloromethane solution. 
 
5.2.5.2.6. Preparation of [IrCp*Cl(L4)]OTf (141) 
A suspension of L4H·OTf (100 mg, 0.30 mmol), Me4NCl (33 mg, 0.30 mmol), 
Ag2O (140 mg, 0.6 mmol) in MeCN (8 mL) was stirred protected from light for 21 h. 
The suspension was then filtered through celite, and the volatiles removed under 
reduced pressure. The residue was suspended in CH2Cl2 (8 mL) and [Ir(Cp*)Cl2]2 (90 
mg, 0.11 mmol, 0.4 equiv) was added. The reaction mixture was stirred for 20 h 
protected from light, then filtered over celite, and all volatiles were removed under 
reduced pressure to yield the crude products. Purification by column chromatography 
(neutral Al2O3; CH2Cl2/MeCN gradient, 3:1 to 0:1) yielded product 141 as yellow solid 
(70 mg, 37%). 
1
H NMR (400 MHz, CDCl3): δ = 7.98 (d, 
3
JH-H  = 3.5 Hz, 1H, CH=), 
7.75 (d, 
3
JH-H = 3.5 Hz, 1H, CH=), 4.50 (s, 3H, CH3–N), 4.35 (s, 3H, CH3–N), 1.86 (s, 




H} NMR (101 MHz, CDCl3): δ = 158.5 (C–5), 158.3 (C=N), 
145.7 (C–4), 140.7 (CH=), 122.9 (CH=), 120.7 (q, 
1
JC-F =320.06, CF3), 90.8 (C, Cp*), 
39.9 (CH3–N), 38.7 (CH3–N), 9.7 (CH3, Cp*). 
19
F NMR (377 MHz, CDCl3): δ = -78.53 
(s). MS HR-ESI [found 543.0961 (M-OTf)
+
, C17H23ClIrN4S requires 543.0950]. Anal. 
Calcd for C18H23ClF3IrN4O3S2: C, 31.23; H, 3.35; N, 8.09; S, 9.26%. Found: C, 31.41; 




H, 3.00; N, 7.77; S, 9.77%.  Suitable crystals for X-ray diffraction were achieved by 
slow diffusion of pentane to dichloromethane solution. 
 
5.2.5.2.7. Preparation of [IrCl(L2)(COD)] (142) 
A suspension of L2H·BF4 (90 mg, 0.30 mmol), Me4NCl (33 mg, 0.30 mmol), Ag2O 
(140 mg, 0.6 mmol) in MeCN/CH2Cl2 (10 mL 1:1 v/v) was stirred protected from light 
for 15 h. The suspension was then filtered through celite, and the volatiles removed 
under reduced pressure. The residue was suspended in CH2Cl2 (10 mL) under Ar 
atmosphere and [Ir(μ-Cl)(COD)]2 (100 mg, 0.15 mmol, 0.5 equiv) was added. The 
reaction mixture was stirred for 1 h protected from light, then filtered over celite, and all 
volatiles were removed under reduced pressure. The crude product dissolved in Et2O in 
order to precipitate out the remaining ligand. Purification by column chromatography 
(SiO2; CH2Cl2/MeOH 20:1) yielded product 142 as a yellow solid (57 mg, 35%). 
1
H 
NMR (400 MHz, CDCl3): δ = 4.88 – 4.72 (m, 2H, CH2–N), 4.55 (m, 1H, CH=, COD), 
4.44 (m, 1H, CH=, COD), 4.14 (s, 3H, CH3–N), 3.11 (s, 3H, CH3–O), 2.82 – 2.68 (m, 
2H, CH=, COD), 2.26 – 2.11 (s, 5H, CH2, COD and CH2), 2.04 (s, 3H, CH3, CMe2), 
2.01 – 1.91 (m, 1H, CH2, COD), 1.86 (s, 3H, CH3, CMe2), 1.74 – 1.58 (m, 2H, CH2), 
1.40 – 1.43 (m, 4H, CH2, cod), 1.03 (t, 
3




H} NMR (101 
MHz, CDCl3): δ = 169.0 (C–5), 146.7 (C–4), 81.3 (CH=, COD), 79.8 (CH=, COD), 
74.6 (CMe2), 55.7 (CH2–N), 51.3 (CH=, COD), 51.2 (CH3–O), 51.1 (CH=, COD), 38.8 
(CH3-N), 33.6 (CH2, COD), 33.4 (CH2, COD), 30.0 (CH2), 29.5 (CH2, COD), 29.3 
(CH3, CMe2), 28.9 (CH3, CMe2), 20.2 (CH2, COD), 13.8 (CH3). MS HR-ESI [found 
548.2014 (M-Cl)
+
, C19H33IrN3O requires 548.2006]. Anal. Calcd for C19H33ClIrN3O: C, 
41.71; H, 6.08; N, 7.68%. Found: C, 41.71; H, 6.10; N, 7.72%. Suitable crystals for X-
ray diffraction were achieved by slow diffusion of pentane to dichloromethane solution. 
 
5.2.5.2.8. Typical procedure for the transfer hydrogenation 
The desired catalyst precursor (0.025 mmol), were treated under vacuum for 10 min. 
Under argon, propan-2-ol (2.5 mL), NaO
i
Pr (0.1 M in 
i
PrOH, 0.25 mL, 0.025 mmol) 
and the corresponding internal standard (0.166 mmol; mesytilene for 
1
H NMR or 
dodecane for GC) were sequentially added and stirred at reflux for 10 minutes. The 
reaction was initiated by adding the substrate (0.5 mmol). Aliquotes were taken and 
were analyzed either by 
1
H NMR or by GC. 
 




5.2.5.2.9. Typical procedure for the base-free dehydrogenation of alcohols 
A mixture of substrate alcohol (0.1 mmol) and the iridium complex (0.005 mmol, 
final alcohol/Ir concentration always 20:1) in 1,2-dichlorobenzene (1 mL) was heated at 
150 ºC in a closed vial. Aliquots were taken at specific times, diluted with CDCl3 and 
then analyzed by 
1
H NMR spectroscopy. Hexamethylbenzene (0.0165 mmol) was used 
in all cases as internal standard in order to accurately determine the percentage 
conversions and yields. 
 
5.2.5.2.10. Crystal Structure Determination 
Crystal data for all compounds were collected on a Oxford Diffraction SuperNova 
area-detector diffractometer using mirror optics monochromated Mo Kα radiation (λ = 
0.71073 Å) and Al filtered. Data reduction was performed using the CrysAlisPro 
program.
30
 The intensities were corrected for Lorentz and polarization effects, and an 
absorption correction based on the multi-scan method using SCALE3 ABSPACK in 
CrysAlisPro
30
 was applied. The structure was solved by direct methods using 
SHELXT,
31
 which revealed the positions of all nonhydrogen atoms of the title 
compound. The non-hydrogen atoms were refined anisotropically. All H atoms were 
placed in geometrically calculated positions and refined using a riding model. 
Refinement of the structure was carried out on F
2
 using full-matrix least-squares 






. The weighting scheme was 
based on counting statistics and included a factor to downweight the intense reflections. 
All calculations were performed using the SHELXL-2014/7 program.
32
 Further 
crystallographic details are compiled in the Supporting Information.. 
 
  




5.2.6. Supporting information 
5.2.6.1. Conversion vs time plots of the TH of S1. Effect of the catalyst 
precursor, base loading and catalysts loading. 
 
 
- Effect of the catalyst precursor. Conditions: 0.5 mol% cat precursor, 5 mol% base. 
 
 
- Effect of the base loading. Conditions: 0.5 mol% of 142. 
 
  




- Effect of the catalyst loading. Conditions: 5 mol% of base. 
 
5.2.6.2. Conversion vs time plots of the dehydrogenation of S43. Effect 
of the catalyst precursors. 
 
-Effect of the catalyst precursor. Conditions: 5 mol% cat precursor. 
 
 




5.2.6.3. Characterization details and methods yield determination of TH 





H NMR (CDCl3): δ = 2.19 (d, 1H, CH3, J=4.0 Hz), 5.86 (d, 1H, 
OH, J=4.0 Hz), 7.27 (m, 2H, CH=), 7.34 (m, 4H, CH=), 7.39 (m, 4H). 
Yield determined by 
1
H-NMR using mesytilene as internal standard. 
Cyclohexanol. 
1
H NMR (CDCl3): δ = 1.21 (m, 4H, CH2), 1.52 (m, 2H, CH2), 1.70 (m, 
2H, CH2), 1.83 (m, 2H, CH2), 2.23 (b, 1H, OH), 3.59 (m, 1H, CH). Yield 
determined by 
1





H NMR (CDCl3): δ = 1.51 (d, 3H, CH3, J=6.8 Hz), 1.80 (d, 1H, 
OH, J=3.2 Hz), 4.91 (dq, 1H, CH, J=6.8, J=3.2 Hz), 7.31-7.24 (m, 1H, 
CH=), 7.41-7.33 (m, 4H). Yield determined by GC using Chiralsil-Dex CB 
column (80 kPa H2, Hold 110 C for 15 min, rate 10 C/min
-1
 to 180 C    





H NMR (CDCl3): δ = 0.92 (t, 3H, J= 7.6 Hz, CH3), 1.80 (m, 
2H, CH2), 4.61 (d, 1H, CH, J=6.8 Hz), 7.30 (m, 5H, CH=). Yield 
determined by GC using Chiralsil-Dex CB column (80 kPa H2, Hold 
110 C for 15 min, rate 10 C/min
-1
 to 180 C and hold for 20 min). tR 





H NMR (CDCl3): δ = 0.91–1.24 (m, 5H, CH2), 1.29–
1.35 (m, 1H, CH2), 1.59-1.65 (m, 3H, CH2), 1.74-1.86 (m, 2H, CH2), 
1.97-2.00 (m, 1H, CH), 4.37 (d, 1H, J=6.9 Hz), 7.24-7.35 (m, 5H, 
CH=). Yield determined by 
1






H NMR (CDCl3): δ = 1.48 (d, 3H, J=6.4 Hz), 1.79 (b, 1H, 
OH), 2.34 (s, 3H, CH3), 4.82-4.92 (m, 1H, CH), 7.16 (d, 2H, CH=, 
J=7.8 Hz), 7.27 (d, 2H, CH=, J=7.8 Hz). Yield determined by GC using 
Chiralsil-Dex CB column (80 kPa H2, Hold 110 C for 15 min, rate 10 
C/min
-1
 to 180 C and hold for 20 min). tR 14.2 min (R); tR 15.3 min (S). 








H NMR (CDCl3): δ = 1.48 (d, 3H, J=6.2 Hz), 1.73 
(b, 1H, OH), 3.81 (s, 3H, CH3), 4.82-4.91 (m, 1H, CH), 6.88 (d, 2H, 
CH=, J=7.8 Hz), 7.30 (d, 2H, CH=, J=7.8 Hz, 2H). Yield determined 
by GC using Chiralsil-Dex CB column (80 kPa H2, Hold 110 C for 
15 min, rate 10 C/min
-1






H NMR (CDCl3): δ = 1.47 (d, 3H, CH3, 
J=6.6 Hz), 2.43 (b, 1H, OH), 4.87-4.96 (m, 1H, CH), 7.45 (d, 2H, 
CH=, J=8.0 Hz), 7.58 (d, 2H, CH=, J=7.6 Hz). Yield determined by 
GC using Chiralsil-Dex CB column (80 kPa H2, Hold 110 C for 15 
min, rate 10 C/min
-1





H NMR (CDCl3): δ = 1.48 (d, 3H, CH3, J=6.2 
Hz), 1.73 (b, 1H, OH), 3.81 (s, 3H, CH3), 4.82-4.91 (m, 1H, CH), 
6.88 (d, 2H, CH=, J=7.8 Hz), 7.30 (d, 2H, CH=, J=7.8 Hz). Yield 
determined by GC using Chiralsil-Dex CB column (80 kPa H2, Hold 
110 C for 15 min, rate 10 C/min
-1
 to 180 C and hold for 20 min). tR 22.0 min (R); tR 





H NMR (CDCl3): δ = 1.52 (d, 3H, CH3, 
J=6.6 Hz), 1.90 (b, 1H, OH), 4.93-5.02 (m, 1H, CH), 7.43-7.51 (m, 
1H, CH=), 7.51-7.61 (m, 2H, CH=), 7.65 (s, 1H, CH=). Yield 
determined by GC using Chiralsil-Dex CB column (100 kPa H2, 
Hold 110 C for 15 min, rate 10 C/min
-1
 to 180 C and hold for 20 min). tR 5.6 min 





H NMR (CDCl3): δ = 1.51 (d, 3H, CH3, J=6.2 
Hz), 2.66 (b, 1H, OH), 3.87 (s, 3H, CH3), 5.05-5.14 (m, 1H, CH), 6.88 (d, 
1H, CH=, J=8.0 Hz), 6.93-7.00 (m, 1H, CH=), 7.21-7.28 (m, 1H, CH=), 
7.31-7.37 (m, 1H, CH=). Yield determined by GC using Chiralsil-Dex CB 
column (80 kPa H2, Hold 110 C for 15 min, rate 10 C/min
-1
 to 180 C and hold for 20 
min). tR 21.2 min (R); tR 21.5 min (S). 








H NMR (CDCl3): δ = 1.46 (d, 3H, CH3, J=6.4 Hz), 4.13 
(s, 1H, OH), 4.86 (q, 1H, CH, J=6.4 Hz), 7.27 (d, 2H, J=4.5 Hz, CH=), 
8.42 (d, 1H, J=4.5 Hz, OH). Yield determined by GC using Chiraldex β-
DM column (100 kPa H2, Hold 110 C for 25 min, rate 3 C/min
-1
 to 180 





H NMR (CDCl3): δ = 1.44 (d, 3H, CH3, J=6.4 Hz), 4.6 
(b, 1H, OH), 4.85 (q, 1H, CH, J=6.4 Hz), 7.15-7.24 (m, 1H, CH=), 7.64-
7.75 (m, 1H, CH=), 8.29 (dd, 1H, CH=, J=1.3 Hz, J=4.6 Hz), 8.38 (d, 1H, 
CH=, J=2.4 Hz). Yield determined by 
1






H NMR (CDCl3): δ = 1.51 (d, 3H, CH3, J=6.4 Hz), 4.7 
(b, 1H, OH), 4.91 (q, 1H, CH, J=6.4 Hz), 7.15-7.23 (m, 1H, CH=), 7.34 (d, 
1H, CH=, J=8.0 Hz), 7.69 (m, 1H, CH=), 8.51 (d, 1H, CH=, J=4.0 Hz). 
Yield determined by 
1





H NMR (CDCl3): δ = 1.52 (d, 1H, CH3, J=6.8 Hz), 
1.89 (s, 1H, OH), 4.97 (q, 1H, CH, J=6.8 Hz), 7.09-7.10 (m, 1H, CH=), 
7.29-7.31 (m, 1H, CH=), 7.18-7.20 (m, 1H, CH=). Yield determined by 
1
H-





H NMR (CDCl3): δ = 1.54 (d, 3H, CH3, J=6.8 Hz), 2.30 
(b, 1H, OH), 4.88 (q, 1H, CH, J=6.4 Hz), 6.22 (d, 1H, CH=, J=3.2 Hz), 
6.32 (dd, 1H, CH=, J=3.2 Hz, J=1.2 Hz), 7.35-7.40 (m, 1H, CH=). Yield 
determined by 
1





H NMR (CDCl3): δ = 1.54 (d, 3H, CH3, J=6.4 Hz), 1.99 
(b, 1H, OH), 4.88 (q, 1H, CH, J=6.4 Hz), 6.22 (d, 1H, CH=, J=3.2 Hz), 
6.32 (dd, 1H, CH=, J=3.2 Hz, J=2.0 Hz), 7.37 (d, 1H, CH=, J=2.0 Hz). 
Yield determined by 
1





H NMR (CDCl3): δ = 2.62 (b, 1H, OH), 4.59 (s, 2H, CH2), 7.28 (m, 
5H, CH=). Yield determined by 
1
H-NMR using mesytilene as internal 
standard. 








H NMR (CDCl3): δ = 2.57 (b, 1H), 3.77 (s, 3H, 
CH3O), 4.53 (s, 2H, CH2), 6.85 (d, 2H, CH=, J= 8.6 Hz), 7.23 (d, 
2H, CH=, J= 8.6 Hz. Yield determined by 
1
H-NMR using 





H NMR (CDCl3): δ = 1.93 (b, 1H), 4.58 (d, 
2H, CH2, J= 4.8 Hz), 7.55 (d, 2H, CH=, J= 8.4 Hz), 8.23 (d, 2H, 
CH=, J= 8.4 Hz). Yield determined by 
1




H NMR (CDCl3): δ = 2.67 (b, 1H), 3.83 (s, 3H, 
CH3O), 4.66 (s, 2H, CH2), 6.89 (m, 2H, CH=), 7.26 (m, 2H, CH=). 
Yield determined by 
1






H NMR (CDCl3): δ = 1.91 (b, 1H), 4.76 (b, 
2H, CH2), 7.47 (t, 1H, CH=, J= 7.4 Hz), 7.55 (m, 2H, CH=), 7.64 
(s, 1H, CH=). Yield determined by 
1






H NMR (CDCl3): δ = 2.52 (b, 1H), 3.73 (s, 3H, 
CH3O), 4.6 (d, 2H, CH2, J= 4.6 Hz), 6.80 (m, 2H, CH=), 7.16 (m, 2H, 
CH=).Yield determined by 
1




H NMR (CDCl3): δ = 1.60 (b, 1H, NH), 3.78 (s, 4H, CH2), 7.2-7.4 (m, 
10H, CH=). Yield determined by GC using HP-5 column (150 
kPa H2, Hold 200 C for 0 min, rate 10 C/min
-1
 to 280 C and 





H NMR (CDCl3): δ = 1.51 (d, 3H, CH3, J=6.8 Hz), 4.00 
(b, 1H, NH), 4.48 (q, 1H, CH, J=6.8 Hz), 6.50 (d, 2H, CH=, J=8.0 
Hz), 6.63 (t, 1H, CH=, J=7.2 Hz), 7.08 (t, 2H, CH=, J=8.0 Hz), 7.23 
(m, 1H, CH=), 7.33 (m, 4H, CH=). Yield determined by 
1
H-NMR 
using mesytilene as internal standard. 






H NMR (CDCl3): δ = 1.55 (s, 14H, CH2). Yield determined by 
1
H-
NMR using mesytilene as internal standard. 
Cyclooctane. 
1
H NMR (CDCl3): δ = 1.52 (s, 16H, CH2). Yield determined by 
1
H-NMR 






H NMR (CDCl3): δ = 0.89 (m, 6H, CH3), 1.27 (b, 12H, CH2). Yield 
determined by GC using HP-5 column (100 kPa H2, Hold 50 C for 
10 min, rate 3 C/min
-1





H NMR (CDCl3): δ = 0.91 (t, 3H, CH3, J=6.8 Hz), 1.91 (m, 2H, 
CH2), 2.49 (m, 2H, CH2), 7.0-7.4 (m, 5H, CH=). Yield determined by 
GC using HP-5 column (100 kPa H2, Hold 80 C for 10 min, rate 3 
C/min
-1





H NMR (CDCl3): δ = 1.22 (t, 3H, CH3, J=6.4 Hz), 2.63 (q, 2H, CH2, 
J=6.4 Hz), 7.0-7.5 (m, 5H, CH=). Yield determined by GC using HP-5 
column (100 kPa H2, Hold 80 C for 10 min, rate 3 C/min
-1
 to 120 C and 
hold for 20 min). tR 3.8 min. 
Cumene. 
1
H NMR (CDCl3): δ = 1.21 (d, 6H, CH3, J=7.2 Hz), 2.82 (sp, 1H, CH, J=7.2 
Hz), 7.1-7.40 (m, 5H, CH=). Yield determined by 
1
H-NMR using 





H NMR (CDCl3): δ = 0.84 (d, 3H, J = 6.8 Hz), 0.87 
(d, 3H, J = 6.8 Hz), 1.21 (d, 3H, J = 7.2 Hz), 1.36 (m, 2H), 1.45 (m, 
1H), 2.79 (m, 1H), 7.19 (m, 2H), 7.29 (m, 3H). Yield determined by 
GC using Chiradex B-DM column (100 kPa H2, 60 °C for 30 min, 3 





H NMR (CDCl3): δ = 0.83 (s, 9H), 1.24 (d, 3H, J= 
6.8 Hz), 2.54 (q, 1H, J= 6.8 Hz), 7.1-7.3 (m, 5H). Yield determined by 
GC using Chiradex B-DM column (100 kPa H2, 60 °C for 30 min, 3 
°C/min until 175 °C). tR 47.2 min (S); tR 47.8 min (R). 








H NMR (CDCl3): δ = 0.80 (t, 3H, J= 7.6 Hz), 1.22 (d, 3H, J= 6.4 
Hz), 1.61 (m, 2H), 2.60 (m, 1H), 7.18 (m, 3H), 7.33 (m, 2H). Yield 
determined by GC using Chiradex B-DM column (100 kPa H2, 50 °C 





H NMR (CDCl3): δ = 1.97-2.11 (m, 1H, CH2), 2.12-2.17 
(m, 1H, CH2), 2.64-2.71 (m, 1H, CH2), 2.72-2.78 (m, 1H, CH2), 
4.70 (dd, 1H, CH, J=8.0 Hz, J=5.6 Hz), 7.17 (m, 3H, CH=), 7.21-
7.28 (m, 3H, CH=), 7.30-7.37 (m, 4H, CH=). Yield determined 
by 
1





H NMR (CDCl3): δ = 1.21 (d, 3H, CH3, J=6.0 Hz), 1.73 (m, 
2H, CH2), 2.65 (m, 1H, CH2), 2.74 (m, 1H, CH2), 3.82 (m, 1H, CH), 
7.12 (m, 3H, CH=), 7.25 (m, 2H, CH=). Yield determined by 
1
H-NMR 





H NMR (CDCl3): δ = 0.94 (t, 3H, J=8.0 Hz, 
CH3), 1.82-1.91 (m, 2H, CH2), 4.75 (t, 1H, CH, J=6.4 Hz), 7.48 (m, 
3H, CH=), 7.77 (s, 1H, CH=), 7.82 (m, 3H, CH=). Yield 
determined by GC using Chiralsil-Dex CB column (80 kPa H2, 
Hold 110 C for 15 min, rate 10 C/min
-1
 to 180 C and hold for 20 min). tR 30.9 min 
(R); tR 31.3 min (S). 
Benzaldehyde. 
1
H NMR (CDCl3): δ = 7.52 (m, 2H, CH=), 7.63 (m, 1H, CH=), 7.89 (m, 
2H, CH=), 10.02 (s, 1H, CHO). Yield determined by 
1
H-NMR using 





H NMR (CDCl3): δ = 2.41 (s, 3H, CH3), 7.30 (d, 2H, CH=, 
J=7.4 Hz), 7.75 (d, 2H, CH=, J=7.4 Hz), 10.03 (s, 1H, CHO). Yield 
determined by 
1
H-NMR using mesytilene as internal standard. 
4-Trifluoromethylbenzaldehyde. 
1
H NMR (CDCl3): δ = 7.81 (d, 2H, CH=, J=7.8 Hz), 
7.99 (d, 2H, CH=, J=7.8 Hz), 10.10 (s, 1H, CHO). Yield determined 
by 
1
H-NMR using mesytilene as internal standard. 
  






H NMR (CDCl3): δ = 2.50 (s, 3H, CH3), 7.46 (m, 2H, CH=), 
7.64 (m, 1H, CH=), 9.93 (s, 1H, CHO). Yield determined by 
1
H-NMR 
using mesytilene as internal standard. 
Acetophenone. 
1
H NMR (CDCl3): δ = 2.54 (s, 3H, CH3), 7.45 (m, 2H, CH=), 7.63 (m, 
1H, CH=), 7.92 (m, 2H, CH=). Yield determined by GC using Chiralsil-
Dex CB column (80 kPa H2, Hold 110 C for 15 min, rate 10 C/min
-1
 to 
180 C and hold for 20 min). tR 4.2 min. 
1-(p-Tolyl)ethan-1-one. 
1
H NMR (CDCl3): δ = 2.40 (s, 3H, CH3), 2.56 (s, 3H, CH3), 
7.21 (d, 2H, CH=, J=7.8 Hz), 7.85 (d, 2H, CH=, J=7.8 Hz). Yield 
determined by GC using Chiralsil-Dex CB column (100 kPa H2, Hold 
110 C for 15 min, rate 10 C/min
-1




H NMR (CDCl3): δ = 2.66 (s, 3H, CH3), 
7.73 (d, 2H, CH=, J=8.0 Hz), 8.04 (m, 1H, CH=, J=8.0 Hz). Yield 
determined by GC using Chiralsil-Dex CB column (80 kPa H2, Hold 
110 C for 15 min, rate 10 C/min
-1
 to 180 C and hold for 20 min). 
tR 3.8 min. 
1-(m-Tolyl)ethan-1-one. 
1
H NMR (CDCl3): δ = 2.40 (s, 3H, CH3), 2.57 (s, 3H, CH3), 
7.32 (m, 3H, CH=), 7.75 (m, 2H, CH=). Yield determined by GC using 
Chiralsil-Dex CB column (80 kPa H2, Hold 110 C for 15 min, rate 10 
C/min
-1
 to 180 C and hold for 20 min). tR 4.3 min. 
  




5.2.6.4 GC’s, 1H-NMR and mass spectra of transfer hydrogenation and 
transfer deuterination experiments of substrates S30 and S31 
 














Mass spectrum and 
1
H-NMR of transfer deuterogenation of S30 
 




H-NMR of the deuterated final product 
 
 




Mass spectrum and 1H-NMR of transfer deuterogenation of S31 
 












5.2.6.5. Crystal data and structure refinement for ligand L3H·OTf and Ir-
complexes 138-142. 
- Crystal data and structure refinement for ligand L3H·OTf 
Empirical formula  C12 H11 F3 N4 O4 S 
Formula weight  364.31 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21/n 
Unit cell dimensions a = 10.49444(10) Å    α = 90°. 
 b = 8.65841(7) Å   β= 93.2254(8)°. 
 c = 16.56110(15) Å     γ = 90°. 
Volume 1502.44(2) Å3 
Z 4 
Density (calculated) 1.611 Mg/m3 
Absorption coefficient 0.277 mm-1 
F(000) 744 
Crystal size 0.367 x 0.228 x 0.073 mm3 
Theta range for data collection 2.242 to 26.369°. 
Index ranges                                                                 -13<=h<=13, -10<=k<=10, -20<=l<=20 
Reflections collected 25549 
Independent reflections 3066 [R(int) = 0.0284] 
Completeness to theta = 25.242° 100 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1 and 0.80197 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3066 / 0 / 219 
Goodness-of-fit on F2 1.059 
Final R indices [I>2sigma(I)] R1 = 0.0331, wR2 = 0.0862 
R indices (all data) R1 = 0.0377, wR2 = 0.0896 
Largest diff. peak and hole 0.351 and -0.32 e.Å-3 
  




- Crystal data and structure refinement for [IrCl(L3)(COD)] (138). 
 
Empirical formula  C19 H22 Cl Ir N4 O 
Formula weight  550.05 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P n a 21 
Unit cell dimensions a = 21.2461(2) Å        α= 90°. 
 b = 7.15410(10) Å      β= 90°. 
 c = 12.48750(10) Å    γ = 90°. 
Volume 1898.06(4) Å3 
Z 4 
Density (calculated) 1.925 Mg/m3 
Absorption coefficient 7.191 mm-1 
F(000) 1064 
Crystal size 0.301 x 0.215 x 0.022 mm3 
Theta range for data collection 1.917 to 26.371°. 
Index ranges -26<=h<=26, -8<=k<=8, -15<=l<=15 
Reflections collected 25483 
Independent reflections 3856 [R(int) = 0.0343] 
Completeness to theta = 25.242° 100 %  
Absorption correction Gaussian 
Max. and min. transmission 0.857 and 0.324 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3856 / 5 / 250 
Goodness-of-fit on F2 1.083 
Final R indices [I>2sigma(I)] R1 = 0.0186, wR2 = 0.0401 
R indices (all data) R1 = 0.0214, wR2 = 0.0415 
Absolute structure parameter -0.022(10) 
Largest diff. peak and hole 0.647 and -0.472 e.Å-3 
  




- Crystal data and structure refinement for [IrCp*Cl(L3)]OTf (139). 
 
Empirical formula  C22 H25 Cl F3 Ir N4 O4 S 
Formula weight  726.17 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 8.4198(3) Å         α= 70.626(4)°. 
 b = 10.8029(4) Å       β= 77.463(4)°. 
 c = 15.3887(8) Å       γ = 80.308(3)°. 
Volume 1281.91(10) Å3 
Z 2 
Density (calculated) 1.881 Mg/m3 
Absorption coefficient 5.451 mm-1 
F(000) 708 
Crystal size 0.365 x 0.253 x 0.083 mm3 
Theta range for data collection 2.009 to 28.269°. 
Index ranges                                                                      -11<=h<=11, -14<=k<=14, -20<=l<=20 
Reflections collected 64250 
Independent reflections 6374 [R(int) = 0.0319] 
Completeness to theta = 25.242° 100 %  
Absorption correction Gaussian 
Max. and min. transmission 0.648 and 0.248 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6374 / 279 / 405 
Goodness-of-fit on F2 1.111 
Final R indices [I>2sigma(I)] R1 = 0.0344, wR2 = 0.0818 
R indices (all data) R1 = 0.0351, wR2 = 0.0823 
Largest diff. peak and hole 9.196 and -0.954 e.Å-3 




- Crystal data and structure refinement for [IrCp*Cl2(L3)] (140). 
 
Empirical formula  C21 H25 Cl2 Ir N4 O  
Formula weight  612.55 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a =  8.4361(6)Å            α=  90°. 
 b =  16.4263(11)Å  β = 103.6862(14)°. 
 c =  16.0490(10)Å        γ =  90°. 
Volume 2160.8(3) Å3 
Z 4 
Density (calculated) 1.883 Mg/m3 
Absorption coefficient 6.446 mm-1 
F(000)  1192 
Crystal size  0.20 x 0.15 x 0.10 mm3 
Theta range for data collection 1.801 to 30.595°. 
Index ranges -12<=h<=11,-23<=k<=23,-22<=l<=21 
Reflections collected  21761 
Independent reflections 6354[R(int) = 0.0235] 
Completeness to theta =30.595°  95.5%  
Absorption correction  Multi-scan 
Max. and min. transmission  0.565 and 0.402 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters  6354/ 0/ 269 
Goodness-of-fit on F2  1.034 
Final R indices [I>2sigma(I)]  R1 = 0.0174, wR2 = 0.0403 
R indices (all data)  R1 = 0.0201, wR2 = 0.0411 
Largest diff. peak and hole  1.341 and -0.747 e.Å-3 
 
  




- Crystal data and structure refinement for [IrCp*Cl(L4)] (141). 
 
Empirical formula  C18 H23 Cl F3 Ir N4 O3 S2  
Formula weight  692.17 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a =  8.5926(17)Å     α =  90°. 
 b =  16.579(3)Å       β = 99.975(5)°. 
 c =  16.372(3)Å       γ =  90°. 
Volume 2297.0(8) Å3 
Z 4 
Density (calculated) 2.002 Mg/m3 
Absorption coefficient 6.164 mm-1 
F(000)  1344 
Crystal size  0.50 x 0.02 x 0.01 mm3 
Theta range for data collection 1.762 to 34.957°. 
Index ranges -13<=h<=11,-12<=k<=26,-11<=l<=25 
Reflections collected  18301 
Independent reflections 9156[R(int) = 0.0422] 
Completeness to theta =34.957°  90.7%  
Absorption correction  Multi-scan 
Max. and min. transmission  0.941 and 0.724 
Refinement method  Full-matrix least-squares on F2 
Data / restraints / parameters  9156/ 237/ 368 
Goodness-of-fit on F2  0.984 
Final R indices [I>2sigma(I)]  R1 = 0.0384, wR2 = 0.0679 
R indices (all data)  R1 = 0.0678, wR2 = 0.0769 
Largest diff. peak and hole  2.223 and -1.677 e.Å-3 
 
 




- Crystal data and structure refinement for [IrCl(L2)(COD)] (142). 
 
Empirical formula  C19 H33 Cl Ir N3 O 
Formula weight  547.13 
Temperature  123(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P 21/n 
Unit cell dimensions a = 9.21700(10) Å     α= 90°. 
 b = 12.4893(2) Å    β= 97.311(2)°. 
 c = 17.9919(5) Å       γ = 90°. 
Volume 2054.28(7) Å3 
Z 4 
Density (calculated) 1.769 Mg/m3 
Absorption coefficient 6.641 mm-1 
F(000) 1080 
Crystal size 0.1341 x 0.0993 x 0.0287 mm3 
Theta range for data collection 1.990 to 28.209°. 
Index ranges                                                        -12<=h<=12, -16<=k<=14, -23<=l<=22 
Reflections collected 19216 
Independent reflections 4654 [R(int) = 0.0464] 
Completeness to theta = 25.000° 100.0 %  
Absorption correction Gaussian 
Max. and min. transmission 0.83 and 0.472 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4654 / 1 / 243 
Goodness-of-fit on F2 1.051 
Final R indices [I>2sigma(I)] R1 = 0.0317, wR2 = 0.0629 
R indices (all data) R1 = 0.0413, wR2 = 0.0670 
Extinction coefficient n/a 
Largest diff. peak and hole 2.243 and -1.671 e.Å-3 
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6.1. Benzoxazole/thiazole-triazolidene iridium complexes as 
new efficient molecular catalysts for water oxidation 
Mazloomi, Z.; Gil, M.; Albrecht, M.; Salas, X.; Pàmies, O.; Diéguez, M. 
Manuscript in prepration. 
 
6.1.1. Introduction 
Nowadays, the major part of the global energy supply is provided by carbon-based 
energy sources, which are connected to severe environmental issues, such as the 
greenhouse effect and air pollution. Consequently, exist a strong social demand for 
clean and environmentally friendly carbon-free alternatives to fossil fuels. However, the 




One of the potential alternatives to fossil fuels is water splitting to produce hydrogen 
as fuel.
2
  This process requires the coupling of the two half-reactions: (i) water 
oxidation to produce the reducing equivalents (electrons) and oxygen as the only 
byproduct and (ii) reduction of protons using the electrons of the former reaction to 
generate molecular hydrogen. Albeit, both reaction steps are crucial for the generation 
of hydrogen from water, water oxidation is considered to be the bottleneck in the 
sustainable production of hydrogen from water.
3
 This is because water oxidation is both 
thermodynamically and kinetically unfavorable, resulting in slow kinetics without the 
use of a catalyst.
3b
 The development of powerful and stable water oxidation catalysts is 
therefore of great importance. For decades, scientists have sought to understand and 





 catalysts. One of the key features that 
water oxidation catalysts need to fulfill is the high redox flexibility of the metal center 
because the formation of molecular oxygen from water requires the transfer of four 











 based catalysts have also given 
promising results. 
The redox behavior of the metal center can be modulated by the coordinated ligands. 
In this respect mesoionic carbenes (MIC), such as 1,2,3-triazol-5-ylidenes, facilitate the 
stabilization of different metal oxidation states mainly because of the large 




contributions from zwittterionic resonance forms and also because they can serve as a 
transient reservoir of both negative and positive charge.
8d
 Such advantages have been 
used mainly by the groups of Bernhard and Albrecht to develop a new class of efficient 
Ir-complexes containing pyridyl-triazolidene ligands for water oxidation (Figure 
6.1.1).
8d,9
  For instance, compound 80 provided high turnover numbers (up to 40000) in 
the cerium ammonium nitrate ((NH4)2Ce(NO3)6, CAN) mediated water oxidation. Later, 
modification of the remote position of the carbene ligand (complexes 81 and 82) led to 
a substantially increase in activity. It should be pointed out that the simple and 
counterintuitive introduction of more lipophilic n-octyl chain (complex 82) led to one of 
the most active Ir-catalysts. Nevertheless, activity substantially decrease when using 
sodium metaperiodate as sacrificial oxidant under nearly neutral media (pH 5.6). Thus, 
for instance, the activity of complex 82 dropped from TOF’s up to 2 s
-1
 using CAN at 
pH = 1 to TOF’s up to 0.1 s
-1
 using NaIO4 at pH = 5.6. 
 
 
Figure 6.1.1. Representative pyridine-triazolidene iridium water oxidation catalyst 
precursors. TOF measured in the CAN-mediated water oxidation at pH = 1. 
 
6.1.2. Objectives 
We have recently shown that the replacement of the pyridyl group in Ir-complexes 
containing pyridyl-triazolidene ligands by other robust nitrogen or oxygen groups, such 
as benzoxazole and thiazole, is highly advantageous in hydrogen transfer reactions 
(both transfer hydrogenation and dehydrogenation reactions, see Chapter 5). Having in 
mind the large effect observed using simple and sometimes counterintuitive 
modifications in the pyridyl-triazolidene scaffold for Ir-catalyzed water oxidation, the 
decision was made to study the effect of varying the pyridine group by a benzoxazole 
and a thiazole moiety (complexes 139 and 141; Figure 6.1.2). We also would like to 
study the effect of the nature of catalyst precursors, from cationic to neutral complexes, 
by means of complexes 139 and 140 (Figure 6.1.2). Furthermore, we also seek to 




evaluate complex 148 (Figure 6.1.2), without an extra coordinative group rather than 
the triazolidene moiety, to prove if the presence of bidentated ligands is crucial for high 
activities and, more importantly, if ligand chelatation is key to avoid the decomposition 




Figure 6.1.2. Ir catalyst precurssors 139-141 and 148 for water oxidation using both 
CAN and NaIO4 as sacrificial one-electron oxidants. 
 
6.1.3. Results and discusion 
6.1.3.1. Synthesis and characterization of Ir-complexes 
Complexes 139-141 were prepared as previously reported in Chapter 5. The new Ir-
complex 148 was prepared by a one-pot reaction from the corresponding triazolium salt 
149, using Ag2O and Me4NCl to form the desired Ag-carbene intermediate, and 
subsequent in situ transmetallation with [Ir(Cp*)Cl2]2 (Scheme 6.1.1). Triazolium salt 
149 was prepared via conventional copper-catalyzed [3+2] of the methyl azide and 1-
hexyne, followed by the methylation at the triazole N3 position as illustrated in Scheme 




C NMR spectroscopy and mass spectroscopy. Coordination of 148 through the 1,2,3-
triazol-5-ylidene group was confirmed by the disappearance of the H-5 proton signal in 
the 
1





Scheme 6.1.1. Synthesis of 1,2,3-triazol-5-ylidene iridium complex 148. (i) MeN3, 
CuSO4·5H2O, C6H7O6Na, THF/H2O. (ii) MeOTf, CH2Cl2. (iii) Ag2O, Me4NCl, 
[IrCp*Cl2]2, CH2Cl2. 




6.1.3.2. Electrochemical analysis 
To examine the oxidation behavior of complexes 139 and 141 we studied the 
electrocatalytic properties in a non-protic solvent (dichloromethane) as well as in 
aqueous solutions in acidic (pH = 1) and an almost neutral (pH = 5.6) media. 
Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) in dichloromethane 
shows a redox couple at 1.61 V vs SVE for 4 and at 1.55 V vs SVE for 5 (Figure 6.1.3). 
 
 
Figure 6.1.3. (Left) Cyclic Voltammetry of 139 and 141 in DCM (0.1 M TBAP) with a 
scan rate of 100 mV/s. (Right) Differential Pulse Voltammetry of 139 and 141 in DCM 
(0.1 M TBAP) recorded using pulse amplitudes of 0.05 V, pulse widths of 0.05 s, 
sampling widths of 0.02 s, pulse periods of 0.1 s, and quiet times of 2 s. 
 
Cyclic voltammograms of aqueous solutions of 139 and 141, however, showed 
different behaviors in acidic and an almost neutral media (Figure 6.1.4). Under acid 
conditions, complexes 139 and 141 show waves at 1.24 V and 1.29 V vs SCE, which 
can be assigned to Ir(III)/Ir(IV), and strong irreversible waves at a higher potentials due 
to the electrocatalytic water oxidation. An unassigned redox process at ca. 0.25-0.3 V 
was also observed. Under almost neutral pH conditions, the Ir(III)/Ir(IV) event shifted 
to 1.08 V and 1.05 V vs SCE for complexes 139 and 141, respectively. As expected, the 
potential at which the water oxidation appear increased substantially as did the current 
at the highest applied voltage at elevated pH.  
  






Figure 6.1.4. Top: cyclic voltammetries of 139 (left) and 141 (right) at different scan 
rates at pH = 1. Conditions: 1mM concentration of both complexes in a pH = 1 aqueous 
solution (0.1M triflic acid). Bottom: cyclic voltammetries of 139 (left) and 141 (right) at 
different scan rates at pH = 5.6. Conditions: 1mM concentration of both complexes in a 
pH = 5.6 aqueous solution (NaOAc buffer).  
 
The stability of the both complexes at a different pH conditions was studied using 
consecutive CV experiments (Figure 6.1.5). Again, the results using complexes 139 and 
141 showed different behaviors in acidic and an almost neutral media. Under acidic 
conditions, a significant decrease in the current of the waves at 1.24 and 1.29 V was 
observed after 10 consecutive potential cycles (Figure 6.1.5). The decrease on intensity 
of such waves is attributed to passivation of the electrode surface. A plausible 
explanation is the degradation of the molecular complexes at highly positive potentials 
and subsequent formation of IrOx heterogeneous materials that cover the electrode.
12
 To 
confirm the electrodeposition of IrOx, the electrodes after the consecutive CVs were 
washed with water, acetone and methanol, and were placed in neat triflic acid. The CV 
of the recovered electrode material show clear electrocatalytic water oxidation waves in 
both complexes (Figure 6.1.6), which clearly indicates the presence of catalytically 
active heterogeneous materials on the surface of both electrodes. 






Figure 6.1.5. Top: consecutive cyclic voltammetries of 139 (left) and 141 (right) with a 
scan rate of 100 mV/s (black line), 100 mV/s during 11 cycles (grey line) and blank 
(dashed line) n a pH = 1 aqueous solution (0.1M triflic acid). Bottom: consecutive 
cyclic voltammetries of 139 (left) and 141 (right) with a scan rate of 100 mV/s in a pH 
= 5.6 aqueous solution (NaOAc buffer). 
 
On the other hand, at almost neutral pH conditions, no signs of electrodeposition, 
and therefore of decomposition, on the surface of the electrode were observed for both 
complexes 139 and 141 (Figure 6.1.5). 
 
Figure 6.1.6. Cyclic voltammetries of 139 (left) and 141 (right) after washing the 
electrode with water, acetone and MeOH (black line) and blank (dashed line). 
  




6.1.3.3. Reactivity of complexes 139-141 towards water 
In order to investigate the Cl
-
/H2O ligand exchange propensity of complexes 139 
and 141 in solution, their behavior in D2O was studied by 
1
H-NMR (Scheme 6.1.2). 
Interestingly, different behavior was observed for both complexes. Complex 139 is very 
robust and no detectable ligand exchange was observed by 
1
H-NMR even after 4 days. 
However, for complex 141 two compounds at a ratio of ca 9:1 were observed when 
performing the 
1
H-NMR in D2O. Thus, for instance, two set of the thiazole signals were 
observed. The major compound presents two doublets at 8.00 ppm and at 8.16 ppm, 
whereas the corresponding signals of the minor compound are downfield shifted to 8.07 
ppm and 8.29 ppm, respectively. The downfield shift of the thiazole signals in the minor 
compound is indicative of the formation of the corresponding dicationic aquo complex, 





/H2O ligand exchange equilibria of complexes 139 and 141. 
 
To provide further evidence of the formation of the dicationic aquo complexes, we 
prepared such species by irreversible abstraction of the chloride anion with silver triflate 
in the presence of water (Scheme 6.1.3). In line with the different behavior in aqueous 
solution of complexes 139 and 141 previously observed, the formation of dicationic 
aquo complex 150 requires longer reaction times (2 days) than for thiazole analogue 
151 (12 h). Under this reaction conditions, chloride abstraction of dichloro complex 140 
affords complex 139 instead of the corresponding aquo complexes after 12 hours 




C NMR spectroscopy 
and mass spectroscopy. To date, we have been unable to achieve crystals of sufficient 
quality to make X-ray diffraction measurements. As expected, for both complexes 150 
and 151, the benzoxazole and thiazole signals appear more downfield shifted than those 
of cationic chloro complexes 139 and 141. The number of water molecules coordinated 
could not be determined by mass spectroscopy because, as expected, the HRMS-ESI 
spectra show the heaviest ions at m/z which correspond to the loss of the solvato 




molecules and of the triflate anion. Nevertheless, the 
13
C NMR spectra of complexes 
150 and 151 also indicates that the signals from the quaternary X-C=N group were 
downfield shifted compared to the free ligand (i.e. 153.8 ppm for complex 150 and 
151.2 ppm for benzoxazole-triazolylidene salt), which clearly indicates the coordination 
of the benzoxazole and thiazole moieties and that therefore only one water molecule is 
coordinated in complexes 150 and 151. In the case of monoaquo complex 150 is it 
possible to coordinate a second molecule of water if the reaction is carried in water as 
solvent and heated to 70 °C for more than 3 days (compound 152). The coordination of 
the second water molecule is associated with the concomitant decoordination of the 
benzoxazole moiety, which is demonstrated by the deshielding of the 
1
H-NMR signals 
of the benzoxazole unit (Figure 6.1.7). The coordination ability of the thiazole group is 
greater than the benzoxazole moiety. Therefore, the presence of diaquo complex 153 
was not observed after 3 days of reaction. 
 





H-NMR spectra of compounds 139, 150 and 152 in D2O.  




6.1.3.4. Water oxidation catalysis 
Complexes 139 and 141 were evaluated as water oxidation catalyst precursors using 
either cerium ammonium nitrate ((NH4)2Ce(NO3)6, CAN) or sodium metaperiodate 
(NaIO4) as sacrificial one-electron oxidants. Catalytic activity was monitored by 
combining differential pressure manometry with a molecular oxygen selective Clark 
electrode. In a first set of experiments the ability to promote water oxidation of 
complexes 139 and 141 was evaluated using CAN as oxidant at pH = 1 (0.1 M HOTf). 
The reactions were carried out using 1 mM of Ir-catalysts and three consecutive 
additions of CAN (100 eq in each addition). For both catalyst precursors fast production 
of gas was observed after the addition of the sacrificial oxidant (Figure 6.1.8). Both 
catalyst showed similar catalytic behavior with TOF’s ca 0.06 s
-1
.  It should be pointed 
out that no other gases rather than molecular oxygen were obtained in all the runs. As 
previously observed for other Cp*Ir-MIC complexes, considerable amounts of CAN 
were used to generate the active species rather than to be used as oxidant, which affects 
the TON in the first injection. We also carried out the reaction using 4000 equivalents 
of CAN, providing similar TOF’s and TON around 1000 after 2.5 h runs (see 
Supporting Information). 
 
Figure 6.1.8. Manometric monitoring of gas evolution vs. time for complex 139 (left) 
and 141 (right) during three consecutive additions of CAN (100 eq). Conditions for 
each addition: 1 mM catalyst / pH = 1 (0.1M triflic acid) solution / 100 mM 
(NH4)2Ce(NO3)6. (a) TON measured from O2-selective clarck-type electrode analysis of 
the reaction headspace. TONmax = 25. (b) O2% in the total gas evolved by combining 
manometry (total gas) + O2-selective clark-type electrode analysis. (c) TOF values 








































Over the last years it has been a controversy whether the IrCp* catalyst precursors 
are stable under the presence of CAN,
16
 and therefore if the catalysis occurs in 
homogeneous or in heterogeneous phase. The presence of heterogenized catalysts (e.g. 
IrOx nanoparticles) have been usually disclosed by in situ UV-VIS or by TEM analysis. 
However, these two methodologies have recently proved to be not fully reliable in WO 
catalysis. Thus, for instance the UV-VIS absorbance around 560 nm, which was 
attributed to the presence of IrOx, could alternatively indicate the presence of 
homogeneous Ir(IV) species, as described by Crabtree, Brudvig et al.
8g,17
  On the other 
hand the high-energy of the electron beam in a TEM analysis can induce the formation 
of clusters and nanoparticles from homogeneous samples.
18
 As demonstrated by 
Crabtree and Brudvig, one of the simple ways to circumvent this problem is the use of 
dynamic light scattering (DLS).
19
 The DLS of the resulting purple solutions after 
catalysis indicate the presence of aggregates in the range of 0.78 – 0.92 nm (Figure 
6.1.9), which rather than indicating the presence of Ir-NPs, it is in agreement with the 
estimated hydrodynamic volumes of the Crabtree’s type dimeric iridium species 
[(C,N)X2Ir(μ2-X)2IrX2(C,N)] (X = O, OH),
20
 which have been recently proposed to play 




Figure 6.1.9. DLS measurements of solutions after catalysis using 139 (left) and 141 
(right). Conditions: 1 mM of catalyts in a pH = 1.0 (0.1M triflic acid) aqueous solution 
in the presence of 100 mM (NH4)2Ce(NO3)6. 
 
We have also evaluated the performance of complexes 139 and 141 as WOC using 
sodium periodate as sacrificial oxidant at pH = 5.6. The development of WOC able to 
work in almost neutral pH conditions instead of at highly corrosive low pH conditions is 
of great important for large-scale application. For the purpose of comparison, the 
experiments were carried out using the so-called “Crabtree’s conditions”: 20 mM NaIO4 
(4000 eq) in NaOAc buffer at pH = 5.6. As previously observed when CAN was used as 
oxidant, water oxidation began immediately after the addition of NaIO4 to the catalyst 
(Figure 6.1.10). However, in contrast to CAN, complete consumption of NaIO4 to form 




molecular oxygen was observed for both 139 and 141 leading to efficiencies close to 
100 % (TON’s 996 and 998 for 139 and 141, respectively). It should be highlighted the 
high activity of the catalytic systems (TOF’s up to 0.58 s
-1
 and 0.21 s
-1
 for 139 and 141, 
respectively). These results competes favorably with most of the Ir-catalyst developed 
(including other triazolylidene Cp*Ir catalyst precursors),
21
 with the exception of 




 The potential formation of Ir-NPs 
under these catalytic conditions was also examined by DLS. No evidence of NPs 
formation was obtained for neither 139 nor 141 in a 2 h analysis. Further indication of 
the homogeneous nature of the active species is the quick color change from the initially 
pale yellow of the catalyst precursors to the blue solution in both cases. Given the 
relative structural similarity of 139 and 141 with Crabtree’s complexes the stable and 
highly active blue solutions observed could indicate the formation of similar dinuclear 
active species (Figure 6.1.11), which has been proposed to be resting state in WOC.
8j    
 
 
Figure 6.1.10. Monitoring of O2 evolution vs. time using a Clark-type electrode for 
complexes 139 (orange line) and 141 (blue line) triggered by sodium periodate. 
Conditions: 5 µM catalyst, acetate buffer pH = 5.6, 4000 eq of NaIO4 (TONmax = 
1000). 
 
Figure 6.1.11. Structure of the catalytically active Ir “blue solution” formed from 
Cp*Ir(pyalk)OH catalyst precursor in the presence of NaIO4.
8j  





In this chapter we have disclosed the electrochemical properties of complexes 139 
and 141 in a non-protic solvent as well as in aqueous solution at different pHs. We have 
also studied the Cl
-
/H2O ligand exchange propensity of complexes 139 and 141 in water 
solution. More inportantly, we have demonstrated that complexes 139 and 141 are able 
to promote water oxidation using both CAN and NaIO4 as sacrificial oxidant. The 
molecular nature of the active species have been corroborated using both oxidants. 
Using CAN as oxidant at low pH, both catalyst precursors provided similar activities 
(TOF’s ca 0.06s
-1
) and lower than those achieved using parent pyridine complex 80. 
However, excellent activities (much better than related pyridine analogues 80-82; 
TOF’s up to 0.58 s
-1
) were achieved when using more appealing almost neutral 
conditions (pH = 5.6) and NaIO4 as oxidant. Although the results using CAN can be 
simply rationalized by the lower donor abilities of the benzoxale and thiazole groups 
compared to the pyridine moiety,
22
 this explanation is in disagreement with the results 
using NaIO4. The most probable explanation for the substantial rate enhancement using 
NaIO4 instead of CAN can be found in the different nature of the active species formed 
by a specific aggregation process under different reaction conditions.
9b
 Work is still in 
progress to study the catalytic behavior of complexes 140 and 148 using CAN and 
NaIO4 as sacrificial oxidants. 
 
6.1.5. Experimental section 
6.1.5.1. General information 
All reactions for the synthesis of Ir-complexes were carried out using standard Schlenk 
techniques under an atmosphere of argon. Solvents were purified and dried by standard 
procedures. Ir-complexes 139-141 were prepared as previously described. All other 








F NMR spectra were recorded using a 400 MHz spectrometer. Chemical shifts are 








C assignments were 












C gHMBC experiments. 
Dynamic light scattering experiments (DLS) were carried out using a Zetazizer Nano 
ZS at 25 
o
C with an operating range of measurement from 0.3 nm to 10 microns. 
 




6.1.5.2. Preparation of 4-butyl-1,3-dimethyl-1H-1,2,3-triazole 
trifluoromethanesulfonate (149)  
A suspension of MeI (0.58 ml, 9.33 mmol) and NaN3 (1.84 g, 28 mmol) in 
H2O/THF (32 mL 1:1 v/v) was stirred at room temperature for 48 h. CuSO4·5H2O (141 
mg, 0.56 mmol), sodium ascorbate (1.12 g, 5.65 mmol) and 1-hexyne (1.33 g, 11.2 
mmol) were added subsequently and the mixture was stirred in the oil bath at 55 ºC for 
48 hours. The organic solvent (THF) was removed under reduced pressure and the 
residue was suspended in CH2Cl2 (40 mL) and washed with water (2 × 50 mL), and 
brine (2 × 50 mL). After drying over MgSO4, charcoal was added to the solution and 
stirred for 30 min to further purify the compound. The suspension filtered off through 
celite, washed with CH2Cl2 (30 ml) and evaporated the solvent to obtain 4-butyl-1-
methyl-1H-1,2,3-triazole as a white powder. The compound is suitable to be used for 
the next step. Yield: 750 mg (48%) 
1
H NMR (400 MHz, CDCl3): δ = 7.24 (s, 1H, H-5), 
4.01 (s, 3H, CH3˗N), 2.69 – 2.63 (t, 
3
JH-H = 7.3 Hz, 2H, CH2˗C4), 1.60 (quintet, 2H, 
CH2˗CH2), 1.33 (sextet, 2H, CH2˗CH3), 0.88 (t, 
3







NMR (100 MHz, CDCl3): δ = 148.8 (C–4), 121.7 (C–5), 36.5 (CH3˗N), 31.6 
(CH2˗CH2), 25.3 (CH2˗CH2), 22.3 (CH2˗CH3), 13.8 (CH3, n-Bu). MS HR-ESI [found 
139.1116 (M-H)
+
, C7H13N3 requires 139.1109].  
MeOTf (600 μL, 6.20 mmol, 1.2 equiv) was added to a solution of 4-butyl-1-
methyl-1H-1,2,3-triazole (713 mg, 5.13 mmol) in CH2Cl2 (5 mL) at 0 °C then the 
solution kept to stir at 23 ºC for 12 h (the reaction monitored by TLC). All volatiles 
were evaporated under reduced pressure. Purification by column chromatography (SiO2; 
CH2Cl2/MeOH 30:1) yielded product 149 as a pale yellow liquid.Yield: 1.00 g (64%). 
1
H NMR (400 MHz, CDCl3): δ 8.43 (s, 1H, H5), 4.27 (s, 3H, CH3˗N), 4.16 (s, 3H, 
CH3˗N), 2.78 (t, 2H, 
3
JH-H = 15.96, CH2CH2), 1.69 (quintet, 2H, CH2CH2), 1.42 (sextet, 
2H, CH2CH3), 0.93 (t, 
3






 NMR (100 MHz, CDCl3): 
δ = 144.9 (C–4), 129.3 (C–5), 120.6 (q, 
1
JC-F = 320.33, CF3), 40.0 (CH3˗N), 37.4 
(CH3˗N), 28.7 (CH2˗CH2), 23.0 (CH2˗CH2), 22.1 (CH2˗CH3), 13.5 (CH3,n-Bu). 
19
F NMR 









6.1.5.3. Synthesis of [IrCp*Cl(149)]OTf (148) 
Triazolium salt 149 (65 mg, 0.21 mmol), Me4NCl (46 mg, 0.42 mmol), Ag2O (97 
mg, 0.42 mmol) and [Ir(Cp*)Cl2]2 (67 mg, 0.084 mmol, 0.4 equiv) were stirred in 
CH2Cl2 (10 ml) at 40 °C for 8 h. After cooling to rt, the suspension was filtered through 
celite and the solvent was removed under reduced pressure to yield the crude product. 
Purification by column chromatography (SiO2; CH2Cl2/MeOH, 40:1) yielded product 
148 as yellow solid (12 mg, 10%). 
1
H NMR (400 MHz, CDCl3): δ = 
1
H NMR 4.27 (s, 
3H, CH3˗N), 3.96 (s, 3H, CH3˗N), 2.95 (m, 2H, CH2˗CH2), 2.01 – 1.74 (m, 1H, 
CH2˗CH2), 1.61 (s, 15H, Cp*), 1.55 – 1.18 (m, 3H, CH2˗CH2), 0.95 (t, 
3





H} NMR (101 MHz, CDCl3), δ: 148.9 (C˗5), 144.4 (C˗4), 87.8 (C, Cp*), 40.9 
(CH3–N), 36.3 (CH3–N),, 32.1 (CH2), 29.8 (CH2), 23.2 (CH2), 14.0 (CH3,n-Bu), 9.2 (CH3, 
Cp*). MS HR-ESI [found 516.1718 (M-Cl)
+
, C18H30ClIr requires 516.1756]. Suitable 
crystals for X-ray diffraction were achieved by slow diffusion of pentane to 
dichloromethane solution.  
 
6.1.5.4. Preparation of dicationic monoaquo complexes 150 and 151 
To a solution of the corresponding [IrCp*Cl(L)]OTf (0.01 mmol) in 
dichloromethane (1.5 mL) was sequentially added water (18 μL, 1.1 mmol) and AgOTf 
(3.1 mg, 1.2 eq). The reaction was stirred for 48 h (compound 150) or 12 h (for 
compound 151) protected from light. Then the resulting suspension was filtered over 
celite, and all volatiles were removed under reduced pressure to yield the crude 
products.  
[IrCp*(L3)(H2O)](OTf)2 (150). Yield: 7.7 mg, 88%. 
1
H NMR (400 MHz, D2O), δ: 
7.73-7.78 (m, 2H, CH=), 7.52 (m, 2H, CH=), 4.38 (s, 3H, CH3–N), 4.32 (s, 3H, CH3–




H} NMR (101 MHz, D2O), δ: 156.8 (C–5), 151.5 
(C=N), 135.9 (C–4), 128.1 (CH=), 127.3 (CH=), 120.0 (q, 
1
JC-F =210.2, CF3), 90.8 (C, 
Cp*), 40.8 (CH3–N), 38.3 (CH3–N), 9.2 (CH3, Cp*). 
19
F NMR (377 MHz, D2O), δ: -
79.1 (s).  
[IrCp*(L4)(H2O)](OTf)2 (151). Yield: 7.5 mg, 89%. 
1
H NMR (400 MHz, D2O), δ: 
8.15 (d, 
3
JH-H = 3.6 Hz, 1H, CH=), 7.93 (d, 
3
JH-H = 3.6 Hz, 1H, CH=), 4.29 (s, 3H, CH3–




H} NMR (101 MHz, D2O), δ: 
159.6 (C–5), 157.53 (C=N), 147.0 (C–4), 141.5 (CH=), 124.8 (CH=), 119.2 (q, 
1
JC-F 
=320.0, CF3), 90.3 (C, Cp*), 40.3 (CH3–N), 37.9 (CH3–N), 8.6 (CH3, Cp*). 
19
F NMR 




(377 MHz, D2O), δ: -79.1 (s). MS HR-ESI [found 509.1351 (M-(OTf)2-H2O)
+
, 
C17H24IrN4S requires 509.1345]. 
 
6.1.5.5. Preparation of dicationic diaquo complex 152  
Monoaquo complexes [IrCp*(L3)(H2O)](OTf)2 (0.01 mmol) were dissolved in D2O 
(1 mL) and allowed to stir at 70 C for 3 days.   




H NMR (400 MHz, 
D2O), δ: 6.98 (m, 2H, CH=), 6.86 (m, 2H, CH=), 4.17 (s, 3H, CH3–N), 4.08 (s, 3H, 




H} NMR (101 MHz, D2O), δ: 166.6 (C–5), 
149.9 (C=N), 144.4 (C–4), 136.4 (C), 128.0 (CH=), 127.2 (CH=), 126.5 (CH=), 119.2 
(q, 
1
JC-F = 260.7, CF3), 116.1 (CH=), 88.7 (C, Cp*), 39.6 (CH3–N), 35.8 (CH3–N), 8.1 
(CH3, Cp*). 
19
F NMR (377 MHz, D2O), δ: -79.0 (s).  
 
6.1.5.6. Electrochemistry 
Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) experiments 
were performed on a Biologic SP-150 potentiostat, using EC Lab software for data 
acquisition and data handling. Measurements were made using a standard three-
electrode cell using glassy carbon disk electrode of 3.0 mm diameter as a working 
electrode, a Pt disk of 1 mm diameter as counter electrode and an aqueous saturated 
calomel electrode (SCE) as a reference electrode. All of the potentials are reported 
versus SCE isolated from the working electrode compartment by a salt bridge. Working 
electrodes were polished with 1 and 0.05 micron Alumina paste washed with distilled 
water and acetone and sonicated in acetone for 5 minutes before each measurement. The 
complexes were disolved in DCM containing the necessary amount of 
n
Bu4NPF6 
(TBAPF6) as supporting electrolyte to yield 0.1 M ionic strength solutions. For 
electrocatalytic experiments, complexes were disolved in the corresponding water 
solutions (0.1 M triflic acid solution or acetate buffer pH 5.6). CV were recorded at 
different scan rates (50-1000 mV/s) and DPV were recorded using pulse amplitudes of 
0.05 V, pulse widths of 0.05 s, sampling widths of 0.02 s, pulse periods of 0.1 s and 
quite times of 2 s. E0 values reported in this work were estimated from DPV 
experiments. The error associated with the potential values is less than 5 mV. 
  




6.1.5.7. Typical procedure for the water oxidation  
Catalysis experiments were performed in a homemade thermostated glass cell (V = 
15 mL) at 25 °C which was closed with a septum. The evolution of gases were 
monitored by on-line manometry with a differential pressure manometer (Testo 521), 
with an operating range of 0.1−10 kPa and accuracy within 0.5%, which was connected 
to a reference cell of approximately the same size, as well as by a gas phase oxygen 
sensor (Unisense Ox-N sensor) controlled by Unisense multimeter. The oxygen sensor 
was calibrated after each experiment by addition of known amounts of oxygen to the 
cell.  
In a typical experiment, a solution of complex in 0.1 M triflic acid (pH 1) was degassed 
for 10 minutes using N2 flow. After pressure equilibration between reference and 
measurement cell, baseline was recorded for 20-30 minutes and a solution of cerium 
ammonium nitrate (CAN) in 0.1 M Triflic acid was added to the reference and 
measurement cell. Resulting a final concentration of catalyst 1mM and concentration of 
CAN 100 mM. For second and third injections, this procedure was carried out again 
adding 100 more equivalents of CAN in 0.1 M Triflic acid to the measurement and 
reference cells. Experiments with NaIO4 were performed by using diluted degassed 
solutions of the complex in acetate buffer pH 5.6 in the same setup, resulting a final 
ratio Catalyst/Oxidant 1:4000 and a final concentration 5µM for the catalyst and 20 
mM for the NaIO4. 
TON was calculated from O2-selective clark-type electrode analysis of the reaction 
headspace and TOF values were calculated from the increase of TON in the initial 5 
minutes after addition of oxidant. O2/Gas ratios were calculated dividing total oxygen 
produced detected by O2-selective clark probe by the total gas evolved obtained by 
manometric experiments.  
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7.1. Air stable and simple phosphite-oxazoline ligands for 
Pd-intermolecular asymmetric Heck reaction. Mechanistic 
insights 
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7.1.1. Introduction 
The Pd-catalyzed Heck reaction (also known as Mizoroki-Heck), i.e., the coupling 
of an alkenyl, aryl halide or triflate to an alkene, is one of the most powerful C-C bond 
forming reactions, as it was recognized with the Nobel Prize in Chemistry in 2010.1 Its 
applicability to highly functionalized substrates confers the reaction a large substrate 
scope and it is widely applied in the synthesis of pharmaceuticals, natural products and 
fine chemicals.
1
 The extensive research dedicated to this process can give the erroneous 
impression that Heck chemistry is a mature area. Although the Heck reaction has been 
known since the late 1960s, its asymmetric version was not published until 1980, with 
most examples dealing with intramolecular reactions, where the alkene regiochemistry 
and geometry of the product can be easily controlled.1 The asymmetric intermolecular 
Heck reaction was not published until 1991.2 Although since then many research groups 
have devoted considerable efforts to the intermolecular version, it is still less developed 
than the intramolecular version and its synthetic utility remains limited. This is due in 
part to regioselectivity problems caused by the possible migration of the carbon-carbon 
double bond, which leads to mixtures of products. For example, in the Heck coupling of 
the model 2,3-dihydrofuran substrate (S51) with phenyl triflate (Scheme 7.1.1), both the 
desired 2-phenyl-2,5-dihydrofuran (84) and the undesired 2-phenyl-2,3-dihydrofuran 
(83) can be obtained.  
 
 
Scheme 7.1.1. Model Pd-catalyzed Heck reaction of 2,3-dihydrofuran (S51)with phenyl 
triflate. 
 




At the beginning, the research in the asymmetric intermolecular reaction focused in 
the development of diphosphine ligands, being BINAP the central ligand.
1
 Although 
Pd-diphosphine catalysts provided high enantioselectivities, the regioselectivity and 
activity were less favorable (e.g., BINAP provided enantioselectivities up to 96% but 
the main product was 83, in only 71% of regioselectivity, and the reaction time was 9 
days)
2
. This moved the research to other types of ligands. A breakthrough was the 
report by Pfaltz et al., who showed that phosphine-oxazoline PHOX ligands (93c, 
Figure 7.1.1) minimize the double bond isomerization providing high regio- and 
enantioselectivity to the desired product 84, although still at low activity with long 
reaction times (3-7 days to achieve full conversion).3 Then, the follow up work for the 
intermolecular Heck reaction focused in Pd-catalysts modified with chiral phosphine-
oxazoline ligands.4
,5  Although many of these ligands were developed, only a few of 
them provided high selectivity (Figure 7.1.1) and the problems of low reaction rates and 
low substrate specificity remained. Although microwave irradiation considerably 
reduced the reaction times from weeks to days, it affected enantioselectivity − and 
sometimes regioselectivity − negatively.6 Additionally, the most successful phosphine-
oxazoline ligands contained a 
t
Bu group in the ozaxoline and their synthesis required 
starting from the very expensive amino acid tert-leucine. Although alternative 




 were developed to solve this limitation, they had lower substrate scope 
and/or required more reaction steps. A final limitation of phosphine-oxazoline ligands is 
that most of them are prone to oxidation. 
 
Figure 7.1.1. Representative privileged P-oxazoline ligands for Pd-catalyzed 
asymmetric intermolecular Heck reaction. 
 
The search for efficient ligands prepared in only a few steps from inexpensive raw 
materials, easy to handle (i.e., solid, robust and air stable) and that induce higher rates 
and substrate scope has therefore attracted the attention of many researchers. For this 
purpose two main strategies have been used for ligand design. One, developed recently 




by the groups of Oestrich and Zhou, illustrates the power of mixed phosphine-
phosphine oxides which had been discarded in the Heck reaction for decades. 
Pd/phosphine-phosphine oxide systems were successfully applied in the intermolecular 
Heck reaction of several cyclic alkene substrates with various aryl triflates and aryl 
halides.7 The second strategy developed by our group was based on biaryl phosphite-
oxazoline ligands. Phosphite-containing ligands are particularly useful for asymmetric 
catalysis.8 Their highly modular construction, facile synthesis from available alcohols 
and greater resistance to oxidation than the phosphines have proved to be highly 
advantageous. In this respect, our group has contributed with an improved generation of 
air stable phosphite-oxazoline ligand libraries for several asymmetric catalytic 
transformations.9 The application of two of these phosphite-oxazoline libraries in the 
Heck reaction  lead us to identify a Pd/phosphite-oxazoline 131a catalyst (Figure 7.1.1) 
that provided activities of 100% in only 10 min with excellent regio- and 
enantioselectivities in the coupling of several cyclic substrates and a variety of 
triflates.10 To the best of our knowledgement no other phosphite-oxazoline ligands have 
been applied. Despite the mentioned developments, the use of the phosphite-oxazoline 
ligands in the intermolecular Heck reaction has unknowns that must be explored in the 
search of better catalysts. For example, no mechanistic studies have been made to 
discern the role of the ligand structure parameters that should lead to a conclusive 
reason of the higher activity of our chiral phosphite-oxazoline compared with their 
analogues phosphine-N ligands. Different from other C-C bond forming reaction such 
as Pd Tsuji-Trost reactions, most of the mechanistic studies in Heck reaction have 
focused on achiral systems. 11  For example, the rate determining step using achiral 
diphosphine Pd-catalysts is well determined.
11b,c,f
 Achiral phosphite ligands, however, 
have been less studied.
11a,d,e
 Moreover, the investigations of catalytic intermediates in 
asymmetric Heck reaction are still preliminary. No kinetic studies have been carried out 
and the very few mechanistic studies for specific ligands are mainly 
computational.
4o,5g, 12  Experimental studies by NMR and kinetic studies are difficult 
because of the high reactivity and multifaceted aggregation behavior of Pd-precursor 
that gives unreactive Pd-black species. The experimental protocol to control the 
formation of Pd-black under reaction conditions must still be developed.  
  





The potential of phosphite containing-ligands in enantioselective Pd-catalyzed Heck 
reaction and the species responsible for the catalytic performance must be studied with 
new phosphite-oxazoline ligands. To address these points, we report a reduced but 
structurally valuable library of readily accessible phosphite-oxazoline ligands L5-L9a-e 
(Figure 7.1.2). These are based on privileged phosphine-oxazoline ligands 108-109
4o
 
(Figure 7.1.1) in which the phosphine moiety has been replaced by biaryl phosphite 
moieties that increase robustness and modularity (that allows a better control of the 
flexibility of the chiral pocket). In addition these ligands are solid and stable to air and 
other oxidizing agents. In a simple two or four step-procedure, that starts from 
commercially available materials, (Scheme 7.1.2) several ligand parameters can be 
easily tuned to maximize the catalyst performance. With this ligand library we 




Bu) and their configuration, the substituents in the benzylic position (ligands L5-L7a-e 
with a hydrogen group and ligands L8a-e with a methyl group) and the substituents and 
configurations of the biaryl phosphite moiety (a-e). Interestingly, we found that the 
range of substrates and triflate sources that can be successfully coupled was higher than 
for the previous phosphine-oxazoline 108-109 counterparts, which have emerged as 
some of the most successful catalysts designed for this process. In addition, the 
phosphite-oxazoline ligands that provided the best selectivities contained the 
i
Pr 
substituent in the oxazoline moiety instead of the pricy 
t
Bu substituent found in the 
related phosphine-oxazoline 108-109. Finally, in this paper we have also successfully 




Figure 7.1.2. Phosphite-oxazoline ligand library (L5-L9a-e).  




7.1.3. Results and discussion 
7.1.3.1. Synthesis of ligands 
The sequence of ligand synthesis is illustrated in Scheme 7.1.2. Phosphite-oxazoline 
ligands L5-L9a-e were synthesized very efficiently from the corresponding easily 
accessible hydroxyl-oxazolines 155-158 and 161. Hydroxyl-oxazoline 155-158 were 
prepared, in only one step, as previously reported in the literature from readily available 
starting materials. Therefore, coupling of hydroxyl-cyanide 154 with the appropriate 
amino alcohol yielded the hydroxyl-oxazolines 155-158 with diverse oxazoline 
substituents (Scheme 7.1.2, step i).13 For the synthesis of the hydroxyl-oxazoline 161, 
which differs from 155-158 in the presence of methyl groups on the benzylic position, 
the commercially available 2(3H)-benzofuranone
 
159 was converted into the 
corresponding benzofuranone 160 by treatment with methyl iodide and sodium hydride 
(step ii). 14  Subsequent reaction of 160 with 3-amino-3-phenylpropan-1-ol (amino 
alcohol) followed by cyclization with p-TsCl afforded the desired hydroxyl-oxazoline 
161 (steps iii and iv). 
 
 
Scheme 7.1.2. Synthetic route for the synthesis of phosphite-oxazoline ligands L5-L9a-
e. (i) amino alcohol, ZnCl2, C6H5Cl, reflux, 16 h (yields 68-78%);
13
 (ii) NaH, MeI, 
THF, -78°C to rt (43% yield);
14
 (iii) Aminoalcohol, NaH, MeOH, THF, 0°C to rt, 4 h, 
(75% yield). (iv) p-TsCl, NEt3, DMAP, CH2Cl2, 0 °C to rt, overnight (89% yield).
 
(v) 
ClP(OR)2 ((OR)2 = a-e), Py, toluene at rt for 18 h (40-78% yields).  
 
The last step of the synthesis is common for all ligands (Scheme 7.1.2, step v). 
Condensation of the desired in situ formed phosphorochloridites (ClP(OR)2 (OR)2 = a-
e) with the corresponding hydroxyl-oxazoline 155-158 and 161 yielded phosphite-
oxazoline ligands L5-L9a-e, with different biaryl phosphite groups. They were isolated 
as white solids in good-to-high yields. As mentioned earlier, L5-L9a-e can be 














H} NMR spectra and mass spectrometry. All data were in agreement with 







P NMR spectra showed the expected pattern for these C1-complexes. 
The VT-NMR spectra in CD2Cl2 (+35 to -85 °C) showed only one isomer in solution. 
 
7.1.3.2. Asymmetric Heck reaction of 2,3-dihydrofuran (S1) 
We first applied the ligands L5–L9a-e to the Pd-catalyzed phenylation of 2,3-
dihydrofuran S51. For comparison, we evaluated them using the optimal reaction 
conditions reported in our previous studies with other phosphite-oxazoline ligands.
10 
 
Reactions were therefore performed in tetrahydrofuran, at 50°C, using 2.5 mol% of in-
situ generated catalyst, by mixing the [Pd2(dba)3].C6H6
15 with the corresponding chiral 
ligand, and 
i
Pr2NEt as base. The results are collected in Table 7.1.1. The catalytic 
performance was found to depend on the ligand structure, i.e., the substituents on the 
oxazoline ring and on the benzylic position and the substituents/configuration of the 
biaryl phosphite moiety.  
The reactions that proceeded with the highest activities, regio- and 
enantioselectivities (e.g. entries 4-6 vs 1-3 and 9-11) had ligands containing the 
i
Pr 
oxazoline group (ligands L6). This contrasts with the oxazoline-substituent effect 
observed in the vast majority of successful P-oxazoline ligands (such as the 
t
BuPHOX 
93c and the Gilberston phosphine-oxazoline ligand based on ketopinic acid 99b; see 
Figure 7.1.1) whose enantioselectivities are higher when tert-butyl groups are present. 
Interestingly, by comparing our results with those from the analogous Pd-phosphine-
oxazoline systems 108-109
4o
 (Figure 7.1.1, R=H) we found that the simple substitution 
of the phosphine by biaryl phosphite groups is advantageous since the ligands that 
provided the best selectivities contained the 
i
Pr substituent in the oxazoline moiety 
instead of the costly 
t
Bu substituent. We also found, as expected, that the sense of 
enantioselectivity is governed by the absolute configuration of the oxazoline substituent 
(entry 4 ligand L6a vs 15 ligand L9a). Both enantiomers of the phenylation product 84 
can therefore be accessed by simple changing the absolute configuration of the 
oxazoline group.   




Table 7.1.1. Pd-catalyzed enantioselective phenylation of 2,3-dihydrofuran 




Entry Ligand %Conv (84:83)b %ee 84c 
1 L5a 94 (98:2) 67 (R) 
2 L5b 50 (52:48) 81 (R) 
3 L5c 92 (99:1) 75 (R) 
4 L6a 100 (97:3)
d 90 (R) 
5 L6b 42 (58:42) 47 (S) 
6 L6c 97 (96:4) 71(R) 
7 L6d 99 (98:2)
e 92 (R) 
8 L6e 88 (97:3)
f 92 (R) 
9 L7a 20 (44:56) 85 (R) 
10 L7b 47 (43:54) 10 (S) 
11 L7c 85 (96:4) 81 (R) 
12 L8a 48 (20:80) 4 (R) 
13 L8b 5( 45:55) 15 (R) 
14 L8c 13 (43:57) 20 (R) 
15 L9a 100 (96:4)
g 90 (S) 
16h L6a 6 (89:11) 78 (R) 
17i L6a 100 (97:3) 85 (R) 
18j L6a 64 (87:13) 71 (R) 
(a) [Pd2(dba)3].benzene (1.25×10
-2 mmol), S51 (2.0 mmol), phenyl triflate (0.5 mmol), ligand 
(2.8×10-2 mmol), THF (3 ml), iPr2NEt (1 mmol), T = 50 °C, t = 24 h. 
(b) Conversion 
percentages determined by GC. (c) Enantiomeric excesses measured by GC. (d) 89% isolated 
yield. (e) 86% isolated yield. (f) 71% isolated yield. (g) 87% isolated yield. (h) Reaction carried out 
at 23 °C. (i) Reaction carried out at 70 °C. (j) Reaction carried out in benzene.  
 
Concerning the effect of the biaryl phosphite group, we found that its configuration 
affected activity and selectivity. In general, ligands with an S-configuration of the biaryl 
phosphite moiety provided higher conversion, regio- and enantioselectivities than 
ligands with an R-configuration (Table 7.1.1, entries 6-8 vs 5) although ligand L6a with 
the aquiral biaryl phosphite group also provided high activities and selectivities (Table 
7.1.1, entry 4). This ligand maintains the economic benefits of using an 
i
Pr oxazoline 
substituent and has the added advantage that an achiral inexpensive biaryl phosphite 
moiety a is used. If we compare the results of L6a with those of the related enantiopure 
biaryl ligands L6b and L6c, (entry 4 vs 5 and 6), we can conclude that the 




tropoisomeric biphenyl moiety in L6a adopts an S-configuration. We also found that the 
substituent of the biaryl phosphite moiety has an important effect on selectivity since 
ligands L6d-e provided higher selectivity than L6c (entries 7-8 vs 6). Finally, the 
introduction of methyl groups at the benzylic position had a negative effect on both 
activity and selectivity (Table 7.1.1, entries 12-14 vs 1-3). This contrasts with the results 
reported for related phosphine-oxazoline 108-109
4o
 where the introduction of Me 
substituents at the benzylic position provided the reverse enantiomer although with 
somewhat lower enantioselectivity (from 93 % (R) with a H substituent to 81 % (S) with 
a Me substituent) and regioselectivity. 
In summary, the highest regio- (up to 98%) and enantioselectivities (up to 92%) 
were achieved with phosphite-oxazoline ligands L6a,d-e and L9a. Moreover, both 
enantiomers of phenylation product 84 can be accessed in high regio- and 
enantioselectivity simply by changing the configuration of the oxazoline substituent. 
We next studied the effect of the temperature with one of the best ligands (entries 16-
17). Lowering the temperature to 23 ºC has a negative effect on both selectivity and 
activity (only 6% of conversion after two days). High temperature (70 ºC) has also a 
negative effect on enantioselectivity whereas the good regioselectivity is maintained. 
Finally, we studied the effect of changing the solvent to benzene. Most of the successful 
ligands reported in the literature gave better catalytic performance using benzene 
instead of THF.
3
 This was not the case with our ligands: activities and selectivities were 
lower with benzene (entry 18). 
Other triflate sources. We next studied other triflate sources. The results (Scheme 7. 
1.3) follow the same trend, in terms of the effect of the ligand parameters, as the 
phenylation of S51. Again, the best results were obtained with L6a,d-e and L9a. As an 
example, Scheme 7.1.3 shows the results using ligand L6d which had provided one of 
the best results in the phenylation of S51 (the full results are shown in the supporting 
information). Both enantiomers of the coupling products 84a-h were accessible with 
high activity, regio- (up to 99%) and enantioselectivity (up to 98%). Improving results 
reported in the literature, we found that the catalytic performance was almost not 
affected by the steric and electronic properties of the aryl groups. Therefore, a variety of 
triflates with different electronic and steric properties (1- and 2-naphthyl, p-CH3-C6H4, 
p-NO2-C6H4, p-OMe-C6H4 and o-OMe-C6H4) reacted with S51 in regio- and 
enantioselectivities as high as or higher than those obtained with phenyl triflate. Even 
the sterically demanding o-methoxyphenyl and 1-naphthyl triflates were cross-coupled 




efficiently. Finally, it is also worth mentioning that the addition of the cyclohexenyl 
triflate that usually reacted with less regio- and enantioselectively than the coupling of 
phenyl triflate proceeded with comparable high regio- and enantioselectivity. All these 
results are among the best that have been reported in the literature
1c,n
 and surpass the 
range of triflate sources that could be coupled with higher enantioselectivity than using 





Scheme 7.1.3. Asymmetric Heck reaction of 2,3-dihydrofuran S51.  
 
7.1.3.3. Asymmetric Heck reaction of other substrates 
To further study the potential of L5-L9a-e ligands, we used them in the Pd-
catalyzed Heck reaction of other challenging substrates. We initially studied the 
arylation of 4,7-dihydro-1,3-dioxepin S52 with phenyl- and p-CH3-C6H4 triflates 
(Scheme 7.1.4a). The enol ethers 162 resulting from these substrates are easily 
converted into chiral β-aryl-γ-butyrolactones, which are useful synthetic intermediates.16 
Despite its relevance, the successful examples found in the literature are scarce and 
require long reaction times (typically 5-7 days). 17  The results are summarized in 
Scheme 7.1.4a and followed the same trends as for the arylation of S51. Again, catalysts 
Pd/L6a,d-e and Pd/L9a provided both enantiomers of the arylation products 162a and 
162b in high enantioselectivities (up to 95%) comparable to the best reported so far.  




Dihydropyrroles are another important set of substrates which are widely present in 
biological compounds and have versatile synthetic applications.18 We investigated the 
asymmetric Heck reaction of N-Boc-2,3-dihydropyrrole S53 with phenyl- and p-CH3-
C6H4 triflates (Scheme 7.1.4b). Although their Pd-catalyzed alkenylation has been 
studied before, the few reported examples had a limited success.
1
 Again, ligands L6a,d-
e and L9a that contain the 
i
Pr substituent in the oxazoline moiety (see the complete 
results in the Supporting Information section) provided the best results with activities, 
regio- (up to 98%) and enantioselectivities (up to 94%) comparable to the best one 





Scheme 7.1.4. Asymmetric Heck reaction of (a) 4,7-dihydro-1,3-dioxepin S52 and (b) 
N-Boc-2,3-dihydropyrrole S53.  
 
We finally turned our attention to the asymmetric alkenylation of cyclopentene S54 
(Scheme 7.1.5). Due to extensive double-bond migration, the selectivity is more 
difficult to control in this substrate than in functionalized alkenes, such as S51 and S53.
1
 
Most of the catalysts fail to control the regioselectivivity and, in addition to the desired 
product 165, the corresponding achiral regioisomers 166 and 167 can be obtained. 
Therefore, the reported catalysts for the Pd-catalyzed arylation of this substrate are 
fewer than for the arylation of functionalized alkenes.
1
 Our Pd/L6a,d-e and Pd/L9a 




catalytic systems turned out to be efficient in the alkenylation of S54 using four triflate 
sources with different electronic and steric proprieties (Scheme 7.1.5). In all cases high 
activities, regio- and enantioselectivities in both enantiomers of the arylation products 
165a-d were achieved without the formation of the undesired achiral product 167.  
 
 
Scheme 7.1.5. Asymmetric Heck reaction of cyclopentene S54.  
 
In summary, the replacement of the phosphine by a phosphite group in the 
phosphine-oxazoline ligands 108-109 extended the range of substrates and triflate 
sources that could be successfully coupled with regio- and enantioselectivities that were 
among the best reported so far.
1
 In addition, the ligands that provided the best 
enantioselectivities contained the 
i





7.1.3.4. Asymmetric Heck reaction of 2,3-dihydrofuran with aryl halides 
Carbon electrophiles in the asymmetric intermolecular Heck reaction have been 
mostly restricted to aryl or vinyl triflates, thus limiting the synthetic value of 
intermolecular coupling. To date, only a few successful examples using aryldiazonium 
salts,
5h
 arylboronic acids19 and benzylic electrophiles20 and one using aryl halides
7c 
have 
been reported. With aryl halides, mixed phosphine-phosphine oxide ligands were found 
to be the best choice whilst BINAP and 
t
Bu-PHOX provided very low activities (less 
10%) and BINAP also extremely low enantioselectivity (<5% ee). The success of this 
transformation also required the addition of 1 equiv. of additive (mainly p-NO2PhCO2H 
although silver salts such us AgOTf were also used) and ethylene glycol, MeOH or 
(CH2OH)2 as solvents (the more common toluene, ether and 1,4 dioxane led to poor 
results). In addition, most of the electrophiles were aryl bromides and only a few were 




ArCl. Aryl iodides gave not only lower enantioselectivity but also a shift to the 
preferential formation of regiosomer 83 (i.e., the phenylation of S51 afforded 84 and 83 
at a 1:2 ratio). Under this reaction conditions, we test whether our ligands could do the 
same coupling (Scheme 7.1.6). The reaction of S51 with phenyl bromide provided the 
desired regioisomer 84 as a major product in high enantioselectivity (91% ee).  The use 
of phenyl iodide, led to similar levels of enantioselectivities albeit the formation of the 
isomer 83 is favored.  
 
Scheme 7.1.6. Asymmetric Heck reaction of S51 with aryl halides. 
 
7.1.3.5. Mechanistic insights 
There are no mechanistic studies that give a conclusive reason for the chiral 
phosphite-oxazoline ligands giving a higher activity than most of the phosphine-
oxazolines. Kinetic studies with achiral diphosphine ligands in the Pd-catalyzed 
coupling of iodobenzene with styrene showed that the rate limiting step is the oxidative 
addition.
11b,c,f
 Van Leeuwen and Kamer's kinetic studies with achiral monophosphite 
ligands showed that the rate determining step is not the oxidative addition but rather the 
alkene coordination or the migratory insertion, being the migratory insertion the most 
plausible choice as suggested, although not conclusively, by further electronic alkene 
effects.
11a,e
 So, we performed a kinetic study to discover the rate determining step in the 
Pd/phosphite-oxazoline catalysts reported in this manuscript. Scheme 7.1.7 presents the 
most accepted mechanism for the Heck coupling reaction that served as the basis for the 
kinetic study. The catalytic cycle is initiated by the oxidative addition of phenyl triflate 
to the Pd(0)-NP* complex resulting in the four coordinate aryl-Pd(II) complex which 
then reacts with the olefin to form the -complex. Insertion of the olefin into the Pd-Ph 
bond leads to a Pd-alkyl species which undergoes -hydride elimination, followed by 
dissociation to the product and a Pd-hydride complex. The catalytic cycle is completed 
by base-assisted reductive elimination of HOTf regenerating the catalytically active 
Pd(0)complex.  





Scheme 7.1.7. Accepted mechanism for the asymmetric Pd-catalyzed Heck reaction of 
2,3-dihydrofuran S51. 
As a viable catalyst precursor for the our kinetic study we used [Pd(Ph)(OTf)(L6a)] 
168. Using Pd2(dba)3/L6a or its [Pd(dba)(L6a)] analogues was discarded because the 
active species form too slowly under the employed conditions.21 [Pd(Ph)(OTf)(L6a)] 
168 was synthesized in two steps (Scheme 7.1.8). First reaction of the 
[Pd(Ph)(I)(TMEDA)] (TMEDA= N,N,N,N-tetramethylethylendiamine)22 with one equiv 
of phosphite-oxazoline ligand L6a afforded the corresponding compound 
[Pd(Ph)(I)(L6a)] 169. Then, iodine abstraction in 169 by treatment with AgOTf yielded 







C NMR spectroscopies. The VT-NMR experiments (-78 to 30 °C) 
indicated the formation of a single stereoisomer. This is in agreement with the 
tropoisomeration of the biphenyl phosphite moiety being controlled by the ligand 
backbone upon coordination to the Pd-center observed in Table 7.1.1 (vidre supra). The 
NMR data also indicated that, as previously observed for other P,N-containing 
complexes, the phenyl ligand is located cis to the phosphite moiety.
5a
 To prove the 
viability of 168 as a catalyst precursor, we first performed the stoichiometric reaction by 
adding 2 equivalents of S51 and an excess of base. The regio- and enantioselectivity 
achieved were similar to those achieved using the catalytic conditions (95% 




regioselectivity and 88% ee), which clearly indicated that [Pd(Ph)(OTf)(L6a)] is a 
viable intermediate.  
 
Scheme 7.1.8. Preparation of [Pd(Ph)(OTf)(L6a)]. (i) L6a, C6H6 (66% yield); (ii) 
AgOTf, THF (90% yield). 
The kinetic studies were performed using the classical approach, varying the 
concentration of each of the reagents involved in the catalysis and studying the reaction 
rate after 5 minutes (TOFini) vs the concentration. Deactivation of the molecular system 
due to the formation of inactive Pd-black was observed after 10-15 minutes. This 
contrasts with the stability observed in the catalytic runs using [Pd2(dba)3]/L5-L9a-e 
catalytic precursors (see vidre supra) and suggest that although the dba does not 
participate in the catalytic cycle, it stabilizes the molecular species thus preventing the 
formation of the inactive Pd black. 
The rate of the reaction between S51 and phenyl triflate catalyzed by Pd-complex 
168 was independent of the concentration of N,N-diisopropylethylamine (0.16-2.7 M; 
Figure 7.1.3a) and phenyl triflate (0.16-2 M; Figure 7.1.3b). The zero order dependence 
in phenyl triflate agrees with a rapid oxidative addition. The independence of the 
reaction rate on the concentration of N,N-diisopropylethylamine agrees with the fact 
that the elimination/reduction steps, that are base-assisted, are also fast. The effect of 
the Pd loading (2-16 mM) on activity (Figure 7.1.3c) indicates a first order-dependency, 
because the rate of product formation is proportional to the Pd concentration. Figure 
7.1.3d shows a linear dependence of the initial turn over frequency (TOFini) on alkene 
concentration. The first-order rate dependence on the alkene concentration clearly 
shows that the substrate is involved in the turn-over limiting step of the catalytic cycle. 
This implies that either the alkene coordination to Pd or the subsequent insertion into 
the Pd-Ph bond must be the turn-over limiting step. However these two steps cannot be 
distinguished from our kinetic results. We therefore determined the initial reaction rates 
with several para-substituted phenyl triflate sources (p-R-C6H4OTf; R= OMe, Me, H, 
NO2) using Pd-complex 168 under our reaction conditions. The Hammet plot (Figure 
7.1.4) showed a linear correlation between the Hammet  value and the relative reaction 
rates,23 with a negative  value ( = -0.89). Therefore, the use of electronwithdrawing 




aryl triflates led to lower reaction rates, exhibiting the order p-NO2<p-H<p-Me<p-OMe. 
This indicates that the electron density decreases in the rate determining step and 




Figure 7.1.3. Kinetic measurements. Plots of TOFini versus (a) [N
i
Pr2Et], (b) [PhOTf], 
(c) [Pd] and (d) S51 for the reaction of S51 with PhOTf in THF at 50°C catalyzed with 
complex [Pd(Ph)(OTf)(L6a)]. 
 
Figure 7.1.4. Hammet plot showing the effect of substituents on the Heck reaction 
using catalytic system Pd/L6a. 
 






We have replaced the phosphine group with several biaryl phosphite moieties in one 
of the most successful phosphine-oxazoline ligand family 108-109 for the Pd-catalyzed 
intermolecular Heck reaction. With these simple modifications, the phosphite-based 
ligands not only had a more modular design than the source phosphine-oxazoline 108-
109, but also were air-stable solids with no increase in the number of synthetic steps. 
With a careful selection of the ligand components, (oxazoline substituent and its 
configuration, the substituents in the benzylic position and the substituents and 
configurations of the biaryl phosphite moiety) the new ligands were superior to the 
privileged phosphine-oxazolines 108-109, extending the range of substrates and triflates 
sources than can been coupled with regio- and enantioselectivities comparable to the 
best ones reported. In addition, the phosphite-oxazoline ligands that provided the best 
selectivities contained the 
i
Pr substituent in the oxazoline moiety instead of the 
expensive 
t
Bu substituent found in the related phosphine-oxazoline 108-109. Finally, in 
this paper we have also carried out mechanistic investigations by combining kinetic 
studies and Hammet plots. The results indicates that the migratory insertion of the aryl 
group to the olefin is the rate determining step. 
 
7.1.5. Experimental section 
7.1.5.1. General information 
All syntheses were performed with standard Schlenck techniques under argon 
atmosphere. The kinetic studies were performed using a glove box. Solvents were 





 phosphochloridites 24  and[Pd(Ph)(I)(TMEDA)]
22
 were 










H} NMR spectra were recorded 





C) as internal standard or H3PO4 (
31
















correlation spectra.  
  




7.1.5.2. General procedure for the preparation of phosphite-oxazoline 
ligands (L5-L9a-e) 
To a solution of in situ generated phosphochloridite (1.1 mmol) in dry toluene (6 
mL), pyridine (0.16 mL, 2.0 mmol) was added. Then, this solution was placed in a -78 
ºC bath. After 2 min at that temperature, a solution of the corresponding alcohol 
oxazoline (1.0 mmol) and pyridine (0.16 mL, 2.0 mmol) in toluene (6 mL) was added 
drop wise at -78 °C. The mixture was left to warm to room temperature and stirred 
overnight at this temperature. The precipitate formed was filtered under argon and the 
solvent was evaporated under vacuum. The residue was purified by flash 
chromatography (under argon, using neutral alumina and dry toluene as eluent system) 
to afford the corresponding phosphite-oxazoline (L5-L9a-e) as white solids. 
L5a. Yield: 449.7 mg (65%); 
31
P NMR (161.9 MHz, C6D6): δ = 139.1 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 1.27 (s, 9H, CH3, 
t
Bu), 1.28 (s, 9H, CH3, 
t
Bu), 1.51 (s, 9H, 
CH3, 
t
Bu), 1.52 (s, 9H, CH3, 
t
Bu), 3.6 (pt, 1H, CH-O, JH-H= 8.4 Hz), 3.8 (s, 2H, CH2), 
4.73 (dd, 1H, CH-O, 
2
JH-H = 10.0 Hz, 
3
JH-H = 8.0 Hz), 4.9 (m, 1H, CH-N), 6.8-7.15 (m, 




H} (1006. MHz, C6D6): δ = 
28.7 (CH2), 30.9 (CH3, 
t
Bu), 31.2 (CH3, 
t
Bu), 34.3 (C, 
t
Bu), 35.3 (C, 
t
Bu), 69.6 (CH-N), 
74.1 (CH2-O), 120.8-150.2 (aromatic carbons), 166.0 (C=N). MS HR-ESI [found 
714.3679, C44H54NO4P (M-Na)
+
 requires 714.3683]. 
L5b. Yield: 512.5 mg (72%); 
31
P NMR (161.9 MHz, C6D6): δ = 144.2 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 0.4 (s, 9H, CH3, SiMe3), 0.6 (s, 9H, CH3, SiMe3), 3.1 (pt, 
1H, CHO, JH-H = 8.4 Hz), 3.2 (d, 1H, CH2, 
2
JH-H = 16.0 Hz) 3.36 (d, 1H, CH2, 
2
JH-H = 
16.0 Hz), 3.5 (dd, 1H, CH-O, 
2
JH-H = 10.0 Hz, 
3
JH-H = 8.0 Hz), 4.9 (m, 1H, CH-N), 6.91 
(m, 4H, CH=), 7.02-7.23 (m, 7H, CH=), 7.43 (m, 4H, CH=), 7.78 (m, 2H, CH=), 8.16 




H} (100.6 MHz, C6D6): δ = -0.5 (d, CH3, SiMe3, 
JC-P = 4.6 Hz), 0.1 (CH3, SiMe3), 28.3 (CH2), 69.6 (CH-N), 73.9 (CH2-O), 120.3-152.4 
(aromatic carbons), 165.7 (C=N). MS HR-ESI [found 734.2280, C42H42NO4PSi2 (M-
Na)
+
 requires 734.2282]. 
L5c. Yield: 555.3 mg (78%); 
31
P NMR (161.9 MHz, C6D6): δ = 143.5 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 0.0 (s, 9H, CH3, SiMe3), 0.2 (s, 9H, CH3, SiMe3), 3.1 (pt, 
1H, CHO, JH-H = 8.4 Hz), 3.2 (d, 1H, CH2, 
2
JH-H = 16.0 Hz) 3.3 (d, 1H, CH2, 
2
JH-H = 16.0 
Hz), 3.5 (dd, 1H, CH-O, 
2
JH-H = 10.0 Hz, 
3
JH-H = 8.0 Hz), 4.4 (m, 1H, CH-N), 6.54 (m, 
4H, CH=), 6.69-6.82 (m, 8H, CH=), 7.04 (m, 4H, CH=), 7.38 (m, 5H, CH=), 7.75 (s, 




H}  (100.6 MHz, C6D6): δ = -0.5 (d, CH3, SiMe3, JC-




P = 4.6 Hz), 0.0 (CH3, SiMe3), 28.3 (CH2), 69.5 (CH-N), 73.9 (CH2-O), 120.5-149.5 
(aromatic carbons), 165.7 (C=N). MS HR-ESI [found 734.2279, C42H42NO4PSi2 (M-
Na)
+
 requires 734.2282]. 
L6a. Yield: 394.72 mg (60%); 
31
P NMR (161.9 MHz, C6D6): δ = 139.2 ppm (s). 
1
H 








JH-H = 6.4 Hz), 1.28 (s, 18H, CH3, 
t
Bu), 1.5 (s, 18H, CH3, 
t
Bu), 1.55 (m, 1H, CH, 
i
Pr), 3.55 (m, 1H, CH-O), 3.64 (m, 1H, CH-O), 3.77 (m, 3H, CH2, CH-N), 6.8-6.9 (m, 





(100.6 MHz, C6D6): δ = 19.0 (CH3, 
i
Pr), 19.4 (CH3, 
i





Bu), 31.9 (CH3, 
t
Bu), 33.6 (CH, 
i
Pr), 35.0 (C, 
t
Bu), 36.0 (C, 
t
Bu), 70.5 (CH2-
O), 73.2 (CHN), 121.5-150.8 (aromatic carbons), 165.1 (C=N). MS HR-ESI [found 
680.3834, C41H56NO4P (M-Na)
+
 requires 680.3839]. 
L6b. Yield: 467.8 mg (69%); 
31
P NMR (161.9 MHz, C6D6): δ = 143.7 ppm (s). 
1
H 









JH-H = 6.8 Hz), 1.33 (m, 1H, CH, 
i
Pr), 3.34 (pt, 1H, CH-O, JH-H = 7.6 Hz), 3.4-3.6 (m, 4H, CH2, CH-O, CH-N), 6.7-6.83 
(m, 3H, CH=), 6.96-7.11 (m, 5H, CH=), 7.29 (m, 2H, CH=), 7.64 (d, 1H, CH=, 
3
JH-H = 
8.4 Hz), 7.68 (d, 1H, CH=, 
3





H} (100.6 MHz, C6D6): δ = 0.2 (d, CH3, SiMe3, JC-P = 4.8 Hz), 0.7 (CH3, SiMe3), 18.9 
(CH3, 
i
Pr), 19.3 (CH3, 
i
Pr), 29.3 (CH2), 33.4 (CH, 
i
Pr), 70.4 (CH2-O), 73.0 (CH-N), 
121.3-154.5 (aromatic carbons), 164.9 (C=N). MS HR-ESI [found 700.2435, 
C39H44NO4PSi2 (M-Na)
+
 requires 700.2439]. 
L6c. Yield: 508.4 mg (75%); 
31
P NMR (161.9 MHz, C6D6): δ = 143.3 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 0.33 (s, 9H, CH3, SiMe3), 0.55 (s, 9H, CH3, SiMe3), 0.66 








JH-H = 6.8 Hz), 1.41 (m, 1H, 
CH, 
i
Pr), 3.37 (pt, 1H, CH-O, JH-H = 8.4 Hz), 3.5 (m, 2H), 3.6-3.71 (m, 2H), 6.82 (m, 
2H, CH=), 6.90 (m, 2H, CH=), 7.00-7.15 (m, 3H, CH=), 7.34 (m, 3H, CH=), 7.68 (d, 
1H, CH=, 
3
JH-H = 7.6 Hz), 7.72 (d, 1H, CH=, 
3





H} (100.6 MHz, C6D6): δ = 0.21 (d, CH3, SiMe3, JC-P = 3.8 Hz), 0.7 
(CH3, SiMe3), 19.0 (CH3, 
i
Pr), 19.4 (CH3, 
i
Pr), 29.2 (CH2), 33.5 (CH, 
i
Pr), 70.4 (CH2-
O), 73.1 (CH-N), 121.4-153.1 (aromatic carbons), 164.9 (C=N). MS HR-ESI [found 
700.2437, C39H44NO4PSi2 (M-Na)
+
 requires 700.2439]. 
L6d. Yield: 261.5 mg (40%); 
31
P NMR (161.9 MHz, C6D6): δ = 134.4 ppm (s). 
1
H 




JH-H = 6.4 Hz), 0.96 (d, 3H, CH3, 







JH-H = 6.4 Hz), 1.44 (s, 9H, CH3, 
t
Bu), 1.60 (m, 1H, CH, 
i
Pr, 1.70 (s, 9H, CH3, 
t
Bu), 
1.31-1.8 (m, 10H, CH2), 2.27 (m, 2H, CH2), 2.56 (m, 4H, CH2), 2.78 (m, 2H, CH2), 3.58 
(m, 1H, CH-O), 3.75 (m, 3H, CH-O, CH2), 3.81 (m, 1H, CH-N), 6.9 (m, 1H, CH=), 7.1 




H} (100.6 MHz, C6D6): δ= 
18.4 (CH3, 
i
Pr), 18.7 (CH3, 
i
Pr), 22.8 (CH2), 23.0 (CH2), 23.1 (CH2), 23.2 (CH2), 27.4 
(CH2), 27.7 (CH2), 28.6 (CH2), 28.6 (CH2), 29.6 (CH2), 30.0 (d, CH3, 
t
Bu, JC-P= 4.7 Hz), 
31.5 (CH3, 
t
Bu), 33.0 (CH, 
i
Pr), 34.5 (C, 
t
Bu), 34.8 (C, 
t
Bu), 69.9 (CH2-O), 72.6 (CH-
N), 120.9-150.1 (aromatic carbons), 164.5 (C=N). MS HR-ESI [found 676.3524, 
C41H52NO4P (M-Na)
+
 requires 676.3526]. 
L6e. Yield: 409.2 mg (68%); 
31
P NMR (161.9 MHz, C6D6): δ = 133.9 ppm (s). 
1
H 








JH-H = 7.2 Hz), 1.39 (s, 9H, CH3, 
t
Bu), 1.43 (m, 1H, CH, 
i
Pr), 1.54 (s, 9H, CH3, 
t
Bu), 1.69 (CH3), 1.74 (CH3), 2.01 (CH3), 2.08 (CH3), 3.48 (m, 1H, CH-O), 3.60 (m, 
2H, CH-, CH-O), 3.70 (m, 2H, CH-, CH-N), 6.8-6.9 (m, 1H, CH=), 6.98 (m, 2H, CH=), 




H}  (100.6 MHz, C6D6): δ= 16.2 (CH3), 
16.5 (CH3), 18.3 (CH3, 
i
Pr), 18.6 (CH3, 
i
Pr), 20.0 (CH3), 20.1 (CH3), 28.4 (CH2), 31.6 
(d, CH3, 
t
Bu, JC-P= 4.6 Hz), 31.5 (CH3, 
t
Bu), 32.9 (CH, 
i
Pr), 34.5 (C, 
t
Bu), 34.8 (C, 
t
Bu), 
69.8 (CH2-O), 72.4 (CH-N), 120.7-150.0 (aromatic carbons), 164.4 (C=N). MS HR-ESI 
[found 624.3209, C37H48NO4P (M-Na)
+
 requires 624.3213]. 
L7a. Yield: 470.3 mg (70%); 
31
P NMR (161.9 MHz, C6D6): δ = 139.2 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 0.79 (s, 9H, CH3, 
t
Bu), 1.28 (s, 18H, CH3, 
t
Bu), 1.52 (s, 
9H, CH3, 
t
Bu), 1.53 (s, 9H, CH3, 
t
Bu), 3.63-3.75 (m, 5H, CH2, CH2-O, CH-N), 6.82-
6.91 (m, 2H, CH=), 7.0-7.15 (m, 1H, CH=), 7.36 (m, 2H, CH=), 7.39 (m, 1H, CH=), 




H} (100.6 MHz, C6D6): δ = 19.0 (CH3, 
i
Pr), 19.4 (CH3, 
i
Pr), 
28.7 (CH2), 31.6 (CH3, 
t
Bu), 31.7 (CH3, 
t
Bu), 31.9 (CH3, 
t
Bu), 33.9 (C, 
t
Bu), 35.0 (C, 
t
Bu), 36.0 (C, 
t
Bu), 68.8 (CH2-O), 76.6 (CH-N), 121.5-150.8 (aromatic carbons), 165.1 
(C=N). MS HR-ESI [found 694.3992, C42H58NO4P (M-Na)
+
 requires 694.3996]. 
L7b. Yield: 498.2 mg (72%); 
31
P NMR (161.9 MHz, C6D6): δ = 144.1 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 0.33 (s, 9H, CH3, SiMe3), 0.55 (s, 9H, CH3, SiMe3), 0.73 
(S, 9H, CH3, 
t
Bu), 3.45-3.65 (m, 5H, CH2, CH2-O, CH-N), 6.82 (m, 2H, CH=), 6.87 (m, 
2H, CH=), 7.00-7.15 (m, 4H, CH=), 7.35 (m, 2H, CH=), 7.68 (d, 1H, CH=, 
3
JH-H = 8.4 
Hz), 7.73 (d, 1H, CH=, 
3





(100.6 MHz, C6D6): δ = 0.2 (d, CH3, SiMe3, JC-P = 4.6 Hz), 0.7 (CH3, SiMe3), 26.3 
(CH3, 
t
Bu), 29.1 (CH2), 33.4 (C, 
t
Bu), 68.6 (CH2-O), 76.5 (CH-N), 121.1-153.1 




(aromatic carbons), 164.9 (C=N). MS HR-ESI [found 714.2591, C40H46NO4PSi2 (M-
Na)
+
 requires 714.2595]. 
L7c. Yield: 512.0 mg (74%); 
31
P NMR (161.9 MHz, C6D6): δ = 143.1 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 0.33 (s, 9H, CH3, SiMe3), 0.56 (s, 9H, CH3, SiMe3), 0.74 
(CH3, 
t
Bu), 3.50-3.71 (m, 5H, CH2, CH2-O, CH-N), 6.81 (m, 2H, CH=), 6.89 (m, 2H, 
CH=), 7.00-7.16 (m, 3H, CH=), 7.34 (d, 2H, CH=, 
4
JH-H = 2.2 Hz), 7.39 (m, 1H, CH=), 
7.68 (d, 1H, CH=, 
4
JH-H = 2.0 Hz), 7.72 (d, 1H, CH=, 
4
JH-H = 2.1 Hz), 8.07 (s, 1H, CH=), 




H}  (100.6 MHz, C6D6): δ = -0.5 (d, CH3, SiMe3, JC-P = 4.62 
Hz), 0.0 (CH3, SiMe3), 25.6 (CH3, 
t
Bu), 28.3 (CH2), 33.1 (C, 
t
Bu), 67.9 (CH2-O), 75.7 
(CH-N), 120.4-152.3 (aromatic carbons), 164.1 (C=N). MS HR-ESI [found 714.2592, 
C40H46NO4PSi2 (M-Na)
+
 requires 714.2595]. 
L8a: Yield: 261.5 mg (40%); 
31
P NMR (161.9 MHz, C6D6): δ = 137.0 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 1.22 (s, 9H, CH3, 
t
Bu), 1.24 (s, 9H, CH3, 
t
Bu), 1.42 (s, 9H, 
CH3, 
t
Bu), 1.45 (s, 9H, CH3, 
t
Bu), 1.78 (s, 3H, CH3), 1.80 (s, 3H, CH3), 3.71 (m, 1H, 
CH2-O), 3.98 (dd, 1H, CH2-O, 
2
JH-H = 10.0 Hz, 
3
JH-H = 7.6 Hz), 4.92 (dd, 1H, CH-N, 
3
JH-
H = 9.6 Hz, 
3
JH-H = 7.6 Hz), 6.83 (m, 1H, CH=), 6.90 (m, 1H, CH=), 7.01 (m, 2H, CH=), 
7.09 (m, 3H, CH=), 7.21 (s, 1H, CH=), 7.23 (s, 1H, CH=), 7.03 (d, 1H, 
3
JH-H = 2.0 Hz), 
7.35 (d, 1H, 
3




H} (100.6 MHz, C6D6): δ= 27.0 
(CH3), 27.9 (CH3), 30.9 (CH3, 
t
Bu), 31.2 (CH3, 
t
Bu), 34.3 (C, 
t





Bu), 39.7 (C, CMe2), 69.6 (CH-N), 74.5 (CH2-O), 120.6-150.3 (aromatic carbons), 
173.1 (C=N). MS HR-ESI [found 719.4098, C46H58NO4P (M-H)
+
 requires 720.4103]. 
L8b. Yield: 261.5 mg (40%); 
31
P NMR (161.9 MHz, C6D6): δ = 142.1 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 0.37 (s, 9H, CH3-Si), 0.41 (s, 9H, CH3-Si), 1.61 (s, 3H, 




JH-H = 10.0 Hz), 3.86 (dd, 1H, 
CH2-O, 
2
JH-H = 10.0 Hz, 
3
JH-H = 8.0 Hz), 4.60 (dd, 1H, CH-N, 
3
JH-H = 10.0 Hz, 
3
JH-H = 
8.0 Hz), 6.79 (m, 4H, CH=), 6.96 (m, 2H, CH=), 7.07 (m, 4H, CH=), 7.24 (m, 4H, 




H} (100.6 MHz, 
C6D6): δ= -0.2 (d, CH3-Si, JC-P=  4.5 Hz), 0.0 (CH3-Si), 27.0 (CH3), 27.9 (CH3), 40.0 (C, 
CMe2), 69.0 (CH-N), 74.1 (CH2-O), 119.6-152.4 (aromatic carbons), 172.8 (C=N). MS 
HR-ESI [found 739.2698, C44H56NO4PSi2 (M+H)
+
 requires 739.2703]. 
L8c. Yield: 261.5 mg (40%); 
31
P NMR (161.9 MHz, C6D6): δ = 142.3 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 0.38 (s, 9H, CH3-Si), 0.40 (s, 9H, CH3-Si), 1.62 (s, 3H, 
CH3), 1.76 (s, 3H, CH3), 3.48 (m, 1H, CH2-O), 3.68 (dd, 1H, CH2-O, 
2
JH-H = 10.4 Hz, 
3
JH-H = 8.0 Hz), 4.25 (dd, 1H, CH-N, 
3
JH-H = 10.0 Hz, 
3
JH-H = 8.0 Hz), 6.80 (m, 5H, 




CH=), 6.88 (m, 1H, CH=), 6.9-7.1 (m, 5H, CH=), 7.23 (m, 4H, CH=), 7.63 (m, 1H, 




H} (100.6 MHz, 
C6D6): δ= -0.2 (d, CH3-Si, JC-P=  4.5 Hz), 0.0 (CH3-Si), 26.8 (CH3), 28.4 (CH3), 39.7 (C, 
CMe2), 69.0 (CH-N), 74.4 (CH2-O), 119.9-152.3 (aromatic carbons), 172.5 (C=N). MS 
HR-ESI [found 739.2699, C44H56NO4PSi2 (M+H)
+
 requires 739.2703]. 
L9a. Yield: 432.1 mg (62%); 
31
P NMR (161.9 MHz, C6D6): δ = 139.1 ppm (s). 
1
H 
NMR (400 MHz, C6D6): δ = 1.27 (s, 9H, CH3, 
t
Bu), 1.28 (s, 9H, CH3, 
t
Bu), 1.51 (s, 9H, 
CH3, 
t
Bu), 1.52 (s, 9H, CH3, 
t
Bu), 3.6 (pt, 1H, CH-O, JH-H= 8.4 Hz), 3.8 (s, 2H, CH2), 
4.73 (dd, 1H, CH-O, 
2
JH-H = 10.0 Hz, 
3
JH-H = 8.0 Hz), 4.9 (m, 1H, CH-N), 6.8-7.15 (m, 




H} (1006. MHz, C6D6): δ = 
28.7 (CH2), 30.9 (CH3, 
t
Bu), 31.2 (CH3, 
t
Bu), 34.3 (C, 
t
Bu), 35.3 (C, 
t
Bu), 69.6 (CH-N), 
74.1 (CH2-O), 120.8-150.2 (aromatic carbons), 166.0 (C=N). MS HR-ESI [found 
714.3677, C44H54NO4P (M-Na)
+
 requires 714.3683]. 
 
7.1.5.3. Synthesis of (S)-2-(2-(4-phenyl-4,5-dihydrooxazol-2-yl)propan-2-
yl)phenol (161) 
MeOH (7.21 ml, 0.29 mmol) was added to a solution of NaH (60% in mineral oil, 
244.16 mg, 6.10 mmol) in THF (5.1 ml) at 0°C under argon and string for 1 h. The 
solution of 3,3-dimethylbenzofuran-2(3H)-one 160 (700 mg, 5.55 mmol) in THF (5.1 
ml) was added at 0 °C. The resultant mixture was warmed to room temperature during 1 
h. A solution of (S)-(+)-2-phenylglycinol (837.34 mg, 6.10 mmol) in THF (5.1 ml) was 
added dropwise. The mixture was stirred for 2 h. The mixture was suspended in CH2Cl2 
(30 mL) and washed with NaOH solution (2 × 50 mL), then with 2 M HCl solution to 
reach to pH = 2. After drying over MgSO4, solvent was evaporated to obtain 
intermediate (S)-N-(2-hydroxy-1-phenylethyl)-2-(2-hydroxyphenyl)-2-methylpropana-
mide as a white solid. Yield: 1.17 g (75%). 
1
H NMR (400 MHz, C6D6): δ = 1.59 (s, 3H, 
CH3), 1.63 (s, 3H, CH3), 3.72 (dd, 1H, CH2-O, 
2
JH-H = 11.4 Hz, 
3
JH-H = 7.2 Hz), 3.90 
(dd, 1H, CH2-O, 
2
JH-H = 11.4 Hz, 
3
JH-H = 4.0 Hz), 5.11 (m, 1H, CH), 6.12 (d, 1H, NH,
 
3





(100.6 MHz, C6D6): δ= 25.2 (CH3), 25.9 (CH3), 45.3 (C, CMe2), 55.6 (CH-N), 66.05 
(CH2-O), 117-155 (aromatic carbons). 
To a cold (0 °C) solution of (S)-N-(2-hydroxy-1-phenylethyl)-2-(2-hydroxyphenyl)-
2-methylpropanamide (1.25 g, 4.18 mmol) in CH2Cl2 (10 mL) was sequentially added 
triethylamine (2.91 mL, 20.88 mmol), DMAP (76 mg, 0.63 mmol) and methanesulfonyl 




chloride (0.36 mL, 4.59 mmol). The resultant mixture was warmed to room temperature 
and stirred overnight. The excess methanesulfonyl chloride was hydrolyzed by adding 
water (10 mL) and heating to reflux for 30 min. Another portion of water (25 mL) was 
added, and the mixture was extracted with CH2Cl2 (3 × 25 mL). The combined organic 
phases were washed with saturated NaCl solution and dried over Na2SO4. After 
filtration and removal of the solvent under vacuum, the product was purified by flash 
chromatography, 5 % methanol in dichloromethane. Yield: 705 mg (60%). 
1
H NMR 
(400 MHz, C6D6): δ = 1.69 (b, 6H, CH3), 4.08 (b, 1H, CH2), 4.63 (b, 1H, CH), 4.5.17 (b, 
1H, CH2), 6.8-7.4 (m, 9H, CH=). MS HR-ESI [found 281.1416, C18H19NO2 requires 
281.1417]. 
 
7.1.5.4. Synthesis of [PdPhI(L6a)] 
A solution of [PhPdI(TMEDA)] (25 mg, 0.058 mmol) and the ligand L6a (38 mg, 
0.058 mmol) in dry degassed benzene (3 ml) was stirred under Ar atmosphere at r.t. for 




H} NMR during this time. The organic 
solvent was removed under reduced pressure. Purification by column chromatography 
(neutral Al2O3; toluene/CH2Cl2 gradient 1:0 to 0:1) yielded the desired product as pale-
yellow solid (37 mg, 66 %). 
31
P NMR (162 MHz, C6D6): δ = 139.23.
 1
H NMR (400 
MHz, C6D6): δ = 7.56 (d, 2H, J  = 2.3 Hz, CH=), 7.46 (d, 1H, J = 2.3 Hz, CH=), 7.13 (d, 
1H, 
3
JH-H = 7.5 Hz, CH=), 7.02 (d, 1H, 
3
JH-H = 6.9 Hz, CH=), 6.85-6.80 (m, 4H, CH=), 
6.77 – 6.68 (m, 2H, CH=), 6.63 – 6.54 (m, 2H, CH=), 5.94 (d, 1H, 
3
JH-H = 7.3 Hz, 
CH˗N), 4.67 (d, 1H, 
2
JH-H = 14.5 Hz, CH2), 3.72 – 3.60 (m, 2H, CH˗O), 3.10 (d, 1H, 
2
JH-
H = 14.6 Hz, CH2), 2.94 (m, 1H, CH, 
i
Pr), 1.58 (s, 18 H, CH3, 
t
Bu), 1.19 (s, 9 H, CH3, 
t
Bu), 1.13 (s, 9 H, CH3, 
t
Bu), 0.97 (d, 3H, 
3
JH-H = 6.8 Hz, CH3, 
i
Pr), 0.87 (d, 3H, 
3
JH-H = 






H} NMR (100 MHz, C6D6): δ = 166.3 (C=N), 138.7-124-7 





Bu), 31.4 (CH3, 
t
Bu), 31.3 (CH3, 
t
Bu), 31.0 (C, 
i
Pr), 19.3 (CH3, 
i
Pr), 16.2 (CH3, 
i
Pr). MS HR-ESI [found 840.3369, C47H61NO4PPd (M-I)
+
 requires 840.3373]. 
 
7.1.5.5. Synthesis of [PdPhOTf(L6a)]  
Silver triflate (16 mg, 0.062 mmol) was added to a vigorously stirred solution of the 
complex [PdPhI(L6a)] (30 mg, 0.031 mmol) in dry degassed THF (4 ml) under Ar 
atmosphere at room temperature. Stirring was continued for 1h, during which period a 
pale grey precipitate was formed. The reaction mixture then filtered over celite, and all 




volatiles were removed under reduced pressure to yield the final product as a pale 
brown solid (55 mg, 90 %). 
31
P NMR (162 MHz, CD2Cl2): δ = 96.99. 
1
H NMR (401 
MHz, CD2Cl2): δ = 7.59 (d, 1H, 
3
JH-H = 2.3 Hz, CH=), 7.47 (d, 1H, 
3
JH-H = 2.1 Hz, 
CH=), 7.34 – 7.27 (m, 3H, CH=), 7.09 (t, 1H, 
3
JH-H = 7.5 Hz, CH=), 7.01 (dd, 1H,  
3
JH-H 
= 7.9, 1.3 Hz, CH=), 6.99 – 6.88 (m, 6H, CH=), 5.84 (d, 1H,
 3
JH-H = 8.1 Hz, CH˗N), 
4.57 (d, 1H,  
2
JH-H = 14.6 Hz, CH2), 4.48 (d, 1H,  
3
JH-H = 8.3 Hz, CH˗O), 4.32 – 4.27 (m, 
1H, CH˗O), 3.71 (d, 1H, 
2
JH-H = 14.5 Hz, CH2), 2.52 (m, 1H, CH, 
i
Pr), 1.60 (s, 9H, CH3, 
t
Bu), 1.54 (s, 9H, CH3, 
t
Bu), 1.34 (s, 9H, CH3, 
t
Bu), 1.30 (s, 9H, CH3, 
t












H}  NMR (101 MHz, 
CD2Cl2): δ = 169.2 (C=N), 151.7˗121.9 (aromatic carbones), 121.3 (CH˗N), 70.9 
(CH˗O), 34.5 (CH2), 31.9 (CH3, 
t
Bu), 31.6 (CH3, 
t
Bu), 31.4 (CH3, 
t





Pr), 19.1 (CH3, 
i




F NMR (377 MHz, CD2Cl2): δ = -78.01. 
MS HR-ESI [found 840.3376, C47H61NO4PPd (M-OTf)
+
 requires 840.3373]. 
 
7.1.5.6. General procedure for Pd-catalyzed enantioselective Heck 
reactions with several triflates 
A mixture of [Pd2(dba)3]·C6H6 (12 mg, 1.25 × 10
-2
 mmol) and the corresponding 
chiral ligand (2.3 equiv) in dry degassed solvent (3.0 mL) was stirred at room 
temperature for 20 min. The corresponding olefin (2.0 mmol), triflate (0.50 mmol) and 
N-diisopropylethylamine (1.0 mmol) were added to the catalyst solution. The vial was 
sealed and brought out and the solution was vigorously stirred at the desired 
temperature. After the desired reaction time, the reaction mixture was cooled to ambient 
temperature and internal standard (undecane, 0.5 mmol) was added. The mixture was 
diluted with additional diethyl ether and after agitation, the mixture was filtered through 
a short silica gel plug and analyzed by 
1
H-NMR or GC to determine the conversion and 
regioselectivity. The crude was subjected to flash chromatography (pentane/Et2O) to 
give the purified product. Enantioselectivities were determined using chiral HPLC or 
GC (see supporting information for details). 
 
7.1.5.7. Pd- catalyzed enantioselective Heck reactions of 2,3-dihydrofuran 
with aryl halides 
[Pd(dba)2]·C6H6 (8.5 mg, 0.013 mmol) and ligand (0.015 mmol) in degassed 
ethylene glycol (1.0 mL) were stirred at room temperature for 20 min. Aryl halide (0.50 




mmol), N-diisopropylethylamine (255 μL, 1.5 mmol, 3 equiv), silver triflate (192.7 mg, 
0.75 mmol, 1.5 equiv) and 2,3-dihydrofuran (75 μL, 1.0 mmol, 2 equiv) were added to 
the catalyst solution. The vial was sealed and brought out and the mixture was 
vigorously stirred in an oil bath at 80 °C, for 24h. The reaction mixture was cooled to 
ambient temperature and internal standard (undecane, 0.5 mmol) was added. The 
mixture was diluted with additional diethyl ether and after agitation, the mixture was 
filtered through a short silica gel plug and analyzed by 
1
H-NMR or GC to determine the 
conversion and regioselectivity. The crude was subjected to flash chromatography 
(pentane/Et2O) to give the purified product. Enantioselectivities were determined using 
chiral HPLC or GC (see supporting information for details).  
 
7.1.6. Supporting information 
 



























L5a 100 (97) 65 (R) 83 (98) 67 (R) 89 (99) 71 (R) 100 (95) 68 (R) 
L6a 100 (97)
 
89 (R) 88 (99)
 
94 (R) 92 (98)
 
97 (R) 100 (95)
 
94 (R) 
L6b 57 (61) 49 (S) 39 (61) 38 (S) 40 (63) 51 (S) 67 (72) 37 (S) 
L6c 99 (96) 79 (R) 85 (98) 84 (R) 91 (98) 91(R) 100 (96) 82(R) 
L6d 94 (97)
 
91 (R) 89 (99)
 
97 (R) 89 (99)
 
98 (R) 100 (96)
 
95 (R) 
L7a 34 (41) 85 (R) 16 (43) 79 (R) 31 (44) 76 (R) 49 (53) 76 (R) 
(a) [Pd2(dba)3].benzene (1.25×10
-2 mmol), S51 (2.0 mmol), phenyl triflate (0.5 mmol), ligand (2.8×10-2 
mmol), THF (3 ml), iPr2NEt (1 mmol), T = 50 °C, t = 24 h. 
(b) Conversion percentages determined by 1H-
NMR or GC. (c) Enantiomeric excesses measured by GC or HPLC. 
  




7.1.6.2. Table SI.2. Asymmetric Pd-catalyzed Heck reaction of substrates S52-S54 
with PhOTf. 
 
   
L %Conv 162a %ee %Conv (%163a) %ee %Conv (%165a) %ee 
L5a 87 72 (R) 94 (97) 76 (R) 99 (95) 74 (R) 
L6a 90
 91 (R) 91 (96) 91 (R) 97 (95) 89 (R) 
L6b 56 38 (S) 42 (94) 42 (S) 51 (93) 38 (S) 
L6c 93 86 (R) 86 (97) 84 (R) 99 (95) 90 (R) 
L6d 91
 93 (R) 92 (98) 94 (R) 97 (96) 91 (R) 
L7a 28 79 (R) 31 (64) 73 (R) 56 (61) 81 (R) 
(a) [Pd2(dba)3].benzene (1.25×10
-2 mmol), substrate (2.0 mmol), phenyl triflate (0.5 mmol), ligand (2.8×10-2 
mmol), THF (3 ml), iPr2NEt (1 mmol), T = 65 °C (for S52 and S53) or 50 °C (for S54), t = 72 h (for S52 and 
S53) or 48 h (for S54). (b) Conversion percentages determined by 1H-NMR or GC. (c)  Enantiomeric excesses 
measured by GC or HPLC. 
 
7.1.6.3. Characterization details and methods for ee determination of Heck 
products 
2-Phenyl-2,5-dihydrofuran (1a). Enantiomeric excess determined by GC using 
Chiralsil-Dex CB column (105 kPa H2, 90 °C for 30 min, 10 °C/min, to 
180 °C). tR 17.4 min (S); tR 18.3 min (R).
1
H NMR (CDCl3): δ = 4.76 
(m, 1H), 4.87 (m, 1H), 5.79 (m, 1H), 5.88 (m, 1H), 6.03 (m, 1H), 7.2-
7.4 (m, 5H). 
2-(4-Methoxyphenyl)-2,5-dihydrofuran (1b). Enantiomeric excess determined by 
HPLC using Chiracel OD-H column (hexane/2-propanol=98/2, 
0.5 mL/min, 254 nm). tR 18.5 min (S); tR 20.8 min (R). 
1
H NMR 
(CDCl3): δ = 3.80 (s, 3H), 4.69 (m, 1H), 4.84 (m, 1H), 5.75 (m, 
1H): 5.87 (m, 1H), 6.04 (m, 1H), 6.88 (m, 2H), 7.23 (m, 2H). 
2-(4-Tolyl)-2,5-dihydrofuran (1c).
25
 Enantiomeric excess determined by HPLC using 
Chiracel IC-H column (hexane/2-propanol=98/2, 0.5 mL/min, 254 
nm). tR 21.1 min (S); tR 22.2 min (R). 
1
H NMR (CDCl3): δ = 2.33 (s, 
3H), 4.76 (m, 1H), 4.86 (m, 1H), 5.76 (m, 1H), 5.87 (m, 1H), 6.03 
(m, 1H), 7.15 (d, 2H, J= 8 Hz), 7.19 (d, 2H, J= 8 Hz). 
  




2-(4-Nitrophenyl)-2,5-dihydrofuran (1d). Enantiomeric excess determined by HPLC 
using Chiracel OJ-H column (hexane/2-propanol=87/13, 0.7 
mL/min, 220 nm). tR 11.4 min (R); tR 12.6 min (S). 
1
H NMR 
(CDCl3): δ = 4.74 (m, 1H), 4.82 (m, 1H), 5.46 (m, 2H), 5.61 (m, 
1H), 7.59 (d, 2H, J= 7.2 Hz), 7.79 (d, 2H, J= 7.2 Hz). 
2-(Naphthalen-2-yl)-2,5-dihydrofuran (1e). Enantiomeric excess determined by 
HPLC using Chiracel OD-H column (hexane/2-propanol=98/2, 0.5 
mL/min, 210 nm). tR 20.4 min (S); tR 24.3 min (R). 
1
H NMR 
(CDCl3): δ = 4.83 (m, 1H), 4.96 (m, 1H), 5.94 (m, 2H), 6.07 (m, 
1H), 7.41 (d, 1H, J= 8.4 Hz), 7.46 (m, 2H), 7.76 (s, 1H), 7.82 (m, 3H). 
2-(Naphthalen-1-yl)-2,5-dihydrofuran (1f). Enantiomeric excess determined by 
HPLC using Chiracel OD-H column (hexane/2-propanol=98/2, 0.5 
mL/min, 210 nm). tR 29.4 min (R); tR 34.9 min (S). 
1
H NMR (CDCl3): 
δ = 4.87 (m, 2H), 6.05 (m, 1H), 6.55 (m, 1H), 7.46 (m, 4H), 7.76 (d, 
1H, J= 8.0 Hz), 7.84 (m, 1H), 8.11 (d, 1H, J= 8.0 Hz). 
2-(2-Methoxyphenyl)-2,5-dihydrofuran (1g). Enantiomeric excess determined by 
HPLC using Chiracel OJ-H column (hexane/2-propanol=98/2, 0.5 
mL/min, 254 nm). tR 16.8 min (S); tR 18.5 min (R). 
1
H NMR (CDCl3): 
δ = 3.85 (s, 3H), 4.77 (m, 1H), 4.87 (m, 1H), 5.96 (m, 2H), 6.13 (m, 
1H), 6.87 (d, 1H, J= 8.0 Hz), 6.95 (t, 1H, J= 7.6 Hz), 7.23 (m, 1H), 7.34 (d, 1H, J= 7.6 
Hz). 
2-(Cyclohex-1-en-1-yl)-2,5-dihydrofuran (1h). Enantiomeric excess determined by 
GC using Chiralsil-Dex CB column (115 kPa H2, 80 °C for 40 min, 10 
°C/min, to 180 °C). tR 27.5 min (R); tR 29.6 min (S). 
1
H NMR (CDCl3): 
δ = 1.4-1.7 (m, 4H), 1.8-2.1 (m, 4H), 4.63 (m, 1H), 4.69 (m, 1H), 5.12 
(m, 1H), 5.69 (m, 2H), 5.94 (m, 1H). 
5-Phenyl-4,5-dihydro-1,3-dioxepine (16a). Enantiomeric excess determined by HPLC 
using Chiracel OD-H column (hexane/2-propanol=99/1, 0.5 mL/min, 
210 nm). tR 12.1 min (R); tR 14.4 min (S). 
1
H NMR (CDCl3): δ = 3.46 
(dd, 1H, J= 11.2 Hz, J= 8.4 Hz), 3.81 (m, 1H), 3.98 (dd, 1H, J= 12.0 
Hz, J= 4.4 Hz), 4.85 (d, 1H, J= 7.2 Hz), 4.95 (m, 1H), 5.20 (d, 1H, J= 6.8 Hz), 6.48 
(dd, 1H, J= 7.2 Hz, J= 2.0 Hz), 7.2-7.4 (m, 5H). 
  




5-(4-Tolyl)-4,5-dihydro-1,3-dioxepine (16b). Enantiomeric excess determined by 
HPLC using Chiracel OD-H column (hexane/2-propanol=98/2, 0.5 
mL/min, 210 nm). tR 10.2 min (R); tR 13.5 min (S). 
1
H NMR 
(CDCl3): δ = 2.33 (s, 3H), 3.42 (dd, 1H, J= 11.6 Hz, J=8.8 Hz), 
3.77 (m, 1H), 3.96 (dd, 1H, J= 11.6 Hz, J= 4.4 Hz), 4.83 (m, 1H), 4.91 (dd, 1H, J== 
7.4 Hz, J= 3.6 Hz), 5.20 (d, 1H, J= 7.2 Hz), 6.46 (dd, 1H, J= 7.4 Hz, J= 2.4 Hz), 7.1-
7.2 (m, 4H) 
tert-Butyl 2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxylate (17a). Enantiomeric 
excess determined by HPLC using Chiracel IC column (hexane/2-
propanol=95/5, 0.5 mL/min, 210 nm). tR 18.3 min (R); tR 19.9 min (S). 
1
H NMR (CDCl3): δ = 1.21 (s, 9H), 4.33 (s, 2H), 5.37 (s, 1H), 5.73 (s, 
1H), 5.84 (s, 1H), 7.1-7.3 (m, 5H). 
tert-Butyl 2-(4-tolyl)-2,5-dihydro-1H-pyrrole-1-carboxylate (17b). Enantiomeric 
excess determined by HPLC using Chiracel OJ-H column (hexane/2-
propanol=99/1, 0.5 mL/min, 210 nm). tR 13.3 min (S); tR 16.4 min (R). 
1
H NMR (CDCl3): δ = 1.32 (s, 9H), 2.32 (s, 3H), 4.28 (m, 2H), 5.41 
(s, 1H), 5.71 (m, 1H), 5.85 (m, 1H), 7.0-7.2 (m, 4H). 
Cyclopent-2-en-1-ylbenzene (19a). Enantiomeric excess determined by HPLC using 
Chiracel OJ-H column (hexane/2-propanol=98/2, 0.5 mL/min, 210 
nm). tR 9.4 min (S); tR 9.8 min (R). 
1
H NMR (CDCl3): δ = 1.73 (m, 1H), 
2.3-2.6 (m, 3H), 3.99 (m, 1H), 5.78 (m, 1H), 5.94 (m, 1H), 7.18 (m, 
3H), 7.28 (m, 2H). 
1-(Cyclopent-2-en-1-yl)-4-methylbenzene (19b). Enantiomeric excess determined by 
HPLC using Chiracel OJ-H column (hexane/2-propanol=98/2, 0.5 
mL/min, 210 nm). tR 10.2 min (S); tR 11.1 min (R). 
1
H NMR 
(CDCl3): δ = 1.70 (m, 1H), 2.31 (s, 3H), 2.39 (m, 2H), 3.85 (m, 1H), 
5.76 (m, 1H), 5.91 (m, 1H), 7.0-7.2 (m, 4H). 
2-(Cyclopent-2-en-1-yl)naphthalene (19c). Enantiomeric excess determined by HPLC 
using Chiracel OJ-H column (hexane/2-propanol=98/2, 0.5 
mL/min, 210 nm). tR 15.0 min (R); tR 16.6 min (S). 
1
H NMR 
(CDCl3): δ = 1.80 (m, 1H), 2.4-2.6 (m, 3H), 4.05 (m, 1H), 5.84 (m, 
1H), 5.99 (m, 1H), 7.31 (d, 1H, J= 8.4 Hz), 7.39 (m, 2H), 7.59 (s, 1H), 7.77 (m, 3H). 
  




1-(Cyclopent-2-en-1-yl)naphthalene (19d). Enantiomeric excess determined by 
HPLC using Chiracel OJ-H column (hexane/2-propanol=98/2, 0.5 
mL/min, 210 nm). tR 11.7 min (S); tR 12.6 min (R). 
1
H NMR (CDCl3): 
δ = 1.78 (m, 1H), 2.49 (m, 2H), 2.62 (m, 1H), 4.65 (m, 1H), 5.95 (m, 
1H), 6.04 (m, 1H), 7.30 (d, 1H, J= 7.2 Hz), 7.39 (m, 1H), 7.49 (m, 2H), 7.69 (d, 1H, J= 
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1. Progres in perfluoroalkylation of aromatic compounds. The conclusions of this 
chapter can be summarized as follows: 
 
- For the first time, the sucessful production of CuCF3 reagent in continuous flow 
process in four different set up configurations have been carried out. Based on the 
reagent sensitivity and important parameters which should be taken in account for 
preparation of the reagent several modifications were done in order to reach to the high 
yield comparable to the nonindustrial batch setting. The reagent efficiency was also 
examined in the trifluoromethylation of different aromatic halides. The results therefore 
demostrated the high efficiency of the CuCF3 reagent in continuous flow regime. 
- We have sucessfully  trifluoromethylated and pentafluoroethylated a broad range of 
vinylic bromides and iodides (44 examples with different electron donating and 
withdrawing groups) with RfH-derived CuCF3 and CuC2F5 to give the corresponding 
fluroalkylated olefins. These reactions proceed with high yields and excellent chemo- 
and stereoselectivity under mild reaction conditions. Twelve examples of 
trifluoromethylated and pentafluoroethylated products were isolated in 1-10 mmol 
scale. The X-ray structure of two perfluoroalkylated compounds are also presented to 
confirm the structure and stereochemistry in the solid state. 
 
2. Ru- and Ir-catalyzed transfer hydrogenation and dehydrogenation reactions. The 
conclusions of this chapter can be summarized as follows: 
- A series of O-functionalised 1,2,3-triazolyldiene iridium(III) and ruthenium(II) 
complexes were sucessfully synthesized and applied in transfer hydrogenation of 
benzophenone. Ether- and hydroxy-substituted 1,2,3-triazolylidene iridium(III) 
complexes were isolated with the ligand both in mono- and bidentate coordination 
mode. Also, monodentated and C,O-bidentated, hydroxy-functionalised 1,2,3-
triazolylidene ruthenium complexes are described. The monodentated complexes were 
converted to the chelating species by chloride abstraction and vice versa, the chelates 
were transformed into monodentate ligands in the presence of excess of halide. Transfer 
hydrogenation studies revealed that pendant hydroxy-donors substantially enhance the 





functionalised triazolylidene ruthenium(II) complexes did not outperform analogous 
unfunctionalised complexes. Generally, activity was much higher for the ruthenium(II) 
complexes than the iridium(III) homologues, which hints towards diverging activation 
mechanisms. 
- For the first time mixed benzoxazole/thiazole-MIC ligands were synthesized by 
efficient click reactions. For comparison purposes we also synthesized the ether-
functionalized 1,2,3-triazolylidene analoguous. We used these ligands to generate the 
corresponding Ir(I) and Ir(III) benzoxazole/thiazole/ether-appended MIC complexes. 
The coordination was sucessfully achieved by a transmetallation protocol and the 




C NMR spectroscopy, 
high resolution mass spectrometry, elementary analysis and X-ray diffraction. We also 
sucessfully applied these complexes in transfer hydrogenation of a broad range of 
ketones, including the most challenging heteroaromatic ones, aldehydes and imines in 
high activities (TOF’s up to 2090 mol x (mol x h)
-1
). The best results were obtained 
with the Ir(I) containing an ether-appended MIC catalyst precursor. Although there are 
some metal-carbene species, mainly Ru-NHC complexes, able to promote these 
transformations more efficiently, our results compete favorably with known Ir-MIC 
catalytic systems. We also obtain high activity in the reduction of a broad range of 
olefins. The catalytic performance is relatively insensitive to the olefins substitution 
pattern and to the geometry of the double bond. Similar high activities were therefore 
achieved for a range of linear mono-, 1,2-di- and 1,1-disubstituted olefins as well as for 
cyclic olefins (TOF’s up to 260 mol x (mol x h)-1). Ir(I) ether-triazolylidene catalyst 
precursor is also one of the rare examples of catalyst able to efficiently reduce a broad a 
range of olefins. Finally, high activities could also be obtained in the reduction of α,β-
unsaturated ketones and allylic alcohols. Mechanistic investigations indicated that the 
transfer hydrogenation of ketones proceeds via an iridium-monohydride species, being 
the rate determining step the C=O insertion on the M-H bond. 
- We also succesfully aplied these iridium complexes to the base-free Ir-catalyzed 
dehydrogenation reactions with 12 different primary and secondary alcohols. In this 
case and in contrast to the TH, Ir(III) complexes specially complexes showed better 
results rather than Ir(I) conterparts. The mechanistic studies by KIE and Hammet plots 
seems to indicate that the substrate coordination to the metal center is the rate 
determining step. 
 




3. Iridium molecular catalysts for catalytic water oxidation. The conclusions of this 
chapter can be summarized as follows: 
- Benzoxazole/thiazole-triazolylidene iridium (III) complexes synthesized in 
previous chapter were sucessfully applied in the water oxidation reactions using CAN 
and NaIO4 as oxidants. Using CAN as oxidant at low pH, the catalyst precursors 
provided similar activities (TOF’s ca 0.06 s
-1
) and lower than those achieved using 
parent pyridine complex. However, excellent activities (much better than related 
pyridine analogues; TOF’s up to 0.58 s
-1
) were achieved when using more appealing 
almost neutral conditions (pH = 5.6) and NaIO4 as oxidant.  
- In this chapter we have also disclosed the electrochemical properties of the 
complexes in a non-protic solvent as well as in aqueous solution at different pHs. We 
have also studied the Cl
-
/H2O ligand exchange propensity of the complexes in water 
solution. The results indicated that the chloro anion can be exchanged by water. In this 
respect both dicationic mono- and diaquo complexes have been synthesized. 
 
4. Pd-catalyzed asymmetric intermolecular Heck reaction. The conclusions of this 
chapter can be summarized as follows: 
- A reduced but structurally valuable library of phosphite-oxazoline ligands have 
been sucessfully synthetized and applied in the enantioselective Pd-catalyzed 
intermolecular Heck reaction. These ligands, which are prepared in a few steps from 
commercially available materials, include the benefits of the high robustness of the 
phosphite moiety and the additional control provided by the flexibility of the chiral 
pocket through a modular ligand scaffold. Other advantages of these ligands are that 
they are solid, stable to air and other oxidizing agents and are, therefore, easy to handle 
and can be manipulated and stored in air. In a simple two or four step-procedure several 
ligand parameters could easily be tuned to maximize the catalyst performance. We have 
therefore investigated the effect of systematically changing the oxazoline substitents 
and its configuration, the substituents in the benzylic position and the substituents and 
configurations of the biaryl phosphite moiety. By carefully selecting the ligand 
parameters we could obtained high activities, regio- and enantioselectivities in both 
enantiomers of the Heck products using several cyclic substrates and a broad range of 
triflates. The results are comparable to the best one reported in the literature. Another 





our case the ligands that provided the best enantioselectivities contained the 
i
Pr 
substituent in the oxazoline moiety instead of the pricy 
t
Bu substituent. 
- In this paper we have also carried out mechanistic investigations by combining 
kinetics studies and Hammet plots. The results suggest that the alkene insertion is the 
rate determining step. The mecahistic results also indicates that althought 
dibenzylideneacetone (dba) doesn’t play any role in the catalysis it is necessary to 















































It is widely accepted that sustainable industrial production and the generation of 
clean energy must be two of the pillars of our society. Huge amounts of resources for 
research and technological development in this direction have been dedicated. Catalysis 
is one of the driving force of these advances. Catalyzed chemical processes allow to 
increase production, reduce the number of reaction steps, work under more favorable 
energy conditions and generate less byproducts than the uncatalyzed processes. The 
improvement of the catalyst stability and selectivity is a fundamental and strategic 
research for achieving sustainable industrial production and clean energy generation. In 
this respect, this thesis focused on improving the current state-of-the-art by the design, 
synthesis and screening of new molecular catalysts very active and selective for 
catalytic reactions of industrial interest and for water oxidation. The main innovations 
can been divided in two parts: 
The first part of the thesis (done in the ICIQ, 2012-15) is about perfluoroalkylation 
of aromatic substrates. Perfluoroalkylated organic compounds have an outstanding 
place in pharmaceuticals and agrochemicals. There are some famous drugs containing 
CF3 and C2F5 groups and also compounds including C2F5 group are more biologically 
active. Therefore, the development of new suitable protocols for their synthesis are an 
important field of research. After the introduction (Chapter 2), Chapter 3 is focused in 
perfluoroalkylation of organic compounds. This part is divided in two sections. Section 
3.1 presents the first continuous flow process for the synthesis of a superior 
trifluoromethylating reagent, "ligandless" CuCF3, from fluoroform, by far the best CF3 
source in terms of availability, cost and atom economy. In section 3.2, the target was the 
trifluoromethylation and pentafluoroethylation of a variety of vinylic bromides and 
iodides (44 examples with several electron donating and withdrawing groups) with RfH-
derived CuRf (Rf = CF3, C2F5) to give the corresponding fluroalkylated olefins. These 
reactions proceed with high yields and excellent chemo- and stereoselectivity under 
mild reaction conditions. 
The second part of the thesis (done in the URV, 2015-17) is about the preparation of 
tailor-made catalysts for C-X forming (transfer hydrogenation, dehydrogenation, and 
intermolecular Heck reactions) and water oxidation reactions. This part of the thesis is 





importance of the design and preparation of ligands in the synthesis of organic 
compounds and then a detailed review of the four reaction studied are contemplated. 
Chapter 5 contains two sections on the development of new Ru- and Ir-complexes with 
mesionic carbene-based ligands. The first section 5.1 includes the synthesis and 
characterization of iridium(III) and ruthenium(II) complexes bearing pendant hydroxy- 
and ester-wingtip substituents. Both monodentated and C,O-bidentated binding modes 
were observed for these O-functionalised triazolylidene complexes. The catalytic 
activity of the complexes was compared in transfer hydrogenation, revealing that 
pendant hydroxyfunctionalities are beneficial for enhancing the performance of 
triazolylidene iridium(III) catalysts, while they have no effect in ruthenium-catalyzed 
transfer hydrogenation. The second section 5.2 reports the first examples of mixed 
benzoxazole/thiazole-MIC ligands. We used these ligands to generate the corresponding 
Ir(I) and Ir(III) benzoxazole/thiazole/ether-appended MIC complexes. The coordination 
was achieved by a transmetallation protocol and the corresponding complexes were 
fully characterized. Apart from synthetic and structural aspects, we also present the 
successful application of these complexes in transfer hydrogenation of a broad range of 
substrates (ketones, aldehydes, imines, etc.) and also the more challenging mono-, di- 
and trisubstituted olefins and in the base-free dehydrogenation reactions of alcohols. We 
also discuss some mechanistic insights for both transformations.  
Then, Chapter 6 focuses on the application of previous benzoxazole/thiazole-
triazolidene iridium complexes on water oxidation using CAN and NaIO4 as oxidants. 
Using CAN as oxidant at low pH, the catalyst precursors provided similar activities 
(TOF’s ca 0.06 s
-1
) and lower than those achieved using parent pyridine complex. 
However, excellent activities (much better than related pyridine analogues; TOF’s up to 
0.58 s
-1
) were achieved when using more appealing almost neutral conditions (pH = 5.6) 
and NaIO4 as oxidant. In this chapter we have also disclosed the electrochemical 
properties of the complexes in a non-protic solvent as well as in aqueous solution at 
different pHs. We have also studied the Cl
-
/H2O ligand exchange propensity of the 
complexes in water solution.  
Finally, Chapter 7 includes the synthesis of a reduced but structurally valuable library of 
phosphite-oxazoline ligands for the enantioselective Pd-catalyzed Heck reaction of 
several cyclic substrates and triflates. These ligands, which are prepared in a few steps 
from commercially available materials include the benefits of the high robustness of the 
phosphite moiety and the additional control provided by the flexibility of the chiral 




pocket through a modular ligand scaffold. Other advantages of these ligands are that 
they are solid, stable to air and other oxidizing agents and are, therefore, easy to handle 
and can be manipulated and stored in air. In a simple two or four step-procedure, 
several ligand parameters have been easily tuned to maximize the catalyst performance. 
In this paper we also carried out mechanistic investigations by combining in situ NMR 
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